id	sid	tid	token	lemma	pos
dpc-5333	1	1	dermatology	dermatology	NOUN
dpc-5333	1	2	:	:	PUNCT
dpc-5333	1	3	practical	practical	ADJ
dpc-5333	1	4	and	and	CCONJ
dpc-5333	1	5	conceptual	conceptual	ADJ
dpc-5333	1	6	review	review	NOUN
dpc-5333	1	7	|	|	ADV
dpc-5333	1	8	dermatol	dermatol	ADJ
dpc-5333	1	9	pract	pract	NOUN
dpc-5333	1	10	concept	concept	NOUN
dpc-5333	1	11	.	.	PUNCT
dpc-5333	2	1	2025;15(3):5333	2025;15(3):5333	NUM
dpc-5333	2	2	1	1	NUM
dpc-5333	2	3	stem	stem	NOUN
dpc-5333	2	4	cell	cell	NOUN
dpc-5333	2	5	therapy	therapy	NOUN
dpc-5333	2	6	:	:	PUNCT
dpc-5333	2	7	a	a	DET
dpc-5333	2	8	new	new	ADJ
dpc-5333	2	9	approach	approach	NOUN
dpc-5333	2	10	and	and	CCONJ
dpc-5333	2	11	effective	effective	ADJ
dpc-5333	2	12	treatment	treatment	NOUN
dpc-5333	2	13	for	for	ADP
dpc-5333	2	14	psoriasis	psoriasis	NOUN
dpc-5333	2	15	mohamed	mohamed	PROPN
dpc-5333	2	16	j.	j.	PROPN
dpc-5333	2	17	saadh1	saadh1	PROPN
dpc-5333	2	18	,	,	PUNCT
dpc-5333	2	19	hanan	hanan	PROPN
dpc-5333	2	20	hassan	hassan	PROPN
dpc-5333	2	21	ahmed2	ahmed2	PROPN
dpc-5333	2	22	,	,	PUNCT
dpc-5333	2	23	radhwan	radhwan	PROPN
dpc-5333	2	24	abdul	abdul	PROPN
dpc-5333	2	25	kareem3	kareem3	PROPN
dpc-5333	2	26	,	,	PUNCT
dpc-5333	2	27	suhas	suhas	PROPN
dpc-5333	2	28	ballal4	ballal4	PROPN
dpc-5333	2	29	,	,	PUNCT
dpc-5333	2	30	shilpa	shilpa	PROPN
dpc-5333	2	31	sharma5	sharma5	PROPN
dpc-5333	2	32	,	,	PUNCT
dpc-5333	2	33	j.	j.	PROPN
dpc-5333	2	34	guntaj6	guntaj6	PROPN
dpc-5333	2	35	,	,	PUNCT
dpc-5333	2	36	g.	g.	PROPN
dpc-5333	2	37	v.	v.	CCONJ
dpc-5333	2	38	siva	siva	PROPN
dpc-5333	2	39	prasad7	prasad7	PROPN
dpc-5333	2	40	,	,	PUNCT
dpc-5333	2	41	waam	waam	NOUN
dpc-5333	2	42	mohammed	mohammed	PROPN
dpc-5333	2	43	taher8	taher8	PROPN
dpc-5333	2	44	,	,	PUNCT
dpc-5333	2	45	mariem	mariem	ADJ
dpc-5333	2	46	alwan9	alwan9	PROPN
dpc-5333	2	47	,	,	PUNCT
dpc-5333	2	48	mahmood	mahmood	PROPN
dpc-5333	2	49	jasem	jasem	PROPN
dpc-5333	2	50	jawad10	jawad10	PROPN
dpc-5333	2	51	,	,	PUNCT
dpc-5333	2	52	atheer	atheer	PROPN
dpc-5333	2	53	khdyair	khdyair	ADJ
dpc-5333	2	54	hamad11	hamad11	NOUN
dpc-5333	2	55	1	1	NUM
dpc-5333	2	56	faculty	faculty	NOUN
dpc-5333	2	57	of	of	ADP
dpc-5333	2	58	pharmacy	pharmacy	NOUN
dpc-5333	2	59	,	,	PUNCT
dpc-5333	2	60	middle	middle	PROPN
dpc-5333	2	61	east	east	PROPN
dpc-5333	2	62	university	university	PROPN
dpc-5333	2	63	,	,	PUNCT
dpc-5333	2	64	amman	amman	PROPN
dpc-5333	2	65	,	,	PUNCT
dpc-5333	2	66	jordan	jordan	PROPN
dpc-5333	2	67	2	2	NUM
dpc-5333	2	68	college	college	NOUN
dpc-5333	2	69	of	of	ADP
dpc-5333	2	70	pharmacy	pharmacy	NOUN
dpc-5333	2	71	,	,	PUNCT
dpc-5333	2	72	alnoor	alnoor	PROPN
dpc-5333	2	73	university	university	PROPN
dpc-5333	2	74	,	,	PUNCT
dpc-5333	2	75	nineveh	nineveh	PROPN
dpc-5333	2	76	,	,	PUNCT
dpc-5333	2	77	iraq	iraq	PROPN
dpc-5333	2	78	3	3	NUM
dpc-5333	2	79	ahl	ahl	PROPN
dpc-5333	2	80	al	al	PROPN
dpc-5333	2	81	bayt	bayt	VERB
dpc-5333	2	82	university	university	NOUN
dpc-5333	2	83	,	,	PUNCT
dpc-5333	2	84	kerbala	kerbala	PROPN
dpc-5333	2	85	,	,	PUNCT
dpc-5333	2	86	iraq	iraq	PROPN
dpc-5333	2	87	4	4	NUM
dpc-5333	2	88	department	department	NOUN
dpc-5333	2	89	of	of	ADP
dpc-5333	2	90	chemistry	chemistry	NOUN
dpc-5333	2	91	and	and	CCONJ
dpc-5333	2	92	biochemistry	biochemistry	NOUN
dpc-5333	2	93	,	,	PUNCT
dpc-5333	2	94	school	school	NOUN
dpc-5333	2	95	of	of	ADP
dpc-5333	2	96	sciences	science	NOUN
dpc-5333	2	97	,	,	PUNCT
dpc-5333	2	98	jain	jain	NOUN
dpc-5333	2	99	(	(	PUNCT
dpc-5333	2	100	deemed	deem	VERB
dpc-5333	2	101	to	to	PART
dpc-5333	2	102	be	be	AUX
dpc-5333	2	103	university	university	NOUN
dpc-5333	2	104	)	)	PUNCT
dpc-5333	2	105	,	,	PUNCT
dpc-5333	2	106	bangalore	bangalore	NOUN
dpc-5333	2	107	,	,	PUNCT
dpc-5333	2	108	karnataka	karnataka	PROPN
dpc-5333	2	109	,	,	PUNCT
dpc-5333	2	110	india	india	PROPN
dpc-5333	2	111	5	5	NUM
dpc-5333	2	112	chandigarh	chandigarh	NOUN
dpc-5333	2	113	pharmacy	pharmacy	NOUN
dpc-5333	2	114	college	college	NOUN
dpc-5333	2	115	,	,	PUNCT
dpc-5333	2	116	chandigarh	chandigarh	NOUN
dpc-5333	2	117	group	group	NOUN
dpc-5333	2	118	of	of	ADP
dpc-5333	2	119	colleges	college	NOUN
dpc-5333	2	120	-	-	PUNCT
dpc-5333	2	121	jhanjeri	jhanjeri	NOUN
dpc-5333	2	122	,	,	PUNCT
dpc-5333	2	123	mohali	mohali	PROPN
dpc-5333	2	124	,	,	PUNCT
dpc-5333	2	125	punjab	punjab	PROPN
dpc-5333	2	126	,	,	PUNCT
dpc-5333	2	127	india	india	PROPN
dpc-5333	2	128	6	6	NUM
dpc-5333	2	129	centre	centre	NOUN
dpc-5333	2	130	for	for	ADP
dpc-5333	2	131	research	research	NOUN
dpc-5333	2	132	impact	impact	NOUN
dpc-5333	2	133	&	&	CCONJ
dpc-5333	2	134	outcome	outcome	PROPN
dpc-5333	2	135	,	,	PUNCT
dpc-5333	2	136	chitkara	chitkara	PROPN
dpc-5333	2	137	university	university	PROPN
dpc-5333	2	138	institute	institute	NOUN
dpc-5333	2	139	of	of	ADP
dpc-5333	2	140	engineering	engineering	NOUN
dpc-5333	2	141	and	and	CCONJ
dpc-5333	2	142	technology	technology	NOUN
dpc-5333	2	143	,	,	PUNCT
dpc-5333	2	144	chitkara	chitkara	ADJ
dpc-5333	2	145	university	university	NOUN
dpc-5333	2	146	,	,	PUNCT
dpc-5333	2	147	rajpura	rajpura	NOUN
dpc-5333	2	148	,	,	PUNCT
dpc-5333	2	149	punjab	punjab	PROPN
dpc-5333	2	150	,	,	PUNCT
dpc-5333	2	151	india	india	PROPN
dpc-5333	2	152	7	7	NUM
dpc-5333	2	153	department	department	NOUN
dpc-5333	2	154	of	of	ADP
dpc-5333	2	155	basic	basic	ADJ
dpc-5333	2	156	sciences	science	NOUN
dpc-5333	2	157	and	and	CCONJ
dpc-5333	2	158	humanities	humanity	NOUN
dpc-5333	2	159	,	,	PUNCT
dpc-5333	2	160	raghu	raghu	PROPN
dpc-5333	2	161	engineering	engineering	PROPN
dpc-5333	2	162	college	college	PROPN
dpc-5333	2	163	,	,	PUNCT
dpc-5333	2	164	visakhapatnam	visakhapatnam	PROPN
dpc-5333	2	165	,	,	PUNCT
dpc-5333	2	166	andhra	andhra	PROPN
dpc-5333	2	167	pradesh	pradesh	PROPN
dpc-5333	2	168	,	,	PUNCT
dpc-5333	2	169	india	india	PROPN
dpc-5333	2	170	8	8	NUM
dpc-5333	2	171	college	college	NOUN
dpc-5333	2	172	of	of	ADP
dpc-5333	2	173	nursing	nursing	NOUN
dpc-5333	2	174	,	,	PUNCT
dpc-5333	2	175	national	national	ADJ
dpc-5333	2	176	university	university	PROPN
dpc-5333	2	177	of	of	ADP
dpc-5333	2	178	science	science	NOUN
dpc-5333	2	179	and	and	CCONJ
dpc-5333	2	180	technology	technology	NOUN
dpc-5333	2	181	,	,	PUNCT
dpc-5333	2	182	dhi	dhi	PROPN
dpc-5333	2	183	qar	qar	PROPN
dpc-5333	2	184	,	,	PUNCT
dpc-5333	2	185	iraq	iraq	PROPN
dpc-5333	2	186	9	9	NUM
dpc-5333	2	187	pharmacy	pharmacy	NOUN
dpc-5333	2	188	college	college	NOUN
dpc-5333	2	189	,	,	PUNCT
dpc-5333	2	190	al	al	PROPN
dpc-5333	2	191	-	-	PUNCT
dpc-5333	2	192	farahidi	farahidi	PROPN
dpc-5333	2	193	university	university	NOUN
dpc-5333	2	194	,	,	PUNCT
dpc-5333	2	195	iraq	iraq	PROPN
dpc-5333	2	196	10	10	NUM
dpc-5333	2	197	department	department	NOUN
dpc-5333	2	198	of	of	ADP
dpc-5333	2	199	pharmacy	pharmacy	NOUN
dpc-5333	2	200	,	,	PUNCT
dpc-5333	2	201	al	al	PROPN
dpc-5333	2	202	-	-	PUNCT
dpc-5333	2	203	zahrawi	zahrawi	PROPN
dpc-5333	2	204	university	university	PROPN
dpc-5333	2	205	college	college	NOUN
dpc-5333	2	206	,	,	PUNCT
dpc-5333	2	207	karbala	karbala	PROPN
dpc-5333	2	208	,	,	PUNCT
dpc-5333	2	209	iraq	iraq	PROPN
dpc-5333	2	210	11	11	NUM
dpc-5333	2	211	gilgamesh	gilgamesh	PROPN
dpc-5333	2	212	ahliya	ahliya	PROPN
dpc-5333	2	213	university	university	PROPN
dpc-5333	2	214	,	,	PUNCT
dpc-5333	2	215	baghdad	baghdad	PROPN
dpc-5333	2	216	,	,	PUNCT
dpc-5333	2	217	iraq	iraq	PROPN
dpc-5333	2	218	key	key	ADJ
dpc-5333	2	219	words	word	NOUN
dpc-5333	2	220	:	:	PUNCT
dpc-5333	2	221	psoriasis	psoriasis	NOUN
dpc-5333	2	222	,	,	PUNCT
dpc-5333	2	223	stem	stem	NOUN
dpc-5333	2	224	cell	cell	NOUN
dpc-5333	2	225	therapy	therapy	NOUN
dpc-5333	2	226	,	,	PUNCT
dpc-5333	2	227	interleukin	interleukin	NOUN
dpc-5333	2	228	,	,	PUNCT
dpc-5333	2	229	regenerative	regenerative	ADJ
dpc-5333	2	230	medicine	medicine	NOUN
dpc-5333	2	231	,	,	PUNCT
dpc-5333	2	232	immune	immune	ADJ
dpc-5333	2	233	modulation	modulation	NOUN
dpc-5333	2	234	citation	citation	NOUN
dpc-5333	2	235	:	:	PUNCT
dpc-5333	2	236	saadh	saadh	PROPN
dpc-5333	2	237	mj	mj	PROPN
dpc-5333	2	238	,	,	PUNCT
dpc-5333	2	239	ahmed	ahmed	PROPN
dpc-5333	2	240	hh	hh	PROPN
dpc-5333	2	241	,	,	PUNCT
dpc-5333	2	242	kareem	kareem	PROPN
dpc-5333	2	243	ra	ra	PROPN
dpc-5333	2	244	,	,	PUNCT
dpc-5333	2	245	et	et	PROPN
dpc-5333	2	246	al	al	PROPN
dpc-5333	2	247	.	.	PROPN
dpc-5333	3	1	stem	stem	NOUN
dpc-5333	3	2	cell	cell	NOUN
dpc-5333	3	3	therapy	therapy	NOUN
dpc-5333	3	4	:	:	PUNCT
dpc-5333	3	5	a	a	DET
dpc-5333	3	6	new	new	ADJ
dpc-5333	3	7	approach	approach	NOUN
dpc-5333	3	8	and	and	CCONJ
dpc-5333	3	9	effective	effective	ADJ
dpc-5333	3	10	treatment	treatment	NOUN
dpc-5333	3	11	for	for	ADP
dpc-5333	3	12	psoriasis	psoriasis	NOUN
dpc-5333	3	13	.	.	PUNCT
dpc-5333	4	1	dermatol	dermatol	NOUN
dpc-5333	4	2	pract	pract	PROPN
dpc-5333	4	3	concept	concept	NOUN
dpc-5333	4	4	.	.	PUNCT
dpc-5333	5	1	2025;15(3):5333	2025;15(3):5333	NUM
dpc-5333	5	2	.	.	PUNCT
dpc-5333	6	1	doi	doi	NOUN
dpc-5333	6	2	:	:	PUNCT
dpc-5333	6	3	https://doi.org/10.5826/dpc.1503a5333	https://doi.org/10.5826/dpc.1503a5333	NOUN
dpc-5333	6	4	accepted	accept	VERB
dpc-5333	6	5	:	:	PUNCT
dpc-5333	6	6	february	february	PROPN
dpc-5333	6	7	23	23	NUM
dpc-5333	6	8	,	,	PUNCT
dpc-5333	6	9	2025	2025	NUM
dpc-5333	6	10	;	;	PUNCT
dpc-5333	6	11	published	publish	VERB
dpc-5333	6	12	:	:	PUNCT
dpc-5333	6	13	july	july	PROPN
dpc-5333	6	14	2025	2025	NUM
dpc-5333	6	15	copyright	copyright	NOUN
dpc-5333	6	16	:	:	PUNCT
dpc-5333	6	17	©	©	PROPN
dpc-5333	6	18	2025	2025	NUM
dpc-5333	6	19	saadh	saadh	NOUN
dpc-5333	6	20	et	et	PROPN
dpc-5333	6	21	al	al	PROPN
dpc-5333	6	22	.	.	PUNCT
dpc-5333	7	1	this	this	PRON
dpc-5333	7	2	is	be	AUX
dpc-5333	7	3	an	an	DET
dpc-5333	7	4	open	open	ADJ
dpc-5333	7	5	-	-	PUNCT
dpc-5333	7	6	access	access	NOUN
dpc-5333	7	7	article	article	NOUN
dpc-5333	7	8	distributed	distribute	VERB
dpc-5333	7	9	under	under	ADP
dpc-5333	7	10	the	the	DET
dpc-5333	7	11	terms	term	NOUN
dpc-5333	7	12	of	of	ADP
dpc-5333	7	13	the	the	DET
dpc-5333	7	14	creative	creative	ADJ
dpc-5333	7	15	commons	common	NOUN
dpc-5333	7	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-5333	7	17	license	license	NOUN
dpc-5333	7	18	(	(	PUNCT
dpc-5333	7	19	by	by	ADP
dpc-5333	7	20	-	-	PUNCT
dpc-5333	7	21	nc-4.0	nc-4.0	NOUN
dpc-5333	7	22	)	)	PUNCT
dpc-5333	7	23	,	,	PUNCT
dpc-5333	7	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-5333	7	25	,	,	PUNCT
dpc-5333	7	26	which	which	PRON
dpc-5333	7	27	permits	permit	VERB
dpc-5333	7	28	unrestricted	unrestricted	ADJ
dpc-5333	7	29	noncommercial	noncommercial	ADJ
dpc-5333	7	30	use	use	NOUN
dpc-5333	7	31	,	,	PUNCT
dpc-5333	7	32	distribution	distribution	NOUN
dpc-5333	7	33	,	,	PUNCT
dpc-5333	7	34	and	and	CCONJ
dpc-5333	7	35	reproduction	reproduction	NOUN
dpc-5333	7	36	in	in	ADP
dpc-5333	7	37	any	any	DET
dpc-5333	7	38	medium	medium	NOUN
dpc-5333	7	39	,	,	PUNCT
dpc-5333	7	40	provided	provide	VERB
dpc-5333	7	41	the	the	DET
dpc-5333	7	42	original	original	ADJ
dpc-5333	7	43	authors	author	NOUN
dpc-5333	7	44	and	and	CCONJ
dpc-5333	7	45	source	source	NOUN
dpc-5333	7	46	are	be	AUX
dpc-5333	7	47	credited	credit	VERB
dpc-5333	7	48	.	.	PUNCT
dpc-5333	8	1	funding	funding	NOUN
dpc-5333	8	2	:	:	PUNCT
dpc-5333	8	3	none	none	NOUN
dpc-5333	8	4	.	.	PUNCT
dpc-5333	9	1	competing	compete	VERB
dpc-5333	9	2	interests	interest	NOUN
dpc-5333	9	3	:	:	PUNCT
dpc-5333	9	4	none	none	NOUN
dpc-5333	9	5	.	.	PUNCT
dpc-5333	10	1	authorship	authorship	NOUN
dpc-5333	10	2	:	:	PUNCT
dpc-5333	10	3	all	all	DET
dpc-5333	10	4	authors	author	NOUN
dpc-5333	10	5	have	have	AUX
dpc-5333	10	6	contributed	contribute	VERB
dpc-5333	10	7	significantly	significantly	ADV
dpc-5333	10	8	to	to	ADP
dpc-5333	10	9	this	this	DET
dpc-5333	10	10	publication	publication	NOUN
dpc-5333	10	11	.	.	PUNCT
dpc-5333	11	1	authors	author	NOUN
dpc-5333	11	2	are	be	AUX
dpc-5333	11	3	grateful	grateful	ADJ
dpc-5333	11	4	to	to	ADP
dpc-5333	11	5	the	the	DET
dpc-5333	11	6	researchers	researcher	NOUN
dpc-5333	11	7	supporting	support	VERB
dpc-5333	11	8	project	project	NOUN
dpc-5333	11	9	(	(	PUNCT
dpc-5333	11	10	anui2024m111	anui2024m111	PROPN
dpc-5333	11	11	)	)	PUNCT
dpc-5333	11	12	,	,	PUNCT
dpc-5333	11	13	alnoor	alnoor	PROPN
dpc-5333	11	14	university	university	PROPN
dpc-5333	11	15	,	,	PUNCT
dpc-5333	11	16	mosul	mosul	PROPN
dpc-5333	11	17	,	,	PUNCT
dpc-5333	11	18	iraq	iraq	PROPN
dpc-5333	11	19	.	.	PUNCT
dpc-5333	12	1	corresponding	correspond	VERB
dpc-5333	12	2	author	author	NOUN
dpc-5333	12	3	:	:	PUNCT
dpc-5333	12	4	hanan	hanan	PROPN
dpc-5333	12	5	hassan	hassan	PROPN
dpc-5333	12	6	ahmed	ahmed	PROPN
dpc-5333	12	7	,	,	PUNCT
dpc-5333	12	8	college	college	NOUN
dpc-5333	12	9	of	of	ADP
dpc-5333	12	10	pharmacy	pharmacy	NOUN
dpc-5333	12	11	,	,	PUNCT
dpc-5333	12	12	alnoor	alnoor	PROPN
dpc-5333	12	13	university	university	PROPN
dpc-5333	12	14	,	,	PUNCT
dpc-5333	12	15	nineveh	nineveh	PROPN
dpc-5333	12	16	,	,	PUNCT
dpc-5333	12	17	iraq	iraq	PROPN
dpc-5333	12	18	.	.	PUNCT
dpc-5333	13	1	e	e	X
dpc-5333	13	2	-	-	NOUN
dpc-5333	13	3	mail	mail	NOUN
dpc-5333	13	4	:	:	PUNCT
dpc-5333	13	5	hanan.hasan@alnoor.edu.iq	hanan.hasan@alnoor.edu.iq	ADJ
dpc-5333	13	6	introduction	introduction	NOUN
dpc-5333	13	7	:	:	PUNCT
dpc-5333	13	8	the	the	DET
dpc-5333	13	9	underlying	underlying	ADJ
dpc-5333	13	10	mechanisms	mechanism	NOUN
dpc-5333	13	11	behind	behind	ADP
dpc-5333	13	12	the	the	DET
dpc-5333	13	13	development	development	NOUN
dpc-5333	13	14	of	of	ADP
dpc-5333	13	15	psoriasis	psoriasis	NOUN
dpc-5333	13	16	have	have	AUX
dpc-5333	13	17	become	become	AUX
dpc-5333	13	18	better	well	ADV
dpc-5333	13	19	understood	understand	VERB
dpc-5333	13	20	in	in	ADP
dpc-5333	13	21	recent	recent	ADJ
dpc-5333	13	22	years	year	NOUN
dpc-5333	13	23	.	.	PUNCT
dpc-5333	14	1	key	key	ADJ
dpc-5333	14	2	factors	factor	NOUN
dpc-5333	14	3	involved	involve	VERB
dpc-5333	14	4	include	include	VERB
dpc-5333	14	5	the	the	DET
dpc-5333	14	6	heightened	heighten	VERB
dpc-5333	14	7	reactivity	reactivity	NOUN
dpc-5333	14	8	of	of	ADP
dpc-5333	14	9	certain	certain	ADJ
dpc-5333	14	10	t	t	NOUN
dpc-5333	14	11	cell	cell	NOUN
dpc-5333	14	12	subsets	subset	NOUN
dpc-5333	14	13	(	(	PUNCT
dpc-5333	14	14	th1	th1	NOUN
dpc-5333	14	15	and	and	CCONJ
dpc-5333	14	16	th17	th17	PROPN
dpc-5333	14	17	cells	cell	NOUN
dpc-5333	14	18	)	)	PUNCT
dpc-5333	14	19	as	as	ADV
dpc-5333	14	20	well	well	ADV
dpc-5333	14	21	as	as	ADP
dpc-5333	14	22	dysregulation	dysregulation	NOUN
dpc-5333	14	23	of	of	ADP
dpc-5333	14	24	regulatory	regulatory	ADJ
dpc-5333	14	25	t	t	NOUN
dpc-5333	14	26	cell	cell	NOUN
dpc-5333	14	27	(	(	PUNCT
dpc-5333	14	28	t	t	NOUN
dpc-5333	14	29	-	-	PUNCT
dpc-5333	14	30	reg	reg	NOUN
dpc-5333	14	31	)	)	PUNCT
dpc-5333	14	32	function	function	NOUN
dpc-5333	14	33	.	.	PUNCT
dpc-5333	15	1	additionally	additionally	ADV
dpc-5333	15	2	,	,	PUNCT
dpc-5333	15	3	the	the	DET
dpc-5333	15	4	complex	complex	ADJ
dpc-5333	15	5	interplay	interplay	NOUN
dpc-5333	15	6	between	between	ADP
dpc-5333	15	7	immune	immune	ADJ
dpc-5333	15	8	cells	cell	NOUN
dpc-5333	15	9	,	,	PUNCT
dpc-5333	15	10	skin	skin	NOUN
dpc-5333	15	11	cells	cell	NOUN
dpc-5333	15	12	(	(	PUNCT
dpc-5333	15	13	keratinocytes	keratinocyte	NOUN
dpc-5333	15	14	)	)	PUNCT
dpc-5333	15	15	,	,	PUNCT
dpc-5333	15	16	and	and	CCONJ
dpc-5333	15	17	the	the	DET
dpc-5333	15	18	blood	blood	NOUN
dpc-5333	15	19	vessel	vessel	NOUN
dpc-5333	15	20	endothelium	endothelium	NOUN
dpc-5333	15	21	has	have	AUX
dpc-5333	15	22	been	be	AUX
dpc-5333	15	23	shown	show	VERB
dpc-5333	15	24	to	to	PART
dpc-5333	15	25	play	play	VERB
dpc-5333	15	26	an	an	DET
dpc-5333	15	27	important	important	ADJ
dpc-5333	15	28	role	role	NOUN
dpc-5333	15	29	in	in	ADP
dpc-5333	15	30	the	the	DET
dpc-5333	15	31	pathogenesis	pathogenesis	NOUN
dpc-5333	15	32	of	of	ADP
dpc-5333	15	33	psoriasis	psoriasis	NOUN
dpc-5333	15	34	.	.	PUNCT
dpc-5333	16	1	objectives	objective	NOUN
dpc-5333	16	2	:	:	PUNCT
dpc-5333	16	3	a	a	DET
dpc-5333	16	4	more	more	ADV
dpc-5333	16	5	thorough	thorough	ADJ
dpc-5333	16	6	investigation	investigation	NOUN
dpc-5333	16	7	of	of	ADP
dpc-5333	16	8	these	these	DET
dpc-5333	16	9	mechanisms	mechanism	NOUN
dpc-5333	16	10	could	could	AUX
dpc-5333	16	11	present	present	VERB
dpc-5333	16	12	an	an	DET
dpc-5333	16	13	opportunity	opportunity	NOUN
dpc-5333	16	14	to	to	PART
dpc-5333	16	15	devise	devise	VERB
dpc-5333	16	16	novel	novel	ADJ
dpc-5333	16	17	therapeutic	therapeutic	ADJ
dpc-5333	16	18	approaches	approach	NOUN
dpc-5333	16	19	.	.	PUNCT
dpc-5333	17	1	methods	method	NOUN
dpc-5333	17	2	:	:	PUNCT
dpc-5333	17	3	in	in	ADP
dpc-5333	17	4	this	this	DET
dpc-5333	17	5	study	study	NOUN
dpc-5333	17	6	,	,	PUNCT
dpc-5333	17	7	we	we	PRON
dpc-5333	17	8	reviewed	review	VERB
dpc-5333	17	9	the	the	DET
dpc-5333	17	10	evidence	evidence	NOUN
dpc-5333	17	11	regarding	regard	VERB
dpc-5333	17	12	the	the	DET
dpc-5333	17	13	role	role	NOUN
dpc-5333	17	14	played	play	VERB
dpc-5333	17	15	by	by	ADP
dpc-5333	17	16	stem	stem	NOUN
dpc-5333	17	17	cells	cell	NOUN
dpc-5333	17	18	in	in	ADP
dpc-5333	17	19	the	the	DET
dpc-5333	17	20	pathogenesis	pathogenesis	NOUN
dpc-5333	17	21	of	of	ADP
dpc-5333	17	22	psoriasis	psoriasis	NOUN
dpc-5333	17	23	as	as	ADV
dpc-5333	17	24	well	well	ADV
dpc-5333	17	25	as	as	ADP
dpc-5333	17	26	initial	initial	ADJ
dpc-5333	17	27	attempts	attempt	NOUN
dpc-5333	17	28	at	at	ADP
dpc-5333	17	29	leveraging	leverage	VERB
dpc-5333	17	30	stem	stem	NOUN
dpc-5333	17	31	cells	cell	NOUN
dpc-5333	17	32	as	as	ADP
dpc-5333	17	33	a	a	DET
dpc-5333	17	34	treatment	treatment	NOUN
dpc-5333	17	35	modality	modality	NOUN
dpc-5333	17	36	.	.	PUNCT
dpc-5333	18	1	abstract	abstract	ADJ
dpc-5333	18	2	2	2	NUM
dpc-5333	18	3	review	review	NOUN
dpc-5333	18	4	|	|	ADV
dpc-5333	18	5	dermatol	dermatol	ADJ
dpc-5333	18	6	pract	pract	NOUN
dpc-5333	18	7	concept	concept	NOUN
dpc-5333	18	8	.	.	PUNCT
dpc-5333	19	1	2025;15(3):5333	2025;15(3):5333	NUM
dpc-5333	19	2	introduction	introduction	NOUN
dpc-5333	19	3	more	more	ADJ
dpc-5333	19	4	than	than	ADP
dpc-5333	19	5	125	125	NUM
dpc-5333	19	6	million	million	NUM
dpc-5333	19	7	people	people	NOUN
dpc-5333	19	8	worldwide	worldwide	ADV
dpc-5333	19	9	suffer	suffer	VERB
dpc-5333	19	10	from	from	ADP
dpc-5333	19	11	the	the	DET
dpc-5333	19	12	chronic	chronic	ADJ
dpc-5333	19	13	condition	condition	NOUN
dpc-5333	19	14	of	of	ADP
dpc-5333	19	15	psoriasis	psoriasis	NOUN
dpc-5333	19	16	,	,	PUNCT
dpc-5333	19	17	and	and	CCONJ
dpc-5333	19	18	data	datum	NOUN
dpc-5333	19	19	suggest	suggest	VERB
dpc-5333	19	20	that	that	SCONJ
dpc-5333	19	21	this	this	DET
dpc-5333	19	22	number	number	NOUN
dpc-5333	19	23	has	have	AUX
dpc-5333	19	24	been	be	AUX
dpc-5333	19	25	increasing	increase	VERB
dpc-5333	19	26	over	over	ADP
dpc-5333	19	27	time	time	NOUN
dpc-5333	19	28	[	[	X
dpc-5333	19	29	1,2	1,2	NUM
dpc-5333	19	30	]	]	PUNCT
dpc-5333	19	31	.	.	PUNCT
dpc-5333	20	1	psoriasis	psoriasis	NOUN
dpc-5333	20	2	is	be	AUX
dpc-5333	20	3	a	a	DET
dpc-5333	20	4	systemic	systemic	ADJ
dpc-5333	20	5	inflammatory	inflammatory	ADJ
dpc-5333	20	6	process	process	NOUN
dpc-5333	20	7	that	that	PRON
dpc-5333	20	8	increases	increase	VERB
dpc-5333	20	9	the	the	DET
dpc-5333	20	10	risk	risk	NOUN
dpc-5333	20	11	of	of	ADP
dpc-5333	20	12	metabolic	metabolic	NOUN
dpc-5333	20	13	disorders	disorder	NOUN
dpc-5333	20	14	,	,	PUNCT
dpc-5333	20	15	including	include	VERB
dpc-5333	20	16	insulin	insulin	NOUN
dpc-5333	20	17	resistance	resistance	NOUN
dpc-5333	20	18	,	,	PUNCT
dpc-5333	20	19	unhealthy	unhealthy	ADJ
dpc-5333	20	20	cholesterol	cholesterol	NOUN
dpc-5333	20	21	levels	level	NOUN
dpc-5333	20	22	,	,	PUNCT
dpc-5333	20	23	high	high	ADJ
dpc-5333	20	24	blood	blood	NOUN
dpc-5333	20	25	pressure	pressure	NOUN
dpc-5333	20	26	,	,	PUNCT
dpc-5333	20	27	and	and	CCONJ
dpc-5333	20	28	cardiovascular	cardiovascular	ADJ
dpc-5333	20	29	disease	disease	NOUN
dpc-5333	20	30	,	,	PUNCT
dpc-5333	20	31	by	by	ADP
dpc-5333	20	32	about	about	ADV
dpc-5333	20	33	two	two	NUM
dpc-5333	20	34	times	time	NOUN
dpc-5333	20	35	the	the	DET
dpc-5333	20	36	normal	normal	ADJ
dpc-5333	20	37	population	population	NOUN
dpc-5333	20	38	rate	rate	NOUN
dpc-5333	20	39	.	.	PUNCT
dpc-5333	21	1	consequently	consequently	ADV
dpc-5333	21	2	,	,	PUNCT
dpc-5333	21	3	this	this	PRON
dpc-5333	21	4	heightens	heighten	VERB
dpc-5333	21	5	the	the	DET
dpc-5333	21	6	risk	risk	NOUN
dpc-5333	21	7	of	of	ADP
dpc-5333	21	8	premature	premature	ADJ
dpc-5333	21	9	mortality	mortality	NOUN
dpc-5333	21	10	[	[	X
dpc-5333	21	11	3	3	NUM
dpc-5333	21	12	]	]	PUNCT
dpc-5333	21	13	.	.	PUNCT
dpc-5333	22	1	furthermore	furthermore	ADV
dpc-5333	22	2	,	,	PUNCT
dpc-5333	22	3	this	this	DET
dpc-5333	22	4	condition	condition	NOUN
dpc-5333	22	5	diminishes	diminish	VERB
dpc-5333	22	6	the	the	DET
dpc-5333	22	7	quality	quality	NOUN
dpc-5333	22	8	of	of	ADP
dpc-5333	22	9	life	life	NOUN
dpc-5333	22	10	for	for	ADP
dpc-5333	22	11	affected	affect	VERB
dpc-5333	22	12	individuals	individual	NOUN
dpc-5333	22	13	and	and	CCONJ
dpc-5333	22	14	results	result	NOUN
dpc-5333	22	15	in	in	ADP
dpc-5333	22	16	retreat	retreat	NOUN
dpc-5333	22	17	from	from	ADP
dpc-5333	22	18	communal	communal	ADJ
dpc-5333	22	19	life	life	NOUN
dpc-5333	22	20	and	and	CCONJ
dpc-5333	22	21	the	the	DET
dpc-5333	22	22	emergence	emergence	NOUN
dpc-5333	22	23	of	of	ADP
dpc-5333	22	24	mood	mood	NOUN
dpc-5333	22	25	disorder	disorder	NOUN
dpc-5333	22	26	.	.	PUNCT
dpc-5333	23	1	research	research	NOUN
dpc-5333	23	2	has	have	AUX
dpc-5333	23	3	shown	show	VERB
dpc-5333	23	4	that	that	SCONJ
dpc-5333	23	5	patients	patient	NOUN
dpc-5333	23	6	suffering	suffer	VERB
dpc-5333	23	7	from	from	ADP
dpc-5333	23	8	psoriasis	psoriasis	NOUN
dpc-5333	23	9	exhibit	exhibit	VERB
dpc-5333	23	10	a	a	DET
dpc-5333	23	11	markedly	markedly	ADV
dpc-5333	23	12	elevated	elevate	VERB
dpc-5333	23	13	probability	probability	NOUN
dpc-5333	23	14	of	of	ADP
dpc-5333	23	15	harboring	harbor	VERB
dpc-5333	23	16	suicidal	suicidal	ADJ
dpc-5333	23	17	thoughts	thought	NOUN
dpc-5333	23	18	,	,	PUNCT
dpc-5333	23	19	making	make	VERB
dpc-5333	23	20	suicide	suicide	NOUN
dpc-5333	23	21	attempts	attempt	NOUN
dpc-5333	23	22	,	,	PUNCT
dpc-5333	23	23	and	and	CCONJ
dpc-5333	23	24	,	,	PUNCT
dpc-5333	23	25	tragically	tragically	ADV
dpc-5333	23	26	,	,	PUNCT
dpc-5333	23	27	completing	complete	VERB
dpc-5333	23	28	suicide	suicide	NOUN
dpc-5333	23	29	[	[	X
dpc-5333	23	30	4	4	NUM
dpc-5333	23	31	]	]	PUNCT
dpc-5333	23	32	.	.	PUNCT
dpc-5333	24	1	this	this	DET
dpc-5333	24	2	dermatological	dermatological	ADJ
dpc-5333	24	3	condition	condition	NOUN
dpc-5333	24	4	represents	represent	VERB
dpc-5333	24	5	a	a	DET
dpc-5333	24	6	grave	grave	ADJ
dpc-5333	24	7	economic	economic	ADJ
dpc-5333	24	8	and	and	CCONJ
dpc-5333	24	9	societal	societal	ADJ
dpc-5333	24	10	burden	burden	NOUN
dpc-5333	24	11	,	,	PUNCT
dpc-5333	24	12	taxing	tax	VERB
dpc-5333	24	13	not	not	PART
dpc-5333	24	14	merely	merely	ADV
dpc-5333	24	15	the	the	DET
dpc-5333	24	16	individuals	individual	NOUN
dpc-5333	24	17	suffering	suffer	VERB
dpc-5333	24	18	from	from	ADP
dpc-5333	24	19	it	it	PRON
dpc-5333	24	20	but	but	CCONJ
dpc-5333	24	21	also	also	ADV
dpc-5333	24	22	the	the	DET
dpc-5333	24	23	medical	medical	ADJ
dpc-5333	24	24	infrastructure	infrastructure	NOUN
dpc-5333	24	25	responsible	responsible	ADJ
dpc-5333	24	26	for	for	ADP
dpc-5333	24	27	their	their	PRON
dpc-5333	24	28	treatment	treatment	NOUN
dpc-5333	24	29	[	[	X
dpc-5333	24	30	5	5	NUM
dpc-5333	24	31	]	]	PUNCT
dpc-5333	24	32	.	.	PUNCT
dpc-5333	25	1	although	although	SCONJ
dpc-5333	25	2	recent	recent	ADJ
dpc-5333	25	3	years	year	NOUN
dpc-5333	25	4	have	have	AUX
dpc-5333	25	5	seen	see	VERB
dpc-5333	25	6	considerable	considerable	ADJ
dpc-5333	25	7	progress	progress	NOUN
dpc-5333	25	8	in	in	ADP
dpc-5333	25	9	discovering	discover	VERB
dpc-5333	25	10	the	the	DET
dpc-5333	25	11	mechanisms	mechanism	NOUN
dpc-5333	25	12	of	of	ADP
dpc-5333	25	13	psoriasis	psoriasis	NOUN
dpc-5333	25	14	pathogenesis	pathogenesis	NOUN
dpc-5333	25	15	,	,	PUNCT
dpc-5333	25	16	its	its	PRON
dpc-5333	25	17	full	full	ADJ
dpc-5333	25	18	elucidation	elucidation	NOUN
dpc-5333	25	19	is	be	AUX
dpc-5333	25	20	still	still	ADV
dpc-5333	25	21	a	a	DET
dpc-5333	25	22	long	long	ADJ
dpc-5333	25	23	way	way	NOUN
dpc-5333	25	24	away	away	ADV
dpc-5333	25	25	.	.	PUNCT
dpc-5333	26	1	hyperreactivity	hyperreactivity	NOUN
dpc-5333	26	2	of	of	ADP
dpc-5333	26	3	th1	th1	PROPN
dpc-5333	26	4	,	,	PUNCT
dpc-5333	26	5	th17	th17	PROPN
dpc-5333	26	6	,	,	PUNCT
dpc-5333	26	7	dysregulation	dysregulation	NOUN
dpc-5333	26	8	of	of	ADP
dpc-5333	26	9	regulatory	regulatory	ADJ
dpc-5333	26	10	t	t	NOUN
dpc-5333	26	11	cells	cell	NOUN
dpc-5333	26	12	(	(	PUNCT
dpc-5333	26	13	tregs	treg	NOUN
dpc-5333	26	14	)	)	PUNCT
dpc-5333	26	15	,	,	PUNCT
dpc-5333	26	16	and	and	CCONJ
dpc-5333	26	17	the	the	DET
dpc-5333	26	18	complex	complex	ADJ
dpc-5333	26	19	relationships	relationship	NOUN
dpc-5333	26	20	between	between	ADP
dpc-5333	26	21	immune	immune	ADJ
dpc-5333	26	22	system	system	NOUN
dpc-5333	26	23	cells	cell	NOUN
dpc-5333	26	24	and	and	CCONJ
dpc-5333	26	25	keratinocytes	keratinocyte	NOUN
dpc-5333	26	26	and	and	CCONJ
dpc-5333	26	27	vascular	vascular	ADJ
dpc-5333	26	28	endothelium	endothelium	NOUN
dpc-5333	26	29	obviously	obviously	ADV
dpc-5333	26	30	play	play	VERB
dpc-5333	26	31	a	a	DET
dpc-5333	26	32	significant	significant	ADJ
dpc-5333	26	33	role	role	NOUN
dpc-5333	26	34	[	[	X
dpc-5333	26	35	6	6	NUM
dpc-5333	26	36	]	]	PUNCT
dpc-5333	26	37	.	.	PUNCT
dpc-5333	27	1	the	the	DET
dpc-5333	27	2	interleukin	interleukin	NOUN
dpc-5333	27	3	(	(	PUNCT
dpc-5333	27	4	il)-23	il)-23	PROPN
dpc-5333	27	5	/	/	SYM
dpc-5333	27	6	th17	th17	PROPN
dpc-5333	27	7	/	/	SYM
dpc-5333	27	8	il-17	il-17	NUM
dpc-5333	27	9	axis	axis	NOUN
dpc-5333	27	10	and	and	CCONJ
dpc-5333	27	11	th1	th1	PROPN
dpc-5333	27	12	/	/	SYM
dpc-5333	27	13	ifn	ifn	PROPN
dpc-5333	27	14	-	-	PUNCT
dpc-5333	27	15	γ	γ	NOUN
dpc-5333	27	16	axis	axis	NOUN
dpc-5333	27	17	play	play	VERB
dpc-5333	27	18	a	a	DET
dpc-5333	27	19	critical	critical	ADJ
dpc-5333	27	20	role	role	NOUN
dpc-5333	27	21	in	in	ADP
dpc-5333	27	22	psoriasis	psoriasis	NOUN
dpc-5333	27	23	inflammation	inflammation	NOUN
dpc-5333	27	24	(	(	PUNCT
dpc-5333	27	25	figure	figure	NOUN
dpc-5333	27	26	1	1	NUM
dpc-5333	27	27	)	)	PUNCT
dpc-5333	28	1	[	[	X
dpc-5333	28	2	7	7	NUM
dpc-5333	28	3	]	]	PUNCT
dpc-5333	28	4	.	.	PUNCT
dpc-5333	29	1	the	the	DET
dpc-5333	29	2	effect	effect	NOUN
dpc-5333	29	3	of	of	ADP
dpc-5333	29	4	epidermal	epidermal	ADJ
dpc-5333	29	5	stem	stem	NOUN
dpc-5333	29	6	cells	cell	NOUN
dpc-5333	29	7	and	and	CCONJ
dpc-5333	29	8	stem	stem	NOUN
dpc-5333	29	9	cells	cell	NOUN
dpc-5333	29	10	on	on	ADP
dpc-5333	29	11	t	t	PROPN
dpc-5333	29	12	cells	cell	NOUN
dpc-5333	29	13	is	be	AUX
dpc-5333	29	14	currently	currently	ADV
dpc-5333	29	15	receiving	receive	VERB
dpc-5333	29	16	attention	attention	NOUN
dpc-5333	29	17	.	.	PUNCT
dpc-5333	30	1	therefore	therefore	ADV
dpc-5333	30	2	,	,	PUNCT
dpc-5333	30	3	the	the	DET
dpc-5333	30	4	dysfunction	dysfunction	NOUN
dpc-5333	30	5	of	of	ADP
dpc-5333	30	6	certain	certain	ADJ
dpc-5333	30	7	types	type	NOUN
dpc-5333	30	8	of	of	ADP
dpc-5333	30	9	stem	stem	NOUN
dpc-5333	30	10	cells	cell	NOUN
dpc-5333	30	11	could	could	AUX
dpc-5333	30	12	be	be	AUX
dpc-5333	30	13	the	the	DET
dpc-5333	30	14	root	root	NOUN
dpc-5333	30	15	cause	cause	NOUN
dpc-5333	30	16	of	of	ADP
dpc-5333	30	17	dysregulation	dysregulation	NOUN
dpc-5333	30	18	of	of	ADP
dpc-5333	30	19	the	the	DET
dpc-5333	30	20	inflammatory	inflammatory	ADJ
dpc-5333	30	21	response	response	NOUN
dpc-5333	30	22	in	in	ADP
dpc-5333	30	23	psoriasis	psoriasis	NOUN
dpc-5333	30	24	.	.	PUNCT
dpc-5333	31	1	epidermal	epidermal	ADJ
dpc-5333	31	2	stem	stem	NOUN
dpc-5333	31	3	cells	cell	NOUN
dpc-5333	31	4	epidermal	epidermal	ADJ
dpc-5333	31	5	stem	stem	NOUN
dpc-5333	31	6	cells	cell	NOUN
dpc-5333	31	7	(	(	PUNCT
dpc-5333	31	8	epscs	epsc	NOUN
dpc-5333	31	9	)	)	PUNCT
dpc-5333	31	10	,	,	PUNCT
dpc-5333	31	11	which	which	PRON
dpc-5333	31	12	can	can	AUX
dpc-5333	31	13	replicate	replicate	VERB
dpc-5333	31	14	indefinitely	indefinitely	ADV
dpc-5333	31	15	,	,	PUNCT
dpc-5333	31	16	are	be	AUX
dpc-5333	31	17	unusual	unusual	ADJ
dpc-5333	31	18	cells	cell	NOUN
dpc-5333	31	19	located	locate	VERB
dpc-5333	31	20	in	in	ADP
dpc-5333	31	21	the	the	DET
dpc-5333	31	22	basal	basal	ADJ
dpc-5333	31	23	layer	layer	NOUN
dpc-5333	31	24	of	of	ADP
dpc-5333	31	25	the	the	DET
dpc-5333	31	26	epidermis	epidermis	NOUN
dpc-5333	31	27	.	.	PUNCT
dpc-5333	32	1	when	when	SCONJ
dpc-5333	32	2	prompted	prompt	VERB
dpc-5333	32	3	by	by	ADP
dpc-5333	32	4	a	a	DET
dpc-5333	32	5	signal	signal	NOUN
dpc-5333	32	6	indicating	indicate	VERB
dpc-5333	32	7	growth	growth	NOUN
dpc-5333	32	8	,	,	PUNCT
dpc-5333	32	9	epscs	epsc	NOUN
dpc-5333	32	10	undergo	undergo	VERB
dpc-5333	32	11	an	an	DET
dpc-5333	32	12	asymmetrical	asymmetrical	ADJ
dpc-5333	32	13	division	division	NOUN
dpc-5333	32	14	,	,	PUNCT
dpc-5333	32	15	resulting	result	VERB
dpc-5333	32	16	in	in	ADP
dpc-5333	32	17	two	two	NUM
dpc-5333	32	18	distinct	distinct	ADJ
dpc-5333	32	19	cell	cell	NOUN
dpc-5333	32	20	types	type	NOUN
dpc-5333	32	21	.	.	PUNCT
dpc-5333	33	1	one	one	NUM
dpc-5333	33	2	group	group	NOUN
dpc-5333	33	3	consists	consist	VERB
dpc-5333	33	4	of	of	ADP
dpc-5333	33	5	self	self	NOUN
dpc-5333	33	6	-	-	PUNCT
dpc-5333	33	7	renewing	renew	VERB
dpc-5333	33	8	cells	cell	NOUN
dpc-5333	33	9	that	that	PRON
dpc-5333	33	10	retain	retain	VERB
dpc-5333	33	11	the	the	DET
dpc-5333	33	12	stemness	stemness	ADJ
dpc-5333	33	13	property	property	NOUN
dpc-5333	33	14	,	,	PUNCT
dpc-5333	33	15	while	while	SCONJ
dpc-5333	33	16	the	the	DET
dpc-5333	33	17	other	other	ADJ
dpc-5333	33	18	group	group	NOUN
dpc-5333	33	19	comprises	comprise	VERB
dpc-5333	33	20	transient	transient	VERB
dpc-5333	33	21	amplifying	amplifying	ADJ
dpc-5333	33	22	cells	cell	NOUN
dpc-5333	33	23	(	(	PUNCT
dpc-5333	33	24	ta	ta	ADP
dpc-5333	33	25	cells	cell	NOUN
dpc-5333	33	26	)	)	PUNCT
dpc-5333	33	27	,	,	PUNCT
dpc-5333	33	28	which	which	PRON
dpc-5333	33	29	have	have	AUX
dpc-5333	33	30	limited	limit	VERB
dpc-5333	33	31	proliferative	proliferative	ADJ
dpc-5333	33	32	capacity	capacity	NOUN
dpc-5333	33	33	.	.	PUNCT
dpc-5333	34	1	the	the	DET
dpc-5333	34	2	ta	ta	PROPN
dpc-5333	34	3	cells	cell	NOUN
dpc-5333	34	4	divide	divide	VERB
dpc-5333	34	5	multiple	multiple	ADJ
dpc-5333	34	6	times	time	NOUN
dpc-5333	34	7	before	before	ADP
dpc-5333	34	8	ultimately	ultimately	ADV
dpc-5333	34	9	undergoing	undergo	VERB
dpc-5333	34	10	terminal	terminal	ADJ
dpc-5333	34	11	differentiation	differentiation	NOUN
dpc-5333	34	12	.	.	PUNCT
dpc-5333	35	1	this	this	DET
dpc-5333	35	2	process	process	NOUN
dpc-5333	35	3	gives	give	VERB
dpc-5333	35	4	rise	rise	NOUN
dpc-5333	35	5	to	to	ADP
dpc-5333	35	6	a	a	DET
dpc-5333	35	7	substantial	substantial	ADJ
dpc-5333	35	8	number	number	NOUN
dpc-5333	35	9	of	of	ADP
dpc-5333	35	10	keratinocytes	keratinocyte	NOUN
dpc-5333	35	11	[	[	X
dpc-5333	35	12	8	8	NUM
dpc-5333	35	13	]	]	PUNCT
dpc-5333	35	14	.	.	PUNCT
dpc-5333	36	1	it	it	PRON
dpc-5333	36	2	is	be	AUX
dpc-5333	36	3	noteworthy	noteworthy	ADJ
dpc-5333	36	4	that	that	SCONJ
dpc-5333	36	5	keratinocytes	keratinocyte	NOUN
dpc-5333	36	6	were	be	AUX
dpc-5333	36	7	the	the	DET
dpc-5333	36	8	initial	initial	ADJ
dpc-5333	36	9	focus	focus	NOUN
dpc-5333	36	10	of	of	ADP
dpc-5333	36	11	psoriasis	psoriasis	NOUN
dpc-5333	36	12	research	research	NOUN
dpc-5333	36	13	due	due	ADP
dpc-5333	36	14	to	to	ADP
dpc-5333	36	15	their	their	PRON
dpc-5333	36	16	origin	origin	NOUN
dpc-5333	36	17	from	from	ADP
dpc-5333	36	18	epscs	epsc	NOUN
dpc-5333	36	19	.	.	PUNCT
dpc-5333	37	1	psoriasis	psoriasis	NOUN
dpc-5333	37	2	is	be	AUX
dpc-5333	37	3	mainly	mainly	ADV
dpc-5333	37	4	characterized	characterize	VERB
dpc-5333	37	5	by	by	ADP
dpc-5333	37	6	the	the	DET
dpc-5333	37	7	excessive	excessive	ADJ
dpc-5333	37	8	growth	growth	NOUN
dpc-5333	37	9	of	of	ADP
dpc-5333	37	10	keratinocytes	keratinocyte	NOUN
dpc-5333	37	11	.	.	PUNCT
dpc-5333	38	1	the	the	DET
dpc-5333	38	2	epidermal	epidermal	ADJ
dpc-5333	38	3	turnover	turnover	NOUN
dpc-5333	38	4	time	time	NOUN
dpc-5333	38	5	,	,	PUNCT
dpc-5333	38	6	which	which	PRON
dpc-5333	38	7	refers	refer	VERB
dpc-5333	38	8	to	to	ADP
dpc-5333	38	9	the	the	DET
dpc-5333	38	10	duration	duration	NOUN
dpc-5333	38	11	needed	need	VERB
dpc-5333	38	12	to	to	PART
dpc-5333	38	13	replace	replace	VERB
dpc-5333	38	14	all	all	DET
dpc-5333	38	15	the	the	DET
dpc-5333	38	16	keratinocytes	keratinocyte	NOUN
dpc-5333	38	17	in	in	ADP
dpc-5333	38	18	the	the	DET
dpc-5333	38	19	epidermis	epidermis	NOUN
dpc-5333	38	20	,	,	PUNCT
dpc-5333	38	21	serves	serve	VERB
dpc-5333	38	22	as	as	ADP
dpc-5333	38	23	a	a	DET
dpc-5333	38	24	significant	significant	ADJ
dpc-5333	38	25	measure	measure	NOUN
dpc-5333	38	26	for	for	ADP
dpc-5333	38	27	assessing	assess	VERB
dpc-5333	38	28	keratinocyte	keratinocyte	NOUN
dpc-5333	38	29	proliferation	proliferation	NOUN
dpc-5333	38	30	activity	activity	NOUN
dpc-5333	38	31	[	[	X
dpc-5333	38	32	9	9	NUM
dpc-5333	38	33	]	]	PUNCT
dpc-5333	38	34	.	.	PUNCT
dpc-5333	39	1	current	current	ADJ
dpc-5333	39	2	evidence	evidence	NOUN
dpc-5333	39	3	suggests	suggest	VERB
dpc-5333	39	4	emphasizes	emphasize	VERB
dpc-5333	39	5	that	that	SCONJ
dpc-5333	39	6	determining	determine	VERB
dpc-5333	39	7	the	the	DET
dpc-5333	39	8	time	time	NOUN
dpc-5333	39	9	it	it	PRON
dpc-5333	39	10	takes	take	VERB
dpc-5333	39	11	for	for	SCONJ
dpc-5333	39	12	the	the	DET
dpc-5333	39	13	epidermis	epidermis	NOUN
dpc-5333	39	14	to	to	PART
dpc-5333	39	15	regenerate	regenerate	VERB
dpc-5333	39	16	itself	itself	PRON
dpc-5333	39	17	involves	involve	VERB
dpc-5333	39	18	considering	consider	VERB
dpc-5333	39	19	the	the	DET
dpc-5333	39	20	turnover	turnover	NOUN
dpc-5333	39	21	times	time	NOUN
dpc-5333	39	22	of	of	ADP
dpc-5333	39	23	various	various	ADJ
dpc-5333	39	24	layers	layer	NOUN
dpc-5333	39	25	present	present	ADJ
dpc-5333	39	26	in	in	ADP
dpc-5333	39	27	the	the	DET
dpc-5333	39	28	epidermis	epidermis	NOUN
dpc-5333	39	29	.	.	PUNCT
dpc-5333	40	1	these	these	DET
dpc-5333	40	2	layers	layer	NOUN
dpc-5333	40	3	consist	consist	VERB
dpc-5333	40	4	of	of	ADP
dpc-5333	40	5	the	the	DET
dpc-5333	40	6	stratum	stratum	NOUN
dpc-5333	40	7	basale	basale	PROPN
dpc-5333	40	8	,	,	PUNCT
dpc-5333	40	9	the	the	DET
dpc-5333	40	10	differentiated	differentiated	ADJ
dpc-5333	40	11	compartment	compartment	NOUN
dpc-5333	40	12	,	,	PUNCT
dpc-5333	40	13	and	and	CCONJ
dpc-5333	40	14	the	the	DET
dpc-5333	40	15	stratum	stratum	NOUN
dpc-5333	40	16	corneum	corneum	NOUN
dpc-5333	40	17	.	.	PUNCT
dpc-5333	41	1	several	several	ADJ
dpc-5333	41	2	factors	factor	NOUN
dpc-5333	41	3	play	play	VERB
dpc-5333	41	4	a	a	DET
dpc-5333	41	5	role	role	NOUN
dpc-5333	41	6	in	in	ADP
dpc-5333	41	7	influencing	influence	VERB
dpc-5333	41	8	the	the	DET
dpc-5333	41	9	renewal	renewal	NOUN
dpc-5333	41	10	process	process	NOUN
dpc-5333	41	11	,	,	PUNCT
dpc-5333	41	12	including	include	VERB
dpc-5333	41	13	cell	cell	NOUN
dpc-5333	41	14	density	density	NOUN
dpc-5333	41	15	,	,	PUNCT
dpc-5333	41	16	cell	cell	NOUN
dpc-5333	41	17	proliferation	proliferation	NOUN
dpc-5333	41	18	activity	activity	NOUN
dpc-5333	41	19	,	,	PUNCT
dpc-5333	41	20	desquamation	desquamation	NOUN
dpc-5333	41	21	,	,	PUNCT
dpc-5333	41	22	apoptosis	apoptosis	NOUN
dpc-5333	41	23	,	,	PUNCT
dpc-5333	41	24	and	and	CCONJ
dpc-5333	41	25	other	other	ADJ
dpc-5333	41	26	cellular	cellular	ADJ
dpc-5333	41	27	processes	process	NOUN
dpc-5333	41	28	[	[	X
dpc-5333	41	29	10	10	NUM
dpc-5333	41	30	]	]	PUNCT
dpc-5333	41	31	.	.	PUNCT
dpc-5333	42	1	recent	recent	ADJ
dpc-5333	42	2	studies	study	NOUN
dpc-5333	42	3	confirm	confirm	VERB
dpc-5333	42	4	an	an	DET
dpc-5333	42	5	increased	increase	VERB
dpc-5333	42	6	number	number	NOUN
dpc-5333	42	7	of	of	ADP
dpc-5333	42	8	epscs	epsc	NOUN
dpc-5333	42	9	or	or	CCONJ
dpc-5333	42	10	ta	ta	ADP
dpc-5333	42	11	cells	cell	NOUN
dpc-5333	42	12	become	become	VERB
dpc-5333	42	13	active	active	ADJ
dpc-5333	42	14	in	in	ADP
dpc-5333	42	15	the	the	DET
dpc-5333	42	16	cell	cell	NOUN
dpc-5333	42	17	cycle	cycle	NOUN
dpc-5333	42	18	during	during	ADP
dpc-5333	42	19	psoriasis	psoriasis	NOUN
dpc-5333	42	20	.	.	PUNCT
dpc-5333	43	1	in	in	ADP
dpc-5333	43	2	psoriasis	psoriasis	NOUN
dpc-5333	43	3	,	,	PUNCT
dpc-5333	43	4	it	it	PRON
dpc-5333	43	5	is	be	AUX
dpc-5333	43	6	observed	observe	VERB
dpc-5333	43	7	that	that	SCONJ
dpc-5333	43	8	β1	β1	PROPN
dpc-5333	43	9	-	-	PUNCT
dpc-5333	43	10	integrin+	integrin+	PART
dpc-5333	43	11	cells	cell	NOUN
dpc-5333	43	12	that	that	PRON
dpc-5333	43	13	possess	possess	VERB
dpc-5333	43	14	keratin	keratin	NOUN
dpc-5333	43	15	1	1	NUM
dpc-5333	43	16	/	/	SYM
dpc-5333	43	17	keratin	keratin	NOUN
dpc-5333	43	18	10	10	NUM
dpc-5333	43	19	but	but	CCONJ
dpc-5333	43	20	lack	lack	NOUN
dpc-5333	43	21	epscs	epsc	NOUN
dpc-5333	43	22	/	/	SYM
dpc-5333	43	23	ta	ta	NOUN
dpc-5333	43	24	cells	cell	NOUN
dpc-5333	43	25	demonstrate	demonstrate	VERB
dpc-5333	43	26	an	an	DET
dpc-5333	43	27	augmented	augment	VERB
dpc-5333	43	28	involvement	involvement	NOUN
dpc-5333	43	29	in	in	ADP
dpc-5333	43	30	the	the	DET
dpc-5333	43	31	cell	cell	NOUN
dpc-5333	43	32	cycle	cycle	NOUN
dpc-5333	43	33	[	[	X
dpc-5333	43	34	11	11	NUM
dpc-5333	43	35	]	]	PUNCT
dpc-5333	43	36	.	.	PUNCT
dpc-5333	44	1	this	this	DET
dpc-5333	44	2	augmented	augment	VERB
dpc-5333	44	3	presence	presence	NOUN
dpc-5333	44	4	of	of	ADP
dpc-5333	44	5	β1	β1	PROPN
dpc-5333	44	6	-	-	PUNCT
dpc-5333	44	7	integrin+	integrin+	PART
dpc-5333	44	8	cells	cell	NOUN
dpc-5333	44	9	is	be	AUX
dpc-5333	44	10	thought	think	VERB
dpc-5333	44	11	to	to	PART
dpc-5333	44	12	indicate	indicate	VERB
dpc-5333	44	13	the	the	DET
dpc-5333	44	14	heightened	heighten	VERB
dpc-5333	44	15	proliferation	proliferation	NOUN
dpc-5333	44	16	of	of	ADP
dpc-5333	44	17	ta	ta	ADP
dpc-5333	44	18	cells	cell	NOUN
dpc-5333	44	19	[	[	X
dpc-5333	44	20	12	12	NUM
dpc-5333	44	21	]	]	PUNCT
dpc-5333	44	22	.	.	PUNCT
dpc-5333	45	1	an	an	DET
dpc-5333	45	2	immune	immune	ADJ
dpc-5333	45	3	staining	stain	VERB
dpc-5333	45	4	test	test	NOUN
dpc-5333	45	5	revealed	reveal	VERB
dpc-5333	45	6	that	that	SCONJ
dpc-5333	45	7	the	the	DET
dpc-5333	45	8	top	top	ADJ
dpc-5333	45	9	layer	layer	NOUN
dpc-5333	45	10	of	of	ADP
dpc-5333	45	11	the	the	DET
dpc-5333	45	12	psoriatic	psoriatic	ADJ
dpc-5333	45	13	lesion	lesion	NOUN
dpc-5333	45	14	had	have	VERB
dpc-5333	45	15	high	high	ADJ
dpc-5333	45	16	levels	level	NOUN
dpc-5333	45	17	of	of	ADP
dpc-5333	45	18	two	two	NUM
dpc-5333	45	19	proteins	protein	NOUN
dpc-5333	45	20	:	:	PUNCT
dpc-5333	45	21	fabp5	fabp5	NOUN
dpc-5333	45	22	,	,	PUNCT
dpc-5333	45	23	which	which	PRON
dpc-5333	45	24	is	be	AUX
dpc-5333	45	25	a	a	DET
dpc-5333	45	26	marker	marker	NOUN
dpc-5333	45	27	for	for	ADP
dpc-5333	45	28	ta	ta	ADP
dpc-5333	45	29	cells	cell	NOUN
dpc-5333	45	30	,	,	PUNCT
dpc-5333	45	31	and	and	CCONJ
dpc-5333	45	32	nestin	nestin	PROPN
dpc-5333	45	33	,	,	PUNCT
dpc-5333	45	34	which	which	PRON
dpc-5333	45	35	may	may	AUX
dpc-5333	45	36	be	be	AUX
dpc-5333	45	37	a	a	DET
dpc-5333	45	38	marker	marker	NOUN
dpc-5333	45	39	for	for	ADP
dpc-5333	45	40	escs	esc	NOUN
dpc-5333	45	41	[	[	X
dpc-5333	45	42	13	13	NUM
dpc-5333	45	43	]	]	PUNCT
dpc-5333	45	44	.	.	PUNCT
dpc-5333	46	1	the	the	DET
dpc-5333	46	2	studies	study	NOUN
dpc-5333	46	3	concluded	conclude	VERB
dpc-5333	46	4	that	that	SCONJ
dpc-5333	46	5	the	the	DET
dpc-5333	46	6	excessive	excessive	ADJ
dpc-5333	46	7	proliferation	proliferation	NOUN
dpc-5333	46	8	of	of	ADP
dpc-5333	46	9	keratinocytes	keratinocyte	NOUN
dpc-5333	46	10	led	lead	VERB
dpc-5333	46	11	to	to	ADP
dpc-5333	46	12	an	an	DET
dpc-5333	46	13	increase	increase	NOUN
dpc-5333	46	14	in	in	ADP
dpc-5333	46	15	the	the	DET
dpc-5333	46	16	growth	growth	NOUN
dpc-5333	46	17	of	of	ADP
dpc-5333	46	18	epscs	epsc	NOUN
dpc-5333	46	19	/	/	SYM
dpc-5333	46	20	ta	ta	NOUN
dpc-5333	46	21	cells	cell	NOUN
dpc-5333	46	22	.	.	PUNCT
dpc-5333	47	1	the	the	DET
dpc-5333	47	2	environment	environment	NOUN
dpc-5333	47	3	in	in	ADP
dpc-5333	47	4	which	which	PRON
dpc-5333	47	5	stem	stem	NOUN
dpc-5333	47	6	cells	cell	NOUN
dpc-5333	47	7	reside	reside	VERB
dpc-5333	47	8	partially	partially	ADV
dpc-5333	47	9	controls	control	VERB
dpc-5333	47	10	their	their	PRON
dpc-5333	47	11	growth	growth	NOUN
dpc-5333	47	12	and	and	CCONJ
dpc-5333	47	13	specialization	specialization	NOUN
dpc-5333	47	14	.	.	PUNCT
dpc-5333	48	1	concurrent	concurrent	ADJ
dpc-5333	48	2	with	with	ADP
dpc-5333	48	3	the	the	DET
dpc-5333	48	4	advancement	advancement	NOUN
dpc-5333	48	5	in	in	ADP
dpc-5333	48	6	theoretical	theoretical	ADJ
dpc-5333	48	7	frameworks	framework	NOUN
dpc-5333	48	8	elucidating	elucidate	VERB
dpc-5333	48	9	the	the	DET
dpc-5333	48	10	relationship	relationship	NOUN
dpc-5333	48	11	between	between	ADP
dpc-5333	48	12	stem	stem	NOUN
dpc-5333	48	13	cells	cell	NOUN
dpc-5333	48	14	and	and	CCONJ
dpc-5333	48	15	their	their	PRON
dpc-5333	48	16	supportive	supportive	ADJ
dpc-5333	48	17	microenvironmental	microenvironmental	ADJ
dpc-5333	48	18	niche	niche	NOUN
dpc-5333	48	19	,	,	PUNCT
dpc-5333	48	20	researchers	researcher	NOUN
dpc-5333	48	21	have	have	AUX
dpc-5333	48	22	dedicated	dedicate	VERB
dpc-5333	48	23	increased	increase	VERB
dpc-5333	48	24	attention	attention	NOUN
dpc-5333	48	25	to	to	ADP
dpc-5333	48	26	investigating	investigate	VERB
dpc-5333	48	27	the	the	DET
dpc-5333	48	28	specific	specific	ADJ
dpc-5333	48	29	environmental	environmental	ADJ
dpc-5333	48	30	factors	factor	NOUN
dpc-5333	48	31	that	that	PRON
dpc-5333	48	32	promote	promote	VERB
dpc-5333	48	33	the	the	DET
dpc-5333	48	34	enhanced	enhanced	ADJ
dpc-5333	48	35	proliferation	proliferation	NOUN
dpc-5333	48	36	of	of	ADP
dpc-5333	48	37	embryonic	embryonic	ADJ
dpc-5333	48	38	stem	stem	NOUN
dpc-5333	48	39	cells	cell	NOUN
dpc-5333	48	40	and	and	CCONJ
dpc-5333	48	41	transit	transit	NOUN
dpc-5333	48	42	-	-	PUNCT
dpc-5333	48	43	amplifying	amplify	VERB
dpc-5333	48	44	cell	cell	NOUN
dpc-5333	48	45	populations	population	NOUN
dpc-5333	48	46	.	.	PUNCT
dpc-5333	49	1	the	the	DET
dpc-5333	49	2	immunomodulatory	immunomodulatory	ADJ
dpc-5333	49	3	signaling	signal	VERB
dpc-5333	49	4	factors	factor	NOUN
dpc-5333	49	5	produced	produce	VERB
dpc-5333	49	6	by	by	ADP
dpc-5333	49	7	the	the	DET
dpc-5333	49	8	t	t	PROPN
dpc-5333	49	9	helper	helper	NOUN
dpc-5333	49	10	(	(	PUNCT
dpc-5333	49	11	th	th	NOUN
dpc-5333	49	12	)	)	PUNCT
dpc-5333	49	13	17	17	NUM
dpc-5333	49	14	lymphocyte	lymphocyte	NOUN
dpc-5333	49	15	subset	subset	NOUN
dpc-5333	49	16	,	,	PUNCT
dpc-5333	49	17	such	such	ADJ
dpc-5333	49	18	as	as	ADP
dpc-5333	49	19	the	the	DET
dpc-5333	49	20	cytokines	cytokine	NOUN
dpc-5333	49	21	interleukin-17a	interleukin-17a	PROPN
dpc-5333	49	22	and	and	CCONJ
dpc-5333	49	23	interleukin-22	interleukin-22	PROPN
dpc-5333	49	24	,	,	PUNCT
dpc-5333	49	25	which	which	PRON
dpc-5333	49	26	were	be	AUX
dpc-5333	49	27	most	most	ADV
dpc-5333	49	28	implicated	implicate	VERB
dpc-5333	49	29	in	in	ADP
dpc-5333	49	30	the	the	DET
dpc-5333	49	31	pathogenesis	pathogenesis	NOUN
dpc-5333	49	32	of	of	ADP
dpc-5333	49	33	the	the	DET
dpc-5333	49	34	inflammatory	inflammatory	ADJ
dpc-5333	49	35	skin	skin	NOUN
dpc-5333	49	36	disease	disease	NOUN
dpc-5333	49	37	results	result	VERB
dpc-5333	49	38	:	:	PUNCT
dpc-5333	49	39	investigations	investigation	NOUN
dpc-5333	49	40	uncovered	uncover	VERB
dpc-5333	49	41	the	the	DET
dpc-5333	49	42	impact	impact	NOUN
dpc-5333	49	43	that	that	PRON
dpc-5333	49	44	epidermal	epidermal	ADJ
dpc-5333	49	45	stem	stem	NOUN
dpc-5333	49	46	cells	cell	NOUN
dpc-5333	49	47	and	and	CCONJ
dpc-5333	49	48	their	their	PRON
dpc-5333	49	49	interactions	interaction	NOUN
dpc-5333	49	50	with	with	ADP
dpc-5333	49	51	t	t	NOUN
dpc-5333	49	52	cells	cell	NOUN
dpc-5333	49	53	have	have	VERB
dpc-5333	49	54	in	in	ADP
dpc-5333	49	55	psoriasis	psoriasis	NOUN
dpc-5333	49	56	.	.	PUNCT
dpc-5333	50	1	importantly	importantly	ADV
dpc-5333	50	2	,	,	PUNCT
dpc-5333	50	3	malfunctions	malfunction	NOUN
dpc-5333	50	4	across	across	ADP
dpc-5333	50	5	diverse	diverse	ADJ
dpc-5333	50	6	stem	stem	NOUN
dpc-5333	50	7	cell	cell	NOUN
dpc-5333	50	8	types	type	NOUN
dpc-5333	50	9	may	may	AUX
dpc-5333	50	10	constitute	constitute	VERB
dpc-5333	50	11	a	a	DET
dpc-5333	50	12	central	central	ADJ
dpc-5333	50	13	mechanism	mechanism	NOUN
dpc-5333	50	14	underlying	underlie	VERB
dpc-5333	50	15	the	the	DET
dpc-5333	50	16	dysregulated	dysregulated	ADJ
dpc-5333	50	17	inflammatory	inflammatory	ADJ
dpc-5333	50	18	processes	process	NOUN
dpc-5333	50	19	that	that	PRON
dpc-5333	50	20	characterize	characterize	VERB
dpc-5333	50	21	this	this	DET
dpc-5333	50	22	condition	condition	NOUN
dpc-5333	50	23	.	.	PUNCT
dpc-5333	51	1	conclusions	conclusion	NOUN
dpc-5333	51	2	:	:	PUNCT
dpc-5333	51	3	nonetheless	nonetheless	ADV
dpc-5333	51	4	,	,	PUNCT
dpc-5333	51	5	a	a	DET
dpc-5333	51	6	more	more	ADV
dpc-5333	51	7	thorough	thorough	ADJ
dpc-5333	51	8	investigation	investigation	NOUN
dpc-5333	51	9	of	of	ADP
dpc-5333	51	10	these	these	DET
dpc-5333	51	11	mechanisms	mechanism	NOUN
dpc-5333	51	12	could	could	AUX
dpc-5333	51	13	present	present	VERB
dpc-5333	51	14	an	an	DET
dpc-5333	51	15	opportunity	opportunity	NOUN
dpc-5333	51	16	to	to	PART
dpc-5333	51	17	devise	devise	VERB
dpc-5333	51	18	novel	novel	ADJ
dpc-5333	51	19	therapeutic	therapeutic	ADJ
dpc-5333	51	20	approaches	approach	NOUN
dpc-5333	51	21	.	.	PUNCT
dpc-5333	52	1	review	review	VERB
dpc-5333	52	2	|	|	ADV
dpc-5333	52	3	dermatol	dermatol	ADJ
dpc-5333	52	4	pract	pract	NOUN
dpc-5333	52	5	concept	concept	NOUN
dpc-5333	52	6	.	.	PUNCT
dpc-5333	53	1	2025;15(3):5333	2025;15(3):5333	NUM
dpc-5333	53	2	3	3	NUM
dpc-5333	53	3	psoriasis	psoriasis	NOUN
dpc-5333	53	4	,	,	PUNCT
dpc-5333	53	5	possess	possess	VERB
dpc-5333	53	6	the	the	DET
dpc-5333	53	7	capacity	capacity	NOUN
dpc-5333	53	8	to	to	PART
dpc-5333	53	9	stimulate	stimulate	VERB
dpc-5333	53	10	the	the	DET
dpc-5333	53	11	epsc	epsc	ADJ
dpc-5333	53	12	populations	population	NOUN
dpc-5333	53	13	to	to	PART
dpc-5333	53	14	transition	transition	VERB
dpc-5333	53	15	from	from	ADP
dpc-5333	53	16	a	a	DET
dpc-5333	53	17	quiescent	quiescent	ADJ
dpc-5333	53	18	state	state	NOUN
dpc-5333	53	19	into	into	ADP
dpc-5333	53	20	a	a	DET
dpc-5333	53	21	hyperproliferative	hyperproliferative	ADJ
dpc-5333	53	22	state	state	NOUN
dpc-5333	53	23	,	,	PUNCT
dpc-5333	53	24	yet	yet	CCONJ
dpc-5333	53	25	simultaneously	simultaneously	ADV
dpc-5333	53	26	impede	impede	VERB
dpc-5333	53	27	the	the	DET
dpc-5333	53	28	differentiation	differentiation	NOUN
dpc-5333	53	29	of	of	ADP
dpc-5333	53	30	the	the	DET
dpc-5333	53	31	epidermal	epidermal	ADJ
dpc-5333	53	32	keratinocytes	keratinocyte	NOUN
dpc-5333	53	33	[	[	X
dpc-5333	53	34	11,14	11,14	X
dpc-5333	53	35	]	]	PUNCT
dpc-5333	53	36	.	.	PUNCT
dpc-5333	54	1	the	the	DET
dpc-5333	54	2	overexpansion	overexpansion	NOUN
dpc-5333	54	3	of	of	ADP
dpc-5333	54	4	embryonic	embryonic	ADJ
dpc-5333	54	5	stem	stem	NOUN
dpc-5333	54	6	cells	cell	NOUN
dpc-5333	54	7	and	and	CCONJ
dpc-5333	54	8	transit	transit	NOUN
dpc-5333	54	9	-	-	PUNCT
dpc-5333	54	10	amplifying	amplify	VERB
dpc-5333	54	11	cells	cell	NOUN
dpc-5333	54	12	in	in	ADP
dpc-5333	54	13	psoriasis	psoriasis	NOUN
dpc-5333	54	14	is	be	AUX
dpc-5333	54	15	widely	widely	ADV
dpc-5333	54	16	accepted	accept	VERB
dpc-5333	54	17	to	to	PART
dpc-5333	54	18	be	be	AUX
dpc-5333	54	19	a	a	DET
dpc-5333	54	20	secondary	secondary	ADJ
dpc-5333	54	21	phenomenon	phenomenon	NOUN
dpc-5333	54	22	,	,	PUNCT
dpc-5333	54	23	driven	drive	VERB
dpc-5333	54	24	by	by	ADP
dpc-5333	54	25	the	the	DET
dpc-5333	54	26	niche	niche	NOUN
dpc-5333	54	27	factors	factor	NOUN
dpc-5333	54	28	originating	originate	VERB
dpc-5333	54	29	from	from	ADP
dpc-5333	54	30	the	the	DET
dpc-5333	54	31	infiltrated	infiltrate	VERB
dpc-5333	54	32	immune	immune	ADJ
dpc-5333	54	33	cells	cell	NOUN
dpc-5333	54	34	,	,	PUNCT
dpc-5333	54	35	along	along	ADP
dpc-5333	54	36	with	with	ADP
dpc-5333	54	37	the	the	DET
dpc-5333	54	38	inflammatory	inflammatory	ADJ
dpc-5333	54	39	cytokines	cytokine	NOUN
dpc-5333	54	40	and	and	CCONJ
dpc-5333	54	41	growth	growth	NOUN
dpc-5333	54	42	factors	factor	NOUN
dpc-5333	54	43	secreted	secrete	VERB
dpc-5333	54	44	by	by	ADP
dpc-5333	54	45	those	those	DET
dpc-5333	54	46	immune	immune	ADJ
dpc-5333	54	47	cells	cell	NOUN
dpc-5333	54	48	.	.	PUNCT
dpc-5333	55	1	mesenchymal	mesenchymal	ADJ
dpc-5333	55	2	stem	stem	NOUN
dpc-5333	55	3	cells	cell	NOUN
dpc-5333	55	4	(	(	PUNCT
dpc-5333	55	5	msc	msc	NOUN
dpc-5333	55	6	)	)	PUNCT
dpc-5333	55	7	mesenchymal	mesenchymal	NOUN
dpc-5333	55	8	stem	stem	NOUN
dpc-5333	55	9	cells	cell	NOUN
dpc-5333	55	10	represent	represent	VERB
dpc-5333	55	11	a	a	DET
dpc-5333	55	12	heterogeneous	heterogeneous	ADJ
dpc-5333	55	13	group	group	NOUN
dpc-5333	55	14	of	of	ADP
dpc-5333	55	15	self	self	NOUN
dpc-5333	55	16	-	-	PUNCT
dpc-5333	55	17	renewing	renew	VERB
dpc-5333	55	18	,	,	PUNCT
dpc-5333	55	19	multipotent	multipotent	NOUN
dpc-5333	55	20	cells	cell	NOUN
dpc-5333	55	21	that	that	PRON
dpc-5333	55	22	are	be	AUX
dpc-5333	55	23	distinct	distinct	ADJ
dpc-5333	55	24	from	from	ADP
dpc-5333	55	25	hematopoietic	hematopoietic	ADJ
dpc-5333	55	26	stem	stem	NOUN
dpc-5333	55	27	cells	cell	NOUN
dpc-5333	55	28	[	[	X
dpc-5333	55	29	15,16	15,16	NUM
dpc-5333	55	30	]	]	PUNCT
dpc-5333	55	31	.	.	PUNCT
dpc-5333	56	1	these	these	DET
dpc-5333	56	2	mscs	msc	NOUN
dpc-5333	56	3	possess	possess	VERB
dpc-5333	56	4	the	the	DET
dpc-5333	56	5	capacity	capacity	NOUN
dpc-5333	56	6	to	to	PART
dpc-5333	56	7	regulate	regulate	VERB
dpc-5333	56	8	immune	immune	ADJ
dpc-5333	56	9	responses	response	NOUN
dpc-5333	56	10	,	,	PUNCT
dpc-5333	56	11	stimulate	stimulate	VERB
dpc-5333	56	12	the	the	DET
dpc-5333	56	13	formation	formation	NOUN
dpc-5333	56	14	of	of	ADP
dpc-5333	56	15	new	new	ADJ
dpc-5333	56	16	blood	blood	NOUN
dpc-5333	56	17	vessels	vessel	NOUN
dpc-5333	56	18	,	,	PUNCT
dpc-5333	56	19	mitigate	mitigate	VERB
dpc-5333	56	20	inflammation	inflammation	NOUN
dpc-5333	56	21	,	,	PUNCT
dpc-5333	56	22	and	and	CCONJ
dpc-5333	56	23	prevent	prevent	VERB
dpc-5333	56	24	apoptotic	apoptotic	ADJ
dpc-5333	56	25	cell	cell	NOUN
dpc-5333	56	26	death	death	NOUN
dpc-5333	57	1	[	[	X
dpc-5333	57	2	17	17	NUM
dpc-5333	57	3	]	]	PUNCT
dpc-5333	57	4	.	.	PUNCT
dpc-5333	58	1	mscs	msc	NOUN
dpc-5333	58	2	possess	possess	VERB
dpc-5333	58	3	several	several	ADJ
dpc-5333	58	4	advantageous	advantageous	ADJ
dpc-5333	58	5	properties	property	NOUN
dpc-5333	58	6	that	that	PRON
dpc-5333	58	7	make	make	VERB
dpc-5333	58	8	them	they	PRON
dpc-5333	58	9	an	an	DET
dpc-5333	58	10	ideal	ideal	ADJ
dpc-5333	58	11	cell	cell	NOUN
dpc-5333	58	12	therapy	therapy	NOUN
dpc-5333	58	13	for	for	ADP
dpc-5333	58	14	various	various	ADJ
dpc-5333	58	15	conditions	condition	NOUN
dpc-5333	58	16	,	,	PUNCT
dpc-5333	58	17	especially	especially	ADV
dpc-5333	58	18	immune	immune	NOUN
dpc-5333	58	19	-	-	PUNCT
dpc-5333	58	20	mediated	mediate	VERB
dpc-5333	58	21	inflammatory	inflammatory	ADJ
dpc-5333	58	22	diseases	disease	NOUN
dpc-5333	58	23	(	(	PUNCT
dpc-5333	58	24	imids	imid	NOUN
dpc-5333	58	25	)	)	PUNCT
dpc-5333	58	26	.	.	PUNCT
dpc-5333	59	1	mscs	msc	NOUN
dpc-5333	59	2	are	be	AUX
dpc-5333	59	3	easily	easily	ADV
dpc-5333	59	4	isolated	isolate	VERB
dpc-5333	59	5	from	from	ADP
dpc-5333	59	6	human	human	ADJ
dpc-5333	59	7	tissues	tissue	NOUN
dpc-5333	59	8	and	and	CCONJ
dpc-5333	59	9	exhibit	exhibit	VERB
dpc-5333	59	10	low	low	ADJ
dpc-5333	59	11	immunogenicity	immunogenicity	NOUN
dpc-5333	59	12	due	due	ADP
dpc-5333	59	13	to	to	ADP
dpc-5333	59	14	lacking	lack	VERB
dpc-5333	59	15	major	major	ADJ
dpc-5333	59	16	histocompatibility	histocompatibility	NOUN
dpc-5333	59	17	complex	complex	NOUN
dpc-5333	59	18	(	(	PUNCT
dpc-5333	59	19	mhc)-ii	mhc)-ii	PROPN
dpc-5333	59	20	and	and	CCONJ
dpc-5333	59	21	costimulatory	costimulatory	ADJ
dpc-5333	59	22	molecules	molecule	NOUN
dpc-5333	59	23	(	(	PUNCT
dpc-5333	59	24	cd80/	cd80/	PROPN
dpc-5333	59	25	cd86	cd86	PROPN
dpc-5333	59	26	)	)	PUNCT
dpc-5333	59	27	,	,	PUNCT
dpc-5333	59	28	minimizing	minimize	VERB
dpc-5333	59	29	allogeneic	allogeneic	ADJ
dpc-5333	59	30	rejection	rejection	NOUN
dpc-5333	59	31	[	[	X
dpc-5333	59	32	18,19	18,19	X
dpc-5333	59	33	]	]	PUNCT
dpc-5333	59	34	.	.	PUNCT
dpc-5333	60	1	they	they	PRON
dpc-5333	60	2	also	also	ADV
dpc-5333	60	3	do	do	AUX
dpc-5333	60	4	not	not	PART
dpc-5333	60	5	have	have	VERB
dpc-5333	60	6	many	many	ADJ
dpc-5333	60	7	mhc	mhc	NOUN
dpc-5333	60	8	class	class	NOUN
dpc-5333	60	9	i	i	PROPN
dpc-5333	60	10	molecules	molecule	NOUN
dpc-5333	60	11	.	.	PUNCT
dpc-5333	61	1	this	this	PRON
dpc-5333	61	2	enables	enable	VERB
dpc-5333	61	3	the	the	DET
dpc-5333	61	4	use	use	NOUN
dpc-5333	61	5	of	of	ADP
dpc-5333	61	6	msc	msc	NOUN
dpc-5333	61	7	-	-	PUNCT
dpc-5333	61	8	based	base	VERB
dpc-5333	61	9	therapies	therapy	NOUN
dpc-5333	61	10	without	without	ADP
dpc-5333	61	11	the	the	DET
dpc-5333	61	12	need	need	NOUN
dpc-5333	61	13	for	for	ADP
dpc-5333	61	14	cytotoxic	cytotoxic	ADJ
dpc-5333	61	15	conditioning	conditioning	NOUN
dpc-5333	61	16	regimens	regimen	NOUN
dpc-5333	61	17	,	,	PUNCT
dpc-5333	61	18	which	which	PRON
dpc-5333	61	19	can	can	AUX
dpc-5333	61	20	potentially	potentially	ADV
dpc-5333	61	21	harm	harm	VERB
dpc-5333	61	22	patients	patient	NOUN
dpc-5333	61	23	[	[	X
dpc-5333	61	24	20	20	NUM
dpc-5333	61	25	]	]	PUNCT
dpc-5333	61	26	.	.	PUNCT
dpc-5333	62	1	mscs	msc	NOUN
dpc-5333	62	2	can	can	AUX
dpc-5333	62	3	be	be	AUX
dpc-5333	62	4	found	find	VERB
dpc-5333	62	5	in	in	ADP
dpc-5333	62	6	many	many	ADJ
dpc-5333	62	7	body	body	NOUN
dpc-5333	62	8	tissues	tissue	NOUN
dpc-5333	62	9	,	,	PUNCT
dpc-5333	62	10	but	but	CCONJ
dpc-5333	62	11	bone	bone	NOUN
dpc-5333	62	12	marrow	marrow	NOUN
dpc-5333	62	13	mscs	msc	NOUN
dpc-5333	62	14	(	(	PUNCT
dpc-5333	62	15	bm	bm	NOUN
dpc-5333	62	16	-	-	NOUN
dpc-5333	62	17	mscs	msc	NOUN
dpc-5333	62	18	)	)	PUNCT
dpc-5333	62	19	,	,	PUNCT
dpc-5333	62	20	umbilical	umbilical	ADJ
dpc-5333	62	21	cord	cord	NOUN
dpc-5333	62	22	-	-	PUNCT
dpc-5333	62	23	derived	derive	VERB
dpc-5333	62	24	mscs	msc	NOUN
dpc-5333	62	25	(	(	PUNCT
dpc-5333	62	26	uc	uc	NOUN
dpc-5333	62	27	-	-	PUNCT
dpc-5333	62	28	mscs	msc	NOUN
dpc-5333	62	29	)	)	PUNCT
dpc-5333	62	30	,	,	PUNCT
dpc-5333	62	31	placental	placental	NOUN
dpc-5333	62	32	materials	material	NOUN
dpc-5333	62	33	,	,	PUNCT
dpc-5333	62	34	wharton	wharton	PROPN
dpc-5333	62	35	’s	’s	PART
dpc-5333	62	36	jelly	jelly	NOUN
dpc-5333	62	37	,	,	PUNCT
dpc-5333	62	38	blood	blood	NOUN
dpc-5333	62	39	,	,	PUNCT
dpc-5333	62	40	dental	dental	ADJ
dpc-5333	62	41	pulp	pulp	NOUN
dpc-5333	62	42	,	,	PUNCT
dpc-5333	62	43	and	and	CCONJ
dpc-5333	62	44	adipose	adipose	NOUN
dpc-5333	62	45	deposits	deposit	NOUN
dpc-5333	62	46	are	be	AUX
dpc-5333	62	47	the	the	DET
dpc-5333	62	48	main	main	ADJ
dpc-5333	62	49	places	place	NOUN
dpc-5333	62	50	from	from	ADP
dpc-5333	62	51	which	which	PRON
dpc-5333	62	52	they	they	PRON
dpc-5333	62	53	are	be	AUX
dpc-5333	62	54	taken	take	VERB
dpc-5333	62	55	[	[	PUNCT
dpc-5333	62	56	21	21	NUM
dpc-5333	62	57	]	]	PUNCT
dpc-5333	62	58	.	.	PUNCT
dpc-5333	63	1	the	the	DET
dpc-5333	63	2	source	source	NOUN
dpc-5333	63	3	of	of	ADP
dpc-5333	63	4	mscs	msc	NOUN
dpc-5333	63	5	can	can	AUX
dpc-5333	63	6	impact	impact	VERB
dpc-5333	63	7	their	their	PRON
dpc-5333	63	8	biological	biological	ADJ
dpc-5333	63	9	properties	property	NOUN
dpc-5333	63	10	,	,	PUNCT
dpc-5333	63	11	such	such	ADJ
dpc-5333	63	12	as	as	ADP
dpc-5333	63	13	their	their	PRON
dpc-5333	63	14	differentiation	differentiation	NOUN
dpc-5333	63	15	potential	potential	NOUN
dpc-5333	63	16	,	,	PUNCT
dpc-5333	63	17	paracrine	paracrine	ADJ
dpc-5333	63	18	capabilities	capability	NOUN
dpc-5333	63	19	,	,	PUNCT
dpc-5333	63	20	and	and	CCONJ
dpc-5333	63	21	immunomodulatory	immunomodulatory	ADJ
dpc-5333	63	22	attributes	attribute	NOUN
dpc-5333	63	23	.	.	PUNCT
dpc-5333	64	1	sox2	sox2	NOUN
dpc-5333	64	2	and	and	CCONJ
dpc-5333	64	3	oct4	oct4	NOUN
dpc-5333	64	4	are	be	AUX
dpc-5333	64	5	stemness	stemness	ADJ
dpc-5333	64	6	markers	marker	NOUN
dpc-5333	64	7	that	that	PRON
dpc-5333	64	8	are	be	AUX
dpc-5333	64	9	expressed	express	VERB
dpc-5333	64	10	in	in	ADP
dpc-5333	64	11	bm	bm	NOUN
dpc-5333	64	12	-	-	NOUN
dpc-5333	64	13	mscs	msc	NOUN
dpc-5333	64	14	and	and	CCONJ
dpc-5333	64	15	adscs	adsc	NOUN
dpc-5333	64	16	when	when	SCONJ
dpc-5333	64	17	they	they	PRON
dpc-5333	64	18	are	be	AUX
dpc-5333	64	19	cultured	cultured	ADJ
dpc-5333	64	20	in	in	ADP
dpc-5333	64	21	vitro	vitro	VERB
dpc-5333	64	22	.	.	PUNCT
dpc-5333	65	1	this	this	PRON
dpc-5333	65	2	helps	help	VERB
dpc-5333	65	3	them	they	PRON
dpc-5333	65	4	keep	keep	VERB
dpc-5333	65	5	their	their	PRON
dpc-5333	65	6	ability	ability	NOUN
dpc-5333	65	7	to	to	PART
dpc-5333	65	8	differentiate	differentiate	VERB
dpc-5333	65	9	over	over	ADP
dpc-5333	65	10	time	time	NOUN
dpc-5333	65	11	(	(	PUNCT
dpc-5333	65	12	20	20	NUM
dpc-5333	65	13	)	)	PUNCT
dpc-5333	65	14	.	.	PUNCT
dpc-5333	66	1	adscs	adsc	NOUN
dpc-5333	66	2	,	,	PUNCT
dpc-5333	66	3	on	on	ADP
dpc-5333	66	4	the	the	DET
dpc-5333	66	5	other	other	ADJ
dpc-5333	66	6	hand	hand	NOUN
dpc-5333	66	7	,	,	PUNCT
dpc-5333	66	8	have	have	VERB
dpc-5333	66	9	a	a	DET
dpc-5333	66	10	stronger	strong	ADJ
dpc-5333	66	11	inhibitory	inhibitory	ADJ
dpc-5333	66	12	effect	effect	NOUN
dpc-5333	66	13	on	on	ADP
dpc-5333	66	14	b	b	NOUN
dpc-5333	66	15	cells	cell	NOUN
dpc-5333	66	16	,	,	PUNCT
dpc-5333	66	17	t	t	NOUN
dpc-5333	66	18	cells	cell	NOUN
dpc-5333	66	19	,	,	PUNCT
dpc-5333	66	20	and	and	CCONJ
dpc-5333	66	21	natural	natural	ADJ
dpc-5333	66	22	killer	killer	NOUN
dpc-5333	66	23	(	(	PUNCT
dpc-5333	66	24	nk	nk	PROPN
dpc-5333	66	25	)	)	PUNCT
dpc-5333	66	26	cells	cell	NOUN
dpc-5333	66	27	in	in	ADP
dpc-5333	66	28	vitro	vitro	X
dpc-5333	66	29	compared	compare	VERB
dpc-5333	66	30	to	to	ADP
dpc-5333	66	31	bm	bm	NOUN
dpc-5333	66	32	-	-	PUNCT
dpc-5333	66	33	mscs	msc	NOUN
dpc-5333	66	34	and	and	CCONJ
dpc-5333	66	35	uc	uc	NOUN
dpc-5333	66	36	-	-	PUNCT
dpc-5333	66	37	mscs	mscs	NOUN
dpc-5333	66	38	[	[	X
dpc-5333	66	39	22	22	NUM
dpc-5333	66	40	]	]	PUNCT
dpc-5333	66	41	.	.	PUNCT
dpc-5333	67	1	however	however	ADV
dpc-5333	67	2	,	,	PUNCT
dpc-5333	67	3	the	the	DET
dpc-5333	67	4	three	three	NUM
dpc-5333	67	5	types	type	NOUN
dpc-5333	67	6	can	can	AUX
dpc-5333	67	7	all	all	ADV
dpc-5333	67	8	contribute	contribute	VERB
dpc-5333	67	9	to	to	ADP
dpc-5333	67	10	the	the	DET
dpc-5333	67	11	polarization	polarization	NOUN
dpc-5333	67	12	of	of	ADP
dpc-5333	67	13	tregs	treg	NOUN
dpc-5333	67	14	and	and	CCONJ
dpc-5333	67	15	th1	th1	NOUN
dpc-5333	67	16	cells	cell	NOUN
dpc-5333	67	17	.	.	PUNCT
dpc-5333	68	1	the	the	DET
dpc-5333	68	2	increased	increase	VERB
dpc-5333	68	3	expression	expression	NOUN
dpc-5333	68	4	of	of	ADP
dpc-5333	68	5	transcription	transcription	NOUN
dpc-5333	68	6	factors	factor	NOUN
dpc-5333	68	7	foxp3	foxp3	NOUN
dpc-5333	68	8	and	and	CCONJ
dpc-5333	68	9	t	t	PROPN
dpc-5333	68	10	-	-	PUNCT
dpc-5333	68	11	bet	bet	NOUN
dpc-5333	68	12	within	within	ADP
dpc-5333	68	13	activated	activate	VERB
dpc-5333	68	14	t	t	NOUN
dpc-5333	68	15	cells	cell	NOUN
dpc-5333	68	16	serves	serve	VERB
dpc-5333	68	17	as	as	ADP
dpc-5333	68	18	evidence	evidence	NOUN
dpc-5333	68	19	of	of	ADP
dpc-5333	68	20	this	this	PRON
dpc-5333	68	21	.	.	PUNCT
dpc-5333	69	1	these	these	DET
dpc-5333	69	2	three	three	NUM
dpc-5333	69	3	types	type	NOUN
dpc-5333	69	4	also	also	ADV
dpc-5333	69	5	cause	cause	VERB
dpc-5333	69	6	activated	activate	VERB
dpc-5333	69	7	nk	nk	PROPN
dpc-5333	69	8	cells	cell	NOUN
dpc-5333	69	9	to	to	PART
dpc-5333	69	10	make	make	VERB
dpc-5333	69	11	less	less	ADJ
dpc-5333	69	12	of	of	ADP
dpc-5333	69	13	the	the	DET
dpc-5333	69	14	effector	effector	NOUN
dpc-5333	69	15	molecules	molecule	NOUN
dpc-5333	69	16	tnf	tnf	PROPN
dpc-5333	69	17	-	-	PUNCT
dpc-5333	69	18	α	α	PROPN
dpc-5333	69	19	and	and	CCONJ
dpc-5333	69	20	perforin	perforin	NOUN
dpc-5333	70	1	[	[	X
dpc-5333	70	2	22	22	NUM
dpc-5333	70	3	]	]	PUNCT
dpc-5333	70	4	.	.	PUNCT
dpc-5333	71	1	mesenchymal	mesenchymal	ADJ
dpc-5333	71	2	stem	stem	NOUN
dpc-5333	71	3	cells	cell	NOUN
dpc-5333	71	4	,	,	PUNCT
dpc-5333	71	5	through	through	ADP
dpc-5333	71	6	their	their	PRON
dpc-5333	71	7	immunoregulatory	immunoregulatory	ADJ
dpc-5333	71	8	functions	function	NOUN
dpc-5333	71	9	,	,	PUNCT
dpc-5333	71	10	modulate	modulate	VERB
dpc-5333	71	11	both	both	CCONJ
dpc-5333	71	12	innate	innate	ADJ
dpc-5333	71	13	and	and	CCONJ
dpc-5333	71	14	adaptive	adaptive	ADJ
dpc-5333	71	15	immune	immune	ADJ
dpc-5333	71	16	responses	response	NOUN
dpc-5333	71	17	.	.	PUNCT
dpc-5333	72	1	these	these	DET
dpc-5333	72	2	functions	function	NOUN
dpc-5333	72	3	are	be	AUX
dpc-5333	72	4	exerted	exert	VERB
dpc-5333	72	5	via	via	ADP
dpc-5333	72	6	direct	direct	ADJ
dpc-5333	72	7	interactions	interaction	NOUN
dpc-5333	72	8	with	with	ADP
dpc-5333	72	9	various	various	ADJ
dpc-5333	72	10	immune	immune	ADJ
dpc-5333	72	11	cell	cell	NOUN
dpc-5333	72	12	types	type	NOUN
dpc-5333	72	13	,	,	PUNCT
dpc-5333	72	14	including	include	VERB
dpc-5333	72	15	t	t	NOUN
dpc-5333	72	16	cells	cell	NOUN
dpc-5333	72	17	,	,	PUNCT
dpc-5333	72	18	b	b	NOUN
dpc-5333	72	19	cells	cell	NOUN
dpc-5333	72	20	,	,	PUNCT
dpc-5333	72	21	natural	natural	ADJ
dpc-5333	72	22	killer	killer	NOUN
dpc-5333	72	23	cells	cell	NOUN
dpc-5333	72	24	,	,	PUNCT
dpc-5333	72	25	macrophages	macrophage	NOUN
dpc-5333	72	26	,	,	PUNCT
dpc-5333	72	27	monocytes	monocyte	NOUN
dpc-5333	72	28	,	,	PUNCT
dpc-5333	72	29	dendritic	dendritic	ADJ
dpc-5333	72	30	cells	cell	NOUN
dpc-5333	72	31	,	,	PUNCT
dpc-5333	72	32	and	and	CCONJ
dpc-5333	72	33	figure	figure	VERB
dpc-5333	72	34	1	1	NUM
dpc-5333	72	35	.	.	PUNCT
dpc-5333	72	36	mechanism	mechanism	NOUN
dpc-5333	72	37	of	of	ADP
dpc-5333	72	38	immunopathogenesis	immunopathogenesis	NOUN
dpc-5333	72	39	of	of	ADP
dpc-5333	72	40	psoriasis	psoriasis	NOUN
dpc-5333	72	41	.	.	PUNCT
dpc-5333	73	1	the	the	DET
dpc-5333	73	2	role	role	NOUN
dpc-5333	73	3	of	of	ADP
dpc-5333	73	4	dendritic	dendritic	ADJ
dpc-5333	73	5	cells	cell	NOUN
dpc-5333	73	6	(	(	PUNCT
dpc-5333	73	7	dc	dc	PROPN
dpc-5333	73	8	)	)	PUNCT
dpc-5333	73	9	and	and	CCONJ
dpc-5333	73	10	keratinocytes	keratinocyte	NOUN
dpc-5333	73	11	in	in	ADP
dpc-5333	73	12	the	the	DET
dpc-5333	73	13	activation	activation	NOUN
dpc-5333	73	14	of	of	ADP
dpc-5333	73	15	different	different	ADJ
dpc-5333	73	16	types	type	NOUN
dpc-5333	73	17	of	of	ADP
dpc-5333	73	18	t	t	PROPN
dpc-5333	73	19	lymphocytes	lymphocyte	NOUN
dpc-5333	73	20	has	have	AUX
dpc-5333	73	21	been	be	AUX
dpc-5333	73	22	shown	show	VERB
dpc-5333	73	23	.	.	PUNCT
dpc-5333	74	1	also	also	ADV
dpc-5333	74	2	,	,	PUNCT
dpc-5333	74	3	the	the	DET
dpc-5333	74	4	role	role	NOUN
dpc-5333	74	5	of	of	ADP
dpc-5333	74	6	different	different	ADJ
dpc-5333	74	7	lymphocytes	lymphocyte	NOUN
dpc-5333	74	8	in	in	ADP
dpc-5333	74	9	injury	injury	NOUN
dpc-5333	74	10	and	and	CCONJ
dpc-5333	74	11	inflammation	inflammation	NOUN
dpc-5333	74	12	caused	cause	VERB
dpc-5333	74	13	by	by	ADP
dpc-5333	74	14	vascular	vascular	ADJ
dpc-5333	74	15	permeability	permeability	NOUN
dpc-5333	74	16	has	have	AUX
dpc-5333	74	17	been	be	AUX
dpc-5333	74	18	shown	show	VERB
dpc-5333	74	19	.	.	PUNCT
dpc-5333	75	1	[	[	X
dpc-5333	75	2	created	create	VERB
dpc-5333	75	3	with	with	ADP
dpc-5333	75	4	biorender.com	biorender.com	X
dpc-5333	75	5	]	]	PUNCT
dpc-5333	75	6	4	4	NUM
dpc-5333	75	7	review	review	NOUN
dpc-5333	75	8	|	|	ADV
dpc-5333	75	9	dermatol	dermatol	ADJ
dpc-5333	75	10	pract	pract	NOUN
dpc-5333	75	11	concept	concept	NOUN
dpc-5333	75	12	.	.	PUNCT
dpc-5333	76	1	2025;15(3):5333	2025;15(3):5333	NUM
dpc-5333	76	2	neutrophils	neutrophil	NOUN
dpc-5333	76	3	as	as	ADV
dpc-5333	76	4	well	well	ADV
dpc-5333	76	5	as	as	ADP
dpc-5333	76	6	through	through	ADP
dpc-5333	76	7	paracrine	paracrine	NOUN
dpc-5333	76	8	signaling	signal	VERB
dpc-5333	76	9	mechanisms	mechanism	NOUN
dpc-5333	76	10	[	[	X
dpc-5333	76	11	23	23	NUM
dpc-5333	76	12	-	-	SYM
dpc-5333	76	13	27	27	NUM
dpc-5333	76	14	]	]	PUNCT
dpc-5333	76	15	.	.	PUNCT
dpc-5333	77	1	the	the	DET
dpc-5333	77	2	extracellular	extracellular	ADJ
dpc-5333	77	3	vesicles	vesicle	NOUN
dpc-5333	77	4	released	release	VERB
dpc-5333	77	5	by	by	ADP
dpc-5333	77	6	mesenchymal	mesenchymal	ADJ
dpc-5333	77	7	stem	stem	NOUN
dpc-5333	77	8	cells	cell	NOUN
dpc-5333	77	9	contain	contain	VERB
dpc-5333	77	10	a	a	DET
dpc-5333	77	11	secretome	secretome	NOUN
dpc-5333	77	12	comprising	comprise	VERB
dpc-5333	77	13	numerous	numerous	ADJ
dpc-5333	77	14	cytokines	cytokine	NOUN
dpc-5333	77	15	,	,	PUNCT
dpc-5333	77	16	growth	growth	NOUN
dpc-5333	77	17	factors	factor	NOUN
dpc-5333	77	18	,	,	PUNCT
dpc-5333	77	19	and	and	CCONJ
dpc-5333	77	20	chemokines	chemokine	NOUN
dpc-5333	77	21	.	.	PUNCT
dpc-5333	78	1	this	this	DET
dpc-5333	78	2	repertoire	repertoire	NOUN
dpc-5333	78	3	includes	include	VERB
dpc-5333	78	4	,	,	PUNCT
dpc-5333	78	5	but	but	CCONJ
dpc-5333	78	6	is	be	AUX
dpc-5333	78	7	not	not	PART
dpc-5333	78	8	limited	limit	VERB
dpc-5333	78	9	to	to	ADP
dpc-5333	78	10	,	,	PUNCT
dpc-5333	78	11	transforming	transform	VERB
dpc-5333	78	12	growth	growth	NOUN
dpc-5333	78	13	factor	factor	NOUN
dpc-5333	78	14	-	-	PUNCT
dpc-5333	78	15	beta	beta	NOUN
dpc-5333	78	16	1	1	NUM
dpc-5333	78	17	(	(	PUNCT
dpc-5333	78	18	tgf)-b1	tgf)-b1	PROPN
dpc-5333	78	19	,	,	PUNCT
dpc-5333	78	20	tnfα	tnfα	NOUN
dpc-5333	78	21	,	,	PUNCT
dpc-5333	78	22	prostaglandin	prostaglandin	NOUN
dpc-5333	78	23	e2	e2	NOUN
dpc-5333	78	24	,	,	PUNCT
dpc-5333	78	25	interferonγ	interferonγ	PROPN
dpc-5333	78	26	(	(	PUNCT
dpc-5333	78	27	ifn	ifn	PROPN
dpc-5333	78	28	-	-	PUNCT
dpc-5333	78	29	γ	γ	NOUN
dpc-5333	78	30	)	)	PUNCT
dpc-5333	78	31	,	,	PUNCT
dpc-5333	78	32	fibroblast	fibroblast	ADJ
dpc-5333	78	33	growth	growth	NOUN
dpc-5333	78	34	factor	factor	NOUN
dpc-5333	78	35	,	,	PUNCT
dpc-5333	78	36	hepatocyte	hepatocyte	NOUN
dpc-5333	78	37	growth	growth	NOUN
dpc-5333	78	38	factor	factor	NOUN
dpc-5333	78	39	,	,	PUNCT
dpc-5333	78	40	indoleamine	indoleamine	NOUN
dpc-5333	78	41	-	-	PUNCT
dpc-5333	78	42	pyrrole	pyrrole	ADJ
dpc-5333	78	43	2,3	2,3	NUM
dpc-5333	78	44	-	-	NOUN
dpc-5333	78	45	dioxygenase	dioxygenase	NOUN
dpc-5333	78	46	,	,	PUNCT
dpc-5333	78	47	and	and	CCONJ
dpc-5333	78	48	nitric	nitric	ADJ
dpc-5333	78	49	oxide	oxide	NOUN
dpc-5333	78	50	[	[	X
dpc-5333	78	51	28,29	28,29	NUM
dpc-5333	78	52	]	]	PUNCT
dpc-5333	78	53	.	.	PUNCT
dpc-5333	79	1	scalability	scalability	NOUN
dpc-5333	79	2	is	be	AUX
dpc-5333	79	3	one	one	NUM
dpc-5333	79	4	of	of	ADP
dpc-5333	79	5	the	the	DET
dpc-5333	79	6	key	key	ADJ
dpc-5333	79	7	obstacles	obstacle	NOUN
dpc-5333	79	8	in	in	ADP
dpc-5333	79	9	the	the	DET
dpc-5333	79	10	translational	translational	ADJ
dpc-5333	79	11	application	application	NOUN
dpc-5333	79	12	of	of	ADP
dpc-5333	79	13	mesenchymal	mesenchymal	ADJ
dpc-5333	79	14	stem	stem	NOUN
dpc-5333	79	15	cells	cell	NOUN
dpc-5333	79	16	.	.	PUNCT
dpc-5333	80	1	in	in	ADP
dpc-5333	80	2	this	this	DET
dpc-5333	80	3	context	context	NOUN
dpc-5333	80	4	,	,	PUNCT
dpc-5333	80	5	liposuction	liposuction	NOUN
dpc-5333	80	6	procedures	procedure	NOUN
dpc-5333	80	7	readily	readily	ADV
dpc-5333	80	8	harvest	harvest	VERB
dpc-5333	80	9	adscs	adsc	NOUN
dpc-5333	80	10	in	in	ADP
dpc-5333	80	11	large	large	ADJ
dpc-5333	80	12	volumes	volume	NOUN
dpc-5333	80	13	,	,	PUNCT
dpc-5333	80	14	making	make	VERB
dpc-5333	80	15	them	they	PRON
dpc-5333	80	16	the	the	DET
dpc-5333	80	17	preferred	preferred	ADJ
dpc-5333	80	18	option	option	NOUN
dpc-5333	81	1	[	[	X
dpc-5333	81	2	30,31	30,31	NOUN
dpc-5333	81	3	]	]	PUNCT
dpc-5333	81	4	.	.	PUNCT
dpc-5333	82	1	additionally	additionally	ADV
dpc-5333	82	2	,	,	PUNCT
dpc-5333	82	3	adscs	adsc	NOUN
dpc-5333	82	4	demonstrate	demonstrate	VERB
dpc-5333	82	5	enhanced	enhanced	ADJ
dpc-5333	82	6	proliferative	proliferative	ADJ
dpc-5333	82	7	abilities	ability	NOUN
dpc-5333	82	8	,	,	PUNCT
dpc-5333	82	9	higher	high	ADJ
dpc-5333	82	10	cell	cell	NOUN
dpc-5333	82	11	yields	yield	NOUN
dpc-5333	82	12	,	,	PUNCT
dpc-5333	82	13	slower	slow	ADJ
dpc-5333	82	14	rates	rate	NOUN
dpc-5333	82	15	of	of	ADP
dpc-5333	82	16	cellular	cellular	ADJ
dpc-5333	82	17	senescence	senescence	NOUN
dpc-5333	82	18	,	,	PUNCT
dpc-5333	82	19	and	and	CCONJ
dpc-5333	82	20	better	well	ADJ
dpc-5333	82	21	maintenance	maintenance	NOUN
dpc-5333	82	22	of	of	ADP
dpc-5333	82	23	a	a	DET
dpc-5333	82	24	normal	normal	ADJ
dpc-5333	82	25	diploid	diploid	ADJ
dpc-5333	82	26	chromosomal	chromosomal	ADJ
dpc-5333	82	27	complement	complement	NOUN
dpc-5333	82	28	relative	relative	ADJ
dpc-5333	82	29	to	to	ADP
dpc-5333	82	30	bm	bm	NOUN
dpc-5333	82	31	-	-	NOUN
dpc-5333	82	32	mscs	msc	NOUN
dpc-5333	82	33	[	[	X
dpc-5333	82	34	32	32	NUM
dpc-5333	82	35	-	-	SYM
dpc-5333	82	36	35	35	NUM
dpc-5333	82	37	]	]	PUNCT
dpc-5333	82	38	.	.	PUNCT
dpc-5333	83	1	early	early	ADJ
dpc-5333	83	2	phase	phase	NOUN
dpc-5333	83	3	clinical	clinical	ADJ
dpc-5333	83	4	trials	trial	NOUN
dpc-5333	83	5	have	have	AUX
dpc-5333	83	6	shown	show	VERB
dpc-5333	83	7	that	that	SCONJ
dpc-5333	83	8	mscs	msc	NOUN
dpc-5333	83	9	are	be	AUX
dpc-5333	83	10	safe	safe	ADJ
dpc-5333	83	11	and	and	CCONJ
dpc-5333	83	12	effective	effective	ADJ
dpc-5333	83	13	for	for	ADP
dpc-5333	83	14	treating	treat	VERB
dpc-5333	83	15	a	a	DET
dpc-5333	83	16	variety	variety	NOUN
dpc-5333	83	17	of	of	ADP
dpc-5333	83	18	imids	imid	NOUN
dpc-5333	83	19	.	.	PUNCT
dpc-5333	84	1	these	these	PRON
dpc-5333	84	2	include	include	VERB
dpc-5333	84	3	rheumatoid	rheumatoid	NOUN
dpc-5333	84	4	arthritis	arthritis	NOUN
dpc-5333	84	5	,	,	PUNCT
dpc-5333	84	6	systemic	systemic	ADJ
dpc-5333	84	7	lupus	lupus	NOUN
dpc-5333	84	8	erythematosus	erythematosus	NOUN
dpc-5333	84	9	(	(	PUNCT
dpc-5333	84	10	sle	sle	PROPN
dpc-5333	84	11	)	)	PUNCT
dpc-5333	84	12	,	,	PUNCT
dpc-5333	84	13	lupus	lupus	NOUN
dpc-5333	84	14	nephritis	nephritis	PROPN
dpc-5333	84	15	,	,	PUNCT
dpc-5333	84	16	sjögren	sjögren	PROPN
dpc-5333	84	17	’s	’s	PART
dpc-5333	84	18	syndrome	syndrome	PROPN
dpc-5333	84	19	(	(	PUNCT
dpc-5333	84	20	ss	ss	NOUN
dpc-5333	84	21	)	)	PUNCT
dpc-5333	84	22	,	,	PUNCT
dpc-5333	84	23	graft	graft	NOUN
dpc-5333	84	24	-	-	PUNCT
dpc-5333	84	25	versus	versus	ADP
dpc-5333	84	26	-	-	PUNCT
dpc-5333	84	27	host	host	NOUN
dpc-5333	84	28	disease	disease	NOUN
dpc-5333	84	29	(	(	PUNCT
dpc-5333	84	30	gvhd	gvhd	PROPN
dpc-5333	84	31	)	)	PUNCT
dpc-5333	84	32	,	,	PUNCT
dpc-5333	84	33	multiple	multiple	ADJ
dpc-5333	84	34	sclerosis	sclerosis	NOUN
dpc-5333	84	35	,	,	PUNCT
dpc-5333	84	36	type	type	NOUN
dpc-5333	84	37	1	1	NUM
dpc-5333	84	38	diabetes	diabetes	NOUN
dpc-5333	84	39	mellitus	mellitus	NOUN
dpc-5333	84	40	,	,	PUNCT
dpc-5333	84	41	autoimmune	autoimmune	ADJ
dpc-5333	84	42	hepatitis	hepatitis	NOUN
dpc-5333	84	43	,	,	PUNCT
dpc-5333	84	44	and	and	CCONJ
dpc-5333	84	45	inflammatory	inflammatory	ADJ
dpc-5333	84	46	bowel	bowel	NOUN
dpc-5333	84	47	disease	disease	NOUN
dpc-5333	84	48	(	(	PUNCT
dpc-5333	84	49	ibd	ibd	PROPN
dpc-5333	84	50	)	)	PUNCT
dpc-5333	85	1	[	[	X
dpc-5333	85	2	36	36	NUM
dpc-5333	85	3	-	-	SYM
dpc-5333	85	4	43	43	NUM
dpc-5333	85	5	]	]	PUNCT
dpc-5333	85	6	.	.	PUNCT
dpc-5333	86	1	a	a	DET
dpc-5333	86	2	study	study	NOUN
dpc-5333	86	3	of	of	ADP
dpc-5333	86	4	477	477	NUM
dpc-5333	86	5	crohn	crohn	PROPN
dpc-5333	86	6	’s	’s	PART
dpc-5333	86	7	disease	disease	NOUN
dpc-5333	86	8	patients	patient	NOUN
dpc-5333	86	9	with	with	ADP
dpc-5333	86	10	fistulas	fistula	NOUN
dpc-5333	86	11	found	find	VERB
dpc-5333	86	12	that	that	SCONJ
dpc-5333	86	13	those	those	PRON
dpc-5333	86	14	with	with	ADP
dpc-5333	86	15	severe	severe	ADJ
dpc-5333	86	16	disease	disease	NOUN
dpc-5333	86	17	healed	heal	VERB
dpc-5333	86	18	their	their	PRON
dpc-5333	86	19	fistulas	fistula	NOUN
dpc-5333	86	20	much	much	ADV
dpc-5333	86	21	faster	fast	ADV
dpc-5333	86	22	and	and	CCONJ
dpc-5333	86	23	had	have	VERB
dpc-5333	86	24	lower	low	ADJ
dpc-5333	86	25	recurrence	recurrence	NOUN
dpc-5333	86	26	rates	rate	NOUN
dpc-5333	86	27	when	when	SCONJ
dpc-5333	86	28	they	they	PRON
dpc-5333	86	29	were	be	AUX
dpc-5333	86	30	treated	treat	VERB
dpc-5333	86	31	with	with	ADP
dpc-5333	86	32	allogeneic	allogeneic	ADJ
dpc-5333	86	33	adscs	adsc	NOUN
dpc-5333	86	34	instead	instead	ADV
dpc-5333	86	35	of	of	ADP
dpc-5333	86	36	dose	dose	NOUN
dpc-5333	86	37	-	-	PUNCT
dpc-5333	86	38	adjusted	adjust	VERB
dpc-5333	86	39	bmmscs	bmmsc	NOUN
dpc-5333	86	40	.	.	PUNCT
dpc-5333	87	1	the	the	DET
dpc-5333	87	2	optimal	optimal	ADJ
dpc-5333	87	3	therapeutic	therapeutic	ADJ
dpc-5333	87	4	cell	cell	NOUN
dpc-5333	87	5	dose	dose	NOUN
dpc-5333	87	6	was	be	AUX
dpc-5333	87	7	found	find	VERB
dpc-5333	87	8	to	to	PART
dpc-5333	87	9	be	be	AUX
dpc-5333	87	10	2	2	NUM
dpc-5333	87	11	-	-	SYM
dpc-5333	87	12	4	4	NUM
dpc-5333	87	13	x	x	SYM
dpc-5333	87	14	10	10	NUM
dpc-5333	87	15	^	^	SYM
dpc-5333	87	16	7	7	NUM
dpc-5333	87	17	cells	cell	NOUN
dpc-5333	87	18	ml-1	ml-1	ADV
dpc-5333	87	19	,	,	PUNCT
dpc-5333	87	20	indicating	indicate	VERB
dpc-5333	87	21	the	the	DET
dpc-5333	87	22	considerable	considerable	ADJ
dpc-5333	87	23	promise	promise	NOUN
dpc-5333	87	24	of	of	ADP
dpc-5333	87	25	mesenchymal	mesenchymal	ADJ
dpc-5333	87	26	stem	stem	NOUN
dpc-5333	87	27	cells	cell	NOUN
dpc-5333	87	28	for	for	ADP
dpc-5333	87	29	the	the	DET
dpc-5333	87	30	treatment	treatment	NOUN
dpc-5333	87	31	of	of	ADP
dpc-5333	87	32	ibd	ibd	NOUN
dpc-5333	87	33	[	[	X
dpc-5333	87	34	44	44	NUM
dpc-5333	87	35	]	]	PUNCT
dpc-5333	87	36	.	.	PUNCT
dpc-5333	88	1	a	a	DET
dpc-5333	88	2	recent	recent	ADJ
dpc-5333	88	3	phase	phase	NOUN
dpc-5333	88	4	ii	ii	NOUN
dpc-5333	88	5	randomized	randomize	VERB
dpc-5333	88	6	controlled	control	VERB
dpc-5333	88	7	trial	trial	NOUN
dpc-5333	88	8	assessing	assess	VERB
dpc-5333	88	9	the	the	DET
dpc-5333	88	10	efficacy	efficacy	NOUN
dpc-5333	88	11	of	of	ADP
dpc-5333	88	12	autologous	autologous	ADJ
dpc-5333	88	13	mesenchymal	mesenchymal	NOUN
dpc-5333	88	14	stem	stem	NOUN
dpc-5333	88	15	cell	cell	NOUN
dpc-5333	88	16	administration	administration	NOUN
dpc-5333	88	17	in	in	ADP
dpc-5333	88	18	48	48	NUM
dpc-5333	88	19	individuals	individual	NOUN
dpc-5333	88	20	with	with	ADP
dpc-5333	88	21	multiple	multiple	ADJ
dpc-5333	88	22	sclerosis	sclerosis	NOUN
dpc-5333	88	23	(	(	PUNCT
dpc-5333	88	24	ms	ms	NOUN
dpc-5333	88	25	)	)	PUNCT
dpc-5333	88	26	revealed	reveal	VERB
dpc-5333	88	27	that	that	SCONJ
dpc-5333	88	28	58.6	58.6	NUM
dpc-5333	88	29	%	%	NOUN
dpc-5333	88	30	of	of	ADP
dpc-5333	88	31	the	the	DET
dpc-5333	88	32	treatment	treatment	NOUN
dpc-5333	88	33	group	group	NOUN
dpc-5333	88	34	exhibited	exhibit	VERB
dpc-5333	88	35	disease	disease	NOUN
dpc-5333	88	36	remission	remission	NOUN
dpc-5333	88	37	,	,	PUNCT
dpc-5333	88	38	a	a	DET
dpc-5333	88	39	significantly	significantly	ADV
dpc-5333	88	40	higher	high	ADJ
dpc-5333	88	41	proportion	proportion	NOUN
dpc-5333	88	42	than	than	ADP
dpc-5333	88	43	the	the	DET
dpc-5333	88	44	9.7	9.7	NUM
dpc-5333	88	45	%	%	NOUN
dpc-5333	88	46	observed	observe	VERB
dpc-5333	88	47	in	in	ADP
dpc-5333	88	48	the	the	DET
dpc-5333	88	49	sham	sham	NOUN
dpc-5333	88	50	-	-	PUNCT
dpc-5333	88	51	treatment	treatment	NOUN
dpc-5333	88	52	cohort	cohort	NOUN
dpc-5333	88	53	,	,	PUNCT
dpc-5333	88	54	with	with	ADP
dpc-5333	88	55	no	no	DET
dpc-5333	88	56	safety	safety	NOUN
dpc-5333	88	57	concern	concern	NOUN
dpc-5333	88	58	identified	identify	VERB
dpc-5333	88	59	throughout	throughout	ADP
dpc-5333	88	60	the	the	DET
dpc-5333	88	61	study	study	NOUN
dpc-5333	88	62	[	[	X
dpc-5333	88	63	43	43	NUM
dpc-5333	88	64	]	]	PUNCT
dpc-5333	88	65	.	.	PUNCT
dpc-5333	89	1	the	the	DET
dpc-5333	89	2	majority	majority	NOUN
dpc-5333	89	3	of	of	ADP
dpc-5333	89	4	mesenchymal	mesenchymal	NOUN
dpc-5333	89	5	stem	stem	NOUN
dpc-5333	89	6	cell	cell	NOUN
dpc-5333	89	7	-	-	PUNCT
dpc-5333	89	8	based	base	VERB
dpc-5333	89	9	clinical	clinical	ADJ
dpc-5333	89	10	trials	trial	NOUN
dpc-5333	89	11	targeting	target	VERB
dpc-5333	89	12	immune	immune	NOUN
dpc-5333	89	13	-	-	PUNCT
dpc-5333	89	14	mediated	mediate	VERB
dpc-5333	89	15	inflammatory	inflammatory	ADJ
dpc-5333	89	16	diseases	disease	NOUN
dpc-5333	89	17	remain	remain	VERB
dpc-5333	89	18	in	in	ADP
dpc-5333	89	19	early	early	ADJ
dpc-5333	89	20	phase	phase	NOUN
dpc-5333	89	21	i	i	PRON
dpc-5333	89	22	or	or	CCONJ
dpc-5333	89	23	ii	ii	NOUN
dpc-5333	89	24	,	,	PUNCT
dpc-5333	89	25	demonstrating	demonstrate	VERB
dpc-5333	89	26	some	some	DET
dpc-5333	89	27	promising	promising	ADJ
dpc-5333	89	28	results	result	NOUN
dpc-5333	89	29	without	without	ADP
dpc-5333	89	30	any	any	DET
dpc-5333	89	31	observed	observed	ADJ
dpc-5333	89	32	toxicity	toxicity	NOUN
dpc-5333	89	33	thus	thus	ADV
dpc-5333	89	34	far	far	ADV
dpc-5333	89	35	.	.	PUNCT
dpc-5333	90	1	nevertheless	nevertheless	ADV
dpc-5333	90	2	,	,	PUNCT
dpc-5333	90	3	larger	large	ADJ
dpc-5333	90	4	controlled	control	VERB
dpc-5333	90	5	trials	trial	NOUN
dpc-5333	90	6	are	be	AUX
dpc-5333	90	7	still	still	ADV
dpc-5333	90	8	required	require	VERB
dpc-5333	90	9	to	to	PART
dpc-5333	90	10	definitively	definitively	ADV
dpc-5333	90	11	confirm	confirm	VERB
dpc-5333	90	12	the	the	DET
dpc-5333	90	13	efficacy	efficacy	NOUN
dpc-5333	90	14	and	and	CCONJ
dpc-5333	90	15	long	long	ADJ
dpc-5333	90	16	-	-	PUNCT
dpc-5333	90	17	term	term	NOUN
dpc-5333	90	18	safety	safety	NOUN
dpc-5333	90	19	of	of	ADP
dpc-5333	90	20	these	these	DET
dpc-5333	90	21	stem	stem	NOUN
dpc-5333	90	22	cell	cell	NOUN
dpc-5333	90	23	-	-	PUNCT
dpc-5333	90	24	based	base	VERB
dpc-5333	90	25	interventions	intervention	NOUN
dpc-5333	90	26	[	[	X
dpc-5333	90	27	35,36,38,39,42,43	35,36,38,39,42,43	NUM
dpc-5333	90	28	]	]	PUNCT
dpc-5333	90	29	.	.	PUNCT
dpc-5333	91	1	researchers	researcher	NOUN
dpc-5333	91	2	have	have	AUX
dpc-5333	91	3	identified	identify	VERB
dpc-5333	91	4	the	the	DET
dpc-5333	91	5	potential	potential	NOUN
dpc-5333	91	6	for	for	ADP
dpc-5333	91	7	carcinogenesis	carcinogenesis	NOUN
dpc-5333	91	8	as	as	ADP
dpc-5333	91	9	a	a	DET
dpc-5333	91	10	theoretical	theoretical	ADJ
dpc-5333	91	11	pitfall	pitfall	NOUN
dpc-5333	91	12	or	or	CCONJ
dpc-5333	91	13	concern	concern	NOUN
dpc-5333	91	14	associated	associate	VERB
dpc-5333	91	15	with	with	ADP
dpc-5333	91	16	the	the	DET
dpc-5333	91	17	use	use	NOUN
dpc-5333	91	18	of	of	ADP
dpc-5333	91	19	msc	msc	PROPN
dpc-5333	91	20	therapies	therapy	NOUN
dpc-5333	91	21	[	[	X
dpc-5333	91	22	18,45,46	18,45,46	NUM
dpc-5333	91	23	]	]	PUNCT
dpc-5333	91	24	.	.	PUNCT
dpc-5333	92	1	the	the	DET
dpc-5333	92	2	accumulating	accumulate	VERB
dpc-5333	92	3	knowledge	knowledge	NOUN
dpc-5333	92	4	and	and	CCONJ
dpc-5333	92	5	clinical	clinical	ADJ
dpc-5333	92	6	experience	experience	NOUN
dpc-5333	92	7	with	with	ADP
dpc-5333	92	8	mesenchymal	mesenchymal	ADJ
dpc-5333	92	9	stem	stem	NOUN
dpc-5333	92	10	cell	cell	NOUN
dpc-5333	92	11	therapies	therapy	NOUN
dpc-5333	92	12	have	have	AUX
dpc-5333	92	13	not	not	PART
dpc-5333	92	14	yet	yet	ADV
dpc-5333	92	15	led	lead	VERB
dpc-5333	92	16	to	to	ADP
dpc-5333	92	17	the	the	DET
dpc-5333	92	18	establishment	establishment	NOUN
dpc-5333	92	19	of	of	ADP
dpc-5333	92	20	a	a	DET
dpc-5333	92	21	standardized	standardized	ADJ
dpc-5333	92	22	dosing	dose	VERB
dpc-5333	92	23	regimen	regiman	NOUN
dpc-5333	92	24	,	,	PUNCT
dpc-5333	92	25	as	as	SCONJ
dpc-5333	92	26	the	the	DET
dpc-5333	92	27	cell	cell	NOUN
dpc-5333	92	28	dose	dose	NOUN
dpc-5333	92	29	and	and	CCONJ
dpc-5333	92	30	administration	administration	NOUN
dpc-5333	92	31	frequency	frequency	NOUN
dpc-5333	92	32	continue	continue	VERB
dpc-5333	92	33	to	to	PART
dpc-5333	92	34	vary	vary	VERB
dpc-5333	92	35	across	across	ADP
dpc-5333	92	36	different	different	ADJ
dpc-5333	92	37	trials	trial	NOUN
dpc-5333	92	38	.	.	PUNCT
dpc-5333	93	1	therefore	therefore	ADV
dpc-5333	93	2	,	,	PUNCT
dpc-5333	93	3	we	we	PRON
dpc-5333	93	4	have	have	VERB
dpc-5333	93	5	yet	yet	ADV
dpc-5333	93	6	to	to	PART
dpc-5333	93	7	definitively	definitively	ADV
dpc-5333	93	8	determine	determine	VERB
dpc-5333	93	9	the	the	DET
dpc-5333	93	10	optimal	optimal	ADJ
dpc-5333	93	11	dosing	dosing	ADJ
dpc-5333	93	12	parameters	parameter	NOUN
dpc-5333	93	13	for	for	ADP
dpc-5333	93	14	these	these	DET
dpc-5333	93	15	therapeutic	therapeutic	ADJ
dpc-5333	93	16	approaches	approach	NOUN
dpc-5333	93	17	.	.	PUNCT
dpc-5333	94	1	regulatory	regulatory	ADJ
dpc-5333	94	2	t	t	PROPN
dpc-5333	94	3	cells	cell	NOUN
dpc-5333	94	4	regulatory	regulatory	ADJ
dpc-5333	94	5	t	t	PROPN
dpc-5333	94	6	cells	cell	NOUN
dpc-5333	94	7	(	(	PUNCT
dpc-5333	94	8	tregs	treg	NOUN
dpc-5333	94	9	)	)	PUNCT
dpc-5333	94	10	plays	play	VERB
dpc-5333	94	11	a	a	DET
dpc-5333	94	12	suppressive	suppressive	ADJ
dpc-5333	94	13	role	role	NOUN
dpc-5333	94	14	,	,	PUNCT
dpc-5333	94	15	modulating	modulate	VERB
dpc-5333	94	16	the	the	DET
dpc-5333	94	17	responses	response	NOUN
dpc-5333	94	18	of	of	ADP
dpc-5333	94	19	other	other	ADJ
dpc-5333	94	20	immune	immune	ADJ
dpc-5333	94	21	cells	cell	NOUN
dpc-5333	94	22	to	to	ADP
dpc-5333	94	23	the	the	DET
dpc-5333	94	24	body	body	NOUN
dpc-5333	94	25	’s	’s	PART
dpc-5333	94	26	own	own	ADJ
dpc-5333	94	27	environment	environment	NOUN
dpc-5333	94	28	and	and	CCONJ
dpc-5333	94	29	antigens	antigen	NOUN
dpc-5333	94	30	.	.	PUNCT
dpc-5333	95	1	this	this	DET
dpc-5333	95	2	regulatory	regulatory	ADJ
dpc-5333	95	3	function	function	NOUN
dpc-5333	95	4	of	of	ADP
dpc-5333	95	5	tregs	treg	NOUN
dpc-5333	95	6	works	work	VERB
dpc-5333	95	7	to	to	PART
dpc-5333	95	8	prevent	prevent	VERB
dpc-5333	95	9	the	the	DET
dpc-5333	95	10	onset	onset	NOUN
dpc-5333	95	11	of	of	ADP
dpc-5333	95	12	autoimmune	autoimmune	ADJ
dpc-5333	95	13	disorders	disorder	NOUN
dpc-5333	95	14	and	and	CCONJ
dpc-5333	95	15	chronic	chronic	ADJ
dpc-5333	95	16	inflammatory	inflammatory	ADJ
dpc-5333	95	17	states	state	NOUN
dpc-5333	95	18	.	.	PUNCT
dpc-5333	96	1	tregs	treg	NOUN
dpc-5333	96	2	utilize	utilize	VERB
dpc-5333	96	3	multiple	multiple	ADJ
dpc-5333	96	4	methods	method	NOUN
dpc-5333	96	5	to	to	PART
dpc-5333	96	6	execute	execute	VERB
dpc-5333	96	7	their	their	PRON
dpc-5333	96	8	regulatory	regulatory	ADJ
dpc-5333	96	9	and	and	CCONJ
dpc-5333	96	10	suppressive	suppressive	ADJ
dpc-5333	96	11	roles	role	NOUN
dpc-5333	96	12	,	,	PUNCT
dpc-5333	96	13	including	include	VERB
dpc-5333	96	14	releasing	release	VERB
dpc-5333	96	15	inhibitory	inhibitory	ADJ
dpc-5333	96	16	cytokines	cytokine	NOUN
dpc-5333	96	17	like	like	ADP
dpc-5333	96	18	il-10	il-10	PRON
dpc-5333	96	19	,	,	PUNCT
dpc-5333	96	20	interfering	interfere	VERB
dpc-5333	96	21	with	with	ADP
dpc-5333	96	22	the	the	DET
dpc-5333	96	23	metabolism	metabolism	NOUN
dpc-5333	96	24	of	of	ADP
dpc-5333	96	25	other	other	ADJ
dpc-5333	96	26	immune	immune	ADJ
dpc-5333	96	27	cells	cell	NOUN
dpc-5333	96	28	,	,	PUNCT
dpc-5333	96	29	altering	alter	VERB
dpc-5333	96	30	the	the	DET
dpc-5333	96	31	maturation	maturation	NOUN
dpc-5333	96	32	and	and	CCONJ
dpc-5333	96	33	functioning	functioning	NOUN
dpc-5333	96	34	of	of	ADP
dpc-5333	96	35	dendritic	dendritic	ADJ
dpc-5333	96	36	cells	cell	NOUN
dpc-5333	96	37	,	,	PUNCT
dpc-5333	96	38	binding	bind	VERB
dpc-5333	96	39	lymphocyte	lymphocyte	ADJ
dpc-5333	96	40	activation	activation	NOUN
dpc-5333	96	41	gene	gene	NOUN
dpc-5333	96	42	3	3	NUM
dpc-5333	96	43	to	to	ADP
dpc-5333	96	44	mhc	mhc	PROPN
dpc-5333	96	45	class	class	PROPN
dpc-5333	96	46	ii	ii	PROPN
dpc-5333	96	47	,	,	PUNCT
dpc-5333	96	48	and	and	CCONJ
dpc-5333	96	49	carrying	carry	VERB
dpc-5333	96	50	out	out	ADP
dpc-5333	96	51	cytolysis	cytolysis	NOUN
dpc-5333	96	52	via	via	ADP
dpc-5333	96	53	granzyme	granzyme	NOUN
dpc-5333	96	54	a	a	DET
dpc-5333	96	55	/	/	SYM
dpc-5333	96	56	b	b	NOUN
dpc-5333	96	57	and	and	CCONJ
dpc-5333	96	58	perforin	perforin	NOUN
dpc-5333	97	1	[	[	X
dpc-5333	97	2	47	47	NUM
dpc-5333	97	3	]	]	PUNCT
dpc-5333	97	4	.	.	PUNCT
dpc-5333	98	1	numerous	numerous	ADJ
dpc-5333	98	2	therapies	therapy	NOUN
dpc-5333	98	3	for	for	ADP
dpc-5333	98	4	psoriasis	psoriasis	NOUN
dpc-5333	98	5	seem	seem	VERB
dpc-5333	98	6	to	to	PART
dpc-5333	98	7	increase	increase	VERB
dpc-5333	98	8	the	the	DET
dpc-5333	98	9	quantity	quantity	NOUN
dpc-5333	98	10	of	of	ADP
dpc-5333	98	11	tregs	treg	NOUN
dpc-5333	98	12	and	and	CCONJ
dpc-5333	98	13	enhance	enhance	VERB
dpc-5333	98	14	their	their	PRON
dpc-5333	98	15	regulatory	regulatory	ADJ
dpc-5333	98	16	function	function	NOUN
dpc-5333	98	17	in	in	ADP
dpc-5333	98	18	individuals	individual	NOUN
dpc-5333	98	19	with	with	ADP
dpc-5333	98	20	psoriasis	psoriasis	NOUN
dpc-5333	98	21	.	.	PUNCT
dpc-5333	99	1	anti	anti	ADJ
dpc-5333	99	2	-	-	ADJ
dpc-5333	99	3	tnf	tnf	ADJ
dpc-5333	99	4	therapies	therapy	NOUN
dpc-5333	99	5	,	,	PUNCT
dpc-5333	99	6	particularly	particularly	ADV
dpc-5333	99	7	the	the	DET
dpc-5333	99	8	drug	drug	NOUN
dpc-5333	99	9	etanercept	etanercept	VERB
dpc-5333	99	10	,	,	PUNCT
dpc-5333	99	11	have	have	VERB
dpc-5333	99	12	the	the	DET
dpc-5333	99	13	effect	effect	NOUN
dpc-5333	99	14	of	of	ADP
dpc-5333	99	15	boosting	boost	VERB
dpc-5333	99	16	treg	treg	PROPN
dpc-5333	99	17	levels	level	NOUN
dpc-5333	99	18	and	and	CCONJ
dpc-5333	99	19	reducing	reduce	VERB
dpc-5333	99	20	the	the	DET
dpc-5333	99	21	expression	expression	NOUN
dpc-5333	99	22	of	of	ADP
dpc-5333	99	23	the	the	DET
dpc-5333	99	24	inflammatory	inflammatory	ADJ
dpc-5333	99	25	cytokines	cytokine	NOUN
dpc-5333	99	26	il-6	il-6	PRON
dpc-5333	99	27	and	and	CCONJ
dpc-5333	99	28	il-22	il-22	NOUN
dpc-5333	100	1	[	[	X
dpc-5333	100	2	48	48	NUM
dpc-5333	100	3	]	]	PUNCT
dpc-5333	100	4	.	.	PUNCT
dpc-5333	101	1	elevated	elevated	ADJ
dpc-5333	101	2	numbers	number	NOUN
dpc-5333	101	3	of	of	ADP
dpc-5333	101	4	these	these	DET
dpc-5333	101	5	suppressor	suppressor	NOUN
dpc-5333	101	6	t	t	PROPN
dpc-5333	101	7	cells	cell	NOUN
dpc-5333	101	8	seem	seem	VERB
dpc-5333	101	9	to	to	PART
dpc-5333	101	10	correlate	correlate	VERB
dpc-5333	101	11	with	with	ADP
dpc-5333	101	12	enhanced	enhanced	ADJ
dpc-5333	101	13	clinical	clinical	ADJ
dpc-5333	101	14	results	result	NOUN
dpc-5333	101	15	for	for	ADP
dpc-5333	101	16	individuals	individual	NOUN
dpc-5333	101	17	.	.	PUNCT
dpc-5333	102	1	moreover	moreover	ADV
dpc-5333	102	2	,	,	PUNCT
dpc-5333	102	3	the	the	DET
dpc-5333	102	4	anti	anti	ADJ
dpc-5333	102	5	-	-	ADJ
dpc-5333	102	6	tnf	tnf	ADJ
dpc-5333	102	7	drug	drug	NOUN
dpc-5333	102	8	infliximab	infliximab	NOUN
dpc-5333	102	9	appears	appear	VERB
dpc-5333	102	10	to	to	PART
dpc-5333	102	11	promote	promote	VERB
dpc-5333	102	12	a	a	DET
dpc-5333	102	13	more	more	ADV
dpc-5333	102	14	varied	varied	ADJ
dpc-5333	102	15	t	t	NOUN
dpc-5333	102	16	cell	cell	NOUN
dpc-5333	102	17	receptor	receptor	NOUN
dpc-5333	102	18	array	array	VERB
dpc-5333	103	1	[	[	X
dpc-5333	103	2	49	49	NUM
dpc-5333	103	3	]	]	PUNCT
dpc-5333	103	4	.	.	PUNCT
dpc-5333	104	1	one	one	NUM
dpc-5333	104	2	investigation	investigation	NOUN
dpc-5333	104	3	discovered	discover	VERB
dpc-5333	104	4	that	that	SCONJ
dpc-5333	104	5	suppressing	suppress	VERB
dpc-5333	104	6	tnf	tnf	PROPN
dpc-5333	104	7	led	lead	VERB
dpc-5333	104	8	to	to	ADP
dpc-5333	104	9	elevated	elevated	ADJ
dpc-5333	104	10	secretion	secretion	NOUN
dpc-5333	104	11	of	of	ADP
dpc-5333	104	12	inflammatory	inflammatory	ADJ
dpc-5333	104	13	cytokines	cytokine	NOUN
dpc-5333	104	14	and	and	CCONJ
dpc-5333	104	15	heightened	heighten	VERB
dpc-5333	104	16	effector	effector	NOUN
dpc-5333	104	17	th17	th17	PROPN
dpc-5333	104	18	cell	cell	NOUN
dpc-5333	104	19	function	function	NOUN
dpc-5333	104	20	.	.	PUNCT
dpc-5333	105	1	conversely	conversely	ADV
dpc-5333	105	2	,	,	PUNCT
dpc-5333	105	3	the	the	DET
dpc-5333	105	4	quantity	quantity	NOUN
dpc-5333	105	5	of	of	ADP
dpc-5333	105	6	suppressor	suppressor	NOUN
dpc-5333	105	7	tregs	treg	NOUN
dpc-5333	105	8	and	and	CCONJ
dpc-5333	105	9	their	their	PRON
dpc-5333	105	10	foxp3	foxp3	NOUN
dpc-5333	105	11	marker	marker	NOUN
dpc-5333	105	12	were	be	AUX
dpc-5333	105	13	diminished	diminish	VERB
dpc-5333	105	14	.	.	PUNCT
dpc-5333	106	1	this	this	PRON
dpc-5333	106	2	ultimately	ultimately	ADV
dpc-5333	106	3	culminated	culminate	VERB
dpc-5333	106	4	in	in	ADP
dpc-5333	106	5	exacerbation	exacerbation	NOUN
dpc-5333	106	6	of	of	ADP
dpc-5333	106	7	the	the	DET
dpc-5333	106	8	pathological	pathological	ADJ
dpc-5333	106	9	state	state	NOUN
dpc-5333	106	10	[	[	X
dpc-5333	106	11	50	50	NUM
dpc-5333	106	12	]	]	PUNCT
dpc-5333	106	13	.	.	PUNCT
dpc-5333	107	1	a	a	DET
dpc-5333	107	2	number	number	NOUN
dpc-5333	107	3	of	of	ADP
dpc-5333	107	4	biologic	biologic	NOUN
dpc-5333	107	5	drugs	drug	NOUN
dpc-5333	107	6	have	have	AUX
dpc-5333	107	7	received	receive	VERB
dpc-5333	107	8	approval	approval	NOUN
dpc-5333	107	9	for	for	ADP
dpc-5333	107	10	the	the	DET
dpc-5333	107	11	treatment	treatment	NOUN
dpc-5333	107	12	of	of	ADP
dpc-5333	107	13	psoriasis	psoriasis	NOUN
dpc-5333	107	14	,	,	PUNCT
dpc-5333	107	15	such	such	ADJ
dpc-5333	107	16	as	as	ADP
dpc-5333	107	17	anti	anti	ADJ
dpc-5333	107	18	-	-	ADJ
dpc-5333	107	19	il-23	il-23	ADJ
dpc-5333	107	20	therapies	therapy	NOUN
dpc-5333	107	21	including	include	VERB
dpc-5333	107	22	the	the	DET
dpc-5333	107	23	p40	p40	NOUN
dpc-5333	107	24	-	-	PUNCT
dpc-5333	107	25	targeted	target	VERB
dpc-5333	107	26	medication	medication	NOUN
dpc-5333	107	27	ustekinumab	ustekinumab	NOUN
dpc-5333	107	28	and	and	CCONJ
dpc-5333	107	29	the	the	DET
dpc-5333	107	30	p19	p19	NOUN
dpc-5333	107	31	-	-	PUNCT
dpc-5333	107	32	targeted	target	VERB
dpc-5333	107	33	drug	drug	NOUN
dpc-5333	107	34	guselkumab	guselkumab	NOUN
dpc-5333	107	35	,	,	PUNCT
dpc-5333	107	36	as	as	ADV
dpc-5333	107	37	well	well	ADV
dpc-5333	107	38	as	as	ADP
dpc-5333	107	39	the	the	DET
dpc-5333	107	40	anti	anti	ADJ
dpc-5333	107	41	-	-	ADJ
dpc-5333	107	42	il-17a	il-17a	ADJ
dpc-5333	107	43	agent	agent	NOUN
dpc-5333	107	44	secukinumab	secukinumab	NOUN
dpc-5333	108	1	[	[	X
dpc-5333	108	2	51	51	NUM
dpc-5333	108	3	-	-	SYM
dpc-5333	108	4	55	55	NUM
dpc-5333	108	5	]	]	PUNCT
dpc-5333	108	6	.	.	PUNCT
dpc-5333	109	1	beyond	beyond	ADP
dpc-5333	109	2	the	the	DET
dpc-5333	109	3	previously	previously	ADV
dpc-5333	109	4	cited	cite	VERB
dpc-5333	109	5	biologics	biologic	NOUN
dpc-5333	109	6	,	,	PUNCT
dpc-5333	109	7	there	there	PRON
dpc-5333	109	8	are	be	VERB
dpc-5333	109	9	other	other	ADJ
dpc-5333	109	10	anti	anti	ADJ
dpc-5333	109	11	-	-	ADJ
dpc-5333	109	12	il-23	il-23	ADJ
dpc-5333	109	13	medications	medication	NOUN
dpc-5333	109	14	such	such	ADJ
dpc-5333	109	15	as	as	ADP
dpc-5333	109	16	risankizumab	risankizumab	NOUN
dpc-5333	109	17	,	,	PUNCT
dpc-5333	109	18	guselkumab	guselkumab	NOUN
dpc-5333	109	19	,	,	PUNCT
dpc-5333	109	20	briakinumab	briakinumab	NOUN
dpc-5333	109	21	,	,	PUNCT
dpc-5333	109	22	and	and	CCONJ
dpc-5333	109	23	tildrakizumab	tildrakizumab	NOUN
dpc-5333	109	24	,	,	PUNCT
dpc-5333	109	25	in	in	ADP
dpc-5333	109	26	addition	addition	NOUN
dpc-5333	109	27	to	to	ADP
dpc-5333	109	28	anti	anti	ADJ
dpc-5333	109	29	-	-	ADJ
dpc-5333	109	30	il-17	il-17	ADJ
dpc-5333	109	31	agents	agent	NOUN
dpc-5333	109	32	like	like	ADP
dpc-5333	109	33	ixekizumab	ixekizumab	NOUN
dpc-5333	109	34	and	and	CCONJ
dpc-5333	109	35	brodalumab	brodalumab	NOUN
dpc-5333	109	36	,	,	PUNCT
dpc-5333	109	37	that	that	PRON
dpc-5333	109	38	have	have	AUX
dpc-5333	109	39	been	be	AUX
dpc-5333	109	40	approved	approve	VERB
dpc-5333	109	41	and	and	CCONJ
dpc-5333	109	42	are	be	AUX
dpc-5333	109	43	commercially	commercially	ADV
dpc-5333	109	44	available	available	ADJ
dpc-5333	109	45	[	[	X
dpc-5333	109	46	52,53,56	52,53,56	NUM
dpc-5333	109	47	]	]	PUNCT
dpc-5333	109	48	.	.	PUNCT
dpc-5333	110	1	studies	study	NOUN
dpc-5333	110	2	have	have	AUX
dpc-5333	110	3	indicated	indicate	VERB
dpc-5333	110	4	that	that	SCONJ
dpc-5333	110	5	both	both	CCONJ
dpc-5333	110	6	antiil-17a	antiil-17a	PROPN
dpc-5333	110	7	and	and	CCONJ
dpc-5333	110	8	anti	anti	ADJ
dpc-5333	110	9	-	-	ADJ
dpc-5333	110	10	il-23	il-23	ADJ
dpc-5333	110	11	treatments	treatment	NOUN
dpc-5333	110	12	can	can	AUX
dpc-5333	110	13	enhance	enhance	VERB
dpc-5333	110	14	the	the	DET
dpc-5333	110	15	numbers	number	NOUN
dpc-5333	110	16	of	of	ADP
dpc-5333	110	17	foxp3	foxp3	NOUN
dpc-5333	110	18	-	-	PUNCT
dpc-5333	110	19	expressing	express	VERB
dpc-5333	110	20	regulatory	regulatory	ADJ
dpc-5333	110	21	t	t	NOUN
dpc-5333	110	22	cells	cell	NOUN
dpc-5333	110	23	.	.	PUNCT
dpc-5333	111	1	the	the	DET
dpc-5333	111	2	restoration	restoration	NOUN
dpc-5333	111	3	of	of	ADP
dpc-5333	111	4	a	a	DET
dpc-5333	111	5	healthy	healthy	ADJ
dpc-5333	111	6	th17	th17	NOUN
dpc-5333	111	7	/	/	SYM
dpc-5333	111	8	treg	treg	PROPN
dpc-5333	111	9	balance	balance	NOUN
dpc-5333	111	10	through	through	ADP
dpc-5333	111	11	anti	anti	ADJ
dpc-5333	111	12	-	-	ADJ
dpc-5333	111	13	il-17	il-17	ADJ
dpc-5333	111	14	treatment	treatment	NOUN
dpc-5333	111	15	may	may	AUX
dpc-5333	111	16	therefore	therefore	ADV
dpc-5333	111	17	serve	serve	VERB
dpc-5333	111	18	to	to	PART
dpc-5333	111	19	reduce	reduce	VERB
dpc-5333	111	20	inflammation	inflammation	NOUN
dpc-5333	111	21	and	and	CCONJ
dpc-5333	111	22	ameliorate	ameliorate	VERB
dpc-5333	111	23	the	the	DET
dpc-5333	111	24	disease	disease	NOUN
dpc-5333	111	25	in	in	ADP
dpc-5333	111	26	psoriasis	psoriasis	NOUN
dpc-5333	111	27	patients	patient	NOUN
dpc-5333	111	28	.	.	PUNCT
dpc-5333	112	1	a	a	DET
dpc-5333	112	2	recently	recently	ADV
dpc-5333	112	3	conducted	conduct	VERB
dpc-5333	112	4	preliminary	preliminary	ADJ
dpc-5333	112	5	clinical	clinical	ADJ
dpc-5333	112	6	study	study	NOUN
dpc-5333	112	7	evaluated	evaluate	VERB
dpc-5333	112	8	the	the	DET
dpc-5333	112	9	use	use	NOUN
dpc-5333	112	10	of	of	ADP
dpc-5333	112	11	low	low	ADJ
dpc-5333	112	12	-	-	PUNCT
dpc-5333	112	13	dosage	dosage	NOUN
dpc-5333	112	14	interleukin-2	interleukin-2	NUM
dpc-5333	112	15	therapy	therapy	NOUN
dpc-5333	112	16	in	in	ADP
dpc-5333	112	17	patients	patient	NOUN
dpc-5333	112	18	diagnosed	diagnose	VERB
dpc-5333	112	19	with	with	ADP
dpc-5333	112	20	a	a	DET
dpc-5333	112	21	range	range	NOUN
dpc-5333	112	22	of	of	ADP
dpc-5333	112	23	autoimmune	autoimmune	ADJ
dpc-5333	112	24	diseases	disease	NOUN
dpc-5333	112	25	.	.	PUNCT
dpc-5333	113	1	for	for	SCONJ
dpc-5333	113	2	the	the	DET
dpc-5333	113	3	psoriasis	psoriasis	NOUN
dpc-5333	113	4	patients	patient	NOUN
dpc-5333	113	5	examined	examine	VERB
dpc-5333	113	6	,	,	PUNCT
dpc-5333	113	7	the	the	DET
dpc-5333	113	8	findings	finding	NOUN
dpc-5333	113	9	indicated	indicate	VERB
dpc-5333	113	10	elevated	elevated	ADJ
dpc-5333	113	11	levels	level	NOUN
dpc-5333	113	12	of	of	ADP
dpc-5333	113	13	regulatory	regulatory	ADJ
dpc-5333	113	14	t	t	NOUN
dpc-5333	113	15	cells	cell	NOUN
dpc-5333	113	16	as	as	ADV
dpc-5333	113	17	well	well	ADV
dpc-5333	113	18	as	as	ADP
dpc-5333	113	19	enhancements	enhancement	NOUN
dpc-5333	113	20	in	in	ADP
dpc-5333	113	21	body	body	NOUN
dpc-5333	113	22	surface	surface	NOUN
dpc-5333	113	23	area	area	NOUN
dpc-5333	113	24	and	and	CCONJ
dpc-5333	113	25	pasi	pasi	NOUN
dpc-5333	113	26	(	(	PUNCT
dpc-5333	113	27	psoriasis	psoriasis	NOUN
dpc-5333	113	28	area	area	NOUN
dpc-5333	113	29	and	and	CCONJ
dpc-5333	113	30	severity	severity	NOUN
dpc-5333	113	31	index	index	NOUN
dpc-5333	113	32	)	)	PUNCT
dpc-5333	113	33	outcome	outcome	NOUN
dpc-5333	113	34	measures	measure	NOUN
dpc-5333	113	35	review	review	VERB
dpc-5333	113	36	|	|	ADV
dpc-5333	113	37	dermatol	dermatol	ADJ
dpc-5333	113	38	pract	pract	NOUN
dpc-5333	113	39	concept	concept	NOUN
dpc-5333	113	40	.	.	PUNCT
dpc-5333	114	1	2025;15(3):5333	2025;15(3):5333	NUM
dpc-5333	114	2	5	5	NUM
dpc-5333	115	1	[	[	SYM
dpc-5333	115	2	57	57	NUM
dpc-5333	115	3	]	]	PUNCT
dpc-5333	115	4	.	.	PUNCT
dpc-5333	116	1	consequently	consequently	ADV
dpc-5333	116	2	,	,	PUNCT
dpc-5333	116	3	a	a	DET
dpc-5333	116	4	therapeutic	therapeutic	ADJ
dpc-5333	116	5	intervention	intervention	NOUN
dpc-5333	116	6	involving	involve	VERB
dpc-5333	116	7	the	the	DET
dpc-5333	116	8	administration	administration	NOUN
dpc-5333	116	9	of	of	ADP
dpc-5333	116	10	diminished	diminished	ADJ
dpc-5333	116	11	quantities	quantity	NOUN
dpc-5333	116	12	of	of	ADP
dpc-5333	116	13	interleukin-2	interleukin-2	NOUN
dpc-5333	116	14	in	in	ADP
dpc-5333	116	15	conjunction	conjunction	NOUN
dpc-5333	116	16	with	with	ADP
dpc-5333	116	17	a	a	DET
dpc-5333	116	18	treatment	treatment	NOUN
dpc-5333	116	19	modality	modality	NOUN
dpc-5333	116	20	that	that	PRON
dpc-5333	116	21	rehabilitates	rehabilitate	VERB
dpc-5333	116	22	the	the	DET
dpc-5333	116	23	functional	functional	ADJ
dpc-5333	116	24	capacities	capacity	NOUN
dpc-5333	116	25	of	of	ADP
dpc-5333	116	26	suppressor	suppressor	NOUN
dpc-5333	116	27	t	t	PROPN
dpc-5333	116	28	cells	cell	NOUN
dpc-5333	116	29	,	,	PUNCT
dpc-5333	116	30	such	such	ADJ
dpc-5333	116	31	as	as	ADP
dpc-5333	116	32	phototherapy	phototherapy	NOUN
dpc-5333	116	33	or	or	CCONJ
dpc-5333	116	34	the	the	DET
dpc-5333	116	35	pharmacological	pharmacological	ADJ
dpc-5333	116	36	agent	agent	NOUN
dpc-5333	116	37	sotrastaurin	sotrastaurin	NOUN
dpc-5333	116	38	,	,	PUNCT
dpc-5333	116	39	appears	appear	VERB
dpc-5333	116	40	to	to	PART
dpc-5333	116	41	be	be	AUX
dpc-5333	116	42	an	an	DET
dpc-5333	116	43	encouraging	encouraging	ADJ
dpc-5333	116	44	prospective	prospective	ADJ
dpc-5333	116	45	strategy	strategy	NOUN
dpc-5333	116	46	for	for	ADP
dpc-5333	116	47	managing	manage	VERB
dpc-5333	116	48	the	the	DET
dpc-5333	116	49	psoriatic	psoriatic	ADJ
dpc-5333	116	50	condition	condition	NOUN
dpc-5333	116	51	.	.	PUNCT
dpc-5333	117	1	the	the	DET
dpc-5333	117	2	stability	stability	NOUN
dpc-5333	117	3	and	and	CCONJ
dpc-5333	117	4	proper	proper	ADJ
dpc-5333	117	5	functioning	functioning	NOUN
dpc-5333	117	6	of	of	ADP
dpc-5333	117	7	tregs	treg	NOUN
dpc-5333	117	8	rely	rely	VERB
dpc-5333	117	9	on	on	ADP
dpc-5333	117	10	epigenetic	epigenetic	ADJ
dpc-5333	117	11	mechanisms	mechanism	NOUN
dpc-5333	117	12	that	that	PRON
dpc-5333	117	13	control	control	VERB
dpc-5333	117	14	their	their	PRON
dpc-5333	117	15	gene	gene	NOUN
dpc-5333	117	16	expression	expression	NOUN
dpc-5333	117	17	and	and	CCONJ
dpc-5333	117	18	cellular	cellular	ADJ
dpc-5333	117	19	identity	identity	NOUN
dpc-5333	117	20	.	.	PUNCT
dpc-5333	118	1	individuals	individual	NOUN
dpc-5333	118	2	with	with	ADP
dpc-5333	118	3	psoriasis	psoriasis	NOUN
dpc-5333	118	4	exhibit	exhibit	NOUN
dpc-5333	118	5	expression	expression	NOUN
dpc-5333	118	6	of	of	ADP
dpc-5333	118	7	the	the	DET
dpc-5333	118	8	histone	histone	NOUN
dpc-5333	118	9	deacetylase	deacetylase	PROPN
dpc-5333	118	10	1	1	NUM
dpc-5333	118	11	(	(	PUNCT
dpc-5333	118	12	hdac1	hdac1	NOUN
dpc-5333	118	13	)	)	PUNCT
dpc-5333	118	14	enzyme	enzyme	NOUN
dpc-5333	118	15	in	in	ADP
dpc-5333	118	16	their	their	PRON
dpc-5333	118	17	affected	affect	VERB
dpc-5333	118	18	tissues	tissue	NOUN
dpc-5333	118	19	.	.	PUNCT
dpc-5333	119	1	research	research	NOUN
dpc-5333	119	2	has	have	AUX
dpc-5333	119	3	shown	show	VERB
dpc-5333	119	4	that	that	DET
dpc-5333	119	5	trichostatin	trichostatin	NOUN
dpc-5333	119	6	a	a	PRON
dpc-5333	119	7	,	,	PUNCT
dpc-5333	119	8	an	an	DET
dpc-5333	119	9	inhibitor	inhibitor	NOUN
dpc-5333	119	10	of	of	ADP
dpc-5333	119	11	hdac	hdac	NOUN
dpc-5333	119	12	proteins	protein	NOUN
dpc-5333	119	13	,	,	PUNCT
dpc-5333	119	14	can	can	AUX
dpc-5333	119	15	shift	shift	VERB
dpc-5333	119	16	the	the	DET
dpc-5333	119	17	characteristics	characteristic	NOUN
dpc-5333	119	18	of	of	ADP
dpc-5333	119	19	tregs	treg	NOUN
dpc-5333	119	20	towards	towards	ADP
dpc-5333	119	21	an	an	DET
dpc-5333	119	22	il-17	il-17	ADV
dpc-5333	119	23	-	-	PUNCT
dpc-5333	119	24	producing	produce	VERB
dpc-5333	119	25	cell	cell	NOUN
dpc-5333	119	26	profile	profile	NOUN
dpc-5333	120	1	[	[	X
dpc-5333	120	2	58	58	NUM
dpc-5333	120	3	]	]	PUNCT
dpc-5333	120	4	.	.	PUNCT
dpc-5333	121	1	this	this	DET
dpc-5333	121	2	observation	observation	NOUN
dpc-5333	121	3	implies	imply	VERB
dpc-5333	121	4	that	that	SCONJ
dpc-5333	121	5	drugs	drug	NOUN
dpc-5333	121	6	which	which	PRON
dpc-5333	121	7	block	block	VERB
dpc-5333	121	8	hdac	hdac	NOUN
dpc-5333	121	9	enzymes	enzyme	NOUN
dpc-5333	121	10	could	could	AUX
dpc-5333	121	11	potentially	potentially	ADV
dpc-5333	121	12	be	be	AUX
dpc-5333	121	13	helpful	helpful	ADJ
dpc-5333	121	14	in	in	ADP
dpc-5333	121	15	treating	treat	VERB
dpc-5333	121	16	psoriasis	psoriasis	NOUN
dpc-5333	121	17	.	.	PUNCT
dpc-5333	122	1	therapies	therapy	NOUN
dpc-5333	122	2	using	use	VERB
dpc-5333	122	3	tregs	treg	NOUN
dpc-5333	122	4	may	may	AUX
dpc-5333	122	5	have	have	VERB
dpc-5333	122	6	the	the	DET
dpc-5333	122	7	potential	potential	NOUN
dpc-5333	122	8	to	to	PART
dpc-5333	122	9	disrupt	disrupt	VERB
dpc-5333	122	10	the	the	DET
dpc-5333	122	11	development	development	NOUN
dpc-5333	122	12	of	of	ADP
dpc-5333	122	13	psoriasis	psoriasis	NOUN
dpc-5333	122	14	by	by	ADP
dpc-5333	122	15	rebalancing	rebalance	VERB
dpc-5333	122	16	the	the	DET
dpc-5333	122	17	ratio	ratio	NOUN
dpc-5333	122	18	of	of	ADP
dpc-5333	122	19	th17	th17	PROPN
dpc-5333	122	20	to	to	ADP
dpc-5333	122	21	treg	treg	PROPN
dpc-5333	122	22	cells	cell	NOUN
dpc-5333	122	23	and	and	CCONJ
dpc-5333	122	24	reducing	reduce	VERB
dpc-5333	122	25	certain	certain	ADJ
dpc-5333	122	26	inflammatory	inflammatory	ADJ
dpc-5333	122	27	t	t	NOUN
dpc-5333	122	28	cell	cell	NOUN
dpc-5333	122	29	subsets	subset	NOUN
dpc-5333	122	30	,	,	PUNCT
dpc-5333	122	31	despite	despite	SCONJ
dpc-5333	122	32	the	the	DET
dpc-5333	122	33	high	high	ADJ
dpc-5333	122	34	costs	cost	NOUN
dpc-5333	122	35	and	and	CCONJ
dpc-5333	122	36	risks	risk	NOUN
dpc-5333	122	37	associated	associate	VERB
dpc-5333	122	38	with	with	ADP
dpc-5333	122	39	such	such	ADJ
dpc-5333	122	40	cell	cell	NOUN
dpc-5333	122	41	-	-	PUNCT
dpc-5333	122	42	based	base	VERB
dpc-5333	122	43	treatments	treatment	NOUN
dpc-5333	122	44	[	[	X
dpc-5333	122	45	59	59	NUM
dpc-5333	122	46	]	]	PUNCT
dpc-5333	122	47	.	.	PUNCT
dpc-5333	123	1	hematopoietic	hematopoietic	ADJ
dpc-5333	123	2	stem	stem	NOUN
dpc-5333	123	3	cells	cell	NOUN
dpc-5333	123	4	bone	bone	NOUN
dpc-5333	123	5	marrow	marrow	NOUN
dpc-5333	123	6	-	-	PUNCT
dpc-5333	123	7	derived	derive	VERB
dpc-5333	123	8	hematopoietic	hematopoietic	ADJ
dpc-5333	123	9	stem	stem	NOUN
dpc-5333	123	10	cells	cell	NOUN
dpc-5333	123	11	(	(	PUNCT
dpc-5333	123	12	hscs	hsc	NOUN
dpc-5333	123	13	)	)	PUNCT
dpc-5333	123	14	serve	serve	VERB
dpc-5333	123	15	as	as	ADP
dpc-5333	123	16	the	the	DET
dpc-5333	123	17	principal	principal	ADJ
dpc-5333	123	18	source	source	NOUN
dpc-5333	123	19	for	for	ADP
dpc-5333	123	20	generating	generate	VERB
dpc-5333	123	21	all	all	DET
dpc-5333	123	22	peripheral	peripheral	ADJ
dpc-5333	123	23	immune	immune	ADJ
dpc-5333	123	24	cell	cell	NOUN
dpc-5333	123	25	populations	population	NOUN
dpc-5333	123	26	.	.	PUNCT
dpc-5333	124	1	the	the	DET
dpc-5333	124	2	clinical	clinical	ADJ
dpc-5333	124	3	evidence	evidence	NOUN
dpc-5333	124	4	that	that	PRON
dpc-5333	124	5	allogeneic	allogeneic	VERB
dpc-5333	124	6	hsc	hsc	NOUN
dpc-5333	124	7	transplants	transplant	NOUN
dpc-5333	124	8	can	can	AUX
dpc-5333	124	9	either	either	CCONJ
dpc-5333	124	10	cure	cure	VERB
dpc-5333	124	11	or	or	CCONJ
dpc-5333	124	12	worsen	worsen	VERB
dpc-5333	124	13	psoriasis	psoriasis	NOUN
dpc-5333	124	14	has	have	AUX
dpc-5333	124	15	given	give	VERB
dpc-5333	124	16	rise	rise	NOUN
dpc-5333	124	17	to	to	ADP
dpc-5333	124	18	the	the	DET
dpc-5333	124	19	theory	theory	NOUN
dpc-5333	124	20	that	that	SCONJ
dpc-5333	124	21	the	the	DET
dpc-5333	124	22	immunological	immunological	ADJ
dpc-5333	124	23	dysregulation	dysregulation	NOUN
dpc-5333	124	24	underlying	underlie	VERB
dpc-5333	124	25	psoriasis	psoriasis	NOUN
dpc-5333	124	26	may	may	AUX
dpc-5333	124	27	stem	stem	VERB
dpc-5333	124	28	from	from	ADP
dpc-5333	124	29	defects	defect	NOUN
dpc-5333	124	30	in	in	ADP
dpc-5333	124	31	the	the	DET
dpc-5333	124	32	bone	bone	NOUN
dpc-5333	124	33	marrow	marrow	PROPN
dpc-5333	124	34	hsc	hsc	PROPN
dpc-5333	124	35	compartment	compartment	NOUN
dpc-5333	124	36	[	[	X
dpc-5333	124	37	60,61	60,61	NOUN
dpc-5333	124	38	]	]	PUNCT
dpc-5333	124	39	.	.	PUNCT
dpc-5333	125	1	zhang	zhang	PROPN
dpc-5333	125	2	et	et	PROPN
dpc-5333	125	3	al	al	PROPN
dpc-5333	125	4	.	.	PROPN
dpc-5333	125	5	conducted	conduct	VERB
dpc-5333	125	6	a	a	DET
dpc-5333	125	7	comparative	comparative	ADJ
dpc-5333	125	8	analysis	analysis	NOUN
dpc-5333	125	9	to	to	PART
dpc-5333	125	10	determine	determine	VERB
dpc-5333	125	11	whether	whether	SCONJ
dpc-5333	125	12	the	the	DET
dpc-5333	125	13	t	t	NOUN
dpc-5333	125	14	cells	cell	NOUN
dpc-5333	125	15	of	of	ADP
dpc-5333	125	16	psoriasis	psoriasis	NOUN
dpc-5333	125	17	patients	patient	NOUN
dpc-5333	125	18	exhibit	exhibit	VERB
dpc-5333	125	19	an	an	DET
dpc-5333	125	20	inherent	inherent	ADJ
dpc-5333	125	21	dysfunction	dysfunction	NOUN
dpc-5333	125	22	.	.	PUNCT
dpc-5333	126	1	they	they	PRON
dpc-5333	126	2	compared	compare	VERB
dpc-5333	126	3	in	in	ADP
dpc-5333	126	4	vitro	vitro	X
dpc-5333	126	5	-	-	PUNCT
dpc-5333	126	6	induced	induce	VERB
dpc-5333	126	7	t	t	NOUN
dpc-5333	126	8	cells	cell	NOUN
dpc-5333	126	9	and	and	CCONJ
dpc-5333	126	10	cd4+cd25	cd4+cd25	NOUN
dpc-5333	126	11	+	+	NOUN
dpc-5333	126	12	tregs	treg	NOUN
dpc-5333	126	13	derived	derive	VERB
dpc-5333	126	14	from	from	ADP
dpc-5333	126	15	the	the	DET
dpc-5333	126	16	bone	bone	NOUN
dpc-5333	126	17	marrow	marrow	NOUN
dpc-5333	126	18	cd34	cd34	PROPN
dpc-5333	126	19	+	+	NUM
dpc-5333	126	20	cells	cell	NOUN
dpc-5333	126	21	of	of	ADP
dpc-5333	126	22	psoriasis	psoriasis	NOUN
dpc-5333	126	23	patients	patient	NOUN
dpc-5333	126	24	against	against	ADP
dpc-5333	126	25	the	the	DET
dpc-5333	126	26	analogous	analogous	ADJ
dpc-5333	126	27	cell	cell	NOUN
dpc-5333	126	28	types	type	NOUN
dpc-5333	126	29	isolated	isolate	VERB
dpc-5333	126	30	from	from	ADP
dpc-5333	126	31	the	the	DET
dpc-5333	126	32	peripheral	peripheral	ADJ
dpc-5333	126	33	blood	blood	NOUN
dpc-5333	126	34	of	of	ADP
dpc-5333	126	35	psoriasis	psoriasis	NOUN
dpc-5333	126	36	patients	patient	NOUN
dpc-5333	126	37	.	.	PUNCT
dpc-5333	127	1	t	t	NOUN
dpc-5333	127	2	cells	cell	NOUN
dpc-5333	127	3	generated	generate	VERB
dpc-5333	127	4	in	in	ADP
dpc-5333	127	5	vitro	vitro	X
dpc-5333	127	6	from	from	ADP
dpc-5333	127	7	the	the	DET
dpc-5333	127	8	cd34	cd34	PROPN
dpc-5333	127	9	+	+	NUM
dpc-5333	127	10	cells	cell	NOUN
dpc-5333	127	11	of	of	ADP
dpc-5333	127	12	individuals	individual	NOUN
dpc-5333	127	13	with	with	ADP
dpc-5333	127	14	psoriasis	psoriasis	NOUN
dpc-5333	127	15	exhibited	exhibit	VERB
dpc-5333	127	16	elevated	elevated	ADJ
dpc-5333	127	17	proliferative	proliferative	ADJ
dpc-5333	127	18	activity	activity	NOUN
dpc-5333	127	19	and	and	CCONJ
dpc-5333	127	20	an	an	DET
dpc-5333	127	21	enhanced	enhanced	ADJ
dpc-5333	127	22	ability	ability	NOUN
dpc-5333	127	23	to	to	PART
dpc-5333	127	24	produce	produce	VERB
dpc-5333	127	25	th1	th1	NOUN
dpc-5333	127	26	cytokines	cytokine	NOUN
dpc-5333	127	27	upon	upon	SCONJ
dpc-5333	127	28	exposure	exposure	NOUN
dpc-5333	127	29	to	to	PART
dpc-5333	127	30	streptococcus	streptococcus	VERB
dpc-5333	127	31	a.	a.	NOUN
dpc-5333	127	32	additionally	additionally	ADV
dpc-5333	127	33	,	,	PUNCT
dpc-5333	127	34	these	these	DET
dpc-5333	127	35	t	t	NOUN
dpc-5333	127	36	cells	cell	NOUN
dpc-5333	127	37	showed	show	VERB
dpc-5333	127	38	the	the	DET
dpc-5333	127	39	capacity	capacity	NOUN
dpc-5333	127	40	to	to	PART
dpc-5333	127	41	upregulate	upregulate	VERB
dpc-5333	127	42	the	the	DET
dpc-5333	127	43	expression	expression	NOUN
dpc-5333	127	44	of	of	ADP
dpc-5333	127	45	the	the	DET
dpc-5333	127	46	c	c	NOUN
dpc-5333	127	47	-	-	PUNCT
dpc-5333	127	48	myc	myc	NOUN
dpc-5333	127	49	and	and	CCONJ
dpc-5333	127	50	ki67	ki67	PROPN
dpc-5333	127	51	genes	gene	NOUN
dpc-5333	127	52	when	when	SCONJ
dpc-5333	127	53	cultured	cultured	ADJ
dpc-5333	127	54	together	together	ADV
dpc-5333	127	55	with	with	ADP
dpc-5333	127	56	keratinocytes	keratinocyte	NOUN
dpc-5333	127	57	[	[	X
dpc-5333	127	58	62	62	NUM
dpc-5333	127	59	]	]	PUNCT
dpc-5333	127	60	.	.	PUNCT
dpc-5333	128	1	numerous	numerous	ADJ
dpc-5333	128	2	studies	study	NOUN
dpc-5333	128	3	have	have	AUX
dpc-5333	128	4	found	find	VERB
dpc-5333	128	5	that	that	SCONJ
dpc-5333	128	6	in	in	ADP
dpc-5333	128	7	psoriasis	psoriasis	NOUN
dpc-5333	128	8	,	,	PUNCT
dpc-5333	128	9	the	the	DET
dpc-5333	128	10	cd4+cd25	cd4+cd25	NOUN
dpc-5333	128	11	+	+	NOUN
dpc-5333	128	12	tregs	treg	NOUN
dpc-5333	128	13	present	present	ADJ
dpc-5333	128	14	in	in	ADP
dpc-5333	128	15	the	the	DET
dpc-5333	128	16	peripheral	peripheral	ADJ
dpc-5333	128	17	blood	blood	NOUN
dpc-5333	128	18	,	,	PUNCT
dpc-5333	128	19	and	and	CCONJ
dpc-5333	128	20	skin	skin	NOUN
dpc-5333	128	21	lesions	lesion	NOUN
dpc-5333	128	22	display	display	VERB
dpc-5333	128	23	a	a	DET
dpc-5333	128	24	reduced	reduced	ADJ
dpc-5333	128	25	inhibitory	inhibitory	ADJ
dpc-5333	128	26	effect	effect	NOUN
dpc-5333	128	27	on	on	ADP
dpc-5333	128	28	effector	effector	NOUN
dpc-5333	128	29	t	t	PROPN
dpc-5333	128	30	cells	cell	NOUN
dpc-5333	128	31	[	[	X
dpc-5333	128	32	63	63	NUM
dpc-5333	128	33	-	-	SYM
dpc-5333	128	34	65	65	NUM
dpc-5333	128	35	]	]	PUNCT
dpc-5333	128	36	.	.	PUNCT
dpc-5333	129	1	this	this	DET
dpc-5333	129	2	diminished	diminish	VERB
dpc-5333	129	3	treg	treg	PROPN
dpc-5333	129	4	function	function	PROPN
dpc-5333	129	5	results	result	NOUN
dpc-5333	129	6	in	in	ADP
dpc-5333	129	7	accelerated	accelerated	ADJ
dpc-5333	129	8	proliferation	proliferation	NOUN
dpc-5333	129	9	of	of	ADP
dpc-5333	129	10	the	the	DET
dpc-5333	129	11	pathogenic	pathogenic	ADJ
dpc-5333	129	12	/	/	SYM
dpc-5333	129	13	effector	effector	NOUN
dpc-5333	129	14	t	t	NOUN
dpc-5333	129	15	cell	cell	NOUN
dpc-5333	129	16	populations	population	NOUN
dpc-5333	129	17	in	in	ADP
dpc-5333	129	18	psoriasis	psoriasis	NOUN
dpc-5333	129	19	.	.	PUNCT
dpc-5333	130	1	the	the	DET
dpc-5333	130	2	regulatory	regulatory	ADJ
dpc-5333	130	3	t	t	PROPN
dpc-5333	130	4	cells	cell	NOUN
dpc-5333	130	5	harvested	harvest	VERB
dpc-5333	130	6	from	from	ADP
dpc-5333	130	7	the	the	DET
dpc-5333	130	8	bone	bone	NOUN
dpc-5333	130	9	marrow	marrow	NOUN
dpc-5333	130	10	of	of	ADP
dpc-5333	130	11	psoriasis	psoriasis	NOUN
dpc-5333	130	12	patients	patient	NOUN
dpc-5333	130	13	displayed	display	VERB
dpc-5333	130	14	functional	functional	ADJ
dpc-5333	130	15	characteristics	characteristic	NOUN
dpc-5333	130	16	analogous	analogous	ADJ
dpc-5333	130	17	to	to	ADP
dpc-5333	130	18	those	those	PRON
dpc-5333	130	19	isolated	isolate	VERB
dpc-5333	130	20	from	from	ADP
dpc-5333	130	21	the	the	DET
dpc-5333	130	22	circulating	circulate	VERB
dpc-5333	130	23	blood	blood	NOUN
dpc-5333	130	24	of	of	ADP
dpc-5333	130	25	individuals	individual	NOUN
dpc-5333	130	26	with	with	ADP
dpc-5333	130	27	the	the	DET
dpc-5333	130	28	same	same	ADJ
dpc-5333	130	29	condition	condition	NOUN
dpc-5333	130	30	.	.	PUNCT
dpc-5333	131	1	notably	notably	ADV
dpc-5333	131	2	,	,	PUNCT
dpc-5333	131	3	these	these	DET
dpc-5333	131	4	disease	disease	NOUN
dpc-5333	131	5	-	-	PUNCT
dpc-5333	131	6	associated	associate	VERB
dpc-5333	131	7	tregs	treg	NOUN
dpc-5333	131	8	exhibited	exhibit	VERB
dpc-5333	131	9	reduced	reduce	VERB
dpc-5333	131	10	secretion	secretion	NOUN
dpc-5333	131	11	of	of	ADP
dpc-5333	131	12	the	the	DET
dpc-5333	131	13	anti	anti	ADJ
dpc-5333	131	14	-	-	ADJ
dpc-5333	131	15	inflammatory	inflammatory	ADJ
dpc-5333	131	16	cytokines	cytokine	NOUN
dpc-5333	131	17	il-2	il-2	NUM
dpc-5333	131	18	and	and	CCONJ
dpc-5333	131	19	il-10	il-10	NOUN
dpc-5333	131	20	when	when	SCONJ
dpc-5333	131	21	stimulated	stimulate	VERB
dpc-5333	131	22	with	with	ADP
dpc-5333	131	23	the	the	DET
dpc-5333	131	24	streptococcal	streptococcal	ADJ
dpc-5333	131	25	superantigen	superantigen	NOUN
dpc-5333	131	26	.	.	PUNCT
dpc-5333	132	1	furthermore	furthermore	ADV
dpc-5333	132	2	,	,	PUNCT
dpc-5333	132	3	the	the	DET
dpc-5333	132	4	capacity	capacity	NOUN
dpc-5333	132	5	of	of	ADP
dpc-5333	132	6	these	these	DET
dpc-5333	132	7	tregs	treg	NOUN
dpc-5333	132	8	to	to	PART
dpc-5333	132	9	suppress	suppress	VERB
dpc-5333	132	10	the	the	DET
dpc-5333	132	11	proliferation	proliferation	NOUN
dpc-5333	132	12	of	of	ADP
dpc-5333	132	13	activated	activate	VERB
dpc-5333	132	14	effector	effector	NOUN
dpc-5333	132	15	t	t	PROPN
dpc-5333	132	16	cells	cell	NOUN
dpc-5333	132	17	was	be	AUX
dpc-5333	132	18	diminished	diminish	VERB
dpc-5333	132	19	relative	relative	ADV
dpc-5333	132	20	to	to	ADP
dpc-5333	132	21	tregs	treg	NOUN
dpc-5333	132	22	obtained	obtain	VERB
dpc-5333	132	23	from	from	ADP
dpc-5333	132	24	healthy	healthy	ADJ
dpc-5333	132	25	subjects	subject	NOUN
dpc-5333	132	26	[	[	X
dpc-5333	132	27	66	66	NUM
dpc-5333	132	28	]	]	PUNCT
dpc-5333	132	29	.	.	PUNCT
dpc-5333	133	1	the	the	DET
dpc-5333	133	2	reported	report	VERB
dpc-5333	133	3	results	result	NOUN
dpc-5333	133	4	imply	imply	VERB
dpc-5333	133	5	that	that	SCONJ
dpc-5333	133	6	the	the	DET
dpc-5333	133	7	aberrant	aberrant	ADJ
dpc-5333	133	8	behavior	behavior	NOUN
dpc-5333	133	9	of	of	ADP
dpc-5333	133	10	immune	immune	ADJ
dpc-5333	133	11	cells	cell	NOUN
dpc-5333	133	12	in	in	ADP
dpc-5333	133	13	psoriasis	psoriasis	NOUN
dpc-5333	133	14	may	may	AUX
dpc-5333	133	15	trace	trace	VERB
dpc-5333	133	16	back	back	ADV
dpc-5333	133	17	to	to	ADP
dpc-5333	133	18	the	the	DET
dpc-5333	133	19	hscs	hsc	NOUN
dpc-5333	133	20	located	locate	VERB
dpc-5333	133	21	in	in	ADP
dpc-5333	133	22	the	the	DET
dpc-5333	133	23	bone	bone	NOUN
dpc-5333	133	24	marrow	marrow	NOUN
dpc-5333	133	25	.	.	PUNCT
dpc-5333	134	1	in	in	ADP
dpc-5333	134	2	other	other	ADJ
dpc-5333	134	3	words	word	NOUN
dpc-5333	134	4	,	,	PUNCT
dpc-5333	134	5	the	the	DET
dpc-5333	134	6	immunological	immunological	ADJ
dpc-5333	134	7	abnormalities	abnormality	NOUN
dpc-5333	134	8	characteristic	characteristic	ADJ
dpc-5333	134	9	of	of	ADP
dpc-5333	134	10	psoriasis	psoriasis	NOUN
dpc-5333	134	11	appear	appear	VERB
dpc-5333	134	12	to	to	PART
dpc-5333	134	13	have	have	VERB
dpc-5333	134	14	their	their	PRON
dpc-5333	134	15	origins	origin	NOUN
dpc-5333	134	16	within	within	ADP
dpc-5333	134	17	the	the	DET
dpc-5333	134	18	bone	bone	NOUN
dpc-5333	134	19	marrow	marrow	NOUN
dpc-5333	134	20	compartment	compartment	NOUN
dpc-5333	134	21	.	.	PUNCT
dpc-5333	135	1	advantages	advantage	NOUN
dpc-5333	135	2	of	of	ADP
dpc-5333	135	3	stem	stem	NOUN
dpc-5333	135	4	cell	cell	NOUN
dpc-5333	135	5	therapy	therapy	NOUN
dpc-5333	135	6	for	for	ADP
dpc-5333	135	7	psoriasis	psoriasis	NOUN
dpc-5333	135	8	the	the	DET
dpc-5333	135	9	analysis	analysis	NOUN
dpc-5333	135	10	by	by	ADP
dpc-5333	135	11	the	the	DET
dpc-5333	135	12	researchers	researcher	NOUN
dpc-5333	135	13	[	[	X
dpc-5333	135	14	67	67	NUM
dpc-5333	135	15	]	]	PUNCT
dpc-5333	135	16	has	have	AUX
dpc-5333	135	17	documented	document	VERB
dpc-5333	135	18	the	the	DET
dpc-5333	135	19	“	"	PUNCT
dpc-5333	135	20	cure	cure	NOUN
dpc-5333	135	21	”	"	PUNCT
dpc-5333	135	22	of	of	ADP
dpc-5333	135	23	an	an	DET
dpc-5333	135	24	extreme	extreme	ADJ
dpc-5333	135	25	,	,	PUNCT
dpc-5333	135	26	treatment	treatment	NOUN
dpc-5333	135	27	-	-	PUNCT
dpc-5333	135	28	resistant	resistant	ADJ
dpc-5333	135	29	skin	skin	NOUN
dpc-5333	135	30	condition	condition	NOUN
dpc-5333	135	31	in	in	ADP
dpc-5333	135	32	a	a	DET
dpc-5333	135	33	35	35	NUM
dpc-5333	135	34	-	-	PUNCT
dpc-5333	135	35	year	year	NOUN
dpc-5333	135	36	-	-	PUNCT
dpc-5333	135	37	old	old	ADJ
dpc-5333	135	38	individual	individual	NOUN
dpc-5333	135	39	who	who	PRON
dpc-5333	135	40	underwent	undergo	VERB
dpc-5333	135	41	an	an	DET
dpc-5333	135	42	allogeneic	allogeneic	ADJ
dpc-5333	135	43	blood	blood	NOUN
dpc-5333	135	44	stem	stem	NOUN
dpc-5333	135	45	cell	cell	NOUN
dpc-5333	135	46	transplant	transplant	NOUN
dpc-5333	135	47	from	from	ADP
dpc-5333	135	48	his	his	PRON
dpc-5333	135	49	unaffected	unaffected	ADJ
dpc-5333	135	50	sibling	sibling	NOUN
dpc-5333	135	51	for	for	ADP
dpc-5333	135	52	the	the	DET
dpc-5333	135	53	management	management	NOUN
dpc-5333	135	54	of	of	ADP
dpc-5333	135	55	acute	acute	ADJ
dpc-5333	135	56	myelomonocytic	myelomonocytic	ADJ
dpc-5333	135	57	blood	blood	NOUN
dpc-5333	135	58	cancer	cancer	NOUN
dpc-5333	135	59	.	.	PUNCT
dpc-5333	136	1	the	the	DET
dpc-5333	136	2	patient	patient	NOUN
dpc-5333	136	3	continued	continue	VERB
dpc-5333	136	4	to	to	PART
dpc-5333	136	5	be	be	AUX
dpc-5333	136	6	free	free	ADJ
dpc-5333	136	7	of	of	ADP
dpc-5333	136	8	psoriasis	psoriasis	NOUN
dpc-5333	136	9	symptoms	symptom	NOUN
dpc-5333	136	10	for	for	ADP
dpc-5333	136	11	five	five	NUM
dpc-5333	136	12	years	year	NOUN
dpc-5333	136	13	after	after	ADP
dpc-5333	136	14	receiving	receive	VERB
dpc-5333	136	15	the	the	DET
dpc-5333	136	16	stem	stem	NOUN
dpc-5333	136	17	cell	cell	NOUN
dpc-5333	136	18	transplant	transplant	NOUN
dpc-5333	136	19	.	.	PUNCT
dpc-5333	137	1	the	the	DET
dpc-5333	137	2	specific	specific	ADJ
dpc-5333	137	3	reasons	reason	NOUN
dpc-5333	137	4	why	why	SCONJ
dpc-5333	137	5	allogeneic	allogeneic	ADJ
dpc-5333	137	6	hsct	hsct	NOUN
dpc-5333	137	7	is	be	AUX
dpc-5333	137	8	effective	effective	ADJ
dpc-5333	137	9	for	for	ADP
dpc-5333	137	10	treating	treat	VERB
dpc-5333	137	11	psoriasis	psoriasis	NOUN
dpc-5333	137	12	are	be	AUX
dpc-5333	137	13	not	not	PART
dpc-5333	137	14	fully	fully	ADV
dpc-5333	137	15	understood	understand	VERB
dpc-5333	137	16	.	.	PUNCT
dpc-5333	138	1	however	however	ADV
dpc-5333	138	2	,	,	PUNCT
dpc-5333	138	3	it	it	PRON
dpc-5333	138	4	is	be	AUX
dpc-5333	138	5	believed	believe	VERB
dpc-5333	138	6	that	that	SCONJ
dpc-5333	138	7	the	the	DET
dpc-5333	138	8	immunosuppressive	immunosuppressive	ADJ
dpc-5333	138	9	drugs	drug	NOUN
dpc-5333	138	10	and	and	CCONJ
dpc-5333	138	11	immune	immune	ADJ
dpc-5333	138	12	system	system	NOUN
dpc-5333	138	13	depletion	depletion	NOUN
dpc-5333	138	14	required	require	VERB
dpc-5333	138	15	for	for	ADP
dpc-5333	138	16	the	the	DET
dpc-5333	138	17	hsct	hsct	NOUN
dpc-5333	138	18	procedure	procedure	NOUN
dpc-5333	138	19	eliminate	eliminate	VERB
dpc-5333	138	20	the	the	DET
dpc-5333	138	21	self	self	NOUN
dpc-5333	138	22	-	-	PUNCT
dpc-5333	138	23	reactive	reactive	ADJ
dpc-5333	138	24	t	t	NOUN
dpc-5333	138	25	cells	cell	NOUN
dpc-5333	138	26	that	that	PRON
dpc-5333	138	27	drive	drive	VERB
dpc-5333	138	28	the	the	DET
dpc-5333	138	29	psoriasis	psoriasis	NOUN
dpc-5333	138	30	.	.	PUNCT
dpc-5333	139	1	the	the	DET
dpc-5333	139	2	transplanted	transplanted	ADJ
dpc-5333	139	3	immune	immune	ADJ
dpc-5333	139	4	cells	cell	NOUN
dpc-5333	139	5	from	from	ADP
dpc-5333	139	6	a	a	DET
dpc-5333	139	7	donor	donor	NOUN
dpc-5333	139	8	without	without	ADP
dpc-5333	139	9	psoriasis	psoriasis	NOUN
dpc-5333	139	10	then	then	ADV
dpc-5333	139	11	rebuild	rebuild	VERB
dpc-5333	139	12	the	the	DET
dpc-5333	139	13	patient	patient	NOUN
dpc-5333	139	14	’s	’s	PART
dpc-5333	139	15	immune	immune	ADJ
dpc-5333	139	16	system	system	NOUN
dpc-5333	139	17	in	in	ADP
dpc-5333	139	18	a	a	DET
dpc-5333	139	19	way	way	NOUN
dpc-5333	139	20	that	that	PRON
dpc-5333	139	21	is	be	AUX
dpc-5333	139	22	less	less	ADV
dpc-5333	139	23	reactive	reactive	ADJ
dpc-5333	139	24	and	and	CCONJ
dpc-5333	139	25	prone	prone	ADJ
dpc-5333	139	26	to	to	ADP
dpc-5333	139	27	causing	cause	VERB
dpc-5333	139	28	the	the	DET
dpc-5333	139	29	disease	disease	NOUN
dpc-5333	139	30	.	.	PUNCT
dpc-5333	140	1	the	the	DET
dpc-5333	140	2	idea	idea	NOUN
dpc-5333	140	3	that	that	PRON
dpc-5333	140	4	allogeneic	allogeneic	ADJ
dpc-5333	140	5	hsct	hsct	PROPN
dpc-5333	140	6	can	can	AUX
dpc-5333	140	7	treat	treat	VERB
dpc-5333	140	8	psoriasis	psoriasis	NOUN
dpc-5333	140	9	by	by	ADP
dpc-5333	140	10	resetting	reset	VERB
dpc-5333	140	11	the	the	DET
dpc-5333	140	12	immune	immune	ADJ
dpc-5333	140	13	system	system	NOUN
dpc-5333	140	14	is	be	AUX
dpc-5333	140	15	supported	support	VERB
dpc-5333	140	16	by	by	ADP
dpc-5333	140	17	published	publish	VERB
dpc-5333	140	18	reports	report	NOUN
dpc-5333	140	19	documenting	document	VERB
dpc-5333	140	20	long	long	ADJ
dpc-5333	140	21	-	-	PUNCT
dpc-5333	140	22	term	term	NOUN
dpc-5333	140	23	,	,	PUNCT
dpc-5333	140	24	full	full	ADJ
dpc-5333	140	25	resolution	resolution	NOUN
dpc-5333	140	26	of	of	ADP
dpc-5333	140	27	psoriasis	psoriasis	NOUN
dpc-5333	140	28	(	(	PUNCT
dpc-5333	140	29	lasting	last	VERB
dpc-5333	140	30	up	up	ADP
dpc-5333	140	31	to	to	PART
dpc-5333	140	32	20	20	NUM
dpc-5333	140	33	years	year	NOUN
dpc-5333	140	34	)	)	PUNCT
dpc-5333	140	35	in	in	ADP
dpc-5333	140	36	patients	patient	NOUN
dpc-5333	140	37	who	who	PRON
dpc-5333	140	38	underwent	undergo	VERB
dpc-5333	140	39	allogeneic	allogeneic	ADJ
dpc-5333	140	40	hsct	hsct	PROPN
dpc-5333	140	41	,	,	PUNCT
dpc-5333	140	42	as	as	SCONJ
dpc-5333	140	43	opposed	oppose	VERB
dpc-5333	140	44	to	to	ADP
dpc-5333	140	45	autologous	autologous	ADJ
dpc-5333	140	46	hsct	hsct	NOUN
dpc-5333	140	47	[	[	X
dpc-5333	140	48	68	68	NUM
dpc-5333	140	49	-	-	SYM
dpc-5333	140	50	70	70	NUM
dpc-5333	140	51	]	]	PUNCT
dpc-5333	140	52	.	.	PUNCT
dpc-5333	141	1	interestingly	interestingly	ADV
dpc-5333	141	2	,	,	PUNCT
dpc-5333	141	3	the	the	DET
dpc-5333	141	4	occurrence	occurrence	NOUN
dpc-5333	141	5	of	of	ADP
dpc-5333	141	6	graft	graft	NOUN
dpc-5333	141	7	-	-	PUNCT
dpc-5333	141	8	versus	versus	ADP
dpc-5333	141	9	-	-	PUNCT
dpc-5333	141	10	host	host	NOUN
dpc-5333	141	11	disease	disease	NOUN
dpc-5333	141	12	(	(	PUNCT
dpc-5333	141	13	gvhd	gvhd	PROPN
dpc-5333	141	14	)	)	PUNCT
dpc-5333	141	15	appeared	appear	VERB
dpc-5333	141	16	to	to	PART
dpc-5333	141	17	be	be	AUX
dpc-5333	141	18	associated	associate	VERB
dpc-5333	141	19	with	with	ADP
dpc-5333	141	20	long	long	ADJ
dpc-5333	141	21	-	-	PUNCT
dpc-5333	141	22	term	term	NOUN
dpc-5333	141	23	,	,	PUNCT
dpc-5333	141	24	full	full	ADJ
dpc-5333	141	25	remission	remission	NOUN
dpc-5333	141	26	of	of	ADP
dpc-5333	141	27	psoriasis	psoriasis	NOUN
dpc-5333	141	28	in	in	ADP
dpc-5333	141	29	several	several	ADJ
dpc-5333	141	30	reported	report	VERB
dpc-5333	141	31	cases	case	NOUN
dpc-5333	141	32	[	[	X
dpc-5333	141	33	60,68	60,68	NUM
dpc-5333	141	34	-	-	SYM
dpc-5333	141	35	90	90	NUM
dpc-5333	141	36	]	]	PUNCT
dpc-5333	141	37	.	.	PUNCT
dpc-5333	142	1	this	this	PRON
dpc-5333	142	2	suggests	suggest	VERB
dpc-5333	142	3	that	that	SCONJ
dpc-5333	142	4	the	the	DET
dpc-5333	142	5	‘	'	PUNCT
dpc-5333	142	6	graft	graft	NOUN
dpc-5333	142	7	-	-	PUNCT
dpc-5333	142	8	versus	versus	ADP
dpc-5333	142	9	-	-	PUNCT
dpc-5333	142	10	autoimmunity	autoimmunity	NOUN
dpc-5333	142	11	’	'	PUNCT
dpc-5333	142	12	effect	effect	NOUN
dpc-5333	142	13	of	of	ADP
dpc-5333	142	14	allogeneic	allogeneic	ADJ
dpc-5333	142	15	hsct	hsct	NOUN
dpc-5333	142	16	,	,	PUNCT
dpc-5333	142	17	where	where	SCONJ
dpc-5333	142	18	the	the	DET
dpc-5333	142	19	donor	donor	NOUN
dpc-5333	142	20	immune	immune	ADJ
dpc-5333	142	21	cells	cell	NOUN
dpc-5333	142	22	actively	actively	ADV
dpc-5333	142	23	suppress	suppress	VERB
dpc-5333	142	24	or	or	CCONJ
dpc-5333	142	25	eliminate	eliminate	VERB
dpc-5333	142	26	the	the	DET
dpc-5333	142	27	recipient	recipient	NOUN
dpc-5333	142	28	’s	’s	PART
dpc-5333	142	29	autoimmune	autoimmune	ADJ
dpc-5333	142	30	system	system	NOUN
dpc-5333	142	31	,	,	PUNCT
dpc-5333	142	32	may	may	AUX
dpc-5333	142	33	be	be	AUX
dpc-5333	142	34	an	an	DET
dpc-5333	142	35	important	important	ADJ
dpc-5333	142	36	mechanism	mechanism	NOUN
dpc-5333	142	37	behind	behind	ADP
dpc-5333	142	38	the	the	DET
dpc-5333	142	39	lasting	last	VERB
dpc-5333	142	40	resolution	resolution	NOUN
dpc-5333	142	41	of	of	ADP
dpc-5333	142	42	psoriasis	psoriasis	NOUN
dpc-5333	143	1	[	[	X
dpc-5333	143	2	70,76	70,76	X
dpc-5333	143	3	]	]	X
dpc-5333	143	4	.	.	PUNCT
dpc-5333	144	1	many	many	ADJ
dpc-5333	144	2	of	of	ADP
dpc-5333	144	3	the	the	DET
dpc-5333	144	4	patients	patient	NOUN
dpc-5333	144	5	in	in	ADP
dpc-5333	144	6	these	these	DET
dpc-5333	144	7	reports	report	NOUN
dpc-5333	144	8	received	receive	VERB
dpc-5333	144	9	immunosuppressive	immunosuppressive	ADJ
dpc-5333	144	10	conditioning	conditioning	NOUN
dpc-5333	144	11	regimens	regimen	NOUN
dpc-5333	144	12	as	as	ADV
dpc-5333	144	13	well	well	ADV
dpc-5333	144	14	as	as	ADP
dpc-5333	144	15	concurrent	concurrent	ADJ
dpc-5333	144	16	therapies	therapy	NOUN
dpc-5333	144	17	like	like	ADP
dpc-5333	144	18	methotrexate	methotrexate	NOUN
dpc-5333	144	19	and	and	CCONJ
dpc-5333	144	20	cyclosporin	cyclosporin	NOUN
dpc-5333	144	21	.	.	PUNCT
dpc-5333	145	1	these	these	DET
dpc-5333	145	2	additional	additional	ADJ
dpc-5333	145	3	treatments	treatment	NOUN
dpc-5333	145	4	are	be	AUX
dpc-5333	145	5	important	important	ADJ
dpc-5333	145	6	confounding	confound	VERB
dpc-5333	145	7	factors	factor	NOUN
dpc-5333	145	8	that	that	PRON
dpc-5333	145	9	complicate	complicate	VERB
dpc-5333	145	10	the	the	DET
dpc-5333	145	11	assessment	assessment	NOUN
dpc-5333	145	12	of	of	ADP
dpc-5333	145	13	hsct	hsct	PROPN
dpc-5333	145	14	’s	’s	PART
dpc-5333	145	15	therapeutic	therapeutic	ADJ
dpc-5333	145	16	benefit	benefit	NOUN
dpc-5333	145	17	for	for	ADP
dpc-5333	145	18	psoriasis	psoriasis	NOUN
dpc-5333	145	19	(	(	PUNCT
dpc-5333	145	20	figure	figure	NOUN
dpc-5333	145	21	2	2	NUM
dpc-5333	145	22	)	)	PUNCT
dpc-5333	145	23	.	.	PUNCT
dpc-5333	146	1	the	the	DET
dpc-5333	146	2	improvements	improvement	NOUN
dpc-5333	146	3	seen	see	VERB
dpc-5333	146	4	in	in	ADP
dpc-5333	146	5	these	these	DET
dpc-5333	146	6	patients	patient	NOUN
dpc-5333	146	7	can	can	AUX
dpc-5333	146	8	not	not	PART
dpc-5333	146	9	be	be	AUX
dpc-5333	146	10	attributed	attribute	VERB
dpc-5333	146	11	solely	solely	ADV
dpc-5333	146	12	to	to	ADP
dpc-5333	146	13	the	the	DET
dpc-5333	146	14	hsct	hsct	NOUN
dpc-5333	146	15	procedure	procedure	NOUN
dpc-5333	146	16	itself	itself	PRON
dpc-5333	146	17	due	due	ADP
dpc-5333	146	18	to	to	ADP
dpc-5333	146	19	these	these	DET
dpc-5333	146	20	confounding	confound	VERB
dpc-5333	146	21	factors	factor	NOUN
dpc-5333	146	22	.	.	PUNCT
dpc-5333	147	1	in	in	ADP
dpc-5333	147	2	one	one	NUM
dpc-5333	147	3	reported	report	VERB
dpc-5333	147	4	case	case	NOUN
dpc-5333	147	5	,	,	PUNCT
dpc-5333	147	6	the	the	DET
dpc-5333	147	7	patient	patient	NOUN
dpc-5333	147	8	developed	develop	VERB
dpc-5333	147	9	psoriasis	psoriasis	NOUN
dpc-5333	147	10	within	within	ADP
dpc-5333	147	11	10	10	NUM
dpc-5333	147	12	days	day	NOUN
dpc-5333	147	13	after	after	ADP
dpc-5333	147	14	receiving	receive	VERB
dpc-5333	147	15	the	the	DET
dpc-5333	147	16	hsct	hsct	NOUN
dpc-5333	147	17	.	.	PUNCT
dpc-5333	148	1	the	the	DET
dpc-5333	148	2	psoriasis	psoriasis	NOUN
dpc-5333	148	3	persisted	persist	VERB
dpc-5333	148	4	and	and	CCONJ
dpc-5333	148	5	remained	remain	VERB
dpc-5333	148	6	unresponsive	unresponsive	ADJ
dpc-5333	148	7	to	to	ADP
dpc-5333	148	8	treatment	treatment	NOUN
dpc-5333	148	9	,	,	PUNCT
dpc-5333	148	10	even	even	ADV
dpc-5333	148	11	after	after	SCONJ
dpc-5333	148	12	the	the	DET
dpc-5333	148	13	patient	patient	NOUN
dpc-5333	148	14	underwent	undergo	VERB
dpc-5333	148	15	a	a	DET
dpc-5333	148	16	second	second	ADJ
dpc-5333	148	17	6	6	NUM
dpc-5333	148	18	review	review	NOUN
dpc-5333	148	19	|	|	ADV
dpc-5333	148	20	dermatol	dermatol	ADJ
dpc-5333	148	21	pract	pract	NOUN
dpc-5333	148	22	concept	concept	NOUN
dpc-5333	148	23	.	.	PUNCT
dpc-5333	149	1	2025;15(3):5333	2025;15(3):5333	NUM
dpc-5333	149	2	hsct	hsct	NOUN
dpc-5333	149	3	,	,	PUNCT
dpc-5333	149	4	five	five	NUM
dpc-5333	149	5	of	of	ADP
dpc-5333	149	6	them	they	PRON
dpc-5333	149	7	experienced	experience	VERB
dpc-5333	149	8	a	a	DET
dpc-5333	149	9	relapse	relapse	NOUN
dpc-5333	149	10	of	of	ADP
dpc-5333	149	11	their	their	PRON
dpc-5333	149	12	condition	condition	NOUN
dpc-5333	149	13	within	within	ADP
dpc-5333	149	14	two	two	NUM
dpc-5333	149	15	years	year	NOUN
dpc-5333	149	16	after	after	ADP
dpc-5333	149	17	the	the	DET
dpc-5333	149	18	transplantation	transplantation	NOUN
dpc-5333	149	19	procedure	procedure	NOUN
dpc-5333	149	20	.	.	PUNCT
dpc-5333	150	1	additionally	additionally	ADV
dpc-5333	150	2	,	,	PUNCT
dpc-5333	150	3	one	one	NUM
dpc-5333	150	4	patient	patient	NOUN
dpc-5333	150	5	relapsed	relapse	VERB
dpc-5333	150	6	after	after	ADP
dpc-5333	150	7	a	a	DET
dpc-5333	150	8	longer	long	ADJ
dpc-5333	150	9	period	period	NOUN
dpc-5333	150	10	of	of	ADP
dpc-5333	150	11	13	13	NUM
dpc-5333	150	12	years	year	NOUN
dpc-5333	150	13	post	post	ADJ
dpc-5333	150	14	-	-	NOUN
dpc-5333	150	15	transplantation	transplantation	NOUN
dpc-5333	150	16	[	[	X
dpc-5333	150	17	85	85	NUM
dpc-5333	150	18	]	]	PUNCT
dpc-5333	150	19	.	.	PUNCT
dpc-5333	151	1	the	the	DET
dpc-5333	151	2	study	study	NOUN
dpc-5333	151	3	conducted	conduct	VERB
dpc-5333	151	4	by	by	ADP
dpc-5333	151	5	chen	chen	PROPN
dpc-5333	151	6	et	et	PROPN
dpc-5333	151	7	al	al	PROPN
dpc-5333	151	8	.	.	PROPN
dpc-5333	151	9	leveraged	leverage	VERB
dpc-5333	151	10	the	the	DET
dpc-5333	151	11	imiquimod	imiquimod	ADV
dpc-5333	151	12	-	-	PUNCT
dpc-5333	151	13	induced	induce	VERB
dpc-5333	151	14	mouse	mouse	NOUN
dpc-5333	151	15	model	model	NOUN
dpc-5333	151	16	of	of	ADP
dpc-5333	151	17	psoriasis	psoriasis	NOUN
dpc-5333	151	18	to	to	PART
dpc-5333	151	19	explore	explore	VERB
dpc-5333	151	20	the	the	DET
dpc-5333	151	21	mechanistic	mechanistic	ADJ
dpc-5333	151	22	underpinnings	underpinning	NOUN
dpc-5333	151	23	of	of	ADP
dpc-5333	151	24	ucmscs	ucmsc	NOUN
dpc-5333	151	25	and	and	CCONJ
dpc-5333	151	26	their	their	PRON
dpc-5333	151	27	therapeutic	therapeutic	ADJ
dpc-5333	151	28	efficacy	efficacy	NOUN
dpc-5333	151	29	for	for	ADP
dpc-5333	151	30	this	this	DET
dpc-5333	151	31	condition	condition	NOUN
dpc-5333	151	32	.	.	PUNCT
dpc-5333	152	1	the	the	DET
dpc-5333	152	2	researchers	researcher	NOUN
dpc-5333	152	3	noted	note	VERB
dpc-5333	152	4	a	a	DET
dpc-5333	152	5	significant	significant	ADJ
dpc-5333	152	6	reduction	reduction	NOUN
dpc-5333	152	7	in	in	ADP
dpc-5333	152	8	the	the	DET
dpc-5333	152	9	severity	severity	NOUN
dpc-5333	152	10	of	of	ADP
dpc-5333	152	11	psoriatic	psoriatic	ADJ
dpc-5333	152	12	symptoms	symptom	NOUN
dpc-5333	152	13	following	follow	VERB
dpc-5333	152	14	the	the	DET
dpc-5333	152	15	infusion	infusion	NOUN
dpc-5333	152	16	of	of	ADP
dpc-5333	152	17	human	human	ADJ
dpc-5333	152	18	umbilical	umbilical	ADJ
dpc-5333	152	19	cord	cord	NOUN
dpc-5333	152	20	-	-	PUNCT
dpc-5333	152	21	derived	derive	VERB
dpc-5333	152	22	mscs	msc	NOUN
dpc-5333	152	23	[	[	X
dpc-5333	152	24	91	91	NUM
dpc-5333	152	25	]	]	PUNCT
dpc-5333	152	26	.	.	PUNCT
dpc-5333	153	1	a	a	DET
dpc-5333	153	2	key	key	ADJ
dpc-5333	153	3	characteristic	characteristic	NOUN
dpc-5333	153	4	of	of	ADP
dpc-5333	153	5	the	the	DET
dpc-5333	153	6	hsct	hsct	NOUN
dpc-5333	153	7	using	use	VERB
dpc-5333	153	8	stem	stem	NOUN
dpc-5333	153	9	cells	cell	NOUN
dpc-5333	153	10	from	from	ADP
dpc-5333	153	11	the	the	DET
dpc-5333	153	12	same	same	ADJ
dpc-5333	153	13	donor	donor	NOUN
dpc-5333	153	14	.	.	PUNCT
dpc-5333	154	1	additionally	additionally	ADV
dpc-5333	154	2	,	,	PUNCT
dpc-5333	154	3	the	the	DET
dpc-5333	154	4	patient	patient	NOUN
dpc-5333	154	5	also	also	ADV
dpc-5333	154	6	went	go	VERB
dpc-5333	154	7	on	on	ADP
dpc-5333	154	8	to	to	PART
dpc-5333	154	9	develop	develop	VERB
dpc-5333	154	10	psoriatic	psoriatic	ADJ
dpc-5333	154	11	arthritis	arthritis	NOUN
dpc-5333	154	12	alongside	alongside	ADP
dpc-5333	154	13	the	the	DET
dpc-5333	154	14	intractable	intractable	ADJ
dpc-5333	154	15	psoriasis	psoriasis	NOUN
dpc-5333	154	16	.	.	PUNCT
dpc-5333	155	1	this	this	DET
dpc-5333	155	2	case	case	NOUN
dpc-5333	155	3	illustrates	illustrate	VERB
dpc-5333	155	4	that	that	SCONJ
dpc-5333	155	5	the	the	DET
dpc-5333	155	6	cellular	cellular	ADJ
dpc-5333	155	7	components	component	NOUN
dpc-5333	155	8	driving	drive	VERB
dpc-5333	155	9	psoriasis	psoriasis	NOUN
dpc-5333	155	10	appear	appear	VERB
dpc-5333	155	11	to	to	PART
dpc-5333	155	12	be	be	AUX
dpc-5333	155	13	transmissible	transmissible	ADJ
dpc-5333	155	14	through	through	ADP
dpc-5333	155	15	adoptive	adoptive	ADJ
dpc-5333	155	16	cell	cell	NOUN
dpc-5333	155	17	transfer	transfer	NOUN
dpc-5333	155	18	.	.	PUNCT
dpc-5333	156	1	in	in	ADP
dpc-5333	156	2	contrast	contrast	NOUN
dpc-5333	156	3	,	,	PUNCT
dpc-5333	156	4	autologous	autologous	ADJ
dpc-5333	156	5	hsct	hsct	NOUN
dpc-5333	156	6	does	do	AUX
dpc-5333	156	7	not	not	PART
dpc-5333	156	8	appear	appear	VERB
dpc-5333	156	9	to	to	PART
dpc-5333	156	10	be	be	AUX
dpc-5333	156	11	an	an	DET
dpc-5333	156	12	effective	effective	ADJ
dpc-5333	156	13	curative	curative	ADJ
dpc-5333	156	14	approach	approach	NOUN
dpc-5333	156	15	for	for	ADP
dpc-5333	156	16	psoriasis	psoriasis	NOUN
dpc-5333	156	17	.	.	PUNCT
dpc-5333	157	1	relapses	relapse	NOUN
dpc-5333	157	2	of	of	ADP
dpc-5333	157	3	the	the	DET
dpc-5333	157	4	condition	condition	NOUN
dpc-5333	157	5	are	be	AUX
dpc-5333	157	6	frequent	frequent	ADJ
dpc-5333	157	7	following	follow	VERB
dpc-5333	157	8	autologous	autologous	ADJ
dpc-5333	157	9	hsct	hsct	NOUN
dpc-5333	157	10	and	and	CCONJ
dpc-5333	157	11	may	may	AUX
dpc-5333	157	12	occur	occur	VERB
dpc-5333	157	13	more	more	ADJ
dpc-5333	157	14	than	than	ADP
dpc-5333	157	15	a	a	PRON
dpc-5333	157	16	decade	decade	NOUN
dpc-5333	157	17	after	after	ADP
dpc-5333	157	18	the	the	DET
dpc-5333	157	19	transplantation	transplantation	NOUN
dpc-5333	157	20	procedure	procedure	NOUN
dpc-5333	157	21	.	.	PUNCT
dpc-5333	158	1	based	base	VERB
dpc-5333	158	2	on	on	ADP
dpc-5333	158	3	the	the	DET
dpc-5333	158	4	available	available	ADJ
dpc-5333	158	5	evidence	evidence	NOUN
dpc-5333	158	6	,	,	PUNCT
dpc-5333	158	7	out	out	ADP
dpc-5333	158	8	of	of	ADP
dpc-5333	158	9	the	the	DET
dpc-5333	158	10	11	11	NUM
dpc-5333	158	11	psoriasis	psoriasis	NOUN
dpc-5333	158	12	patients	patient	NOUN
dpc-5333	158	13	who	who	PRON
dpc-5333	158	14	underwent	undergo	VERB
dpc-5333	158	15	autologous	autologous	ADJ
dpc-5333	158	16	figure	figure	NOUN
dpc-5333	158	17	2	2	NUM
dpc-5333	158	18	.	.	PUNCT
dpc-5333	159	1	the	the	DET
dpc-5333	159	2	role	role	NOUN
dpc-5333	159	3	of	of	ADP
dpc-5333	159	4	stem	stem	NOUN
dpc-5333	159	5	cells	cell	NOUN
dpc-5333	159	6	in	in	ADP
dpc-5333	159	7	inhibiting	inhibit	VERB
dpc-5333	159	8	the	the	DET
dpc-5333	159	9	immunopathogenesis	immunopathogenesis	NOUN
dpc-5333	159	10	mechanisms	mechanism	NOUN
dpc-5333	159	11	of	of	ADP
dpc-5333	159	12	psoriasis	psoriasis	NOUN
dpc-5333	159	13	.	.	PUNCT
dpc-5333	160	1	[	[	X
dpc-5333	160	2	created	create	VERB
dpc-5333	160	3	with	with	ADP
dpc-5333	160	4	biorender.com	biorender.com	X
dpc-5333	160	5	]	]	X
dpc-5333	160	6	review	review	NOUN
dpc-5333	160	7	|	|	ADV
dpc-5333	160	8	dermatol	dermatol	ADJ
dpc-5333	160	9	pract	pract	NOUN
dpc-5333	160	10	concept	concept	NOUN
dpc-5333	160	11	.	.	PUNCT
dpc-5333	161	1	2025;15(3):5333	2025;15(3):5333	NUM
dpc-5333	161	2	7	7	NUM
dpc-5333	161	3	response	response	NOUN
dpc-5333	161	4	was	be	AUX
dpc-5333	161	5	the	the	DET
dpc-5333	161	6	diminished	diminished	ADJ
dpc-5333	161	7	generation	generation	NOUN
dpc-5333	161	8	of	of	ADP
dpc-5333	161	9	type	type	NOUN
dpc-5333	161	10	i	i	PRON
dpc-5333	161	11	interferons	interferon	VERB
dpc-5333	161	12	by	by	ADP
dpc-5333	161	13	plasmacytoid	plasmacytoid	NOUN
dpc-5333	161	14	dendritic	dendritic	ADJ
dpc-5333	161	15	cells	cell	NOUN
dpc-5333	161	16	.	.	PUNCT
dpc-5333	162	1	wang	wang	PROPN
dpc-5333	162	2	et	et	PROPN
dpc-5333	162	3	al	al	PROPN
dpc-5333	162	4	.	.	PROPN
dpc-5333	162	5	employed	employ	VERB
dpc-5333	162	6	five	five	NUM
dpc-5333	162	7	infusions	infusion	NOUN
dpc-5333	162	8	of	of	ADP
dpc-5333	162	9	allogeneic	allogeneic	ADJ
dpc-5333	162	10	gingival	gingival	NOUN
dpc-5333	162	11	mscs	msc	NOUN
dpc-5333	162	12	to	to	PART
dpc-5333	162	13	treat	treat	VERB
dpc-5333	162	14	a	a	DET
dpc-5333	162	15	19	19	NUM
dpc-5333	162	16	-	-	PUNCT
dpc-5333	162	17	year	year	NOUN
dpc-5333	162	18	-	-	PUNCT
dpc-5333	162	19	old	old	ADJ
dpc-5333	162	20	patient	patient	NOUN
dpc-5333	162	21	with	with	ADP
dpc-5333	162	22	severe	severe	ADJ
dpc-5333	162	23	plaque	plaque	NOUN
dpc-5333	162	24	psoriasis	psoriasis	NOUN
dpc-5333	162	25	that	that	PRON
dpc-5333	162	26	had	have	AUX
dpc-5333	162	27	proven	prove	VERB
dpc-5333	162	28	recalcitrant	recalcitrant	ADJ
dpc-5333	162	29	to	to	ADP
dpc-5333	162	30	systemic	systemic	ADJ
dpc-5333	162	31	therapeutic	therapeutic	ADJ
dpc-5333	162	32	regimens	regimen	NOUN
dpc-5333	162	33	.	.	PUNCT
dpc-5333	163	1	the	the	DET
dpc-5333	163	2	selection	selection	NOUN
dpc-5333	163	3	of	of	ADP
dpc-5333	163	4	gingival	gingival	NOUN
dpc-5333	163	5	mscs	msc	NOUN
dpc-5333	163	6	was	be	AUX
dpc-5333	163	7	motivated	motivate	VERB
dpc-5333	163	8	by	by	ADP
dpc-5333	163	9	their	their	PRON
dpc-5333	163	10	immunomodulatory	immunomodulatory	ADJ
dpc-5333	163	11	and	and	CCONJ
dpc-5333	163	12	anti	anti	ADJ
dpc-5333	163	13	-	-	ADJ
dpc-5333	163	14	inflammatory	inflammatory	ADJ
dpc-5333	163	15	properties	property	NOUN
dpc-5333	163	16	.	.	PUNCT
dpc-5333	164	1	following	follow	VERB
dpc-5333	164	2	the	the	DET
dpc-5333	164	3	sixth	sixth	ADJ
dpc-5333	164	4	infusion	infusion	NOUN
dpc-5333	164	5	,	,	PUNCT
dpc-5333	164	6	the	the	DET
dpc-5333	164	7	patient	patient	NOUN
dpc-5333	164	8	’s	’s	PART
dpc-5333	164	9	psoriasis	psoriasis	NOUN
dpc-5333	164	10	completely	completely	ADV
dpc-5333	164	11	resolved	resolve	VERB
dpc-5333	164	12	,	,	PUNCT
dpc-5333	164	13	and	and	CCONJ
dpc-5333	164	14	the	the	DET
dpc-5333	164	15	patient	patient	NOUN
dpc-5333	164	16	remained	remain	VERB
dpc-5333	164	17	free	free	ADJ
dpc-5333	164	18	of	of	ADP
dpc-5333	164	19	psoriasis	psoriasis	NOUN
dpc-5333	164	20	for	for	ADP
dpc-5333	164	21	the	the	DET
dpc-5333	164	22	subsequent	subsequent	ADJ
dpc-5333	164	23	three	three	NUM
dpc-5333	164	24	years	year	NOUN
dpc-5333	165	1	[	[	X
dpc-5333	165	2	90	90	NUM
dpc-5333	165	3	]	]	PUNCT
dpc-5333	165	4	.	.	PUNCT
dpc-5333	166	1	conclusion	conclusion	NOUN
dpc-5333	166	2	the	the	DET
dpc-5333	166	3	current	current	ADJ
dpc-5333	166	4	evidence	evidence	NOUN
dpc-5333	166	5	indicates	indicate	VERB
dpc-5333	166	6	that	that	SCONJ
dpc-5333	166	7	psoriasis	psoriasis	NOUN
dpc-5333	166	8	is	be	AUX
dpc-5333	166	9	a	a	DET
dpc-5333	166	10	multisystem	multisystem	NOUN
dpc-5333	166	11	disorder	disorder	NOUN
dpc-5333	166	12	characterized	characterize	VERB
dpc-5333	166	13	by	by	ADP
dpc-5333	166	14	the	the	DET
dpc-5333	166	15	abnormalities	abnormality	NOUN
dpc-5333	166	16	of	of	ADP
dpc-5333	166	17	various	various	ADJ
dpc-5333	166	18	stem	stem	NOUN
dpc-5333	166	19	cell	cell	NOUN
dpc-5333	166	20	and	and	CCONJ
dpc-5333	166	21	progenitor	progenitor	NOUN
dpc-5333	166	22	cell	cell	NOUN
dpc-5333	166	23	populations	population	NOUN
dpc-5333	166	24	.	.	PUNCT
dpc-5333	167	1	these	these	DET
dpc-5333	167	2	disruptions	disruption	NOUN
dpc-5333	167	3	in	in	ADP
dpc-5333	167	4	stem	stem	NOUN
dpc-5333	167	5	/	/	SYM
dpc-5333	167	6	progenitor	progenitor	NOUN
dpc-5333	167	7	cell	cell	NOUN
dpc-5333	167	8	biology	biology	NOUN
dpc-5333	167	9	appear	appear	VERB
dpc-5333	167	10	to	to	PART
dpc-5333	167	11	be	be	AUX
dpc-5333	167	12	either	either	CCONJ
dpc-5333	167	13	the	the	DET
dpc-5333	167	14	primary	primary	ADJ
dpc-5333	167	15	driver	driver	NOUN
dpc-5333	167	16	or	or	CCONJ
dpc-5333	167	17	an	an	DET
dpc-5333	167	18	associated	associated	ADJ
dpc-5333	167	19	feature	feature	NOUN
dpc-5333	167	20	of	of	ADP
dpc-5333	167	21	the	the	DET
dpc-5333	167	22	aberrant	aberrant	ADJ
dpc-5333	167	23	immune	immune	ADJ
dpc-5333	167	24	responses	response	NOUN
dpc-5333	167	25	observed	observe	VERB
dpc-5333	167	26	in	in	ADP
dpc-5333	167	27	psoriasis	psoriasis	NOUN
dpc-5333	167	28	patients	patient	NOUN
dpc-5333	167	29	.	.	PUNCT
dpc-5333	168	1	the	the	DET
dpc-5333	168	2	data	datum	NOUN
dpc-5333	168	3	collected	collect	VERB
dpc-5333	168	4	to	to	ADP
dpc-5333	168	5	date	date	NOUN
dpc-5333	168	6	points	point	NOUN
dpc-5333	168	7	to	to	ADP
dpc-5333	168	8	psoriasis	psoriasis	NOUN
dpc-5333	168	9	being	be	AUX
dpc-5333	168	10	a	a	DET
dpc-5333	168	11	multifaceted	multifaceted	ADJ
dpc-5333	168	12	condition	condition	NOUN
dpc-5333	168	13	rather	rather	ADV
dpc-5333	168	14	than	than	ADP
dpc-5333	168	15	one	one	NUM
dpc-5333	168	16	solely	solely	ADV
dpc-5333	168	17	limited	limit	VERB
dpc-5333	168	18	to	to	ADP
dpc-5333	168	19	skin	skin	NOUN
dpc-5333	168	20	pathology	pathology	NOUN
dpc-5333	168	21	or	or	CCONJ
dpc-5333	168	22	immune	immune	ADJ
dpc-5333	168	23	system	system	NOUN
dpc-5333	168	24	dysregulation	dysregulation	NOUN
dpc-5333	168	25	.	.	PUNCT
dpc-5333	169	1	the	the	DET
dpc-5333	169	2	hscs	hsc	NOUN
dpc-5333	169	3	of	of	ADP
dpc-5333	169	4	individuals	individual	NOUN
dpc-5333	169	5	with	with	ADP
dpc-5333	169	6	psoriasis	psoriasis	NOUN
dpc-5333	169	7	appear	appear	VERB
dpc-5333	169	8	to	to	PART
dpc-5333	169	9	give	give	VERB
dpc-5333	169	10	rise	rise	NOUN
dpc-5333	169	11	to	to	ADP
dpc-5333	169	12	a	a	DET
dpc-5333	169	13	t	t	NOUN
dpc-5333	169	14	cell	cell	NOUN
dpc-5333	169	15	subpopulation	subpopulation	NOUN
dpc-5333	169	16	that	that	PRON
dpc-5333	169	17	has	have	VERB
dpc-5333	169	18	an	an	DET
dpc-5333	169	19	increased	increase	VERB
dpc-5333	169	20	tendency	tendency	NOUN
dpc-5333	169	21	to	to	PART
dpc-5333	169	22	secrete	secrete	VERB
dpc-5333	169	23	th1	th1	NOUN
dpc-5333	169	24	-	-	PUNCT
dpc-5333	169	25	type	type	NOUN
dpc-5333	169	26	cytokines	cytokine	NOUN
dpc-5333	169	27	.	.	PUNCT
dpc-5333	170	1	additionally	additionally	ADV
dpc-5333	170	2	,	,	PUNCT
dpc-5333	170	3	there	there	PRON
dpc-5333	170	4	seems	seem	VERB
dpc-5333	170	5	to	to	PART
dpc-5333	170	6	be	be	AUX
dpc-5333	170	7	a	a	DET
dpc-5333	170	8	functionally	functionally	ADV
dpc-5333	170	9	impaired	impaired	ADJ
dpc-5333	170	10	treg	treg	PROPN
dpc-5333	170	11	subgroup	subgroup	PROPN
dpc-5333	170	12	associated	associate	VERB
dpc-5333	170	13	with	with	ADP
dpc-5333	170	14	the	the	DET
dpc-5333	170	15	psoriatic	psoriatic	ADJ
dpc-5333	170	16	hsc	hsc	NOUN
dpc-5333	170	17	compartment	compartment	NOUN
dpc-5333	170	18	.	.	PUNCT
dpc-5333	171	1	these	these	DET
dpc-5333	171	2	alterations	alteration	NOUN
dpc-5333	171	3	in	in	ADP
dpc-5333	171	4	t	t	PROPN
dpc-5333	171	5	cell	cell	NOUN
dpc-5333	171	6	differentiation	differentiation	NOUN
dpc-5333	171	7	and	and	CCONJ
dpc-5333	171	8	treg	treg	PROPN
dpc-5333	171	9	function	function	VERB
dpc-5333	171	10	originating	originate	VERB
dpc-5333	171	11	from	from	ADP
dpc-5333	171	12	the	the	DET
dpc-5333	171	13	dysregulated	dysregulated	ADJ
dpc-5333	171	14	psoriatic	psoriatic	ADJ
dpc-5333	171	15	hscs	hsc	NOUN
dpc-5333	171	16	likely	likely	ADV
dpc-5333	171	17	contribute	contribute	VERB
dpc-5333	171	18	to	to	ADP
dpc-5333	171	19	the	the	DET
dpc-5333	171	20	abnormal	abnormal	ADJ
dpc-5333	171	21	immune	immune	ADJ
dpc-5333	171	22	profiles	profile	NOUN
dpc-5333	171	23	observed	observe	VERB
dpc-5333	171	24	in	in	ADP
dpc-5333	171	25	psoriasis	psoriasis	NOUN
dpc-5333	171	26	.	.	PUNCT
dpc-5333	172	1	psoriatic	psoriatic	ADJ
dpc-5333	172	2	t	t	PROPN
dpc-5333	172	3	cells	cell	NOUN
dpc-5333	172	4	are	be	AUX
dpc-5333	172	5	primed	prime	VERB
dpc-5333	172	6	to	to	PART
dpc-5333	172	7	mount	mount	VERB
dpc-5333	172	8	a	a	DET
dpc-5333	172	9	th1	th1	NOUN
dpc-5333	172	10	immune	immune	ADJ
dpc-5333	172	11	response	response	NOUN
dpc-5333	172	12	when	when	SCONJ
dpc-5333	172	13	triggered	trigger	VERB
dpc-5333	172	14	.	.	PUNCT
dpc-5333	173	1	this	this	DET
dpc-5333	173	2	th1	th1	PROPN
dpc-5333	173	3	response	response	NOUN
dpc-5333	173	4	induces	induce	VERB
dpc-5333	173	5	the	the	DET
dpc-5333	173	6	expansion	expansion	NOUN
dpc-5333	173	7	of	of	ADP
dpc-5333	173	8	ta	ta	ADP
dpc-5333	173	9	cells	cell	NOUN
dpc-5333	173	10	from	from	ADP
dpc-5333	173	11	escs	esc	NOUN
dpc-5333	173	12	,	,	PUNCT
dpc-5333	173	13	leading	lead	VERB
dpc-5333	173	14	to	to	ADP
dpc-5333	173	15	excessive	excessive	ADJ
dpc-5333	173	16	keratinocyte	keratinocyte	NOUN
dpc-5333	173	17	proliferation	proliferation	NOUN
dpc-5333	173	18	.	.	PUNCT
dpc-5333	174	1	the	the	DET
dpc-5333	174	2	th1	th1	PROPN
dpc-5333	174	3	response	response	NOUN
dpc-5333	174	4	also	also	ADV
dpc-5333	174	5	promotes	promote	VERB
dpc-5333	174	6	mscs	msc	NOUN
dpc-5333	174	7	to	to	PART
dpc-5333	174	8	transform	transform	VERB
dpc-5333	174	9	into	into	ADP
dpc-5333	174	10	an	an	DET
dpc-5333	174	11	inflammatory	inflammatory	ADJ
dpc-5333	174	12	msc1	msc1	NOUN
dpc-5333	174	13	phenotype	phenotype	NOUN
dpc-5333	174	14	.	.	PUNCT
dpc-5333	175	1	these	these	DET
dpc-5333	175	2	msc1	msc1	PROPN
dpc-5333	175	3	cells	cell	NOUN
dpc-5333	175	4	secrete	secrete	VERB
dpc-5333	175	5	inflammatory	inflammatory	ADJ
dpc-5333	175	6	factors	factor	NOUN
dpc-5333	175	7	that	that	PRON
dpc-5333	175	8	contribute	contribute	VERB
dpc-5333	175	9	to	to	ADP
dpc-5333	175	10	increased	increase	VERB
dpc-5333	175	11	angiogenesis	angiogenesis	NOUN
dpc-5333	175	12	and	and	CCONJ
dpc-5333	175	13	lymphocyte	lymphocyte	ADJ
dpc-5333	175	14	infiltration	infiltration	NOUN
dpc-5333	175	15	in	in	ADP
dpc-5333	175	16	the	the	DET
dpc-5333	175	17	dermal	dermal	ADJ
dpc-5333	175	18	layer	layer	NOUN
dpc-5333	175	19	,	,	PUNCT
dpc-5333	175	20	further	far	ADV
dpc-5333	175	21	perpetuating	perpetuate	VERB
dpc-5333	175	22	the	the	DET
dpc-5333	175	23	local	local	ADJ
dpc-5333	175	24	th1	th1	NOUN
dpc-5333	175	25	response	response	NOUN
dpc-5333	175	26	.	.	PUNCT
dpc-5333	176	1	in	in	ADP
dpc-5333	176	2	this	this	DET
dpc-5333	176	3	way	way	NOUN
dpc-5333	176	4	,	,	PUNCT
dpc-5333	176	5	the	the	DET
dpc-5333	176	6	th1	th1	PROPN
dpc-5333	176	7	response	response	NOUN
dpc-5333	176	8	driven	drive	VERB
dpc-5333	176	9	by	by	ADP
dpc-5333	176	10	psoriatic	psoriatic	ADJ
dpc-5333	176	11	t	t	NOUN
dpc-5333	176	12	cells	cell	NOUN
dpc-5333	176	13	drives	drive	VERB
dpc-5333	176	14	both	both	CCONJ
dpc-5333	176	15	the	the	DET
dpc-5333	176	16	hyperproliferation	hyperproliferation	NOUN
dpc-5333	176	17	of	of	ADP
dpc-5333	176	18	keratinocyte	keratinocyte	NOUN
dpc-5333	176	19	and	and	CCONJ
dpc-5333	176	20	inflammation	inflammation	NOUN
dpc-5333	176	21	in	in	ADP
dpc-5333	176	22	the	the	DET
dpc-5333	176	23	dermis	dermis	NOUN
dpc-5333	176	24	,	,	PUNCT
dpc-5333	176	25	amplifying	amplify	VERB
dpc-5333	176	26	the	the	DET
dpc-5333	176	27	pathological	pathological	ADJ
dpc-5333	176	28	processes	process	NOUN
dpc-5333	176	29	of	of	ADP
dpc-5333	176	30	psoriasis	psoriasis	NOUN
dpc-5333	176	31	.	.	PUNCT
dpc-5333	177	1	abbreviations	abbreviation	NOUN
dpc-5333	177	2	regulatory	regulatory	ADJ
dpc-5333	177	3	t	t	NOUN
dpc-5333	177	4	-	-	PUNCT
dpc-5333	177	5	cell	cell	NOUN
dpc-5333	177	6	(	(	PUNCT
dpc-5333	177	7	t	t	NOUN
dpc-5333	177	8	-	-	PUNCT
dpc-5333	177	9	reg	reg	NOUN
dpc-5333	177	10	)	)	PUNCT
dpc-5333	177	11	,	,	PUNCT
dpc-5333	177	12	interleukin	interleukin	NOUN
dpc-5333	177	13	(	(	PUNCT
dpc-5333	177	14	il	il	PROPN
dpc-5333	177	15	)	)	PUNCT
dpc-5333	177	16	,	,	PUNCT
dpc-5333	177	17	dendritic	dendritic	ADJ
dpc-5333	177	18	cells	cell	NOUN
dpc-5333	177	19	(	(	PUNCT
dpc-5333	177	20	dc	dc	PROPN
dpc-5333	177	21	)	)	PUNCT
dpc-5333	177	22	,	,	PUNCT
dpc-5333	177	23	transient	transient	VERB
dpc-5333	177	24	amplifying	amplifying	ADJ
dpc-5333	177	25	cells	cell	NOUN
dpc-5333	177	26	(	(	PUNCT
dpc-5333	177	27	ta	ta	ADP
dpc-5333	177	28	cells	cell	NOUN
dpc-5333	177	29	)	)	PUNCT
dpc-5333	177	30	,	,	PUNCT
dpc-5333	177	31	epidermal	epidermal	ADJ
dpc-5333	177	32	stem	stem	NOUN
dpc-5333	177	33	cells	cell	NOUN
dpc-5333	177	34	(	(	PUNCT
dpc-5333	177	35	epscs	epsc	NOUN
dpc-5333	177	36	)	)	PUNCT
dpc-5333	177	37	,	,	PUNCT
dpc-5333	177	38	t	t	PROPN
dpc-5333	177	39	helper	helper	NOUN
dpc-5333	177	40	(	(	PUNCT
dpc-5333	177	41	th	th	NOUN
dpc-5333	177	42	)	)	PUNCT
dpc-5333	177	43	,	,	PUNCT
dpc-5333	177	44	immune	immune	NOUN
dpc-5333	177	45	-	-	PUNCT
dpc-5333	177	46	mediated	mediate	VERB
dpc-5333	177	47	inflammatory	inflammatory	ADJ
dpc-5333	177	48	diseases	disease	NOUN
dpc-5333	177	49	(	(	PUNCT
dpc-5333	177	50	imids	imid	NOUN
dpc-5333	177	51	)	)	PUNCT
dpc-5333	177	52	,	,	PUNCT
dpc-5333	177	53	umbilical	umbilical	ADJ
dpc-5333	177	54	cord	cord	NOUN
dpc-5333	177	55	-	-	PUNCT
dpc-5333	177	56	derived	derive	VERB
dpc-5333	177	57	mscs	msc	NOUN
dpc-5333	177	58	(	(	PUNCT
dpc-5333	177	59	uc	uc	NOUN
dpc-5333	177	60	-	-	PUNCT
dpc-5333	177	61	mscs	msc	NOUN
dpc-5333	177	62	)	)	PUNCT
dpc-5333	177	63	,	,	PUNCT
dpc-5333	177	64	bone	bone	NOUN
dpc-5333	177	65	marrow	marrow	NOUN
dpc-5333	177	66	(	(	PUNCT
dpc-5333	177	67	bm	bm	PROPN
dpc-5333	177	68	)	)	PUNCT
dpc-5333	177	69	,	,	PUNCT
dpc-5333	177	70	natural	natural	ADJ
dpc-5333	177	71	killer	killer	NOUN
dpc-5333	177	72	(	(	PUNCT
dpc-5333	177	73	nk	nk	PROPN
dpc-5333	177	74	)	)	PUNCT
dpc-5333	177	75	,	,	PUNCT
dpc-5333	177	76	transforming	transform	VERB
dpc-5333	177	77	growth	growth	NOUN
dpc-5333	177	78	factor	factor	NOUN
dpc-5333	177	79	-	-	PUNCT
dpc-5333	177	80	beta	beta	NOUN
dpc-5333	177	81	1	1	NUM
dpc-5333	177	82	(	(	PUNCT
dpc-5333	177	83	tgf	tgf	NOUN
dpc-5333	177	84	-	-	PUNCT
dpc-5333	177	85	b1	b1	NOUN
dpc-5333	177	86	)	)	PUNCT
dpc-5333	177	87	,	,	PUNCT
dpc-5333	177	88	interferonγ	interferonγ	INTJ
dpc-5333	177	89	(	(	PUNCT
dpc-5333	177	90	ifn	ifn	PROPN
dpc-5333	177	91	-	-	PUNCT
dpc-5333	177	92	γ	γ	NOUN
dpc-5333	177	93	)	)	PUNCT
dpc-5333	177	94	,	,	PUNCT
dpc-5333	177	95	fibroblast	fibroblast	ADJ
dpc-5333	177	96	growth	growth	NOUN
dpc-5333	177	97	factor	factor	NOUN
dpc-5333	177	98	,	,	PUNCT
dpc-5333	177	99	mesenchymal	mesenchymal	NOUN
dpc-5333	177	100	stem	stem	NOUN
dpc-5333	177	101	cells	cell	NOUN
dpc-5333	177	102	(	(	PUNCT
dpc-5333	177	103	mscs	msc	NOUN
dpc-5333	177	104	)	)	PUNCT
dpc-5333	177	105	,	,	PUNCT
dpc-5333	177	106	systemic	systemic	ADJ
dpc-5333	177	107	lupus	lupus	NOUN
dpc-5333	177	108	erythematosus	erythematosus	NOUN
dpc-5333	177	109	(	(	PUNCT
dpc-5333	177	110	sle	sle	PROPN
dpc-5333	177	111	)	)	PUNCT
dpc-5333	177	112	,	,	PUNCT
dpc-5333	177	113	sjögren	sjögren	PROPN
dpc-5333	177	114	’s	’s	PART
dpc-5333	177	115	syndrome	syndrome	PROPN
dpc-5333	177	116	(	(	PUNCT
dpc-5333	177	117	ss	ss	NOUN
dpc-5333	177	118	)	)	PUNCT
dpc-5333	177	119	,	,	PUNCT
dpc-5333	177	120	graft	graft	NOUN
dpc-5333	177	121	-	-	PUNCT
dpc-5333	177	122	versus	versus	ADP
dpc-5333	177	123	-	-	PUNCT
dpc-5333	177	124	host	host	NOUN
dpc-5333	177	125	disease	disease	NOUN
dpc-5333	177	126	(	(	PUNCT
dpc-5333	177	127	gvhd	gvhd	PROPN
dpc-5333	177	128	)	)	PUNCT
dpc-5333	177	129	,	,	PUNCT
dpc-5333	177	130	inflammatory	inflammatory	ADJ
dpc-5333	177	131	bowel	bowel	NOUN
dpc-5333	177	132	disease	disease	NOUN
dpc-5333	177	133	(	(	PUNCT
dpc-5333	177	134	ibd	ibd	PROPN
dpc-5333	177	135	)	)	PUNCT
dpc-5333	177	136	,	,	PUNCT
dpc-5333	177	137	multiple	multiple	ADJ
dpc-5333	177	138	sclerosis	sclerosis	NOUN
dpc-5333	177	139	(	(	PUNCT
dpc-5333	177	140	ms	ms	NOUN
dpc-5333	177	141	)	)	PUNCT
dpc-5333	177	142	,	,	PUNCT
dpc-5333	177	143	histone	histone	NOUN
dpc-5333	177	144	deacetylase	deacetylase	VERB
dpc-5333	177	145	1	1	NUM
dpc-5333	177	146	(	(	PUNCT
dpc-5333	177	147	hdac1	hdac1	NOUN
dpc-5333	177	148	)	)	PUNCT
dpc-5333	177	149	,	,	PUNCT
dpc-5333	177	150	extracellular	extracellular	ADJ
dpc-5333	177	151	matrix	matrix	NOUN
dpc-5333	177	152	(	(	PUNCT
dpc-5333	177	153	ecm	ecm	PROPN
dpc-5333	177	154	)	)	PUNCT
dpc-5333	177	155	,	,	PUNCT
dpc-5333	177	156	cluster	cluster	NOUN
dpc-5333	177	157	of	of	ADP
dpc-5333	177	158	differentiation	differentiation	NOUN
dpc-5333	177	159	(	(	PUNCT
dpc-5333	177	160	cd	cd	PROPN
dpc-5333	177	161	)	)	PUNCT
dpc-5333	177	162	,	,	PUNCT
dpc-5333	177	163	human	human	ADJ
dpc-5333	177	164	leukocyte	leukocyte	NOUN
dpc-5333	177	165	antigen	antigen	NOUN
dpc-5333	177	166	(	(	PUNCT
dpc-5333	177	167	hla	hla	NOUN
dpc-5333	177	168	)	)	PUNCT
dpc-5333	177	169	.	.	PUNCT
dpc-5333	178	1	references	reference	NOUN
dpc-5333	178	2	1	1	NUM
dpc-5333	178	3	.	.	PUNCT
dpc-5333	178	4	danielsen	danielsen	PROPN
dpc-5333	178	5	k	k	PROPN
dpc-5333	178	6	,	,	PUNCT
dpc-5333	178	7	olsen	olsen	NOUN
dpc-5333	178	8	a	a	PRON
dpc-5333	178	9	,	,	PUNCT
dpc-5333	178	10	wilsgaard	wilsgaard	PROPN
dpc-5333	178	11	t	t	PROPN
dpc-5333	178	12	,	,	PUNCT
dpc-5333	178	13	furberg	furberg	ADV
dpc-5333	178	14	as	as	ADP
dpc-5333	178	15	.	.	PUNCT
dpc-5333	178	16	is	be	AUX
dpc-5333	178	17	the	the	DET
dpc-5333	178	18	prevalence	prevalence	NOUN
dpc-5333	178	19	of	of	ADP
dpc-5333	178	20	psoriasis	psoriasis	NOUN
dpc-5333	178	21	increasing	increase	VERB
dpc-5333	178	22	?	?	PUNCT
dpc-5333	179	1	a	a	DET
dpc-5333	179	2	30	30	NUM
dpc-5333	179	3	-	-	PUNCT
dpc-5333	179	4	year	year	NOUN
dpc-5333	179	5	follow	follow	NOUN
dpc-5333	179	6	-	-	PUNCT
dpc-5333	179	7	up	up	NOUN
dpc-5333	179	8	of	of	ADP
dpc-5333	179	9	a	a	DET
dpc-5333	179	10	population	population	NOUN
dpc-5333	179	11	based	base	VERB
dpc-5333	179	12	cohort	cohort	NOUN
dpc-5333	179	13	.	.	PUNCT
dpc-5333	180	1	british	british	ADJ
dpc-5333	180	2	journal	journal	PROPN
dpc-5333	180	3	of	of	ADP
dpc-5333	180	4	dermatology	dermatology	NOUN
dpc-5333	180	5	.	.	PUNCT
dpc-5333	181	1	2013;168(6	2013;168(6	NUM
dpc-5333	181	2	):	):	PUNCT
dpc-5333	181	3	1303–1310	1303–1310	NUM
dpc-5333	181	4	.	.	PUNCT
dpc-5333	182	1	doi:10.1111	doi:10.1111	ADJ
dpc-5333	182	2	/	/	SYM
dpc-5333	182	3	bjd.12230	bjd.12230	NOUN
dpc-5333	182	4	.	.	NOUN
dpc-5333	183	1	2	2	NUM
dpc-5333	183	2	.	.	PUNCT
dpc-5333	183	3	parisi	parisi	PROPN
dpc-5333	183	4	r	r	PROPN
dpc-5333	183	5	,	,	PUNCT
dpc-5333	183	6	symmons	symmon	NOUN
dpc-5333	183	7	dp	dp	PROPN
dpc-5333	183	8	,	,	PUNCT
dpc-5333	183	9	griffiths	griffiths	PROPN
dpc-5333	183	10	ce	ce	PROPN
dpc-5333	183	11	,	,	PUNCT
dpc-5333	184	1	ashcroft	ashcroft	PROPN
dpc-5333	184	2	dm	dm	PROPN
dpc-5333	184	3	.	.	PUNCT
dpc-5333	185	1	global	global	ADJ
dpc-5333	185	2	epidemiology	epidemiology	NOUN
dpc-5333	185	3	of	of	ADP
dpc-5333	185	4	psoriasis	psoriasis	NOUN
dpc-5333	185	5	:	:	PUNCT
dpc-5333	185	6	a	a	DET
dpc-5333	185	7	systematic	systematic	ADJ
dpc-5333	185	8	review	review	NOUN
dpc-5333	185	9	of	of	ADP
dpc-5333	185	10	incidence	incidence	NOUN
dpc-5333	185	11	and	and	CCONJ
dpc-5333	185	12	prevalence	prevalence	NOUN
dpc-5333	185	13	.	.	PUNCT
dpc-5333	186	1	journal	journal	PROPN
dpc-5333	186	2	of	of	ADP
dpc-5333	186	3	investigative	investigative	ADJ
dpc-5333	186	4	dermatology	dermatology	NOUN
dpc-5333	186	5	.	.	PUNCT
dpc-5333	187	1	2013;133(2	2013;133(2	NUM
dpc-5333	187	2	):	):	PUNCT
dpc-5333	187	3	377–385	377–385	NUM
dpc-5333	187	4	.	.	PUNCT
dpc-5333	188	1	doi:10.1038	doi:10.1038	NOUN
dpc-5333	188	2	/	/	SYM
dpc-5333	188	3	jid.2012.339	jid.2012.339	PROPN
dpc-5333	188	4	3	3	NUM
dpc-5333	188	5	.	.	PUNCT
dpc-5333	189	1	singh	singh	PROPN
dpc-5333	189	2	s	s	PROPN
dpc-5333	189	3	,	,	PUNCT
dpc-5333	189	4	young	young	ADJ
dpc-5333	189	5	p	p	X
dpc-5333	189	6	,	,	PUNCT
dpc-5333	189	7	armstrong	armstrong	PROPN
dpc-5333	189	8	aw	aw	INTJ
dpc-5333	189	9	.	.	PUNCT
dpc-5333	190	1	an	an	DET
dpc-5333	190	2	update	update	NOUN
dpc-5333	190	3	on	on	ADP
dpc-5333	190	4	psoriasis	psoriasis	NOUN
dpc-5333	190	5	and	and	CCONJ
dpc-5333	190	6	metabolic	metabolic	NOUN
dpc-5333	190	7	syndrome	syndrome	NOUN
dpc-5333	190	8	:	:	PUNCT
dpc-5333	190	9	a	a	DET
dpc-5333	190	10	meta	meta	ADJ
dpc-5333	190	11	-	-	PUNCT
dpc-5333	190	12	analysis	analysis	NOUN
dpc-5333	190	13	of	of	ADP
dpc-5333	190	14	observational	observational	ADJ
dpc-5333	190	15	studies	study	NOUN
dpc-5333	190	16	.	.	PUNCT
dpc-5333	191	1	plos	plos	PROPN
dpc-5333	191	2	one	one	NUM
dpc-5333	191	3	.	.	PUNCT
dpc-5333	192	1	2017;12(7):e0181039	2017;12(7):e0181039	NUM
dpc-5333	192	2	.	.	PUNCT
dpc-5333	192	3	doi:10.1371	doi:10.1371	NOUN
dpc-5333	192	4	/	/	SYM
dpc-5333	192	5	journal.pone.0181039	journal.pone.0181039	PROPN
dpc-5333	192	6	4	4	NUM
dpc-5333	192	7	.	.	PUNCT
dpc-5333	193	1	singh	singh	PROPN
dpc-5333	193	2	s	s	PROPN
dpc-5333	193	3	,	,	PUNCT
dpc-5333	193	4	taylor	taylor	PROPN
dpc-5333	193	5	c	c	PROPN
dpc-5333	193	6	,	,	PUNCT
dpc-5333	193	7	kornmehl	kornmehl	PROPN
dpc-5333	193	8	h	h	PROPN
dpc-5333	193	9	,	,	PUNCT
dpc-5333	193	10	armstrong	armstrong	PROPN
dpc-5333	193	11	aw	aw	INTJ
dpc-5333	193	12	.	.	PUNCT
dpc-5333	193	13	psoriasis	psoriasis	NOUN
dpc-5333	193	14	and	and	CCONJ
dpc-5333	193	15	suicidality	suicidality	NOUN
dpc-5333	193	16	:	:	PUNCT
dpc-5333	193	17	a	a	DET
dpc-5333	193	18	systematic	systematic	ADJ
dpc-5333	193	19	review	review	NOUN
dpc-5333	193	20	and	and	CCONJ
dpc-5333	193	21	meta	meta	ADJ
dpc-5333	193	22	-	-	PUNCT
dpc-5333	193	23	analysis	analysis	NOUN
dpc-5333	193	24	.	.	PUNCT
dpc-5333	194	1	journal	journal	NOUN
dpc-5333	194	2	of	of	ADP
dpc-5333	194	3	the	the	DET
dpc-5333	194	4	american	american	PROPN
dpc-5333	194	5	academy	academy	PROPN
dpc-5333	194	6	of	of	ADP
dpc-5333	194	7	dermatology	dermatology	NOUN
dpc-5333	194	8	.	.	PUNCT
dpc-5333	195	1	2017;77(3):425–440	2017;77(3):425–440	NUM
dpc-5333	195	2	.	.	PUNCT
dpc-5333	196	1	e2	e2	PROPN
dpc-5333	196	2	.	.	PUNCT
dpc-5333	197	1	doi:10.1016	doi:10.1016	PROPN
dpc-5333	197	2	/	/	SYM
dpc-5333	197	3	j.jaad.2017.05.019	j.jaad.2017.05.019	PROPN
dpc-5333	197	4	5	5	NUM
dpc-5333	197	5	.	.	PUNCT
dpc-5333	198	1	randa	randa	PROPN
dpc-5333	198	2	h	h	PROPN
dpc-5333	198	3	,	,	PUNCT
dpc-5333	198	4	todberg	todberg	PROPN
dpc-5333	198	5	t	t	PROPN
dpc-5333	198	6	,	,	PUNCT
dpc-5333	198	7	skov	skov	PROPN
dpc-5333	198	8	l	l	NOUN
dpc-5333	198	9	,	,	PUNCT
dpc-5333	198	10	larsen	larsen	PROPN
dpc-5333	198	11	ls	ls	PROPN
dpc-5333	198	12	,	,	PUNCT
dpc-5333	198	13	zachariae	zachariae	PROPN
dpc-5333	198	14	r.	r.	PROPN
dpc-5333	198	15	health	health	PROPN
dpc-5333	198	16	related	relate	VERB
dpc-5333	198	17	quality	quality	NOUN
dpc-5333	198	18	of	of	ADP
dpc-5333	198	19	life	life	NOUN
dpc-5333	198	20	in	in	ADP
dpc-5333	198	21	children	child	NOUN
dpc-5333	198	22	and	and	CCONJ
dpc-5333	198	23	adolescents	adolescent	NOUN
dpc-5333	198	24	with	with	ADP
dpc-5333	198	25	psoriasis	psoriasis	NOUN
dpc-5333	198	26	:	:	PUNCT
dpc-5333	198	27	a	a	DET
dpc-5333	198	28	systematic	systematic	ADJ
dpc-5333	198	29	review	review	NOUN
dpc-5333	198	30	and	and	CCONJ
dpc-5333	198	31	meta	meta	ADJ
dpc-5333	198	32	-	-	PUNCT
dpc-5333	198	33	analysis	analysis	NOUN
dpc-5333	198	34	.	.	PUNCT
dpc-5333	199	1	acta	acta	PROPN
dpc-5333	199	2	dermatovenereologica	dermatovenereologica	PROPN
dpc-5333	199	3	.	.	PUNCT
dpc-5333	200	1	2017;97(5):555–563	2017;97(5):555–563	X
dpc-5333	200	2	.	.	PUNCT
dpc-5333	201	1	doi:10.2340/00015555	doi:10.2340/00015555	NOUN
dpc-5333	201	2	-	-	SYM
dpc-5333	201	3	2600	2600	NUM
dpc-5333	201	4	6	6	NUM
dpc-5333	201	5	.	.	PUNCT
dpc-5333	202	1	deng	deng	PROPN
dpc-5333	202	2	y	y	PROPN
dpc-5333	202	3	,	,	PUNCT
dpc-5333	202	4	chang	chang	PROPN
dpc-5333	202	5	c	c	PROPN
dpc-5333	202	6	,	,	PUNCT
dpc-5333	202	7	lu	lu	PROPN
dpc-5333	202	8	q.	q.	VERB
dpc-5333	202	9	the	the	DET
dpc-5333	202	10	inflammatory	inflammatory	ADJ
dpc-5333	202	11	response	response	NOUN
dpc-5333	202	12	in	in	ADP
dpc-5333	202	13	psoriasis	psoriasis	NOUN
dpc-5333	202	14	:	:	PUNCT
dpc-5333	202	15	a	a	DET
dpc-5333	202	16	comprehensive	comprehensive	ADJ
dpc-5333	202	17	review	review	NOUN
dpc-5333	202	18	.	.	PUNCT
dpc-5333	203	1	clinical	clinical	ADJ
dpc-5333	203	2	reviews	review	NOUN
dpc-5333	203	3	in	in	ADP
dpc-5333	203	4	allergy	allergy	NOUN
dpc-5333	203	5	&	&	CCONJ
dpc-5333	203	6	immunology	immunology	NOUN
dpc-5333	203	7	.	.	PUNCT
dpc-5333	204	1	2016;50:377–389	2016;50:377–389	NOUN
dpc-5333	204	2	.	.	PUNCT
dpc-5333	205	1	doi:10.1007	doi:10.1007	VERB
dpc-5333	205	2	/	/	SYM
dpc-5333	206	1	s12016	s12016	PROPN
dpc-5333	206	2	-	-	PUNCT
dpc-5333	206	3	016	016	NUM
dpc-5333	206	4	-	-	PUNCT
dpc-5333	206	5	8535	8535	NUM
dpc-5333	206	6	-	-	PUNCT
dpc-5333	206	7	x	x	SYM
dpc-5333	206	8	7	7	PROPN
dpc-5333	206	9	.	.	PUNCT
dpc-5333	206	10	martin	martin	PROPN
dpc-5333	206	11	da	da	PROPN
dpc-5333	206	12	,	,	PUNCT
dpc-5333	206	13	towne	towne	PROPN
dpc-5333	206	14	je	je	PROPN
dpc-5333	206	15	,	,	PUNCT
dpc-5333	206	16	kricorian	kricorian	PROPN
dpc-5333	206	17	g	g	PROPN
dpc-5333	206	18	,	,	PUNCT
dpc-5333	206	19	et	et	PROPN
dpc-5333	206	20	al	al	PROPN
dpc-5333	206	21	.	.	PUNCT
dpc-5333	207	1	the	the	DET
dpc-5333	207	2	emerging	emerge	VERB
dpc-5333	207	3	role	role	NOUN
dpc-5333	207	4	of	of	ADP
dpc-5333	207	5	il-17	il-17	NUM
dpc-5333	207	6	in	in	ADP
dpc-5333	207	7	the	the	DET
dpc-5333	207	8	pathogenesis	pathogenesis	NOUN
dpc-5333	207	9	of	of	ADP
dpc-5333	207	10	psoriasis	psoriasis	NOUN
dpc-5333	207	11	:	:	PUNCT
dpc-5333	207	12	preclinical	preclinical	ADJ
dpc-5333	207	13	and	and	CCONJ
dpc-5333	207	14	clinical	clinical	ADJ
dpc-5333	207	15	findings	finding	NOUN
dpc-5333	207	16	.	.	PUNCT
dpc-5333	208	1	journal	journal	NOUN
dpc-5333	208	2	of	of	ADP
dpc-5333	208	3	investigative	investigative	ADJ
dpc-5333	208	4	dermatology	dermatology	NOUN
dpc-5333	208	5	.	.	PUNCT
dpc-5333	209	1	2013;133(1	2013;133(1	NUM
dpc-5333	209	2	):	):	PUNCT
dpc-5333	209	3	17–26	17–26	NUM
dpc-5333	209	4	.	.	PUNCT
dpc-5333	209	5	doi:10.1038	doi:10.1038	PROPN
dpc-5333	209	6	/	/	SYM
dpc-5333	209	7	jid.2012.194	jid.2012.194	PROPN
dpc-5333	209	8	8	8	NUM
dpc-5333	209	9	.	.	PUNCT
dpc-5333	209	10	kamstrup	kamstrup	PROPN
dpc-5333	209	11	m	m	PROPN
dpc-5333	209	12	,	,	PUNCT
dpc-5333	209	13	faurschou	faurschou	VERB
dpc-5333	209	14	a	a	DET
dpc-5333	209	15	,	,	PUNCT
dpc-5333	209	16	gniadecki	gniadecki	NOUN
dpc-5333	209	17	r	r	NOUN
dpc-5333	209	18	,	,	PUNCT
dpc-5333	209	19	wulf	wulf	PROPN
dpc-5333	209	20	hc	hc	PROPN
dpc-5333	209	21	.	.	PROPN
dpc-5333	209	22	epidermal	epidermal	ADJ
dpc-5333	209	23	stem	stem	NOUN
dpc-5333	209	24	cells	cell	NOUN
dpc-5333	209	25	-	-	PUNCT
dpc-5333	209	26	role	role	NOUN
dpc-5333	209	27	in	in	ADP
dpc-5333	209	28	normal	normal	ADJ
dpc-5333	209	29	,	,	PUNCT
dpc-5333	209	30	wounded	wounded	ADJ
dpc-5333	209	31	and	and	CCONJ
dpc-5333	209	32	pathological	pathological	ADJ
dpc-5333	209	33	psoriatic	psoriatic	NOUN
dpc-5333	209	34	and	and	CCONJ
dpc-5333	209	35	cancer	cancer	NOUN
dpc-5333	209	36	skin	skin	NOUN
dpc-5333	209	37	.	.	PUNCT
dpc-5333	210	1	current	current	ADJ
dpc-5333	210	2	stem	stem	NOUN
dpc-5333	210	3	cell	cell	NOUN
dpc-5333	210	4	research	research	NOUN
dpc-5333	210	5	&	&	CCONJ
dpc-5333	210	6	therapy	therapy	NOUN
dpc-5333	210	7	.	.	PUNCT
dpc-5333	211	1	2008;3(2):146–150	2008;3(2):146–150	NUM
dpc-5333	211	2	.	.	NOUN
dpc-5333	211	3	doi:10.2174/157488808784223087	doi:10.2174/157488808784223087	ADJ
dpc-5333	211	4	9	9	NUM
dpc-5333	211	5	.	.	PUNCT
dpc-5333	211	6	bergstresser	bergstresser	NOUN
dpc-5333	211	7	pr	pr	PROPN
dpc-5333	211	8	,	,	PUNCT
dpc-5333	211	9	richard	richard	PROPN
dpc-5333	211	10	taylor	taylor	PROPN
dpc-5333	211	11	j.	j.	PROPN
dpc-5333	211	12	epidermal	epidermal	ADJ
dpc-5333	211	13	‘	'	PUNCT
dpc-5333	211	14	turnover	turnover	NOUN
dpc-5333	211	15	time’—a	time’—a	VERB
dpc-5333	211	16	new	new	ADJ
dpc-5333	211	17	examination	examination	NOUN
dpc-5333	211	18	.	.	PUNCT
dpc-5333	212	1	british	british	ADJ
dpc-5333	212	2	journal	journal	PROPN
dpc-5333	212	3	of	of	ADP
dpc-5333	212	4	dermatology	dermatology	NOUN
dpc-5333	212	5	.	.	PUNCT
dpc-5333	213	1	1977;96(5):503–506	1977;96(5):503–506	X
dpc-5333	213	2	.	.	PUNCT
dpc-5333	213	3	doi:10.1111	doi:10.1111	ADJ
dpc-5333	213	4	/	/	SYM
dpc-5333	213	5	j.1365	j.1365	NOUN
dpc-5333	213	6	-	-	PUNCT
dpc-5333	213	7	2133.1977.tb07152.x	2133.1977.tb07152.x	NUM
dpc-5333	213	8	10	10	NUM
dpc-5333	213	9	.	.	PUNCT
dpc-5333	214	1	zhang	zhang	PROPN
dpc-5333	214	2	h	h	PROPN
dpc-5333	214	3	,	,	PUNCT
dpc-5333	214	4	hou	hou	PROPN
dpc-5333	214	5	w	w	PROPN
dpc-5333	214	6	,	,	PUNCT
dpc-5333	214	7	henrot	henrot	PROPN
dpc-5333	214	8	l	l	PROPN
dpc-5333	214	9	,	,	PUNCT
dpc-5333	214	10	et	et	PROPN
dpc-5333	214	11	al	al	PROPN
dpc-5333	214	12	.	.	PROPN
dpc-5333	214	13	modelling	model	VERB
dpc-5333	214	14	epidermis	epidermis	NOUN
dpc-5333	214	15	homoeostasis	homoeostasis	NOUN
dpc-5333	214	16	and	and	CCONJ
dpc-5333	214	17	psoriasis	psoriasis	NOUN
dpc-5333	214	18	pathogenesis	pathogenesis	NOUN
dpc-5333	214	19	.	.	PUNCT
dpc-5333	215	1	journal	journal	NOUN
dpc-5333	215	2	of	of	ADP
dpc-5333	215	3	the	the	DET
dpc-5333	215	4	royal	royal	ADJ
dpc-5333	215	5	society	society	NOUN
dpc-5333	215	6	interface	interface	NOUN
dpc-5333	215	7	.	.	PUNCT
dpc-5333	216	1	2015;12(103):20141071	2015;12(103):20141071	NUM
dpc-5333	216	2	.	.	PUNCT
dpc-5333	217	1	doi:10.1098	doi:10.1098	PROPN
dpc-5333	217	2	/	/	SYM
dpc-5333	217	3	rsif.2014.1071	rsif.2014.1071	ADJ
dpc-5333	217	4	11	11	NUM
dpc-5333	217	5	.	.	PUNCT
dpc-5333	218	1	jia	jia	PROPN
dpc-5333	218	2	h	h	PROPN
dpc-5333	218	3	-	-	PUNCT
dpc-5333	218	4	y	y	PROPN
dpc-5333	218	5	,	,	PUNCT
dpc-5333	218	6	shi	shi	PROPN
dpc-5333	218	7	y	y	PROPN
dpc-5333	218	8	,	,	PUNCT
dpc-5333	218	9	luo	luo	PROPN
dpc-5333	218	10	l	l	PROPN
dpc-5333	218	11	-	-	PROPN
dpc-5333	218	12	f	f	PROPN
dpc-5333	218	13	,	,	PUNCT
dpc-5333	218	14	et	et	PROPN
dpc-5333	218	15	al	al	PROPN
dpc-5333	218	16	.	.	PROPN
dpc-5333	218	17	asymmetric	asymmetric	ADJ
dpc-5333	218	18	stem	stem	NOUN
dpc-5333	218	19	-	-	PUNCT
dpc-5333	218	20	cell	cell	NOUN
dpc-5333	218	21	division	division	NOUN
dpc-5333	218	22	ensures	ensure	VERB
dpc-5333	218	23	sustained	sustain	VERB
dpc-5333	218	24	keratinocyte	keratinocyte	NOUN
dpc-5333	218	25	hyperproliferation	hyperproliferation	NOUN
dpc-5333	218	26	in	in	ADP
dpc-5333	218	27	psoriatic	psoriatic	ADJ
dpc-5333	218	28	skin	skin	NOUN
dpc-5333	218	29	lesions	lesion	NOUN
dpc-5333	218	30	.	.	PUNCT
dpc-5333	219	1	international	international	ADJ
dpc-5333	219	2	journal	journal	NOUN
dpc-5333	219	3	of	of	ADP
dpc-5333	219	4	molecular	molecular	ADJ
dpc-5333	219	5	medicine	medicine	NOUN
dpc-5333	219	6	.	.	PUNCT
dpc-5333	220	1	2016;37(2):359–368	2016;37(2):359–368	X
dpc-5333	220	2	.	.	PUNCT
dpc-5333	220	3	doi:10.3892	doi:10.3892	NOUN
dpc-5333	220	4	/	/	SYM
dpc-5333	220	5	ijmm.2015.2445	ijmm.2015.2445	PROPN
dpc-5333	220	6	12	12	NUM
dpc-5333	220	7	.	.	PUNCT
dpc-5333	221	1	franssen	franssen	VERB
dpc-5333	221	2	me	i	PRON
dpc-5333	221	3	,	,	PUNCT
dpc-5333	221	4	zeeuwen	zeeuwen	PROPN
dpc-5333	221	5	pl	pl	PROPN
dpc-5333	221	6	,	,	PUNCT
dpc-5333	221	7	vierwinden	vierwinden	VERB
dpc-5333	221	8	g	g	PROPN
dpc-5333	221	9	,	,	PUNCT
dpc-5333	221	10	van	van	PROPN
dpc-5333	221	11	de	de	X
dpc-5333	221	12	kerkhof	kerkhof	PROPN
dpc-5333	221	13	pc	pc	PROPN
dpc-5333	221	14	,	,	PUNCT
dpc-5333	221	15	schalkwijk	schalkwijk	PROPN
dpc-5333	221	16	j	j	PROPN
dpc-5333	221	17	,	,	PUNCT
dpc-5333	221	18	van	van	PROPN
dpc-5333	221	19	erp	erp	PROPN
dpc-5333	221	20	pe	pe	PROPN
dpc-5333	221	21	.	.	PROPN
dpc-5333	221	22	phenotypical	phenotypical	ADJ
dpc-5333	221	23	and	and	CCONJ
dpc-5333	221	24	functional	functional	ADJ
dpc-5333	221	25	differences	difference	NOUN
dpc-5333	221	26	in	in	ADP
dpc-5333	221	27	germinative	germinative	ADJ
dpc-5333	221	28	subpopulations	subpopulation	NOUN
dpc-5333	221	29	derived	derive	VERB
dpc-5333	221	30	from	from	ADP
dpc-5333	221	31	normal	normal	ADJ
dpc-5333	221	32	and	and	CCONJ
dpc-5333	221	33	psoriatic	psoriatic	ADJ
dpc-5333	221	34	epidermis	epidermis	NOUN
dpc-5333	221	35	.	.	PUNCT
dpc-5333	222	1	journal	journal	NOUN
dpc-5333	222	2	of	of	ADP
dpc-5333	222	3	investigative	investigative	ADJ
dpc-5333	222	4	dermatology	dermatology	NOUN
dpc-5333	222	5	.	.	PUNCT
dpc-5333	223	1	2005;124(2):373–383	2005;124(2):373–383	X
dpc-5333	223	2	.	.	PUNCT
dpc-5333	224	1	doi:10.1111	doi:10.1111	ADJ
dpc-5333	224	2	/	/	SYM
dpc-5333	224	3	j.0022	j.0022	NOUN
dpc-5333	224	4	-	-	PUNCT
dpc-5333	224	5	202x.2004.23612.x	202x.2004.23612.x	NUM
dpc-5333	224	6	13	13	NUM
dpc-5333	224	7	.	.	PUNCT
dpc-5333	224	8	watarai	watarai	VERB
dpc-5333	224	9	a	a	DET
dpc-5333	224	10	,	,	PUNCT
dpc-5333	224	11	amoh	amoh	PROPN
dpc-5333	224	12	y	y	PROPN
dpc-5333	224	13	,	,	PUNCT
dpc-5333	224	14	maejima	maejima	PROPN
dpc-5333	224	15	h	h	PROPN
dpc-5333	224	16	,	,	PUNCT
dpc-5333	224	17	hamada	hamada	PROPN
dpc-5333	224	18	y	y	PROPN
dpc-5333	224	19	,	,	PUNCT
dpc-5333	224	20	katsuoka	katsuoka	PROPN
dpc-5333	224	21	k.	k.	PROPN
dpc-5333	224	22	nestin	nestin	PROPN
dpc-5333	224	23	expression	expression	NOUN
dpc-5333	224	24	is	be	AUX
dpc-5333	224	25	increased	increase	VERB
dpc-5333	224	26	in	in	ADP
dpc-5333	224	27	the	the	DET
dpc-5333	224	28	suprabasal	suprabasal	NOUN
dpc-5333	224	29	epidermal	epidermal	ADJ
dpc-5333	224	30	layer	layer	NOUN
dpc-5333	224	31	in	in	ADP
dpc-5333	224	32	psoriasis	psoriasis	NOUN
dpc-5333	224	33	vulgaris	vulgaris	NOUN
dpc-5333	224	34	.	.	PUNCT
dpc-5333	225	1	acta	acta	PROPN
dpc-5333	225	2	dermato	dermato	PROPN
dpc-5333	225	3	-	-	PUNCT
dpc-5333	225	4	venereologica	venereologica	NOUN
dpc-5333	225	5	.	.	PUNCT
dpc-5333	226	1	2013;93(1	2013;93(1	NUM
dpc-5333	226	2	)	)	PUNCT
dpc-5333	226	3	doi:10.2340/00015555	doi:10.2340/00015555	NOUN
dpc-5333	226	4	-	-	SYM
dpc-5333	226	5	1420	1420	NUM
dpc-5333	226	6	14	14	NUM
dpc-5333	226	7	.	.	PUNCT
dpc-5333	227	1	nograles	nograles	PROPN
dpc-5333	227	2	k	k	PROPN
dpc-5333	227	3	,	,	PUNCT
dpc-5333	227	4	zaba	zaba	PROPN
dpc-5333	227	5	l	l	NOUN
dpc-5333	227	6	,	,	PUNCT
dpc-5333	227	7	guttman	guttman	ADJ
dpc-5333	227	8	-	-	PUNCT
dpc-5333	227	9	yassky	yassky	NOUN
dpc-5333	227	10	e	e	NOUN
dpc-5333	227	11	,	,	PUNCT
dpc-5333	227	12	et	et	PROPN
dpc-5333	227	13	al	al	PROPN
dpc-5333	227	14	.	.	PUNCT
dpc-5333	228	1	th17	th17	NOUN
dpc-5333	228	2	cytokines	cytokine	VERB
dpc-5333	228	3	interleukin	interleukin	NOUN
dpc-5333	228	4	(	(	PUNCT
dpc-5333	228	5	il)-17	il)-17	PROPN
dpc-5333	228	6	and	and	CCONJ
dpc-5333	228	7	il-22	il-22	NOUN
dpc-5333	228	8	modulate	modulate	VERB
dpc-5333	228	9	distinct	distinct	ADJ
dpc-5333	228	10	inflammatory	inflammatory	ADJ
dpc-5333	228	11	and	and	CCONJ
dpc-5333	228	12	keratinocyte	keratinocyte	NOUN
dpc-5333	228	13	-	-	PUNCT
dpc-5333	228	14	response	response	NOUN
dpc-5333	228	15	pathways	pathway	NOUN
dpc-5333	228	16	.	.	PUNCT
dpc-5333	229	1	british	british	ADJ
dpc-5333	229	2	journal	journal	PROPN
dpc-5333	229	3	of	of	ADP
dpc-5333	229	4	dermatology	dermatology	NOUN
dpc-5333	229	5	.	.	PUNCT
dpc-5333	230	1	2008;159(5):1092–1102	2008;159(5):1092–1102	NUM
dpc-5333	230	2	.	.	PUNCT
dpc-5333	230	3	doi:10.1111	doi:10.1111	ADJ
dpc-5333	230	4	/	/	SYM
dpc-5333	230	5	j.1365	j.1365	NOUN
dpc-5333	230	6	-	-	PUNCT
dpc-5333	230	7	2133.2008.08769.x	2133.2008.08769.x	NUM
dpc-5333	230	8	8	8	NUM
dpc-5333	230	9	review	review	NOUN
dpc-5333	230	10	|	|	ADV
dpc-5333	230	11	dermatol	dermatol	ADJ
dpc-5333	230	12	pract	pract	NOUN
dpc-5333	230	13	concept	concept	NOUN
dpc-5333	230	14	.	.	PUNCT
dpc-5333	231	1	2025;15(3):5333	2025;15(3):5333	NUM
dpc-5333	231	2	15	15	NUM
dpc-5333	231	3	.	.	PUNCT
dpc-5333	232	1	zhou	zhou	PROPN
dpc-5333	232	2	c	c	PROPN
dpc-5333	232	3	,	,	PUNCT
dpc-5333	232	4	kuang	kuang	PROPN
dpc-5333	232	5	m	m	PROPN
dpc-5333	232	6	,	,	PUNCT
dpc-5333	232	7	tao	tao	PROPN
dpc-5333	232	8	y	y	PROPN
dpc-5333	232	9	,	,	PUNCT
dpc-5333	232	10	et	et	PROPN
dpc-5333	232	11	al	al	PROPN
dpc-5333	232	12	.	.	PUNCT
dpc-5333	233	1	nynrin	nynrin	PROPN
dpc-5333	233	2	preserves	preserve	VERB
dpc-5333	233	3	hematopoietic	hematopoietic	ADJ
dpc-5333	233	4	stem	stem	NOUN
dpc-5333	233	5	cell	cell	NOUN
dpc-5333	233	6	function	function	NOUN
dpc-5333	233	7	by	by	ADP
dpc-5333	233	8	inhibiting	inhibit	VERB
dpc-5333	233	9	the	the	DET
dpc-5333	233	10	mitochondrial	mitochondrial	ADJ
dpc-5333	233	11	permeability	permeability	NOUN
dpc-5333	233	12	transition	transition	NOUN
dpc-5333	233	13	pore	pore	ADJ
dpc-5333	233	14	opening	opening	NOUN
dpc-5333	233	15	.	.	PUNCT
dpc-5333	234	1	cell	cell	NOUN
dpc-5333	234	2	stem	stem	NOUN
dpc-5333	234	3	cell	cell	NOUN
dpc-5333	234	4	.	.	PUNCT
dpc-5333	235	1	2024;31(9):1359–1375	2024;31(9):1359–1375	NUM
dpc-5333	235	2	.	.	PUNCT
dpc-5333	236	1	e8	e8	PROPN
dpc-5333	236	2	.	.	PUNCT
dpc-5333	237	1	doi:10.1016	doi:10.1016	PROPN
dpc-5333	237	2	/	/	SYM
dpc-5333	237	3	j.stem.2024.06.007	j.stem.2024.06.007	PROPN
dpc-5333	237	4	16	16	NUM
dpc-5333	237	5	.	.	PUNCT
dpc-5333	238	1	saburi	saburi	PROPN
dpc-5333	238	2	e	e	PROPN
dpc-5333	238	3	,	,	PUNCT
dpc-5333	238	4	abazari	abazari	X
dpc-5333	238	5	mf	mf	NOUN
dpc-5333	238	6	,	,	PUNCT
dpc-5333	238	7	hassannia	hassannia	PROPN
dpc-5333	238	8	h	h	PROPN
dpc-5333	238	9	,	,	PUNCT
dpc-5333	238	10	et	et	PROPN
dpc-5333	238	11	al	al	PROPN
dpc-5333	238	12	.	.	PUNCT
dpc-5333	239	1	the	the	DET
dpc-5333	239	2	use	use	NOUN
dpc-5333	239	3	of	of	ADP
dpc-5333	239	4	mesenchymal	mesenchymal	ADJ
dpc-5333	239	5	stem	stem	NOUN
dpc-5333	239	6	cells	cell	NOUN
dpc-5333	239	7	in	in	ADP
dpc-5333	239	8	the	the	DET
dpc-5333	239	9	process	process	NOUN
dpc-5333	239	10	of	of	ADP
dpc-5333	239	11	treatment	treatment	NOUN
dpc-5333	239	12	and	and	CCONJ
dpc-5333	239	13	tissue	tissue	NOUN
dpc-5333	239	14	regeneration	regeneration	NOUN
dpc-5333	239	15	after	after	ADP
dpc-5333	239	16	recovery	recovery	NOUN
dpc-5333	239	17	in	in	ADP
dpc-5333	239	18	patients	patient	NOUN
dpc-5333	239	19	with	with	ADP
dpc-5333	239	20	covid-19	covid-19	PROPN
dpc-5333	239	21	.	.	PUNCT
dpc-5333	239	22	gene	gene	NOUN
dpc-5333	239	23	.	.	PUNCT
dpc-5333	240	1	2021;777:145471	2021;777:145471	NOUN
dpc-5333	240	2	.	.	PUNCT
dpc-5333	241	1	doi:10.1016	doi:10.1016	PROPN
dpc-5333	241	2	/	/	SYM
dpc-5333	241	3	j.gene.2021.145471	j.gene.2021.145471	NOUN
dpc-5333	241	4	17	17	NUM
dpc-5333	241	5	.	.	PUNCT
dpc-5333	242	1	velier	velier	PROPN
dpc-5333	242	2	m	m	NOUN
dpc-5333	242	3	,	,	PUNCT
dpc-5333	242	4	simoncini	simoncini	PROPN
dpc-5333	242	5	s	s	PART
dpc-5333	242	6	,	,	PUNCT
dpc-5333	242	7	abellan	abellan	NOUN
dpc-5333	242	8	m	m	PROPN
dpc-5333	242	9	,	,	PUNCT
dpc-5333	242	10	et	et	PROPN
dpc-5333	242	11	al	al	PROPN
dpc-5333	242	12	.	.	PUNCT
dpc-5333	242	13	adipose	adipose	NOUN
dpc-5333	242	14	-	-	PUNCT
dpc-5333	242	15	derived	derive	VERB
dpc-5333	242	16	stem	stem	NOUN
dpc-5333	242	17	cells	cell	NOUN
dpc-5333	242	18	from	from	ADP
dpc-5333	242	19	systemic	systemic	ADJ
dpc-5333	242	20	sclerosis	sclerosis	NOUN
dpc-5333	242	21	patients	patient	NOUN
dpc-5333	242	22	maintain	maintain	VERB
dpc-5333	242	23	pro	pro	ADJ
dpc-5333	242	24	-	-	ADJ
dpc-5333	242	25	angiogenic	angiogenic	ADJ
dpc-5333	242	26	and	and	CCONJ
dpc-5333	242	27	antifibrotic	antifibrotic	ADJ
dpc-5333	242	28	paracrine	paracrine	NOUN
dpc-5333	242	29	effects	effect	NOUN
dpc-5333	242	30	in	in	ADP
dpc-5333	242	31	vitro	vitro	X
dpc-5333	242	32	.	.	PUNCT
dpc-5333	243	1	journal	journal	NOUN
dpc-5333	243	2	of	of	ADP
dpc-5333	243	3	clinical	clinical	ADJ
dpc-5333	243	4	medicine	medicine	NOUN
dpc-5333	243	5	.	.	PUNCT
dpc-5333	244	1	2019;8(11):1979	2019;8(11):1979	NUM
dpc-5333	244	2	.	.	PUNCT
dpc-5333	244	3	doi:10.3390	doi:10.3390	PROPN
dpc-5333	244	4	/	/	SYM
dpc-5333	244	5	jcm8111979	jcm8111979	PROPN
dpc-5333	244	6	18	18	NUM
dpc-5333	244	7	.	.	PUNCT
dpc-5333	244	8	ryan	ryan	PROPN
dpc-5333	244	9	jm	jm	PROPN
dpc-5333	244	10	,	,	PUNCT
dpc-5333	244	11	barry	barry	PROPN
dpc-5333	244	12	fp	fp	PROPN
dpc-5333	244	13	,	,	PUNCT
dpc-5333	244	14	murphy	murphy	PROPN
dpc-5333	244	15	jm	jm	PROPN
dpc-5333	244	16	,	,	PUNCT
dpc-5333	244	17	mahon	mahon	PROPN
dpc-5333	244	18	bp	bp	PROPN
dpc-5333	244	19	.	.	PUNCT
dpc-5333	245	1	mesenchymal	mesenchymal	ADJ
dpc-5333	245	2	stem	stem	NOUN
dpc-5333	245	3	cells	cell	NOUN
dpc-5333	245	4	avoid	avoid	VERB
dpc-5333	245	5	allogeneic	allogeneic	ADJ
dpc-5333	245	6	rejection	rejection	NOUN
dpc-5333	245	7	.	.	PUNCT
dpc-5333	246	1	journal	journal	NOUN
dpc-5333	246	2	of	of	ADP
dpc-5333	246	3	inflammation	inflammation	NOUN
dpc-5333	246	4	.	.	PUNCT
dpc-5333	247	1	2005;2:1–11	2005;2:1–11	X
dpc-5333	247	2	.	.	PUNCT
dpc-5333	247	3	doi:10.1186/1476	doi:10.1186/1476	VERB
dpc-5333	247	4	-	-	PUNCT
dpc-5333	247	5	9255	9255	NUM
dpc-5333	247	6	-	-	PUNCT
dpc-5333	247	7	2	2	NUM
dpc-5333	247	8	-	-	SYM
dpc-5333	247	9	8	8	NUM
dpc-5333	247	10	19	19	NUM
dpc-5333	247	11	.	.	PUNCT
dpc-5333	248	1	aggarwal	aggarwal	PROPN
dpc-5333	248	2	s	s	PART
dpc-5333	248	3	,	,	PUNCT
dpc-5333	248	4	pittenger	pittenger	PROPN
dpc-5333	248	5	mf	mf	PROPN
dpc-5333	248	6	.	.	PROPN
dpc-5333	248	7	human	human	ADJ
dpc-5333	248	8	mesenchymal	mesenchymal	NOUN
dpc-5333	248	9	stem	stem	NOUN
dpc-5333	248	10	cells	cell	NOUN
dpc-5333	248	11	modulate	modulate	VERB
dpc-5333	248	12	allogeneic	allogeneic	ADJ
dpc-5333	248	13	immune	immune	ADJ
dpc-5333	248	14	cell	cell	NOUN
dpc-5333	248	15	responses	response	NOUN
dpc-5333	248	16	.	.	PUNCT
dpc-5333	249	1	blood	blood	NOUN
dpc-5333	249	2	.	.	PUNCT
dpc-5333	250	1	2005;105(4	2005;105(4	NUM
dpc-5333	250	2	):	):	PUNCT
dpc-5333	250	3	1815–1822	1815–1822	NUM
dpc-5333	250	4	.	.	PUNCT
dpc-5333	251	1	doi:10.1182	doi:10.1182	NOUN
dpc-5333	251	2	/	/	SYM
dpc-5333	251	3	blood-2004	blood-2004	NOUN
dpc-5333	251	4	-	-	PUNCT
dpc-5333	251	5	04	04	NUM
dpc-5333	251	6	-	-	PUNCT
dpc-5333	251	7	1559	1559	NUM
dpc-5333	251	8	20	20	NUM
dpc-5333	251	9	.	.	PUNCT
dpc-5333	251	10	hu	hu	PROPN
dpc-5333	252	1	ms	ms	PROPN
dpc-5333	252	2	,	,	PUNCT
dpc-5333	252	3	borrelli	borrelli	PROPN
dpc-5333	252	4	mr	mr	PROPN
dpc-5333	252	5	,	,	PUNCT
dpc-5333	252	6	lorenz	lorenz	PROPN
dpc-5333	252	7	hp	hp	PROPN
dpc-5333	252	8	,	,	PUNCT
dpc-5333	252	9	longaker	longaker	PROPN
dpc-5333	252	10	mt	mt	PROPN
dpc-5333	252	11	,	,	PUNCT
dpc-5333	252	12	wan	wan	PROPN
dpc-5333	252	13	dc	dc	PROPN
dpc-5333	252	14	.	.	PUNCT
dpc-5333	253	1	mesenchymal	mesenchymal	ADJ
dpc-5333	253	2	stromal	stromal	ADJ
dpc-5333	253	3	cells	cell	NOUN
dpc-5333	253	4	and	and	CCONJ
dpc-5333	253	5	cutaneous	cutaneous	ADJ
dpc-5333	253	6	wound	wound	NOUN
dpc-5333	253	7	healing	healing	NOUN
dpc-5333	253	8	:	:	PUNCT
dpc-5333	253	9	a	a	DET
dpc-5333	253	10	comprehensive	comprehensive	ADJ
dpc-5333	253	11	review	review	NOUN
dpc-5333	253	12	of	of	ADP
dpc-5333	253	13	the	the	DET
dpc-5333	253	14	background	background	NOUN
dpc-5333	253	15	,	,	PUNCT
dpc-5333	253	16	role	role	NOUN
dpc-5333	253	17	,	,	PUNCT
dpc-5333	253	18	and	and	CCONJ
dpc-5333	253	19	therapeutic	therapeutic	ADJ
dpc-5333	253	20	potential	potential	NOUN
dpc-5333	253	21	.	.	PUNCT
dpc-5333	254	1	stem	stem	NOUN
dpc-5333	254	2	cells	cell	NOUN
dpc-5333	254	3	international	international	ADJ
dpc-5333	254	4	.	.	PUNCT
dpc-5333	255	1	2018;2018doi:10.1155/20	2018;2018doi:10.1155/20	NUM
dpc-5333	255	2	18/6901983	18/6901983	NUM
dpc-5333	255	3	21	21	NUM
dpc-5333	255	4	.	.	PUNCT
dpc-5333	256	1	kozlowska	kozlowska	PROPN
dpc-5333	256	2	u	u	PROPN
dpc-5333	256	3	,	,	PUNCT
dpc-5333	256	4	krawczenko	krawczenko	VERB
dpc-5333	256	5	a	a	PRON
dpc-5333	256	6	,	,	PUNCT
dpc-5333	256	7	futoma	futoma	NOUN
dpc-5333	256	8	k	k	NOUN
dpc-5333	256	9	,	,	PUNCT
dpc-5333	256	10	et	et	PROPN
dpc-5333	256	11	al	al	PROPN
dpc-5333	256	12	.	.	PROPN
dpc-5333	256	13	similarities	similarity	NOUN
dpc-5333	256	14	and	and	CCONJ
dpc-5333	256	15	differences	difference	NOUN
dpc-5333	256	16	between	between	ADP
dpc-5333	256	17	mesenchymal	mesenchymal	NOUN
dpc-5333	256	18	stem	stem	NOUN
dpc-5333	256	19	/	/	SYM
dpc-5333	256	20	progenitor	progenitor	NOUN
dpc-5333	256	21	cells	cell	NOUN
dpc-5333	256	22	derived	derive	VERB
dpc-5333	256	23	from	from	ADP
dpc-5333	256	24	various	various	ADJ
dpc-5333	256	25	human	human	ADJ
dpc-5333	256	26	tissues	tissue	NOUN
dpc-5333	256	27	.	.	PUNCT
dpc-5333	257	1	world	world	PROPN
dpc-5333	257	2	journal	journal	PROPN
dpc-5333	257	3	of	of	ADP
dpc-5333	257	4	stem	stem	NOUN
dpc-5333	257	5	cells	cell	NOUN
dpc-5333	257	6	.	.	PUNCT
dpc-5333	258	1	2019;11(6):347	2019;11(6):347	NUM
dpc-5333	258	2	.	.	PUNCT
dpc-5333	259	1	doi:10.4252	doi:10.4252	PROPN
dpc-5333	259	2	/	/	SYM
dpc-5333	259	3	wjsc.v11.i6.347	wjsc.v11.i6.347	PROPN
dpc-5333	259	4	22	22	NUM
dpc-5333	259	5	.	.	PUNCT
dpc-5333	260	1	ribeiro	ribeiro	PROPN
dpc-5333	260	2	a	a	PROPN
dpc-5333	260	3	,	,	PUNCT
dpc-5333	260	4	laranjeira	laranjeira	PROPN
dpc-5333	260	5	p	p	PROPN
dpc-5333	260	6	,	,	PUNCT
dpc-5333	260	7	mendes	mende	NOUN
dpc-5333	260	8	s	s	PART
dpc-5333	260	9	,	,	PUNCT
dpc-5333	260	10	et	et	PROPN
dpc-5333	260	11	al	al	PROPN
dpc-5333	260	12	.	.	PUNCT
dpc-5333	261	1	mesenchymal	mesenchymal	ADJ
dpc-5333	261	2	stem	stem	NOUN
dpc-5333	261	3	cells	cell	NOUN
dpc-5333	261	4	from	from	ADP
dpc-5333	261	5	umbilical	umbilical	ADJ
dpc-5333	261	6	cord	cord	NOUN
dpc-5333	261	7	matrix	matrix	NOUN
dpc-5333	261	8	,	,	PUNCT
dpc-5333	261	9	adipose	adipose	ADP
dpc-5333	261	10	tissue	tissue	NOUN
dpc-5333	261	11	and	and	CCONJ
dpc-5333	261	12	bone	bone	NOUN
dpc-5333	261	13	marrow	marrow	NOUN
dpc-5333	261	14	exhibit	exhibit	VERB
dpc-5333	261	15	different	different	ADJ
dpc-5333	261	16	capability	capability	NOUN
dpc-5333	261	17	to	to	PART
dpc-5333	261	18	suppress	suppress	VERB
dpc-5333	261	19	peripheral	peripheral	ADJ
dpc-5333	261	20	blood	blood	NOUN
dpc-5333	261	21	b	b	NOUN
dpc-5333	261	22	,	,	PUNCT
dpc-5333	261	23	natural	natural	ADJ
dpc-5333	261	24	killer	killer	NOUN
dpc-5333	261	25	and	and	CCONJ
dpc-5333	261	26	t	t	NOUN
dpc-5333	261	27	cells	cell	NOUN
dpc-5333	261	28	.	.	PUNCT
dpc-5333	262	1	stem	stem	NOUN
dpc-5333	262	2	cell	cell	NOUN
dpc-5333	262	3	research	research	NOUN
dpc-5333	262	4	&	&	CCONJ
dpc-5333	262	5	therapy	therapy	NOUN
dpc-5333	262	6	.	.	PUNCT
dpc-5333	263	1	2013;4:1–16	2013;4:1–16	NOUN
dpc-5333	263	2	.	.	PUNCT
dpc-5333	263	3	doi:10.1186	doi:10.1186	PROPN
dpc-5333	263	4	/	/	SYM
dpc-5333	263	5	scrt336	scrt336	PROPN
dpc-5333	263	6	23	23	NUM
dpc-5333	263	7	.	.	PUNCT
dpc-5333	264	1	gao	gao	PROPN
dpc-5333	264	2	f	f	PROPN
dpc-5333	264	3	,	,	PUNCT
dpc-5333	264	4	chiu	chiu	PROPN
dpc-5333	264	5	s	s	PROPN
dpc-5333	264	6	,	,	PUNCT
dpc-5333	264	7	motan	motan	PROPN
dpc-5333	264	8	d	d	NOUN
dpc-5333	264	9	,	,	PUNCT
dpc-5333	264	10	et	et	PROPN
dpc-5333	264	11	al	al	PROPN
dpc-5333	264	12	.	.	PUNCT
dpc-5333	264	13	mesenchymal	mesenchymal	ADJ
dpc-5333	264	14	stem	stem	NOUN
dpc-5333	264	15	cells	cell	NOUN
dpc-5333	264	16	and	and	CCONJ
dpc-5333	264	17	immunomodulation	immunomodulation	NOUN
dpc-5333	264	18	:	:	PUNCT
dpc-5333	264	19	current	current	ADJ
dpc-5333	264	20	status	status	NOUN
dpc-5333	264	21	and	and	CCONJ
dpc-5333	264	22	future	future	ADJ
dpc-5333	264	23	prospects	prospect	NOUN
dpc-5333	264	24	.	.	PUNCT
dpc-5333	265	1	cell	cell	NOUN
dpc-5333	265	2	death	death	NOUN
dpc-5333	265	3	&	&	CCONJ
dpc-5333	265	4	disease	disease	PROPN
dpc-5333	265	5	.	.	PUNCT
dpc-5333	266	1	2016;7(1):e2062	2016;7(1):e2062	NOUN
dpc-5333	266	2	–	–	PUNCT
dpc-5333	266	3	e2062	e2062	NOUN
dpc-5333	266	4	.	.	PUNCT
dpc-5333	266	5	doi:10.1038	doi:10.1038	PROPN
dpc-5333	266	6	/	/	SYM
dpc-5333	266	7	cddis.2015.327	cddis.2015.327	NOUN
dpc-5333	266	8	24	24	NUM
dpc-5333	266	9	.	.	PUNCT
dpc-5333	266	10	song	song	PROPN
dpc-5333	266	11	n	n	CCONJ
dpc-5333	266	12	,	,	PUNCT
dpc-5333	266	13	scholtemeijer	scholtemeijer	PROPN
dpc-5333	266	14	m	m	PROPN
dpc-5333	266	15	,	,	PUNCT
dpc-5333	266	16	shah	shah	PROPN
dpc-5333	266	17	k.	k.	PROPN
dpc-5333	266	18	mesenchymal	mesenchymal	PROPN
dpc-5333	266	19	stem	stem	NOUN
dpc-5333	266	20	cell	cell	NOUN
dpc-5333	266	21	immunomodulation	immunomodulation	NOUN
dpc-5333	266	22	:	:	PUNCT
dpc-5333	266	23	mechanisms	mechanism	NOUN
dpc-5333	266	24	and	and	CCONJ
dpc-5333	266	25	therapeutic	therapeutic	ADJ
dpc-5333	266	26	potential	potential	NOUN
dpc-5333	266	27	.	.	PUNCT
dpc-5333	267	1	trends	trend	NOUN
dpc-5333	267	2	in	in	ADP
dpc-5333	267	3	pharmacological	pharmacological	ADJ
dpc-5333	267	4	sciences	science	NOUN
dpc-5333	267	5	.	.	PUNCT
dpc-5333	268	1	2020;41(9):653–664	2020;41(9):653–664	NUM
dpc-5333	268	2	.	.	X
dpc-5333	268	3	doi:10.1016	doi:10.1016	PROPN
dpc-5333	268	4	/j.tips.2020.06.009	/j.tips.2020.06.009	PUNCT
dpc-5333	269	1	25	25	NUM
dpc-5333	269	2	.	.	PUNCT
dpc-5333	270	1	an	an	DET
dpc-5333	270	2	y	y	PROPN
dpc-5333	270	3	,	,	PUNCT
dpc-5333	270	4	zhang	zhang	PROPN
dpc-5333	270	5	q	q	PROPN
dpc-5333	270	6	,	,	PUNCT
dpc-5333	270	7	ren	ren	PROPN
dpc-5333	270	8	y	y	PROPN
dpc-5333	270	9	,	,	PUNCT
dpc-5333	270	10	yang	yang	PROPN
dpc-5333	270	11	s	s	PROPN
dpc-5333	270	12	,	,	PUNCT
dpc-5333	270	13	zhang	zhang	PROPN
dpc-5333	270	14	q.	q.	PROPN
dpc-5333	270	15	bml-111	bml-111	PROPN
dpc-5333	270	16	modulates	modulate	NOUN
dpc-5333	270	17	and	and	CCONJ
dpc-5333	270	18	alleviates	alleviate	VERB
dpc-5333	270	19	p38	p38	NOUN
dpc-5333	270	20	/	/	SYM
dpc-5333	270	21	mapk	mapk	NOUN
dpc-5333	270	22	signaling	signal	VERB
dpc-5333	270	23	pathway	pathway	NOUN
dpc-5333	270	24	and	and	CCONJ
dpc-5333	270	25	th1	th1	PROPN
dpc-5333	270	26	/	/	SYM
dpc-5333	270	27	th2/	th2/	PROPN
dpc-5333	270	28	th17	th17	PROPN
dpc-5333	270	29	cytokine	cytokine	ADJ
dpc-5333	270	30	response	response	NOUN
dpc-5333	270	31	in	in	ADP
dpc-5333	270	32	murine	murine	ADJ
dpc-5333	270	33	psoriasis	psoriasis	NOUN
dpc-5333	270	34	-	-	PUNCT
dpc-5333	270	35	like	like	ADJ
dpc-5333	270	36	dermatitis	dermatitis	NOUN
dpc-5333	270	37	.	.	PUNCT
dpc-5333	271	1	discovery	discovery	NOUN
dpc-5333	271	2	medicine	medicine	NOUN
dpc-5333	271	3	.	.	PUNCT
dpc-5333	272	1	2024;36(189):2026–2036	2024;36(189):2026–2036	PROPN
dpc-5333	272	2	.	.	PUNCT
dpc-5333	272	3	doi:10.24976	doi:10.24976	NOUN
dpc-5333	272	4	/discov.med.202436189.186	/discov.med.202436189.186	X
dpc-5333	273	1	26	26	NUM
dpc-5333	273	2	.	.	PUNCT
dpc-5333	274	1	gao	gao	PROPN
dpc-5333	274	2	h	h	PROPN
dpc-5333	274	3	,	,	PUNCT
dpc-5333	274	4	wang	wang	PROPN
dpc-5333	274	5	l	l	PROPN
dpc-5333	274	6	,	,	PUNCT
dpc-5333	274	7	lyu	lyu	VERB
dpc-5333	274	8	y	y	PROPN
dpc-5333	274	9	,	,	PUNCT
dpc-5333	274	10	et	et	PROPN
dpc-5333	274	11	al	al	PROPN
dpc-5333	274	12	.	.	PUNCT
dpc-5333	275	1	the	the	DET
dpc-5333	275	2	p2x7r	p2x7r	NUM
dpc-5333	275	3	/	/	SYM
dpc-5333	275	4	nlrp3	nlrp3	NOUN
dpc-5333	275	5	inflammasome	inflammasome	NOUN
dpc-5333	275	6	axis	axis	NOUN
dpc-5333	275	7	suppresses	suppress	VERB
dpc-5333	275	8	enthesis	enthesis	NOUN
dpc-5333	275	9	regeneration	regeneration	NOUN
dpc-5333	275	10	through	through	ADP
dpc-5333	275	11	inflammatory	inflammatory	ADJ
dpc-5333	275	12	and	and	CCONJ
dpc-5333	275	13	metabolic	metabolic	ADJ
dpc-5333	275	14	macrophage	macrophage	ADJ
dpc-5333	275	15	-	-	PUNCT
dpc-5333	275	16	stem	stem	NOUN
dpc-5333	275	17	cell	cell	NOUN
dpc-5333	275	18	cross	cross	NOUN
dpc-5333	275	19	-	-	NOUN
dpc-5333	275	20	talk	talk	NOUN
dpc-5333	275	21	.	.	PUNCT
dpc-5333	276	1	science	science	NOUN
dpc-5333	276	2	advances	advance	NOUN
dpc-5333	276	3	.	.	PUNCT
dpc-5333	277	1	2025;11(17):eadr4894	2025;11(17):eadr4894	NUM
dpc-5333	277	2	.	.	PUNCT
dpc-5333	277	3	doi:10.1126	doi:10.1126	PROPN
dpc-5333	277	4	/	/	SYM
dpc-5333	277	5	sciadv.adr4894	sciadv.adr4894	PROPN
dpc-5333	277	6	27	27	NUM
dpc-5333	277	7	.	.	PUNCT
dpc-5333	278	1	saburi	saburi	PROPN
dpc-5333	278	2	e	e	PROPN
dpc-5333	278	3	,	,	PUNCT
dpc-5333	278	4	saburi	saburi	PROPN
dpc-5333	278	5	a	a	PROPN
dpc-5333	278	6	,	,	PUNCT
dpc-5333	278	7	ghanei	ghanei	VERB
dpc-5333	278	8	m.	m.	NOUN
dpc-5333	278	9	promising	promise	VERB
dpc-5333	278	10	role	role	NOUN
dpc-5333	278	11	for	for	ADP
dpc-5333	278	12	gc	gc	PROPN
dpc-5333	278	13	-	-	PUNCT
dpc-5333	278	14	maf	maf	PROPN
dpc-5333	278	15	in	in	ADP
dpc-5333	278	16	cancer	cancer	NOUN
dpc-5333	278	17	immunotherapy	immunotherapy	NOUN
dpc-5333	278	18	:	:	PUNCT
dpc-5333	278	19	from	from	ADP
dpc-5333	278	20	bench	bench	NOUN
dpc-5333	278	21	to	to	ADP
dpc-5333	278	22	bedside	bedside	NOUN
dpc-5333	278	23	.	.	PUNCT
dpc-5333	279	1	caspian	caspian	PROPN
dpc-5333	279	2	journal	journal	PROPN
dpc-5333	279	3	of	of	ADP
dpc-5333	279	4	internal	internal	ADJ
dpc-5333	279	5	medicine	medicine	NOUN
dpc-5333	279	6	.	.	PUNCT
dpc-5333	280	1	2017;8(4):228	2017;8(4):228	X
dpc-5333	280	2	.	.	PUNCT
dpc-5333	280	3	doi:10.22088	doi:10.22088	PROPN
dpc-5333	280	4	/	/	SYM
dpc-5333	280	5	cjim.8.4.228	cjim.8.4.228	PROPN
dpc-5333	280	6	28	28	NUM
dpc-5333	280	7	.	.	PUNCT
dpc-5333	281	1	j	j	PROPN
dpc-5333	281	2	salgado	salgado	PROPN
dpc-5333	281	3	a	a	X
dpc-5333	281	4	,	,	PUNCT
dpc-5333	281	5	l	l	PROPN
dpc-5333	281	6	reis	reis	NOUN
dpc-5333	281	7	r	r	NOUN
dpc-5333	281	8	,	,	PUNCT
dpc-5333	281	9	sousa	sousa	NOUN
dpc-5333	281	10	n	n	SYM
dpc-5333	281	11	,	,	PUNCT
dpc-5333	281	12	m	m	PROPN
dpc-5333	281	13	gimble	gimble	ADJ
dpc-5333	281	14	j.	j.	PROPN
dpc-5333	281	15	adipose	adipose	ADP
dpc-5333	281	16	tissue	tissue	NOUN
dpc-5333	281	17	derived	derive	VERB
dpc-5333	281	18	stem	stem	NOUN
dpc-5333	281	19	cells	cell	NOUN
dpc-5333	281	20	secretome	secretome	NOUN
dpc-5333	281	21	:	:	PUNCT
dpc-5333	281	22	soluble	soluble	ADJ
dpc-5333	281	23	factors	factor	NOUN
dpc-5333	281	24	and	and	CCONJ
dpc-5333	281	25	their	their	PRON
dpc-5333	281	26	roles	role	NOUN
dpc-5333	281	27	in	in	ADP
dpc-5333	281	28	regenerative	regenerative	ADJ
dpc-5333	281	29	medicine	medicine	NOUN
dpc-5333	281	30	.	.	PUNCT
dpc-5333	282	1	current	current	ADJ
dpc-5333	282	2	stem	stem	NOUN
dpc-5333	282	3	cell	cell	NOUN
dpc-5333	282	4	research	research	NOUN
dpc-5333	282	5	&	&	CCONJ
dpc-5333	282	6	therapy	therapy	NOUN
dpc-5333	282	7	.	.	PUNCT
dpc-5333	283	1	2010;5(2):103–110	2010;5(2):103–110	NUM
dpc-5333	283	2	.	.	PUNCT
dpc-5333	284	1	doi:10.2174/157488810791268564	doi:10.2174/157488810791268564	NOUN
dpc-5333	284	2	29	29	NUM
dpc-5333	284	3	.	.	PUNCT
dpc-5333	285	1	ferreira	ferreira	PROPN
dpc-5333	285	2	jr	jr	PROPN
dpc-5333	285	3	,	,	PUNCT
dpc-5333	285	4	teixeira	teixeira	PROPN
dpc-5333	285	5	gq	gq	PROPN
dpc-5333	285	6	,	,	PUNCT
dpc-5333	285	7	santos	santos	PROPN
dpc-5333	285	8	sg	sg	PROPN
dpc-5333	285	9	,	,	PUNCT
dpc-5333	285	10	barbosa	barbosa	PROPN
dpc-5333	285	11	ma	ma	PROPN
dpc-5333	285	12	,	,	PUNCT
dpc-5333	285	13	almeidaporada	almeidaporada	PROPN
dpc-5333	285	14	g	g	PROPN
dpc-5333	285	15	,	,	PUNCT
dpc-5333	285	16	gonçalves	gonçalves	PROPN
dpc-5333	285	17	rm	rm	PROPN
dpc-5333	285	18	.	.	PUNCT
dpc-5333	286	1	mesenchymal	mesenchymal	ADJ
dpc-5333	286	2	stromal	stromal	ADJ
dpc-5333	286	3	cell	cell	NOUN
dpc-5333	286	4	secretome	secretome	NOUN
dpc-5333	286	5	:	:	PUNCT
dpc-5333	286	6	influencing	influence	VERB
dpc-5333	286	7	therapeutic	therapeutic	ADJ
dpc-5333	286	8	potential	potential	NOUN
dpc-5333	286	9	by	by	ADP
dpc-5333	286	10	cellular	cellular	ADJ
dpc-5333	286	11	preconditioning	preconditioning	NOUN
dpc-5333	286	12	.	.	PUNCT
dpc-5333	287	1	frontiers	frontier	NOUN
dpc-5333	287	2	in	in	ADP
dpc-5333	287	3	immunology	immunology	NOUN
dpc-5333	287	4	.	.	PUNCT
dpc-5333	288	1	2018;9:2837	2018;9:2837	NOUN
dpc-5333	288	2	.	.	PUNCT
dpc-5333	289	1	doi:10.3389	doi:10.3389	PROPN
dpc-5333	289	2	/	/	SYM
dpc-5333	289	3	fimmu.2018.02837	fimmu.2018.02837	PROPN
dpc-5333	289	4	30	30	NUM
dpc-5333	289	5	.	.	PUNCT
dpc-5333	290	1	zuk	zuk	PROPN
dpc-5333	290	2	pa	pa	PROPN
dpc-5333	290	3	,	,	PUNCT
dpc-5333	290	4	zhu	zhu	PROPN
dpc-5333	290	5	m	m	PROPN
dpc-5333	290	6	,	,	PUNCT
dpc-5333	290	7	mizuno	mizuno	PROPN
dpc-5333	290	8	h	h	PROPN
dpc-5333	290	9	,	,	PUNCT
dpc-5333	290	10	et	et	PROPN
dpc-5333	290	11	al	al	PROPN
dpc-5333	290	12	.	.	PUNCT
dpc-5333	290	13	multilineage	multilineage	NOUN
dpc-5333	290	14	cells	cell	NOUN
dpc-5333	290	15	from	from	ADP
dpc-5333	290	16	human	human	ADJ
dpc-5333	290	17	adipose	adipose	ADJ
dpc-5333	290	18	tissue	tissue	NOUN
dpc-5333	290	19	:	:	PUNCT
dpc-5333	290	20	implications	implication	NOUN
dpc-5333	290	21	for	for	ADP
dpc-5333	290	22	cell	cell	NOUN
dpc-5333	290	23	-	-	PUNCT
dpc-5333	290	24	based	base	VERB
dpc-5333	290	25	therapies	therapy	NOUN
dpc-5333	290	26	.	.	PUNCT
dpc-5333	291	1	tissue	tissue	NOUN
dpc-5333	291	2	engineering	engineering	NOUN
dpc-5333	291	3	.	.	PUNCT
dpc-5333	292	1	2001;7(2):211–228	2001;7(2):211–228	NUM
dpc-5333	292	2	.	.	PUNCT
dpc-5333	292	3	doi:10.1089/107632701300062859	doi:10.1089/107632701300062859	PROPN
dpc-5333	292	4	31	31	NUM
dpc-5333	292	5	.	.	PUNCT
dpc-5333	293	1	mizuno	mizuno	PROPN
dpc-5333	293	2	h	h	PROPN
dpc-5333	293	3	,	,	PUNCT
dpc-5333	293	4	tobita	tobita	PROPN
dpc-5333	293	5	m	m	PROPN
dpc-5333	293	6	,	,	PUNCT
dpc-5333	293	7	uysal	uysal	PROPN
dpc-5333	293	8	ac	ac	PROPN
dpc-5333	293	9	.	.	PROPN
dpc-5333	293	10	concise	concise	PROPN
dpc-5333	293	11	review	review	PROPN
dpc-5333	293	12	:	:	PUNCT
dpc-5333	293	13	adipose	adipose	ADJ
dpc-5333	293	14	-	-	PUNCT
dpc-5333	293	15	derived	derive	VERB
dpc-5333	293	16	stem	stem	NOUN
dpc-5333	293	17	cells	cell	NOUN
dpc-5333	293	18	as	as	ADP
dpc-5333	293	19	a	a	DET
dpc-5333	293	20	novel	novel	ADJ
dpc-5333	293	21	tool	tool	NOUN
dpc-5333	293	22	for	for	ADP
dpc-5333	293	23	future	future	ADJ
dpc-5333	293	24	regenerative	regenerative	ADJ
dpc-5333	293	25	medicine	medicine	NOUN
dpc-5333	293	26	.	.	PUNCT
dpc-5333	294	1	stem	stem	NOUN
dpc-5333	294	2	cells	cell	NOUN
dpc-5333	294	3	.	.	PUNCT
dpc-5333	295	1	2012;30(5):804–810	2012;30(5):804–810	X
dpc-5333	295	2	.	.	PUNCT
dpc-5333	295	3	doi:10.1002	doi:10.1002	NOUN
dpc-5333	295	4	/	/	SYM
dpc-5333	295	5	stem.1076	stem.1076	PROPN
dpc-5333	295	6	32	32	NUM
dpc-5333	295	7	.	.	PUNCT
dpc-5333	296	1	schneider	schneider	PROPN
dpc-5333	296	2	s	s	PROPN
dpc-5333	296	3	,	,	PUNCT
dpc-5333	296	4	unger	unger	PROPN
dpc-5333	296	5	m	m	PROPN
dpc-5333	296	6	,	,	PUNCT
dpc-5333	296	7	van	van	PROPN
dpc-5333	296	8	griensven	griensven	VERB
dpc-5333	296	9	m	m	PROPN
dpc-5333	296	10	,	,	PUNCT
dpc-5333	296	11	balmayor	balmayor	NOUN
dpc-5333	296	12	er	er	INTJ
dpc-5333	296	13	.	.	PUNCT
dpc-5333	296	14	adipose	adipose	NOUN
dpc-5333	296	15	-	-	PUNCT
dpc-5333	296	16	derived	derive	VERB
dpc-5333	296	17	mesenchymal	mesenchymal	NOUN
dpc-5333	296	18	stem	stem	NOUN
dpc-5333	296	19	cells	cell	NOUN
dpc-5333	296	20	from	from	ADP
dpc-5333	296	21	liposuction	liposuction	NOUN
dpc-5333	296	22	and	and	CCONJ
dpc-5333	296	23	resected	resect	VERB
dpc-5333	296	24	fat	fat	NOUN
dpc-5333	296	25	are	be	AUX
dpc-5333	296	26	feasible	feasible	ADJ
dpc-5333	296	27	sources	source	NOUN
dpc-5333	296	28	for	for	ADP
dpc-5333	296	29	regenerative	regenerative	ADJ
dpc-5333	296	30	medicine	medicine	NOUN
dpc-5333	296	31	.	.	PUNCT
dpc-5333	297	1	european	european	ADJ
dpc-5333	297	2	journal	journal	PROPN
dpc-5333	297	3	of	of	ADP
dpc-5333	297	4	medical	medical	ADJ
dpc-5333	297	5	research	research	NOUN
dpc-5333	297	6	.	.	PUNCT
dpc-5333	298	1	2017;22:1–11	2017;22:1–11	X
dpc-5333	298	2	.	.	PUNCT
dpc-5333	298	3	doi:10.1186	doi:10.1186	VERB
dpc-5333	298	4	/s40001	/s40001	X
dpc-5333	298	5	-	-	PUNCT
dpc-5333	298	6	017	017	NUM
dpc-5333	298	7	-	-	PUNCT
dpc-5333	298	8	0258	0258	NUM
dpc-5333	298	9	-	-	SYM
dpc-5333	298	10	9	9	NUM
dpc-5333	298	11	33	33	NUM
dpc-5333	298	12	.	.	PUNCT
dpc-5333	299	1	patrikoski	patrikoski	PROPN
dpc-5333	299	2	m	m	PROPN
dpc-5333	299	3	,	,	PUNCT
dpc-5333	299	4	mannerström	mannerström	NOUN
dpc-5333	299	5	b	b	PROPN
dpc-5333	299	6	,	,	PUNCT
dpc-5333	299	7	miettinen	miettinen	PROPN
dpc-5333	299	8	s.	s.	PROPN
dpc-5333	299	9	perspectives	perspective	NOUN
dpc-5333	299	10	for	for	ADP
dpc-5333	299	11	clinical	clinical	ADJ
dpc-5333	299	12	translation	translation	NOUN
dpc-5333	299	13	of	of	ADP
dpc-5333	299	14	adipose	adipose	ADJ
dpc-5333	299	15	stromal	stromal	ADJ
dpc-5333	299	16	/	/	SYM
dpc-5333	299	17	stem	stem	NOUN
dpc-5333	299	18	cells	cell	NOUN
dpc-5333	299	19	.	.	PUNCT
dpc-5333	300	1	stem	stem	NOUN
dpc-5333	300	2	cells	cell	NOUN
dpc-5333	300	3	international	international	ADJ
dpc-5333	300	4	.	.	PUNCT
dpc-5333	301	1	2019;2019doi:10.1155/2019/5858247	2019;2019doi:10.1155/2019/5858247	PROPN
dpc-5333	301	2	34	34	NUM
dpc-5333	301	3	.	.	PUNCT
dpc-5333	302	1	izadpanah	izadpanah	PROPN
dpc-5333	302	2	r	r	PROPN
dpc-5333	302	3	,	,	PUNCT
dpc-5333	302	4	kaushal	kaushal	PROPN
dpc-5333	302	5	d	d	PROPN
dpc-5333	302	6	,	,	PUNCT
dpc-5333	302	7	kriedt	kriedt	PROPN
dpc-5333	302	8	c	c	PROPN
dpc-5333	302	9	,	,	PUNCT
dpc-5333	302	10	et	et	PROPN
dpc-5333	302	11	al	al	PROPN
dpc-5333	302	12	.	.	PUNCT
dpc-5333	303	1	long	long	ADJ
dpc-5333	303	2	-	-	PUNCT
dpc-5333	303	3	term	term	NOUN
dpc-5333	303	4	in	in	ADP
dpc-5333	303	5	vitro	vitro	X
dpc-5333	303	6	expansion	expansion	NOUN
dpc-5333	303	7	alters	alter	VERB
dpc-5333	303	8	the	the	DET
dpc-5333	303	9	biology	biology	NOUN
dpc-5333	303	10	of	of	ADP
dpc-5333	303	11	adult	adult	NOUN
dpc-5333	303	12	mesenchymal	mesenchymal	NOUN
dpc-5333	303	13	stem	stem	NOUN
dpc-5333	303	14	cells	cell	NOUN
dpc-5333	303	15	.	.	PUNCT
dpc-5333	304	1	cancer	cancer	NOUN
dpc-5333	304	2	research	research	NOUN
dpc-5333	304	3	.	.	PUNCT
dpc-5333	305	1	2008;68(11):4229–4238	2008;68(11):4229–4238	NUM
dpc-5333	305	2	.	.	X
dpc-5333	305	3	doi:10.1158/0008	doi:10.1158/0008	NOUN
dpc-5333	305	4	-5472.can-07	-5472.can-07	PROPN
dpc-5333	305	5	-	-	PUNCT
dpc-5333	305	6	5272	5272	NUM
dpc-5333	305	7	35	35	NUM
dpc-5333	305	8	.	.	PUNCT
dpc-5333	306	1	kern	kern	PROPN
dpc-5333	306	2	s	s	PROPN
dpc-5333	306	3	,	,	PUNCT
dpc-5333	306	4	eichler	eichler	NOUN
dpc-5333	306	5	h	h	PROPN
dpc-5333	306	6	,	,	PUNCT
dpc-5333	306	7	stoeve	stoeve	VERB
dpc-5333	306	8	j	j	PROPN
dpc-5333	306	9	,	,	PUNCT
dpc-5333	306	10	klüter	klüter	NOUN
dpc-5333	306	11	h	h	PROPN
dpc-5333	306	12	,	,	PUNCT
dpc-5333	306	13	bieback	bieback	PROPN
dpc-5333	306	14	k.	k.	PROPN
dpc-5333	306	15	comparative	comparative	ADJ
dpc-5333	306	16	analysis	analysis	NOUN
dpc-5333	306	17	of	of	ADP
dpc-5333	306	18	mesenchymal	mesenchymal	ADJ
dpc-5333	306	19	stem	stem	NOUN
dpc-5333	306	20	cells	cell	NOUN
dpc-5333	306	21	from	from	ADP
dpc-5333	306	22	bone	bone	NOUN
dpc-5333	306	23	marrow	marrow	NOUN
dpc-5333	306	24	,	,	PUNCT
dpc-5333	306	25	umbilical	umbilical	ADJ
dpc-5333	306	26	cord	cord	NOUN
dpc-5333	306	27	blood	blood	NOUN
dpc-5333	306	28	,	,	PUNCT
dpc-5333	306	29	or	or	CCONJ
dpc-5333	306	30	adipose	adipose	PRON
dpc-5333	306	31	tissue	tissue	NOUN
dpc-5333	306	32	.	.	PUNCT
dpc-5333	307	1	stem	stem	NOUN
dpc-5333	307	2	cells	cell	NOUN
dpc-5333	307	3	.	.	PUNCT
dpc-5333	308	1	2006;24(5):1294–1301	2006;24(5):1294–1301	NUM
dpc-5333	308	2	.	.	PUNCT
dpc-5333	309	1	doi:10.1634	doi:10.1634	NOUN
dpc-5333	309	2	/	/	SYM
dpc-5333	309	3	stemcells.2005	stemcells.2005	PROPN
dpc-5333	309	4	-	-	PUNCT
dpc-5333	309	5	0342	0342	NUM
dpc-5333	309	6	36	36	NUM
dpc-5333	309	7	.	.	PUNCT
dpc-5333	310	1	chen	chen	PROPN
dpc-5333	310	2	y	y	PROPN
dpc-5333	310	3	,	,	PUNCT
dpc-5333	310	4	yu	yu	PROPN
dpc-5333	310	5	q	q	PROPN
dpc-5333	310	6	,	,	PUNCT
dpc-5333	310	7	hu	hu	PROPN
dpc-5333	310	8	y	y	PROPN
dpc-5333	310	9	,	,	PUNCT
dpc-5333	310	10	shi	shi	PROPN
dpc-5333	310	11	y.	y.	PROPN
dpc-5333	310	12	current	current	PROPN
dpc-5333	310	13	research	research	NOUN
dpc-5333	310	14	and	and	CCONJ
dpc-5333	310	15	use	use	NOUN
dpc-5333	310	16	of	of	ADP
dpc-5333	310	17	mesenchymal	mesenchymal	ADJ
dpc-5333	310	18	stem	stem	NOUN
dpc-5333	310	19	cells	cell	NOUN
dpc-5333	310	20	in	in	ADP
dpc-5333	310	21	the	the	DET
dpc-5333	310	22	therapy	therapy	NOUN
dpc-5333	310	23	of	of	ADP
dpc-5333	310	24	autoimmune	autoimmune	ADJ
dpc-5333	310	25	diseases	disease	NOUN
dpc-5333	310	26	.	.	PUNCT
dpc-5333	311	1	current	current	ADJ
dpc-5333	311	2	stem	stem	NOUN
dpc-5333	311	3	cell	cell	NOUN
dpc-5333	311	4	research	research	NOUN
dpc-5333	311	5	&	&	CCONJ
dpc-5333	311	6	therapy	therapy	NOUN
dpc-5333	311	7	.	.	PUNCT
dpc-5333	312	1	2019;14(7):579–582	2019;14(7):579–582	NUM
dpc-5333	312	2	.	.	X
dpc-5333	312	3	doi:10.21	doi:10.21	PROPN
dpc-5333	312	4	74/1574888x14666190429141421	74/1574888x14666190429141421	NUM
dpc-5333	312	5	37	37	NUM
dpc-5333	312	6	.	.	PUNCT
dpc-5333	313	1	abedi	abedi	PROPN
dpc-5333	313	2	m	m	PROPN
dpc-5333	313	3	,	,	PUNCT
dpc-5333	313	4	alavi	alavi	NOUN
dpc-5333	313	5	-	-	PUNCT
dpc-5333	313	6	moghadam	moghadam	NOUN
dpc-5333	313	7	s	s	PROPN
dpc-5333	313	8	,	,	PUNCT
dpc-5333	313	9	payab	payab	NOUN
dpc-5333	313	10	m	m	PROPN
dpc-5333	313	11	,	,	PUNCT
dpc-5333	313	12	et	et	PROPN
dpc-5333	313	13	al	al	PROPN
dpc-5333	313	14	.	.	PUNCT
dpc-5333	313	15	mesenchymal	mesenchymal	ADJ
dpc-5333	313	16	stem	stem	NOUN
dpc-5333	313	17	cell	cell	NOUN
dpc-5333	313	18	as	as	ADP
dpc-5333	313	19	a	a	DET
dpc-5333	313	20	novel	novel	ADJ
dpc-5333	313	21	approach	approach	NOUN
dpc-5333	313	22	to	to	ADP
dpc-5333	313	23	systemic	systemic	ADJ
dpc-5333	313	24	sclerosis	sclerosis	NOUN
dpc-5333	313	25	;	;	PUNCT
dpc-5333	313	26	current	current	ADJ
dpc-5333	313	27	status	status	NOUN
dpc-5333	313	28	and	and	CCONJ
dpc-5333	313	29	future	future	ADJ
dpc-5333	313	30	perspectives	perspective	NOUN
dpc-5333	313	31	.	.	PUNCT
dpc-5333	314	1	cell	cell	NOUN
dpc-5333	314	2	regeneration	regeneration	NOUN
dpc-5333	314	3	.	.	PUNCT
dpc-5333	315	1	2020;9:1–19	2020;9:1–19	NUM
dpc-5333	315	2	.	.	PUNCT
dpc-5333	316	1	doi:10.1186	doi:10.1186	PROPN
dpc-5333	316	2	/	/	SYM
dpc-5333	316	3	s13619	s13619	PROPN
dpc-5333	316	4	-	-	PUNCT
dpc-5333	316	5	020	020	NUM
dpc-5333	316	6	-	-	PUNCT
dpc-5333	316	7	00058	00058	NUM
dpc-5333	316	8	-	-	SYM
dpc-5333	316	9	0	0	NUM
dpc-5333	316	10	38	38	NUM
dpc-5333	316	11	.	.	PUNCT
dpc-5333	317	1	bateman	bateman	PROPN
dpc-5333	317	2	me	i	PRON
dpc-5333	317	3	,	,	PUNCT
dpc-5333	317	4	strong	strong	PROPN
dpc-5333	317	5	al	al	PROPN
dpc-5333	317	6	,	,	PUNCT
dpc-5333	317	7	gimble	gimble	PROPN
dpc-5333	317	8	jm	jm	PROPN
dpc-5333	317	9	,	,	PUNCT
dpc-5333	317	10	bunnell	bunnell	PROPN
dpc-5333	317	11	ba	ba	PROPN
dpc-5333	317	12	.	.	PUNCT
dpc-5333	318	1	concise	concise	PROPN
dpc-5333	318	2	review	review	PROPN
dpc-5333	318	3	:	:	PUNCT
dpc-5333	318	4	using	use	VERB
dpc-5333	318	5	fat	fat	NOUN
dpc-5333	318	6	to	to	PART
dpc-5333	318	7	fight	fight	VERB
dpc-5333	318	8	disease	disease	NOUN
dpc-5333	318	9	:	:	PUNCT
dpc-5333	318	10	a	a	DET
dpc-5333	318	11	systematic	systematic	ADJ
dpc-5333	318	12	review	review	NOUN
dpc-5333	318	13	of	of	ADP
dpc-5333	318	14	nonhomologous	nonhomologous	ADJ
dpc-5333	318	15	adipose	adipose	NOUN
dpc-5333	318	16	-	-	PUNCT
dpc-5333	318	17	derived	derive	VERB
dpc-5333	318	18	stromal	stromal	ADJ
dpc-5333	318	19	/	/	SYM
dpc-5333	318	20	stem	stem	NOUN
dpc-5333	318	21	cell	cell	NOUN
dpc-5333	318	22	therapies	therapy	NOUN
dpc-5333	318	23	.	.	PUNCT
dpc-5333	319	1	stem	stem	NOUN
dpc-5333	319	2	cells	cell	NOUN
dpc-5333	319	3	.	.	PUNCT
dpc-5333	320	1	2018;36(9):1311–1328	2018;36(9):1311–1328	NOUN
dpc-5333	320	2	.	.	PUNCT
dpc-5333	321	1	doi:10.1002	doi:10.1002	NOUN
dpc-5333	321	2	/	/	SYM
dpc-5333	321	3	stem.2847	stem.2847	PROPN
dpc-5333	321	4	39	39	NUM
dpc-5333	321	5	.	.	PUNCT
dpc-5333	322	1	álvaro	álvaro	NOUN
dpc-5333	322	2	-	-	PUNCT
dpc-5333	322	3	gracia	gracia	PROPN
dpc-5333	322	4	jm	jm	PROPN
dpc-5333	322	5	,	,	PUNCT
dpc-5333	322	6	jover	jover	PROPN
dpc-5333	322	7	ja	ja	PROPN
dpc-5333	322	8	,	,	PUNCT
dpc-5333	322	9	garcía	garcía	ADJ
dpc-5333	322	10	-	-	PUNCT
dpc-5333	322	11	vicuña	vicuña	ADJ
dpc-5333	322	12	r	r	NOUN
dpc-5333	322	13	,	,	PUNCT
dpc-5333	322	14	et	et	PROPN
dpc-5333	322	15	al	al	PROPN
dpc-5333	322	16	.	.	PROPN
dpc-5333	322	17	intravenous	intravenous	PROPN
dpc-5333	322	18	administration	administration	NOUN
dpc-5333	322	19	of	of	ADP
dpc-5333	322	20	expanded	expand	VERB
dpc-5333	322	21	allogeneic	allogeneic	ADJ
dpc-5333	322	22	adipose	adipose	NOUN
dpc-5333	322	23	-	-	PUNCT
dpc-5333	322	24	derived	derive	VERB
dpc-5333	322	25	mesenchymal	mesenchymal	NOUN
dpc-5333	322	26	stem	stem	NOUN
dpc-5333	322	27	cells	cell	NOUN
dpc-5333	322	28	in	in	ADP
dpc-5333	322	29	refractory	refractory	NOUN
dpc-5333	322	30	rheumatoid	rheumatoid	VERB
dpc-5333	322	31	arthritis	arthritis	NOUN
dpc-5333	322	32	(	(	PUNCT
dpc-5333	322	33	cx611	cx611	PROPN
dpc-5333	322	34	):	):	PUNCT
dpc-5333	322	35	results	result	NOUN
dpc-5333	322	36	of	of	ADP
dpc-5333	322	37	a	a	DET
dpc-5333	322	38	multicentre	multicentre	NOUN
dpc-5333	322	39	,	,	PUNCT
dpc-5333	322	40	dose	dose	NOUN
dpc-5333	322	41	escalation	escalation	NOUN
dpc-5333	322	42	,	,	PUNCT
dpc-5333	322	43	randomised	randomise	VERB
dpc-5333	322	44	,	,	PUNCT
dpc-5333	322	45	single	single	ADJ
dpc-5333	322	46	-	-	PUNCT
dpc-5333	322	47	blind	blind	ADJ
dpc-5333	322	48	,	,	PUNCT
dpc-5333	322	49	placebo	placebo	NOUN
dpc-5333	322	50	-	-	PUNCT
dpc-5333	322	51	controlled	control	VERB
dpc-5333	322	52	phase	phase	NOUN
dpc-5333	322	53	ib	ib	PROPN
dpc-5333	322	54	/	/	SYM
dpc-5333	322	55	iia	iia	VERB
dpc-5333	322	56	clinical	clinical	ADJ
dpc-5333	322	57	trial	trial	NOUN
dpc-5333	322	58	.	.	PUNCT
dpc-5333	323	1	annals	annal	NOUN
dpc-5333	323	2	of	of	ADP
dpc-5333	323	3	the	the	DET
dpc-5333	323	4	rheumatic	rheumatic	ADJ
dpc-5333	323	5	diseases	disease	NOUN
dpc-5333	323	6	.	.	PUNCT
dpc-5333	324	1	2017;76(1):196–202	2017;76(1):196–202	X
dpc-5333	324	2	.	.	PUNCT
dpc-5333	324	3	doi:10.1136	doi:10.1136	PROPN
dpc-5333	324	4	/annrheumdis-2015	/annrheumdis-2015	PROPN
dpc-5333	324	5	-	-	PUNCT
dpc-5333	324	6	208918	208918	NUM
dpc-5333	324	7	40	40	NUM
dpc-5333	324	8	.	.	PUNCT
dpc-5333	325	1	zhou	zhou	PROPN
dpc-5333	325	2	t	t	PROPN
dpc-5333	325	3	,	,	PUNCT
dpc-5333	325	4	li	li	PROPN
dpc-5333	325	5	h	h	PROPN
dpc-5333	325	6	-	-	PUNCT
dpc-5333	325	7	y	y	PROPN
dpc-5333	325	8	,	,	PUNCT
dpc-5333	325	9	liao	liao	PROPN
dpc-5333	325	10	c	c	PROPN
dpc-5333	325	11	,	,	PUNCT
dpc-5333	325	12	lin	lin	PROPN
dpc-5333	325	13	w	w	PROPN
dpc-5333	325	14	,	,	PUNCT
dpc-5333	325	15	lin	lin	PROPN
dpc-5333	325	16	s.	s.	PROPN
dpc-5333	325	17	clinical	clinical	PROPN
dpc-5333	325	18	efficacy	efficacy	NOUN
dpc-5333	325	19	and	and	CCONJ
dpc-5333	325	20	safety	safety	NOUN
dpc-5333	325	21	of	of	ADP
dpc-5333	325	22	mesenchymal	mesenchymal	ADJ
dpc-5333	325	23	stem	stem	NOUN
dpc-5333	325	24	cells	cell	NOUN
dpc-5333	325	25	for	for	ADP
dpc-5333	325	26	systemic	systemic	ADJ
dpc-5333	325	27	lupus	lupus	PROPN
dpc-5333	325	28	erythematosus	erythematosus	PROPN
dpc-5333	325	29	.	.	PUNCT
dpc-5333	326	1	stem	stem	NOUN
dpc-5333	326	2	cells	cell	NOUN
dpc-5333	326	3	international	international	ADJ
dpc-5333	326	4	.	.	PUNCT
dpc-5333	327	1	2020;2020doi:10.1155/2020/6518508	2020;2020doi:10.1155/2020/6518508	NUM
dpc-5333	327	2	41	41	NUM
dpc-5333	327	3	.	.	PUNCT
dpc-5333	328	1	wang	wang	PROPN
dpc-5333	328	2	l	l	PROPN
dpc-5333	328	3	,	,	PUNCT
dpc-5333	328	4	zhu	zhu	PROPN
dpc-5333	328	5	c	c	PROPN
dpc-5333	328	6	-	-	PUNCT
dpc-5333	328	7	y	y	PROPN
dpc-5333	328	8	,	,	PUNCT
dpc-5333	328	9	ma	ma	PROPN
dpc-5333	328	10	d	d	PROPN
dpc-5333	328	11	-	-	PUNCT
dpc-5333	328	12	x	x	NOUN
dpc-5333	328	13	,	,	PUNCT
dpc-5333	328	14	et	et	PROPN
dpc-5333	328	15	al	al	PROPN
dpc-5333	328	16	.	.	PROPN
dpc-5333	328	17	efficacy	efficacy	NOUN
dpc-5333	328	18	and	and	CCONJ
dpc-5333	328	19	safety	safety	NOUN
dpc-5333	328	20	of	of	ADP
dpc-5333	328	21	mesenchymal	mesenchymal	ADJ
dpc-5333	328	22	stromal	stromal	ADJ
dpc-5333	328	23	cells	cell	NOUN
dpc-5333	328	24	for	for	ADP
dpc-5333	328	25	the	the	DET
dpc-5333	328	26	prophylaxis	prophylaxis	NOUN
dpc-5333	328	27	of	of	ADP
dpc-5333	328	28	chronic	chronic	ADJ
dpc-5333	328	29	graft	graft	NOUN
dpc-5333	328	30	-	-	PUNCT
dpc-5333	328	31	versus	versus	ADP
dpc-5333	328	32	-	-	PUNCT
dpc-5333	328	33	host	host	NOUN
dpc-5333	328	34	disease	disease	NOUN
dpc-5333	328	35	after	after	ADP
dpc-5333	328	36	allogeneic	allogeneic	VERB
dpc-5333	328	37	hematopoietic	hematopoietic	ADJ
dpc-5333	328	38	stem	stem	NOUN
dpc-5333	328	39	cell	cell	NOUN
dpc-5333	328	40	transplantation	transplantation	NOUN
dpc-5333	328	41	:	:	PUNCT
dpc-5333	328	42	a	a	DET
dpc-5333	328	43	meta	meta	ADJ
dpc-5333	328	44	-	-	PUNCT
dpc-5333	328	45	analysis	analysis	NOUN
dpc-5333	328	46	of	of	ADP
dpc-5333	328	47	randomized	randomized	ADJ
dpc-5333	328	48	controlled	control	VERB
dpc-5333	328	49	trials	trial	NOUN
dpc-5333	328	50	.	.	PUNCT
dpc-5333	329	1	annals	annal	NOUN
dpc-5333	329	2	of	of	ADP
dpc-5333	329	3	hematology	hematology	NOUN
dpc-5333	329	4	.	.	PUNCT
dpc-5333	330	1	2018;97:1941–1950	2018;97:1941–1950	NUM
dpc-5333	330	2	.	.	PUNCT
dpc-5333	330	3	doi:10.1007	doi:10.1007	PROPN
dpc-5333	330	4	/	/	SYM
dpc-5333	330	5	s00277	s00277	NOUN
dpc-5333	330	6	-	-	PUNCT
dpc-5333	330	7	018	018	NUM
dpc-5333	330	8	-	-	PUNCT
dpc-5333	330	9	3384	3384	NUM
dpc-5333	330	10	-	-	SYM
dpc-5333	330	11	8	8	NUM
dpc-5333	330	12	42	42	NUM
dpc-5333	330	13	.	.	PUNCT
dpc-5333	331	1	lalu	lalu	PROPN
dpc-5333	331	2	mm	mm	PROPN
dpc-5333	331	3	,	,	PUNCT
dpc-5333	331	4	mcintyre	mcintyre	PROPN
dpc-5333	331	5	l	l	PROPN
dpc-5333	331	6	,	,	PUNCT
dpc-5333	331	7	pugliese	pugliese	NOUN
dpc-5333	331	8	c	c	NOUN
dpc-5333	331	9	,	,	PUNCT
dpc-5333	331	10	et	et	PROPN
dpc-5333	331	11	al	al	PROPN
dpc-5333	331	12	.	.	PUNCT
dpc-5333	332	1	safe	safe	ADJ
dpc-5333	332	2	ty	ty	INTJ
dpc-5333	332	3	of	of	ADP
dpc-5333	332	4	cell	cell	NOUN
dpc-5333	332	5	therapy	therapy	NOUN
dpc-5333	332	6	with	with	ADP
dpc-5333	332	7	mesenchymal	mesenchymal	ADJ
dpc-5333	332	8	stromal	stromal	ADJ
dpc-5333	332	9	cells	cell	NOUN
dpc-5333	332	10	(	(	PUNCT
dpc-5333	332	11	safecell	safecell	ADJ
dpc-5333	332	12	):	):	PUNCT
dpc-5333	332	13	a	a	DET
dpc-5333	332	14	systematic	systematic	ADJ
dpc-5333	332	15	review	review	NOUN
dpc-5333	332	16	and	and	CCONJ
dpc-5333	332	17	meta	meta	NOUN
dpc-5333	332	18	-	-	PUNCT
dpc-5333	332	19	analysis	analysis	NOUN
dpc-5333	332	20	of	of	ADP
dpc-5333	332	21	clinical	clinical	ADJ
dpc-5333	332	22	trials	trial	NOUN
dpc-5333	332	23	.	.	PUNCT
dpc-5333	333	1	plos	plos	PROPN
dpc-5333	333	2	one	one	NUM
dpc-5333	333	3	.	.	PUNCT
dpc-5333	334	1	2012;7(10):e47559	2012;7(10):e47559	NOUN
dpc-5333	334	2	.	.	PUNCT
dpc-5333	334	3	doi:10.1371	doi:10.1371	PROPN
dpc-5333	334	4	/	/	SYM
dpc-5333	335	1	journal.pone.0047559	journal.pone.0047559	PROPN
dpc-5333	335	2	43	43	NUM
dpc-5333	335	3	.	.	PUNCT
dpc-5333	336	1	petrou	petrou	PROPN
dpc-5333	336	2	p	p	X
dpc-5333	336	3	,	,	PUNCT
dpc-5333	336	4	kassis	kassis	NOUN
dpc-5333	336	5	i	i	PROPN
dpc-5333	336	6	,	,	PUNCT
dpc-5333	336	7	levin	levin	PROPN
dpc-5333	336	8	n	n	PROPN
dpc-5333	336	9	,	,	PUNCT
dpc-5333	336	10	et	et	PROPN
dpc-5333	336	11	al	al	PROPN
dpc-5333	336	12	.	.	PROPN
dpc-5333	337	1	beneficial	beneficial	ADJ
dpc-5333	337	2	effects	effect	NOUN
dpc-5333	337	3	of	of	ADP
dpc-5333	337	4	autologous	autologous	ADJ
dpc-5333	337	5	mesenchymal	mesenchymal	NOUN
dpc-5333	337	6	stem	stem	NOUN
dpc-5333	337	7	cell	cell	NOUN
dpc-5333	337	8	transplantation	transplantation	NOUN
dpc-5333	337	9	in	in	ADP
dpc-5333	337	10	active	active	ADJ
dpc-5333	337	11	progressive	progressive	ADJ
dpc-5333	337	12	multiple	multiple	ADJ
dpc-5333	337	13	sclerosis	sclerosis	NOUN
dpc-5333	337	14	.	.	PUNCT
dpc-5333	338	1	brain	brain	NOUN
dpc-5333	338	2	.	.	PUNCT
dpc-5333	339	1	2020;143(12):3574–3588	2020;143(12):3574–3588	NUM
dpc-5333	339	2	.	.	PUNCT
dpc-5333	339	3	doi:10.1093	doi:10.1093	NOUN
dpc-5333	339	4	/brain	/brain	PUNCT
dpc-5333	339	5	/	/	SYM
dpc-5333	339	6	awaa333	awaa333	PROPN
dpc-5333	339	7	44	44	NUM
dpc-5333	339	8	.	.	PUNCT
dpc-5333	340	1	cao	cao	PROPN
dpc-5333	340	2	y	y	PROPN
dpc-5333	340	3	,	,	PUNCT
dpc-5333	340	4	ding	de	VERB
dpc-5333	340	5	z	z	PROPN
dpc-5333	340	6	,	,	PUNCT
dpc-5333	340	7	han	han	PROPN
dpc-5333	340	8	c	c	PROPN
dpc-5333	340	9	,	,	PUNCT
dpc-5333	340	10	shi	shi	PROPN
dpc-5333	340	11	h	h	PROPN
dpc-5333	340	12	,	,	PUNCT
dpc-5333	340	13	cui	cui	PROPN
dpc-5333	340	14	l	l	PROPN
dpc-5333	340	15	,	,	PUNCT
dpc-5333	340	16	lin	lin	PROPN
dpc-5333	340	17	r.	r.	PROPN
dpc-5333	340	18	efficacy	efficacy	PROPN
dpc-5333	340	19	of	of	ADP
dpc-5333	340	20	mesenchymal	mesenchymal	ADJ
dpc-5333	340	21	stromal	stromal	ADJ
dpc-5333	340	22	cells	cell	NOUN
dpc-5333	340	23	for	for	ADP
dpc-5333	340	24	fistula	fistula	NOUN
dpc-5333	340	25	treatment	treatment	NOUN
dpc-5333	340	26	of	of	ADP
dpc-5333	340	27	crohn	crohn	PROPN
dpc-5333	340	28	’s	’s	PART
dpc-5333	340	29	disease	disease	NOUN
dpc-5333	340	30	:	:	PUNCT
dpc-5333	340	31	a	a	DET
dpc-5333	340	32	review	review	NOUN
dpc-5333	340	33	|	|	ADV
dpc-5333	340	34	dermatol	dermatol	ADJ
dpc-5333	340	35	pract	pract	NOUN
dpc-5333	340	36	concept	concept	NOUN
dpc-5333	340	37	.	.	PUNCT
dpc-5333	341	1	2025;15(3):5333	2025;15(3):5333	NUM
dpc-5333	341	2	9	9	NUM
dpc-5333	341	3	systematic	systematic	ADJ
dpc-5333	341	4	review	review	NOUN
dpc-5333	341	5	and	and	CCONJ
dpc-5333	341	6	meta	meta	ADJ
dpc-5333	341	7	-	-	PUNCT
dpc-5333	341	8	analysis	analysis	NOUN
dpc-5333	341	9	.	.	PUNCT
dpc-5333	342	1	digestive	digestive	ADJ
dpc-5333	342	2	diseases	disease	NOUN
dpc-5333	342	3	and	and	CCONJ
dpc-5333	342	4	sciences	science	NOUN
dpc-5333	342	5	.	.	PUNCT
dpc-5333	343	1	2017;62:851–860	2017;62:851–860	NOUN
dpc-5333	343	2	.	.	PUNCT
dpc-5333	343	3	doi:10.1007	doi:10.1007	PROPN
dpc-5333	343	4	/	/	SYM
dpc-5333	343	5	s10620	s10620	PROPN
dpc-5333	343	6	-	-	PUNCT
dpc-5333	343	7	017	017	NUM
dpc-5333	343	8	-	-	PUNCT
dpc-5333	343	9	4453	4453	NUM
dpc-5333	343	10	-	-	PUNCT
dpc-5333	343	11	x	x	SYM
dpc-5333	343	12	45	45	NUM
dpc-5333	343	13	.	.	PUNCT
dpc-5333	343	14	william	william	PROPN
dpc-5333	343	15	tt	tt	PROPN
dpc-5333	343	16	,	,	PUNCT
dpc-5333	343	17	pendleton	pendleton	PROPN
dpc-5333	343	18	jd	jd	PROPN
dpc-5333	343	19	,	,	PUNCT
dpc-5333	343	20	beyer	beyer	PROPN
dpc-5333	343	21	wm	wm	PROPN
dpc-5333	343	22	,	,	PUNCT
dpc-5333	343	23	egalka	egalka	PROPN
dpc-5333	343	24	mc	mc	PROPN
dpc-5333	343	25	,	,	PUNCT
dpc-5333	343	26	guinan	guinan	PROPN
dpc-5333	343	27	ec	ec	PROPN
dpc-5333	343	28	.	.	PUNCT
dpc-5333	344	1	suppression	suppression	NOUN
dpc-5333	344	2	of	of	ADP
dpc-5333	344	3	allogeneic	allogeneic	ADJ
dpc-5333	344	4	t	t	PROPN
dpc-5333	344	5	-	-	PUNCT
dpc-5333	344	6	cell	cell	NOUN
dpc-5333	344	7	proliferation	proliferation	NOUN
dpc-5333	344	8	by	by	ADP
dpc-5333	344	9	human	human	ADJ
dpc-5333	344	10	marrow	marrow	NOUN
dpc-5333	344	11	stromal	stromal	ADJ
dpc-5333	344	12	cells	cell	NOUN
dpc-5333	344	13	:	:	PUNCT
dpc-5333	344	14	implications	implication	NOUN
dpc-5333	344	15	in	in	ADP
dpc-5333	344	16	transplantation	transplantation	NOUN
dpc-5333	344	17	.	.	PUNCT
dpc-5333	345	1	transplantation	transplantation	NOUN
dpc-5333	345	2	.	.	PUNCT
dpc-5333	346	1	2003;75(3):389–397	2003;75(3):389–397	X
dpc-5333	346	2	.	.	PUNCT
dpc-5333	347	1	doi:10.1097/01.tp.0000045055.63901.a9	doi:10.1097/01.tp.0000045055.63901.a9	PROPN
dpc-5333	347	2	46	46	NUM
dpc-5333	347	3	.	.	PUNCT
dpc-5333	348	1	beyth	beyth	PROPN
dpc-5333	348	2	s	s	PROPN
dpc-5333	348	3	,	,	PUNCT
dpc-5333	348	4	borovsky	borovsky	PROPN
dpc-5333	348	5	z	z	PROPN
dpc-5333	348	6	,	,	PUNCT
dpc-5333	348	7	mevorach	mevorach	PRON
dpc-5333	348	8	d	d	NOUN
dpc-5333	348	9	,	,	PUNCT
dpc-5333	348	10	et	et	PROPN
dpc-5333	348	11	al	al	PROPN
dpc-5333	348	12	.	.	PROPN
dpc-5333	349	1	human	human	ADJ
dpc-5333	349	2	mesenchymal	mesenchymal	NOUN
dpc-5333	349	3	stem	stem	NOUN
dpc-5333	349	4	cells	cell	NOUN
dpc-5333	349	5	alter	alter	VERB
dpc-5333	349	6	antigen	antigen	ADV
dpc-5333	349	7	-	-	PUNCT
dpc-5333	349	8	presenting	present	VERB
dpc-5333	349	9	cell	cell	NOUN
dpc-5333	349	10	maturation	maturation	NOUN
dpc-5333	349	11	and	and	CCONJ
dpc-5333	349	12	induce	induce	VERB
dpc-5333	349	13	t	t	NOUN
dpc-5333	349	14	-	-	PUNCT
dpc-5333	349	15	cell	cell	NOUN
dpc-5333	349	16	unresponsiveness	unresponsiveness	NOUN
dpc-5333	349	17	.	.	PUNCT
dpc-5333	350	1	blood	blood	NOUN
dpc-5333	350	2	.	.	PUNCT
dpc-5333	351	1	2005;105(5):2214–2219	2005;105(5):2214–2219	X
dpc-5333	351	2	.	.	PUNCT
dpc-5333	351	3	doi:10.1182	doi:10.1182	NOUN
dpc-5333	351	4	/	/	SYM
dpc-5333	351	5	blood-2004	blood-2004	NOUN
dpc-5333	351	6	-	-	PUNCT
dpc-5333	351	7	07	07	NUM
dpc-5333	351	8	-	-	SYM
dpc-5333	351	9	2921	2921	NUM
dpc-5333	351	10	47	47	NUM
dpc-5333	351	11	.	.	PUNCT
dpc-5333	352	1	nussbaum	nussbaum	PROPN
dpc-5333	352	2	l	l	PROPN
dpc-5333	352	3	,	,	PUNCT
dpc-5333	352	4	chen	chen	PROPN
dpc-5333	352	5	y	y	PROPN
dpc-5333	352	6	,	,	PUNCT
dpc-5333	352	7	ogg	ogg	PROPN
dpc-5333	352	8	g.	g.	PROPN
dpc-5333	352	9	role	role	NOUN
dpc-5333	352	10	of	of	ADP
dpc-5333	352	11	regulatory	regulatory	ADJ
dpc-5333	352	12	t	t	NOUN
dpc-5333	352	13	cells	cell	NOUN
dpc-5333	352	14	in	in	ADP
dpc-5333	352	15	psoriasis	psoriasis	NOUN
dpc-5333	352	16	pathogenesis	pathogenesis	NOUN
dpc-5333	352	17	and	and	CCONJ
dpc-5333	352	18	treatment	treatment	NOUN
dpc-5333	352	19	.	.	PUNCT
dpc-5333	353	1	british	british	ADJ
dpc-5333	353	2	journal	journal	PROPN
dpc-5333	353	3	of	of	ADP
dpc-5333	353	4	dermatology	dermatology	NOUN
dpc-5333	353	5	.	.	PUNCT
dpc-5333	354	1	2021;184(1):14–24	2021;184(1):14–24	X
dpc-5333	354	2	.	.	PUNCT
dpc-5333	355	1	doi:10.1111	doi:10.1111	ADJ
dpc-5333	355	2	/	/	SYM
dpc-5333	355	3	bjd.19380	bjd.19380	SYM
dpc-5333	355	4	48	48	NUM
dpc-5333	355	5	.	.	PUNCT
dpc-5333	356	1	cordiali	cordiali	ADJ
dpc-5333	356	2	-	-	PROPN
dpc-5333	356	3	fei	fei	PROPN
dpc-5333	356	4	p	p	NOUN
dpc-5333	356	5	,	,	PUNCT
dpc-5333	356	6	bianchi	bianchi	NOUN
dpc-5333	356	7	l	l	NOUN
dpc-5333	356	8	,	,	PUNCT
dpc-5333	356	9	bonifati	bonifati	PROPN
dpc-5333	356	10	c	c	PROPN
dpc-5333	356	11	,	,	PUNCT
dpc-5333	356	12	et	et	PROPN
dpc-5333	356	13	al	al	PROPN
dpc-5333	356	14	.	.	PROPN
dpc-5333	357	1	immunologic	immunologic	PROPN
dpc-5333	357	2	biomarkers	biomarker	NOUN
dpc-5333	357	3	for	for	ADP
dpc-5333	357	4	clinical	clinical	ADJ
dpc-5333	357	5	and	and	CCONJ
dpc-5333	357	6	therapeutic	therapeutic	ADJ
dpc-5333	357	7	management	management	NOUN
dpc-5333	357	8	of	of	ADP
dpc-5333	357	9	psoriasis	psoriasis	NOUN
dpc-5333	357	10	.	.	PUNCT
dpc-5333	358	1	mediators	mediator	NOUN
dpc-5333	358	2	of	of	ADP
dpc-5333	358	3	inflammation	inflammation	NOUN
dpc-5333	358	4	.	.	PUNCT
dpc-5333	359	1	2014;2014doi:10.1155/2014/236060	2014;2014doi:10.1155/2014/236060	NUM
dpc-5333	359	2	49	49	NUM
dpc-5333	359	3	.	.	PUNCT
dpc-5333	360	1	diluvio	diluvio	NOUN
dpc-5333	360	2	l	l	PROPN
dpc-5333	360	3	,	,	PUNCT
dpc-5333	360	4	romiti	romiti	PROPN
dpc-5333	360	5	m	m	PROPN
dpc-5333	360	6	,	,	PUNCT
dpc-5333	360	7	angelini	angelini	PROPN
dpc-5333	360	8	f	f	PROPN
dpc-5333	360	9	,	,	PUNCT
dpc-5333	360	10	et	et	PROPN
dpc-5333	360	11	al	al	PROPN
dpc-5333	360	12	.	.	PROPN
dpc-5333	360	13	infliximab	infliximab	PROPN
dpc-5333	360	14	therapy	therapy	NOUN
dpc-5333	360	15	induces	induce	VERB
dpc-5333	360	16	increased	increase	VERB
dpc-5333	360	17	polyclonality	polyclonality	NOUN
dpc-5333	360	18	of	of	ADP
dpc-5333	360	19	cd4	cd4	PROPN
dpc-5333	360	20	+	+	PROPN
dpc-5333	360	21	cd25	cd25	PROPN
dpc-5333	360	22	+	+	SYM
dpc-5333	360	23	regulatory	regulatory	ADJ
dpc-5333	360	24	t	t	NOUN
dpc-5333	360	25	cells	cell	NOUN
dpc-5333	360	26	in	in	ADP
dpc-5333	360	27	psoriasis	psoriasis	NOUN
dpc-5333	360	28	.	.	PUNCT
dpc-5333	361	1	british	british	ADJ
dpc-5333	361	2	journal	journal	PROPN
dpc-5333	361	3	of	of	ADP
dpc-5333	361	4	dermatology	dermatology	NOUN
dpc-5333	361	5	.	.	PUNCT
dpc-5333	362	1	2010;162(4	2010;162(4	NUM
dpc-5333	362	2	):	):	PUNCT
dpc-5333	363	1	895–897	895–897	NUM
dpc-5333	363	2	.	.	PUNCT
dpc-5333	364	1	doi:10.1111	doi:10.1111	ADJ
dpc-5333	364	2	/	/	SYM
dpc-5333	364	3	j.1365	j.1365	PROPN
dpc-5333	364	4	-	-	PUNCT
dpc-5333	364	5	2133.2010.09650.x	2133.2010.09650.x	NUM
dpc-5333	364	6	50	50	NUM
dpc-5333	364	7	.	.	PUNCT
dpc-5333	365	1	ma	ma	PROPN
dpc-5333	365	2	hl	hl	PROPN
dpc-5333	365	3	,	,	PUNCT
dpc-5333	365	4	napierata	napierata	PROPN
dpc-5333	365	5	l	l	PROPN
dpc-5333	365	6	,	,	PUNCT
dpc-5333	365	7	stedman	stedman	PROPN
dpc-5333	365	8	n	n	CCONJ
dpc-5333	365	9	,	,	PUNCT
dpc-5333	365	10	et	et	PROPN
dpc-5333	365	11	al	al	PROPN
dpc-5333	365	12	.	.	PROPN
dpc-5333	365	13	tumor	tumor	PROPN
dpc-5333	365	14	necrosis	necrosis	NOUN
dpc-5333	365	15	factor	factor	NOUN
dpc-5333	365	16	α	α	NOUN
dpc-5333	365	17	blockade	blockade	NOUN
dpc-5333	365	18	exacerbates	exacerbate	VERB
dpc-5333	365	19	murine	murine	ADJ
dpc-5333	365	20	psoriasis	psoriasis	NOUN
dpc-5333	365	21	-	-	PUNCT
dpc-5333	365	22	like	like	ADJ
dpc-5333	365	23	disease	disease	NOUN
dpc-5333	365	24	by	by	ADP
dpc-5333	365	25	enhancing	enhance	VERB
dpc-5333	365	26	th17	th17	NOUN
dpc-5333	365	27	function	function	NOUN
dpc-5333	365	28	and	and	CCONJ
dpc-5333	365	29	decreasing	decrease	VERB
dpc-5333	365	30	expansion	expansion	NOUN
dpc-5333	365	31	of	of	ADP
dpc-5333	365	32	treg	treg	PROPN
dpc-5333	365	33	cells	cell	NOUN
dpc-5333	365	34	.	.	PUNCT
dpc-5333	366	1	arthritis	arthritis	NOUN
dpc-5333	366	2	&	&	CCONJ
dpc-5333	366	3	rheumatism	rheumatism	NOUN
dpc-5333	366	4	:	:	PUNCT
dpc-5333	366	5	official	official	ADJ
dpc-5333	366	6	journal	journal	NOUN
dpc-5333	366	7	of	of	ADP
dpc-5333	366	8	the	the	DET
dpc-5333	366	9	american	american	PROPN
dpc-5333	366	10	college	college	PROPN
dpc-5333	366	11	of	of	ADP
dpc-5333	366	12	rheumatology	rheumatology	NOUN
dpc-5333	366	13	.	.	PUNCT
dpc-5333	367	1	2010;62(2):430–440	2010;62(2):430–440	X
dpc-5333	367	2	.	.	PUNCT
dpc-5333	367	3	doi:10.1002	doi:10.1002	NOUN
dpc-5333	367	4	/	/	SYM
dpc-5333	367	5	art.27203	art.27203	SYM
dpc-5333	367	6	51	51	NUM
dpc-5333	367	7	.	.	PUNCT
dpc-5333	368	1	yang	yang	PROPN
dpc-5333	368	2	j	j	PROPN
dpc-5333	368	3	,	,	PUNCT
dpc-5333	368	4	zhu	zhu	PROPN
dpc-5333	368	5	j	j	PROPN
dpc-5333	368	6	,	,	PUNCT
dpc-5333	368	7	lu	lu	PROPN
dpc-5333	368	8	s	s	PROPN
dpc-5333	368	9	,	,	PUNCT
dpc-5333	368	10	qin	qin	PROPN
dpc-5333	368	11	h	h	PROPN
dpc-5333	368	12	,	,	PUNCT
dpc-5333	368	13	zhou	zhou	PROPN
dpc-5333	368	14	w.	w.	PROPN
dpc-5333	368	15	transdermal	transdermal	PROPN
dpc-5333	368	16	psoriasis	psoriasis	NOUN
dpc-5333	368	17	treatment	treatment	NOUN
dpc-5333	368	18	inspired	inspire	VERB
dpc-5333	368	19	by	by	ADP
dpc-5333	368	20	tumor	tumor	NOUN
dpc-5333	368	21	microenvironment	microenvironment	NOUN
dpc-5333	368	22	-	-	PUNCT
dpc-5333	368	23	mediated	mediate	VERB
dpc-5333	368	24	immunomodulation	immunomodulation	NOUN
dpc-5333	368	25	and	and	CCONJ
dpc-5333	368	26	advanced	advance	VERB
dpc-5333	368	27	by	by	ADP
dpc-5333	368	28	exosomal	exosomal	ADJ
dpc-5333	368	29	engineering	engineering	NOUN
dpc-5333	368	30	.	.	PUNCT
dpc-5333	369	1	journal	journal	PROPN
dpc-5333	369	2	of	of	ADP
dpc-5333	369	3	controlled	control	VERB
dpc-5333	369	4	release	release	NOUN
dpc-5333	369	5	.	.	PUNCT
dpc-5333	370	1	2025;382:113664	2025;382:113664	NUM
dpc-5333	370	2	.	.	PUNCT
dpc-5333	370	3	doi:10.1016	doi:10.1016	PROPN
dpc-5333	370	4	/	/	SYM
dpc-5333	370	5	j.jconrel	j.jconrel	NOUN
dpc-5333	370	6	.2025.113664	.2025.113664	NOUN
dpc-5333	371	1	52	52	NUM
dpc-5333	371	2	.	.	PUNCT
dpc-5333	372	1	shu	shu	PROPN
dpc-5333	372	2	m	m	PROPN
dpc-5333	372	3	,	,	PUNCT
dpc-5333	372	4	fan	fan	PROPN
dpc-5333	372	5	z	z	PROPN
dpc-5333	372	6	,	,	PUNCT
dpc-5333	372	7	huang	huang	PROPN
dpc-5333	372	8	b	b	PROPN
dpc-5333	372	9	,	,	PUNCT
dpc-5333	372	10	wang	wang	PROPN
dpc-5333	372	11	c.	c.	PROPN
dpc-5333	372	12	retrospective	retrospective	ADJ
dpc-5333	372	13	analysis	analysis	NOUN
dpc-5333	372	14	of	of	ADP
dpc-5333	372	15	clinical	clinical	ADJ
dpc-5333	372	16	features	feature	NOUN
dpc-5333	372	17	of	of	ADP
dpc-5333	372	18	pembrolizumab	pembrolizumab	NOUN
dpc-5333	372	19	induced	induce	VERB
dpc-5333	372	20	psoriasis	psoriasis	NOUN
dpc-5333	372	21	.	.	PUNCT
dpc-5333	373	1	investigational	investigational	ADJ
dpc-5333	373	2	new	new	ADJ
dpc-5333	373	3	drugs	drug	NOUN
dpc-5333	373	4	.	.	PUNCT
dpc-5333	374	1	2025:1–6	2025:1–6	X
dpc-5333	374	2	.	.	PUNCT
dpc-5333	374	3	doi:10.1007	doi:10.1007	VERB
dpc-5333	374	4	/	/	SYM
dpc-5333	374	5	s10637	s10637	NOUN
dpc-5333	374	6	-	-	PUNCT
dpc-5333	374	7	025	025	NUM
dpc-5333	374	8	-	-	PUNCT
dpc-5333	374	9	01536	01536	NUM
dpc-5333	374	10	-	-	SYM
dpc-5333	374	11	5	5	NUM
dpc-5333	374	12	53	53	NUM
dpc-5333	374	13	.	.	PUNCT
dpc-5333	375	1	zhao	zhao	PROPN
dpc-5333	375	2	s	s	PROPN
dpc-5333	375	3	,	,	PUNCT
dpc-5333	375	4	sun	sun	PROPN
dpc-5333	375	5	w	w	PROPN
dpc-5333	375	6	,	,	PUNCT
dpc-5333	375	7	sun	sun	PROPN
dpc-5333	375	8	j	j	PROPN
dpc-5333	375	9	,	,	PUNCT
dpc-5333	375	10	peng	peng	PROPN
dpc-5333	375	11	l	l	PROPN
dpc-5333	375	12	,	,	PUNCT
dpc-5333	375	13	wang	wang	PROPN
dpc-5333	375	14	c.	c.	PROPN
dpc-5333	375	15	clinical	clinical	PROPN
dpc-5333	375	16	features	feature	NOUN
dpc-5333	375	17	,	,	PUNCT
dpc-5333	375	18	treatment	treatment	NOUN
dpc-5333	375	19	,	,	PUNCT
dpc-5333	375	20	and	and	CCONJ
dpc-5333	375	21	outcomes	outcome	NOUN
dpc-5333	375	22	of	of	ADP
dpc-5333	375	23	nivolumab	nivolumab	NOUN
dpc-5333	375	24	induced	induce	VERB
dpc-5333	375	25	psoriasis	psoriasis	NOUN
dpc-5333	375	26	.	.	PUNCT
dpc-5333	376	1	investigational	investigational	ADJ
dpc-5333	376	2	new	new	ADJ
dpc-5333	376	3	drugs	drug	NOUN
dpc-5333	376	4	.	.	PUNCT
dpc-5333	377	1	2025;43(1):42–49	2025;43(1):42–49	X
dpc-5333	377	2	.	.	PUNCT
dpc-5333	377	3	doi:10.1007	doi:10.1007	VERB
dpc-5333	377	4	/	/	SYM
dpc-5333	377	5	s10637	s10637	ADJ
dpc-5333	377	6	-024	-024	ADJ
dpc-5333	377	7	-	-	PUNCT
dpc-5333	377	8	01494	01494	NUM
dpc-5333	377	9	-	-	SYM
dpc-5333	377	10	4	4	NUM
dpc-5333	377	11	54	54	NUM
dpc-5333	377	12	.	.	PUNCT
dpc-5333	378	1	kashif	kashif	PROPN
dpc-5333	378	2	s	s	PROPN
dpc-5333	378	3	,	,	PUNCT
dpc-5333	378	4	al	al	PROPN
dpc-5333	378	5	-	-	PUNCT
dpc-5333	378	6	mani	mani	PROPN
dpc-5333	378	7	sy	sy	PROPN
dpc-5333	378	8	,	,	PUNCT
dpc-5333	378	9	almani	almani	PROPN
dpc-5333	378	10	ny	ny	PROPN
dpc-5333	378	11	.	.	PROPN
dpc-5333	379	1	a	a	DET
dpc-5333	379	2	rare	rare	ADJ
dpc-5333	379	3	psoriasis	psoriasis	NOUN
dpc-5333	379	4	drug	drug	NOUN
dpc-5333	379	5	eruption	eruption	NOUN
dpc-5333	379	6	induced	induce	VERB
dpc-5333	379	7	by	by	ADP
dpc-5333	379	8	levetiracetam	levetiracetam	NOUN
dpc-5333	379	9	:	:	PUNCT
dpc-5333	379	10	a	a	DET
dpc-5333	379	11	case	case	NOUN
dpc-5333	379	12	study	study	NOUN
dpc-5333	379	13	from	from	ADP
dpc-5333	379	14	saudi	saudi	PROPN
dpc-5333	379	15	arabia	arabia	PROPN
dpc-5333	379	16	.	.	PUNCT
dpc-5333	380	1	international	international	ADJ
dpc-5333	380	2	journal	journal	PROPN
dpc-5333	380	3	of	of	ADP
dpc-5333	380	4	pharmacology	pharmacology	NOUN
dpc-5333	380	5	.	.	PUNCT
dpc-5333	381	1	2024;20(4):704–708	2024;20(4):704–708	X
dpc-5333	381	2	.	.	X
dpc-5333	381	3	doi:10.3923	doi:10.3923	PROPN
dpc-5333	381	4	/	/	SYM
dpc-5333	381	5	ijp.2024.704.708	ijp.2024.704.708	ADJ
dpc-5333	381	6	55	55	NUM
dpc-5333	381	7	.	.	PUNCT
dpc-5333	382	1	atabati	atabati	PROPN
dpc-5333	382	2	h	h	PROPN
dpc-5333	382	3	,	,	PUNCT
dpc-5333	382	4	esmaeili	esmaeili	PROPN
dpc-5333	382	5	sa	sa	PROPN
dpc-5333	382	6	,	,	PUNCT
dpc-5333	382	7	saburi	saburi	PROPN
dpc-5333	382	8	e	e	PROPN
dpc-5333	382	9	,	,	PUNCT
dpc-5333	382	10	et	et	PROPN
dpc-5333	382	11	al	al	PROPN
dpc-5333	382	12	.	.	PUNCT
dpc-5333	383	1	probiotics	probiotic	NOUN
dpc-5333	383	2	with	with	ADP
dpc-5333	383	3	ameliorating	ameliorate	VERB
dpc-5333	383	4	effects	effect	NOUN
dpc-5333	383	5	on	on	ADP
dpc-5333	383	6	the	the	DET
dpc-5333	383	7	severity	severity	NOUN
dpc-5333	383	8	of	of	ADP
dpc-5333	383	9	skin	skin	NOUN
dpc-5333	383	10	inflammation	inflammation	NOUN
dpc-5333	383	11	in	in	ADP
dpc-5333	383	12	psoriasis	psoriasis	NOUN
dpc-5333	383	13	:	:	PUNCT
dpc-5333	383	14	evidence	evidence	NOUN
dpc-5333	383	15	from	from	ADP
dpc-5333	383	16	experimental	experimental	ADJ
dpc-5333	383	17	and	and	CCONJ
dpc-5333	383	18	clinical	clinical	ADJ
dpc-5333	383	19	studies	study	NOUN
dpc-5333	383	20	.	.	PUNCT
dpc-5333	384	1	journal	journal	NOUN
dpc-5333	384	2	of	of	ADP
dpc-5333	384	3	cellular	cellular	ADJ
dpc-5333	384	4	physiology	physiology	NOUN
dpc-5333	384	5	.	.	PUNCT
dpc-5333	385	1	2020;235(12):8925–8937	2020;235(12):8925–8937	NUM
dpc-5333	385	2	.	.	PUNCT
dpc-5333	386	1	doi:10.1002/	doi:10.1002/	NUM
dpc-5333	386	2	jcp.29737	jcp.29737	NUM
dpc-5333	386	3	56	56	NUM
dpc-5333	386	4	.	.	PUNCT
dpc-5333	387	1	erichsen	erichsen	PROPN
dpc-5333	387	2	c	c	PROPN
dpc-5333	387	3	,	,	PUNCT
dpc-5333	387	4	jensen	jensen	PROPN
dpc-5333	387	5	p	p	PROPN
dpc-5333	387	6	,	,	PUNCT
dpc-5333	387	7	kofoed	kofoed	PROPN
dpc-5333	387	8	k.	k.	PROPN
dpc-5333	387	9	biologic	biologic	NOUN
dpc-5333	387	10	therapies	therapy	NOUN
dpc-5333	387	11	targeting	target	VERB
dpc-5333	387	12	the	the	DET
dpc-5333	387	13	interleukin	interleukin	NOUN
dpc-5333	387	14	(	(	PUNCT
dpc-5333	387	15	il)-23	il)-23	NOUN
dpc-5333	387	16	/	/	SYM
dpc-5333	387	17	il-17	il-17	NUM
dpc-5333	387	18	immune	immune	ADJ
dpc-5333	387	19	axis	axis	NOUN
dpc-5333	387	20	for	for	ADP
dpc-5333	387	21	the	the	DET
dpc-5333	387	22	treatment	treatment	NOUN
dpc-5333	387	23	of	of	ADP
dpc-5333	387	24	moderate	moderate	ADJ
dpc-5333	387	25	-	-	PUNCT
dpc-5333	387	26	to	to	ADP
dpc-5333	387	27	-	-	PUNCT
dpc-5333	387	28	severe	severe	ADJ
dpc-5333	387	29	plaque	plaque	NOUN
dpc-5333	387	30	psoriasis	psoriasis	NOUN
dpc-5333	387	31	:	:	PUNCT
dpc-5333	387	32	a	a	DET
dpc-5333	387	33	systematic	systematic	ADJ
dpc-5333	387	34	review	review	NOUN
dpc-5333	387	35	and	and	CCONJ
dpc-5333	387	36	meta	meta	ADJ
dpc-5333	387	37	-	-	PUNCT
dpc-5333	387	38	analysis	analysis	NOUN
dpc-5333	387	39	.	.	PUNCT
dpc-5333	388	1	j	j	PROPN
dpc-5333	388	2	eur	eur	PROPN
dpc-5333	388	3	acad	acad	PROPN
dpc-5333	388	4	dermatol	dermatol	NOUN
dpc-5333	388	5	venereol	venereol	NOUN
dpc-5333	388	6	.	.	PUNCT
dpc-5333	389	1	2020;34(1	2020;34(1	NUM
dpc-5333	389	2	):	):	PUNCT
dpc-5333	389	3	30–38	30–38	NUM
dpc-5333	389	4	.	.	PUNCT
dpc-5333	390	1	doi:10.1111	doi:10.1111	PROPN
dpc-5333	390	2	/	/	SYM
dpc-5333	390	3	jdv.15879	jdv.15879	NUM
dpc-5333	390	4	57	57	NUM
dpc-5333	390	5	.	.	PUNCT
dpc-5333	391	1	rosenzwajg	rosenzwajg	PROPN
dpc-5333	391	2	m	m	PROPN
dpc-5333	391	3	,	,	PUNCT
dpc-5333	391	4	lorenzon	lorenzon	PROPN
dpc-5333	391	5	r	r	NOUN
dpc-5333	391	6	,	,	PUNCT
dpc-5333	391	7	cacoub	cacoub	NOUN
dpc-5333	391	8	p	p	X
dpc-5333	391	9	,	,	PUNCT
dpc-5333	391	10	et	et	PROPN
dpc-5333	391	11	al	al	PROPN
dpc-5333	391	12	.	.	PROPN
dpc-5333	392	1	immunological	immunological	ADJ
dpc-5333	392	2	and	and	CCONJ
dpc-5333	392	3	clinical	clinical	ADJ
dpc-5333	392	4	effects	effect	NOUN
dpc-5333	392	5	of	of	ADP
dpc-5333	392	6	low	low	ADV
dpc-5333	392	7	-	-	PUNCT
dpc-5333	392	8	dose	dose	NOUN
dpc-5333	392	9	interleukin-2	interleukin-2	NOUN
dpc-5333	392	10	across	across	ADP
dpc-5333	392	11	11	11	NUM
dpc-5333	392	12	autoimmune	autoimmune	ADJ
dpc-5333	392	13	diseases	disease	NOUN
dpc-5333	392	14	in	in	ADP
dpc-5333	392	15	a	a	DET
dpc-5333	392	16	single	single	ADJ
dpc-5333	392	17	,	,	PUNCT
dpc-5333	392	18	open	open	ADJ
dpc-5333	392	19	clinical	clinical	ADJ
dpc-5333	392	20	trial	trial	NOUN
dpc-5333	392	21	.	.	PUNCT
dpc-5333	393	1	annals	annal	NOUN
dpc-5333	393	2	of	of	ADP
dpc-5333	393	3	the	the	DET
dpc-5333	393	4	rheumatic	rheumatic	ADJ
dpc-5333	393	5	diseases	disease	NOUN
dpc-5333	393	6	.	.	PUNCT
dpc-5333	394	1	2019;78(2):209–217	2019;78(2):209–217	NUM
dpc-5333	394	2	.	.	PUNCT
dpc-5333	394	3	doi:10.1136	doi:10.1136	NOUN
dpc-5333	394	4	/annrheumdis-2018	/annrheumdis-2018	PROPN
dpc-5333	394	5	-	-	PUNCT
dpc-5333	394	6	214229	214229	NUM
dpc-5333	394	7	58	58	NUM
dpc-5333	394	8	.	.	PUNCT
dpc-5333	395	1	bovenschen	bovenschen	PROPN
dpc-5333	395	2	hj	hj	PROPN
dpc-5333	395	3	,	,	PUNCT
dpc-5333	395	4	van	van	PROPN
dpc-5333	395	5	de	de	X
dpc-5333	395	6	kerkhof	kerkhof	PROPN
dpc-5333	395	7	pc	pc	PROPN
dpc-5333	395	8	,	,	PUNCT
dpc-5333	395	9	van	van	PROPN
dpc-5333	395	10	erp	erp	PROPN
dpc-5333	395	11	pe	pe	PROPN
dpc-5333	395	12	,	,	PUNCT
dpc-5333	395	13	woestenenk	woestenenk	PROPN
dpc-5333	395	14	r	r	NOUN
dpc-5333	395	15	,	,	PUNCT
dpc-5333	395	16	joosten	joosten	VERB
dpc-5333	395	17	i	i	PRON
dpc-5333	395	18	,	,	PUNCT
dpc-5333	395	19	koenen	koenen	PROPN
dpc-5333	395	20	hj	hj	PROPN
dpc-5333	395	21	.	.	PUNCT
dpc-5333	396	1	foxp3	foxp3	PROPN
dpc-5333	396	2	+	+	ADP
dpc-5333	396	3	regulatory	regulatory	ADJ
dpc-5333	396	4	t	t	NOUN
dpc-5333	396	5	cells	cell	NOUN
dpc-5333	396	6	of	of	ADP
dpc-5333	396	7	psoriasis	psoriasis	NOUN
dpc-5333	396	8	patients	patient	NOUN
dpc-5333	396	9	easily	easily	ADV
dpc-5333	396	10	differentiate	differentiate	VERB
dpc-5333	396	11	into	into	ADP
dpc-5333	396	12	il-17a	il-17a	PROPN
dpc-5333	396	13	-	-	PUNCT
dpc-5333	396	14	producing	produce	VERB
dpc-5333	396	15	cells	cell	NOUN
dpc-5333	396	16	and	and	CCONJ
dpc-5333	396	17	are	be	AUX
dpc-5333	396	18	found	find	VERB
dpc-5333	396	19	in	in	ADP
dpc-5333	396	20	lesional	lesional	ADJ
dpc-5333	396	21	skin	skin	NOUN
dpc-5333	396	22	.	.	PUNCT
dpc-5333	397	1	journal	journal	NOUN
dpc-5333	397	2	of	of	ADP
dpc-5333	397	3	investigative	investigative	ADJ
dpc-5333	397	4	dermatology	dermatology	NOUN
dpc-5333	397	5	.	.	PUNCT
dpc-5333	398	1	2011;131(9):1853–1860	2011;131(9):1853–1860	NOUN
dpc-5333	398	2	.	.	PUNCT
dpc-5333	399	1	doi:10.1038	doi:10.1038	NOUN
dpc-5333	399	2	/	/	SYM
dpc-5333	399	3	jid.2011.139	jid.2011.139	PROPN
dpc-5333	399	4	59	59	NUM
dpc-5333	399	5	.	.	PUNCT
dpc-5333	400	1	bluestone	bluestone	PROPN
dpc-5333	400	2	ja	ja	PROPN
dpc-5333	400	3	,	,	PUNCT
dpc-5333	400	4	tang	tang	PROPN
dpc-5333	400	5	q.	q.	PROPN
dpc-5333	400	6	treg	treg	PROPN
dpc-5333	400	7	cells	cells	PROPN
dpc-5333	400	8	—	—	PUNCT
dpc-5333	400	9	the	the	DET
dpc-5333	400	10	next	next	ADJ
dpc-5333	400	11	frontier	frontier	NOUN
dpc-5333	400	12	of	of	ADP
dpc-5333	400	13	cell	cell	NOUN
dpc-5333	400	14	therapy	therapy	NOUN
dpc-5333	400	15	.	.	PUNCT
dpc-5333	401	1	science	science	NOUN
dpc-5333	401	2	.	.	PUNCT
dpc-5333	402	1	2018;362(6411):154–155	2018;362(6411):154–155	NUM
dpc-5333	402	2	.	.	PUNCT
dpc-5333	402	3	doi:10.1126	doi:10.1126	PROPN
dpc-5333	402	4	/	/	SYM
dpc-5333	402	5	science.aau2688	science.aau2688	NOUN
dpc-5333	402	6	60	60	NUM
dpc-5333	402	7	.	.	PUNCT
dpc-5333	403	1	adkins	adkins	PROPN
dpc-5333	404	1	d	d	PROPN
dpc-5333	404	2	,	,	PUNCT
dpc-5333	404	3	abidi	abidi	PROPN
dpc-5333	404	4	m	m	PROPN
dpc-5333	404	5	,	,	PUNCT
dpc-5333	404	6	brown	brown	ADJ
dpc-5333	404	7	r	r	NOUN
dpc-5333	404	8	,	,	PUNCT
dpc-5333	404	9	et	et	PROPN
dpc-5333	404	10	al	al	PROPN
dpc-5333	404	11	.	.	PUNCT
dpc-5333	405	1	resolution	resolution	NOUN
dpc-5333	405	2	of	of	ADP
dpc-5333	405	3	psoriasis	psoriasis	NOUN
dpc-5333	405	4	after	after	ADP
dpc-5333	405	5	allogeneic	allogeneic	ADJ
dpc-5333	405	6	bone	bone	NOUN
dpc-5333	405	7	marrow	marrow	NOUN
dpc-5333	405	8	transplantation	transplantation	NOUN
dpc-5333	405	9	for	for	ADP
dpc-5333	405	10	chronic	chronic	ADJ
dpc-5333	405	11	myelogenous	myelogenous	ADJ
dpc-5333	405	12	leukemia	leukemia	NOUN
dpc-5333	405	13	:	:	PUNCT
dpc-5333	405	14	late	late	ADJ
dpc-5333	405	15	complications	complication	NOUN
dpc-5333	405	16	of	of	ADP
dpc-5333	405	17	therapy	therapy	NOUN
dpc-5333	405	18	.	.	PUNCT
dpc-5333	406	1	bone	bone	NOUN
dpc-5333	406	2	marrow	marrow	NOUN
dpc-5333	406	3	transplantation	transplantation	NOUN
dpc-5333	406	4	.	.	PUNCT
dpc-5333	407	1	2000;26(11):1239–1241	2000;26(11):1239–1241	X
dpc-5333	407	2	.	.	PUNCT
dpc-5333	407	3	doi:10.1038	doi:10.1038	NOUN
dpc-5333	407	4	/	/	SYM
dpc-5333	407	5	sj.bmt.1702703	sj.bmt.1702703	NOUN
dpc-5333	407	6	61	61	NUM
dpc-5333	407	7	.	.	PUNCT
dpc-5333	408	1	snowden	snowden	PROPN
dpc-5333	408	2	j	j	PROPN
dpc-5333	408	3	,	,	PUNCT
dpc-5333	408	4	heaton	heaton	PROPN
dpc-5333	408	5	d.	d.	PROPN
dpc-5333	408	6	development	development	PROPN
dpc-5333	408	7	of	of	ADP
dpc-5333	408	8	psoriasis	psoriasis	NOUN
dpc-5333	408	9	after	after	ADP
dpc-5333	408	10	syngeneic	syngeneic	NOUN
dpc-5333	408	11	bone	bone	NOUN
dpc-5333	408	12	marrow	marrow	PROPN
dpc-5333	408	13	transplant	transplant	NOUN
dpc-5333	408	14	from	from	ADP
dpc-5333	408	15	psoriatic	psoriatic	ADJ
dpc-5333	408	16	donor	donor	NOUN
dpc-5333	408	17	:	:	PUNCT
dpc-5333	408	18	further	further	ADJ
dpc-5333	408	19	evidence	evidence	NOUN
dpc-5333	408	20	for	for	ADP
dpc-5333	408	21	adoptive	adoptive	ADJ
dpc-5333	408	22	autoimmunity	autoimmunity	NOUN
dpc-5333	408	23	.	.	PUNCT
dpc-5333	409	1	british	british	ADJ
dpc-5333	409	2	journal	journal	PROPN
dpc-5333	409	3	of	of	ADP
dpc-5333	409	4	dermatology	dermatology	NOUN
dpc-5333	409	5	.	.	PUNCT
dpc-5333	410	1	1997;137(1	1997;137(1	NUM
dpc-5333	410	2	):	):	PUNCT
dpc-5333	410	3	130–132	130–132	NUM
dpc-5333	410	4	.	.	PUNCT
dpc-5333	410	5	doi:10.1046	doi:10.1046	ADJ
dpc-5333	410	6	/	/	SYM
dpc-5333	410	7	j.1365	j.1365	NOUN
dpc-5333	410	8	-	-	PUNCT
dpc-5333	410	9	2133.1997.17821869.x	2133.1997.17821869.x	NUM
dpc-5333	410	10	62	62	NUM
dpc-5333	410	11	.	.	PUNCT
dpc-5333	411	1	zhang	zhang	PROPN
dpc-5333	411	2	k	k	PROPN
dpc-5333	411	3	,	,	PUNCT
dpc-5333	411	4	li	li	PROPN
dpc-5333	411	5	x	x	PROPN
dpc-5333	411	6	,	,	PUNCT
dpc-5333	411	7	yin	yin	PROPN
dpc-5333	411	8	g	g	PROPN
dpc-5333	411	9	,	,	PUNCT
dpc-5333	411	10	liu	liu	PROPN
dpc-5333	411	11	y	y	PROPN
dpc-5333	411	12	,	,	PUNCT
dpc-5333	411	13	tang	tang	X
dpc-5333	411	14	x.	x.	NOUN
dpc-5333	411	15	functional	functional	ADJ
dpc-5333	411	16	characterization	characterization	NOUN
dpc-5333	411	17	of	of	ADP
dpc-5333	411	18	t	t	NOUN
dpc-5333	411	19	cells	cell	NOUN
dpc-5333	411	20	differentiated	differentiate	VERB
dpc-5333	411	21	in	in	ADP
dpc-5333	411	22	vitro	vitro	X
dpc-5333	411	23	from	from	ADP
dpc-5333	411	24	bone	bone	NOUN
dpc-5333	411	25	marrow	marrow	NOUN
dpc-5333	411	26	-	-	PUNCT
dpc-5333	411	27	derived	derive	VERB
dpc-5333	411	28	cd34	cd34	PROPN
dpc-5333	411	29	+	+	NUM
dpc-5333	411	30	cells	cell	NOUN
dpc-5333	411	31	of	of	ADP
dpc-5333	411	32	psoriatic	psoriatic	ADJ
dpc-5333	411	33	patients	patient	NOUN
dpc-5333	411	34	with	with	ADP
dpc-5333	411	35	family	family	NOUN
dpc-5333	411	36	history	history	NOUN
dpc-5333	411	37	.	.	PUNCT
dpc-5333	412	1	experimental	experimental	ADJ
dpc-5333	412	2	dermatology	dermatology	NOUN
dpc-5333	412	3	.	.	PUNCT
dpc-5333	413	1	2010;19(8):e128	2010;19(8):e128	NOUN
dpc-5333	413	2	–	–	PUNCT
dpc-5333	413	3	e135	e135	NUM
dpc-5333	413	4	.	.	PUNCT
dpc-5333	414	1	doi:10.1111	doi:10.1111	PROPN
dpc-5333	414	2	/j.1600	/j.1600	PROPN
dpc-5333	414	3	-	-	PUNCT
dpc-5333	414	4	0625.2009.01016.x	0625.2009.01016.x	NUM
dpc-5333	414	5	63	63	NUM
dpc-5333	414	6	.	.	PUNCT
dpc-5333	415	1	yang	yang	PROPN
dpc-5333	415	2	l	l	PROPN
dpc-5333	415	3	,	,	PUNCT
dpc-5333	415	4	li	li	PROPN
dpc-5333	415	5	b	b	PROPN
dpc-5333	415	6	,	,	PUNCT
dpc-5333	415	7	dang	dang	INTJ
dpc-5333	415	8	e	e	NOUN
dpc-5333	415	9	,	,	PUNCT
dpc-5333	415	10	jin	jin	PROPN
dpc-5333	415	11	l	l	PROPN
dpc-5333	415	12	,	,	PUNCT
dpc-5333	415	13	fan	fan	NOUN
dpc-5333	415	14	x	x	PROPN
dpc-5333	415	15	,	,	PUNCT
dpc-5333	415	16	wang	wang	PROPN
dpc-5333	415	17	g.	g.	PROPN
dpc-5333	415	18	impaired	impair	VERB
dpc-5333	415	19	function	function	NOUN
dpc-5333	415	20	of	of	ADP
dpc-5333	415	21	regulatory	regulatory	ADJ
dpc-5333	415	22	t	t	NOUN
dpc-5333	415	23	cells	cell	NOUN
dpc-5333	415	24	in	in	ADP
dpc-5333	415	25	patients	patient	NOUN
dpc-5333	415	26	with	with	ADP
dpc-5333	415	27	psoriasis	psoriasis	NOUN
dpc-5333	415	28	is	be	AUX
dpc-5333	415	29	mediated	mediate	VERB
dpc-5333	415	30	by	by	ADP
dpc-5333	415	31	phosphorylation	phosphorylation	NOUN
dpc-5333	415	32	of	of	ADP
dpc-5333	415	33	stat3	stat3	PROPN
dpc-5333	415	34	.	.	PUNCT
dpc-5333	416	1	journal	journal	PROPN
dpc-5333	416	2	of	of	ADP
dpc-5333	416	3	dermatological	dermatological	ADJ
dpc-5333	416	4	science	science	NOUN
dpc-5333	416	5	.	.	PUNCT
dpc-5333	417	1	2016;81(2):85–92	2016;81(2):85–92	X
dpc-5333	417	2	.	.	PUNCT
dpc-5333	417	3	doi:10.1016	doi:10.1016	PROPN
dpc-5333	417	4	/	/	SYM
dpc-5333	417	5	j.jdermsci.2015.11.007	j.jdermsci.2015.11.007	PROPN
dpc-5333	417	6	64	64	NUM
dpc-5333	417	7	.	.	PUNCT
dpc-5333	418	1	terras	terra	NOUN
dpc-5333	418	2	s	s	SYM
dpc-5333	418	3	,	,	PUNCT
dpc-5333	418	4	gambichler	gambichler	PROPN
dpc-5333	418	5	t	t	PROPN
dpc-5333	418	6	,	,	PUNCT
dpc-5333	418	7	moritz	moritz	PROPN
dpc-5333	418	8	rk	rk	PROPN
dpc-5333	418	9	,	,	PUNCT
dpc-5333	418	10	altmeyer	altmeyer	NOUN
dpc-5333	418	11	p	p	NOUN
dpc-5333	418	12	,	,	PUNCT
dpc-5333	418	13	lambert	lambert	PROPN
dpc-5333	418	14	j.	j.	PROPN
dpc-5333	418	15	immunohistochemical	immunohistochemical	ADJ
dpc-5333	418	16	analysis	analysis	NOUN
dpc-5333	418	17	of	of	ADP
dpc-5333	418	18	foxp	foxp	NOUN
dpc-5333	418	19	3	3	NUM
dpc-5333	418	20	+	+	NUM
dpc-5333	418	21	regulatory	regulatory	ADJ
dpc-5333	418	22	t	t	NOUN
dpc-5333	418	23	cells	cell	NOUN
dpc-5333	418	24	in	in	ADP
dpc-5333	418	25	healthy	healthy	ADJ
dpc-5333	418	26	human	human	ADJ
dpc-5333	418	27	skin	skin	NOUN
dpc-5333	418	28	and	and	CCONJ
dpc-5333	418	29	autoimmune	autoimmune	PROPN
dpc-5333	418	30	dermatoses	dermatosis	NOUN
dpc-5333	418	31	.	.	PUNCT
dpc-5333	419	1	international	international	ADJ
dpc-5333	419	2	journal	journal	PROPN
dpc-5333	419	3	of	of	ADP
dpc-5333	419	4	dermatology	dermatology	NOUN
dpc-5333	419	5	.	.	PUNCT
dpc-5333	420	1	2014;53(3):294–299	2014;53(3):294–299	NUM
dpc-5333	420	2	.	.	PUNCT
dpc-5333	421	1	doi:10.1111	doi:10.1111	PROPN
dpc-5333	421	2	/j.1365	/j.1365	PROPN
dpc-5333	421	3	-	-	PUNCT
dpc-5333	421	4	4632.2012.05808.x	4632.2012.05808.x	NUM
dpc-5333	421	5	65	65	NUM
dpc-5333	421	6	.	.	PUNCT
dpc-5333	422	1	soler	soler	PROPN
dpc-5333	422	2	dc	dc	PROPN
dpc-5333	422	3	,	,	PUNCT
dpc-5333	422	4	sugiyama	sugiyama	NOUN
dpc-5333	422	5	h	h	NOUN
dpc-5333	422	6	,	,	PUNCT
dpc-5333	422	7	young	young	PROPN
dpc-5333	422	8	ab	ab	PROPN
dpc-5333	422	9	,	,	PUNCT
dpc-5333	422	10	massari	massari	PROPN
dpc-5333	422	11	jv	jv	PROPN
dpc-5333	422	12	,	,	PUNCT
dpc-5333	422	13	mccormick	mccormick	PROPN
dpc-5333	422	14	ts	ts	PROPN
dpc-5333	422	15	,	,	PUNCT
dpc-5333	422	16	cooper	cooper	PROPN
dpc-5333	422	17	kd	kd	PROPN
dpc-5333	422	18	.	.	PUNCT
dpc-5333	423	1	psoriasis	psoriasis	NOUN
dpc-5333	423	2	patients	patient	NOUN
dpc-5333	423	3	exhibit	exhibit	VERB
dpc-5333	423	4	impairment	impairment	NOUN
dpc-5333	423	5	of	of	ADP
dpc-5333	423	6	the	the	DET
dpc-5333	423	7	high	high	ADJ
dpc-5333	423	8	potency	potency	NOUN
dpc-5333	423	9	ccr5	ccr5	NOUN
dpc-5333	423	10	+	+	CCONJ
dpc-5333	423	11	t	t	PROPN
dpc-5333	423	12	regulatory	regulatory	ADJ
dpc-5333	423	13	cell	cell	NOUN
dpc-5333	423	14	subset	subset	NOUN
dpc-5333	423	15	.	.	PUNCT
dpc-5333	424	1	clinical	clinical	ADJ
dpc-5333	424	2	immunology	immunology	NOUN
dpc-5333	424	3	.	.	PUNCT
dpc-5333	425	1	2013;149(1):111–118	2013;149(1):111–118	NUM
dpc-5333	425	2	.	.	PUNCT
dpc-5333	425	3	doi:10.1016	doi:10.1016	PROPN
dpc-5333	425	4	/	/	SYM
dpc-5333	425	5	j.clim.2013.06.007	j.clim.2013.06.007	PROPN
dpc-5333	425	6	66	66	NUM
dpc-5333	425	7	.	.	PUNCT
dpc-5333	426	1	zhang	zhang	PROPN
dpc-5333	426	2	k	k	PROPN
dpc-5333	426	3	,	,	PUNCT
dpc-5333	426	4	li	li	PROPN
dpc-5333	426	5	x	x	PROPN
dpc-5333	426	6	,	,	PUNCT
dpc-5333	426	7	yin	yin	PROPN
dpc-5333	426	8	g	g	PROPN
dpc-5333	426	9	,	,	PUNCT
dpc-5333	426	10	liu	liu	PROPN
dpc-5333	426	11	y	y	PROPN
dpc-5333	426	12	,	,	PUNCT
dpc-5333	426	13	niu	niu	PROPN
dpc-5333	426	14	x	x	PROPN
dpc-5333	426	15	,	,	PUNCT
dpc-5333	426	16	hou	hou	PROPN
dpc-5333	426	17	r.	r.	PROPN
dpc-5333	426	18	functional	functional	ADJ
dpc-5333	426	19	characterization	characterization	NOUN
dpc-5333	426	20	of	of	ADP
dpc-5333	426	21	cd4	cd4	PROPN
dpc-5333	426	22	+	+	PROPN
dpc-5333	426	23	cd25	cd25	PROPN
dpc-5333	426	24	+	+	SYM
dpc-5333	426	25	regulatory	regulatory	ADJ
dpc-5333	426	26	t	t	NOUN
dpc-5333	426	27	cells	cell	NOUN
dpc-5333	426	28	differentiated	differentiate	VERB
dpc-5333	426	29	in	in	ADP
dpc-5333	426	30	vitro	vitro	X
dpc-5333	426	31	from	from	ADP
dpc-5333	426	32	bone	bone	NOUN
dpc-5333	426	33	marrow	marrow	NOUN
dpc-5333	426	34	-	-	PUNCT
dpc-5333	426	35	derived	derive	VERB
dpc-5333	426	36	haematopoietic	haematopoietic	ADJ
dpc-5333	426	37	cells	cell	NOUN
dpc-5333	426	38	of	of	ADP
dpc-5333	426	39	psoriasis	psoriasis	NOUN
dpc-5333	426	40	patients	patient	NOUN
dpc-5333	426	41	with	with	ADP
dpc-5333	426	42	a	a	DET
dpc-5333	426	43	family	family	NOUN
dpc-5333	426	44	history	history	NOUN
dpc-5333	426	45	of	of	ADP
dpc-5333	426	46	the	the	DET
dpc-5333	426	47	disorder	disorder	NOUN
dpc-5333	426	48	.	.	PUNCT
dpc-5333	427	1	british	british	ADJ
dpc-5333	427	2	journal	journal	PROPN
dpc-5333	427	3	of	of	ADP
dpc-5333	427	4	dermatology	dermatology	NOUN
dpc-5333	427	5	.	.	PUNCT
dpc-5333	428	1	2008;158(2):298–305	2008;158(2):298–305	X
dpc-5333	428	2	.	.	PUNCT
dpc-5333	429	1	doi:10.1111	doi:10.1111	ADJ
dpc-5333	429	2	/	/	SYM
dpc-5333	429	3	j.1365	j.1365	NOUN
dpc-5333	429	4	-2133.2007.08359.x	-2133.2007.08359.x	PROPN
dpc-5333	429	5	67	67	NUM
dpc-5333	429	6	.	.	PUNCT
dpc-5333	430	1	eedy	eedy	PROPN
dpc-5333	430	2	d	d	PROPN
dpc-5333	430	3	,	,	PUNCT
dpc-5333	430	4	burrows	burrow	NOUN
dpc-5333	430	5	d	d	PROPN
dpc-5333	430	6	,	,	PUNCT
dpc-5333	430	7	bridges	bridges	PROPN
dpc-5333	430	8	j	j	PROPN
dpc-5333	430	9	,	,	PUNCT
dpc-5333	430	10	jones	jones	PROPN
dpc-5333	430	11	f.	f.	PROPN
dpc-5333	430	12	clearance	clearance	PROPN
dpc-5333	430	13	of	of	ADP
dpc-5333	430	14	severe	severe	ADJ
dpc-5333	430	15	psoriasis	psoriasis	NOUN
dpc-5333	430	16	after	after	ADP
dpc-5333	430	17	allogenic	allogenic	ADJ
dpc-5333	430	18	bone	bone	NOUN
dpc-5333	430	19	marrow	marrow	NOUN
dpc-5333	430	20	transplantation	transplantation	NOUN
dpc-5333	430	21	.	.	PUNCT
dpc-5333	431	1	bmj	bmj	PROPN
dpc-5333	431	2	:	:	PUNCT
dpc-5333	431	3	british	british	PROPN
dpc-5333	431	4	medical	medical	ADJ
dpc-5333	431	5	journal	journal	PROPN
dpc-5333	431	6	.	.	PUNCT
dpc-5333	432	1	1990;300(6729):908	1990;300(6729):908	NUM
dpc-5333	432	2	.	.	PUNCT
dpc-5333	432	3	doi:10.1136	doi:10.1136	NOUN
dpc-5333	432	4	/bmj.300.6729.908	/bmj.300.6729.908	PUNCT
dpc-5333	433	1	68	68	NUM
dpc-5333	433	2	.	.	PUNCT
dpc-5333	434	1	woods	wood	NOUN
dpc-5333	434	2	a	a	DET
dpc-5333	434	3	,	,	PUNCT
dpc-5333	434	4	mant	mant	ADJ
dpc-5333	434	5	m.	m.	NOUN
dpc-5333	434	6	amelioration	amelioration	NOUN
dpc-5333	434	7	of	of	ADP
dpc-5333	434	8	severe	severe	ADJ
dpc-5333	434	9	psoriasis	psoriasis	NOUN
dpc-5333	434	10	with	with	ADP
dpc-5333	434	11	psoriatic	psoriatic	ADJ
dpc-5333	434	12	arthritis	arthritis	NOUN
dpc-5333	434	13	for	for	ADP
dpc-5333	434	14	20	20	NUM
dpc-5333	434	15	years	year	NOUN
dpc-5333	434	16	after	after	ADP
dpc-5333	434	17	allogeneic	allogeneic	VERB
dpc-5333	434	18	haematopoietic	haematopoietic	ADJ
dpc-5333	434	19	stem	stem	NOUN
dpc-5333	434	20	cell	cell	NOUN
dpc-5333	434	21	transplantation	transplantation	NOUN
dpc-5333	434	22	.	.	PUNCT
dpc-5333	435	1	annals	annal	NOUN
dpc-5333	435	2	of	of	ADP
dpc-5333	435	3	the	the	DET
dpc-5333	435	4	rheumatic	rheumatic	ADJ
dpc-5333	435	5	diseases	disease	NOUN
dpc-5333	435	6	.	.	PUNCT
dpc-5333	436	1	2006;65(5):697–697	2006;65(5):697–697	X
dpc-5333	436	2	.	.	PUNCT
dpc-5333	436	3	doi:10.1136	doi:10.1136	NOUN
dpc-5333	436	4	/	/	SYM
dpc-5333	436	5	ard.2005.039479	ard.2005.039479	ADV
dpc-5333	436	6	69	69	NUM
dpc-5333	436	7	.	.	PUNCT
dpc-5333	437	1	masszi	masszi	PROPN
dpc-5333	437	2	t	t	PROPN
dpc-5333	437	3	,	,	PUNCT
dpc-5333	437	4	farkas	farkas	PROPN
dpc-5333	437	5	a	a	PRON
dpc-5333	437	6	,	,	PUNCT
dpc-5333	437	7	remenyi	remenyi	NOUN
dpc-5333	437	8	p	p	PROPN
dpc-5333	437	9	,	,	PUNCT
dpc-5333	437	10	et	et	PROPN
dpc-5333	437	11	al	al	PROPN
dpc-5333	437	12	.	.	PROPN
dpc-5333	437	13	ten	ten	NUM
dpc-5333	437	14	-	-	PUNCT
dpc-5333	437	15	year	year	NOUN
dpc-5333	437	16	remission	remission	NOUN
dpc-5333	437	17	of	of	ADP
dpc-5333	437	18	psoriasis	psoriasis	NOUN
dpc-5333	437	19	after	after	ADP
dpc-5333	437	20	allogeneic	allogeneic	ADJ
dpc-5333	437	21	but	but	CCONJ
dpc-5333	437	22	not	not	PART
dpc-5333	437	23	autologous	autologous	ADJ
dpc-5333	437	24	bone	bone	NOUN
dpc-5333	437	25	marrow	marrow	NOUN
dpc-5333	437	26	transplantation	transplantation	NOUN
dpc-5333	437	27	.	.	PUNCT
dpc-5333	438	1	dermatology	dermatology	NOUN
dpc-5333	438	2	.	.	PUNCT
dpc-5333	439	1	2006;212(1):88	2006;212(1):88	NUM
dpc-5333	439	2	.	.	PUNCT
dpc-5333	440	1	doi:10.1159/0000	doi:10.1159/0000	PROPN
dpc-5333	441	1	89032	89032	NUM
dpc-5333	441	2	70	70	NUM
dpc-5333	441	3	.	.	PUNCT
dpc-5333	442	1	kaffenberger	kaffenberger	PROPN
dpc-5333	442	2	bh	bh	PROPN
dpc-5333	442	3	,	,	PUNCT
dpc-5333	442	4	wong	wong	PROPN
dpc-5333	442	5	hk	hk	PROPN
dpc-5333	442	6	,	,	PUNCT
dpc-5333	442	7	jarjour	jarjour	PROPN
dpc-5333	442	8	w	w	PROPN
dpc-5333	442	9	,	,	PUNCT
dpc-5333	442	10	andritsos	andritsos	PROPN
dpc-5333	442	11	la	la	PROPN
dpc-5333	442	12	.	.	PUNCT
dpc-5333	442	13	remission	remission	NOUN
dpc-5333	442	14	of	of	ADP
dpc-5333	442	15	psoriasis	psoriasis	NOUN
dpc-5333	442	16	after	after	ADP
dpc-5333	442	17	allogeneic	allogeneic	ADJ
dpc-5333	442	18	,	,	PUNCT
dpc-5333	442	19	but	but	CCONJ
dpc-5333	442	20	not	not	PART
dpc-5333	442	21	autologous	autologous	ADJ
dpc-5333	442	22	,	,	PUNCT
dpc-5333	442	23	hematopoietic	hematopoietic	ADJ
dpc-5333	442	24	stem	stem	NOUN
dpc-5333	442	25	-	-	PUNCT
dpc-5333	442	26	cell	cell	NOUN
dpc-5333	442	27	transplantation	transplantation	NOUN
dpc-5333	442	28	.	.	PUNCT
dpc-5333	443	1	journal	journal	NOUN
dpc-5333	443	2	of	of	ADP
dpc-5333	443	3	the	the	DET
dpc-5333	443	4	american	american	PROPN
dpc-5333	443	5	academy	academy	PROPN
dpc-5333	443	6	of	of	ADP
dpc-5333	443	7	dermatology	dermatology	NOUN
dpc-5333	443	8	.	.	PUNCT
dpc-5333	444	1	2013;68(3):489–492	2013;68(3):489–492	NUM
dpc-5333	444	2	.	.	PUNCT
dpc-5333	444	3	doi:10.1016	doi:10.1016	PROPN
dpc-5333	444	4	/j.jaad.2012.08.021	/j.jaad.2012.08.021	PUNCT
dpc-5333	445	1	71	71	NUM
dpc-5333	445	2	.	.	PUNCT
dpc-5333	446	1	jowitt	jowitt	PROPN
dpc-5333	446	2	s	s	PROPN
dpc-5333	446	3	,	,	PUNCT
dpc-5333	446	4	yin	yin	PROPN
dpc-5333	446	5	j.	j.	PROPN
dpc-5333	446	6	psoriasis	psoriasis	PROPN
dpc-5333	446	7	and	and	CCONJ
dpc-5333	446	8	bone	bone	NOUN
dpc-5333	446	9	marrow	marrow	NOUN
dpc-5333	446	10	transplantation	transplantation	NOUN
dpc-5333	446	11	.	.	PUNCT
dpc-5333	447	1	bmj	bmj	PROPN
dpc-5333	447	2	:	:	PUNCT
dpc-5333	447	3	british	british	PROPN
dpc-5333	447	4	medical	medical	ADJ
dpc-5333	447	5	journal	journal	PROPN
dpc-5333	447	6	.	.	PUNCT
dpc-5333	448	1	1990;300(6736):1398	1990;300(6736):1398	NUM
dpc-5333	448	2	.	.	PUNCT
dpc-5333	449	1	doi:10.1136/	doi:10.1136/	PROPN
dpc-5333	449	2	bmj.300.6736.1398	bmj.300.6736.1398	PROPN
dpc-5333	449	3	-	-	PUNCT
dpc-5333	449	4	c	c	PROPN
dpc-5333	449	5	72	72	NUM
dpc-5333	449	6	.	.	PUNCT
dpc-5333	450	1	yin	yin	PROPN
dpc-5333	450	2	j	j	PROPN
dpc-5333	450	3	,	,	PUNCT
dpc-5333	450	4	jowitt	jowitt	PROPN
dpc-5333	450	5	s.	s.	PROPN
dpc-5333	450	6	resolution	resolution	PROPN
dpc-5333	450	7	of	of	ADP
dpc-5333	450	8	immune	immune	NOUN
dpc-5333	450	9	-	-	PUNCT
dpc-5333	450	10	mediated	mediate	VERB
dpc-5333	450	11	diseases	disease	NOUN
dpc-5333	450	12	following	follow	VERB
dpc-5333	450	13	allogeneic	allogeneic	ADJ
dpc-5333	450	14	bone	bone	NOUN
dpc-5333	450	15	marrow	marrow	NOUN
dpc-5333	450	16	transplantation	transplantation	NOUN
dpc-5333	450	17	for	for	ADP
dpc-5333	450	18	leukaemia	leukaemia	NOUN
dpc-5333	450	19	.	.	PUNCT
dpc-5333	451	1	bone	bone	NOUN
dpc-5333	451	2	marrow	marrow	NOUN
dpc-5333	451	3	transplantation	transplantation	NOUN
dpc-5333	451	4	.	.	PUNCT
dpc-5333	452	1	1992;9(1):31–33	1992;9(1):31–33	NUM
dpc-5333	452	2	.	.	PUNCT
dpc-5333	453	1	10	10	NUM
dpc-5333	453	2	review	review	NOUN
dpc-5333	453	3	|	|	ADV
dpc-5333	453	4	dermatol	dermatol	ADJ
dpc-5333	453	5	pract	pract	NOUN
dpc-5333	453	6	concept	concept	NOUN
dpc-5333	453	7	.	.	PUNCT
dpc-5333	454	1	2025;15(3):5333	2025;15(3):5333	NUM
dpc-5333	454	2	73	73	NUM
dpc-5333	454	3	.	.	PUNCT
dpc-5333	455	1	yokota	yokota	PROPN
dpc-5333	455	2	a	a	PRON
dpc-5333	455	3	,	,	PUNCT
dpc-5333	455	4	hukazawa	hukazawa	PROPN
dpc-5333	455	5	m	m	PROPN
dpc-5333	455	6	,	,	PUNCT
dpc-5333	455	7	nakaseko	nakaseko	PROPN
dpc-5333	455	8	c	c	NOUN
dpc-5333	455	9	,	,	PUNCT
dpc-5333	455	10	et	et	PROPN
dpc-5333	455	11	al	al	PROPN
dpc-5333	455	12	.	.	PUNCT
dpc-5333	455	13	resolution	resolution	NOUN
dpc-5333	455	14	of	of	ADP
dpc-5333	455	15	psoriasis	psoriasis	NOUN
dpc-5333	455	16	vulgaris	vulgaris	NOUN
dpc-5333	455	17	following	follow	VERB
dpc-5333	455	18	allogeneic	allogeneic	ADJ
dpc-5333	455	19	bone	bone	NOUN
dpc-5333	455	20	marrow	marrow	NOUN
dpc-5333	455	21	transplantation	transplantation	NOUN
dpc-5333	455	22	for	for	ADP
dpc-5333	455	23	aplastic	aplastic	ADJ
dpc-5333	455	24	anemia	anemia	NOUN
dpc-5333	455	25	.	.	PUNCT
dpc-5333	456	1	[	[	X
dpc-5333	456	2	rinsho	rinsho	PROPN
dpc-5333	456	3	ketsueki	ketsueki	PROPN
dpc-5333	456	4	]	]	PUNCT
dpc-5333	457	1	the	the	DET
dpc-5333	457	2	japanese	japanese	ADJ
dpc-5333	457	3	journal	journal	NOUN
dpc-5333	457	4	of	of	ADP
dpc-5333	457	5	clinical	clinical	ADJ
dpc-5333	457	6	hematology	hematology	NOUN
dpc-5333	457	7	.	.	PUNCT
dpc-5333	458	1	1996;37(1):35–39	1996;37(1):35–39	X
dpc-5333	458	2	.	.	PUNCT
dpc-5333	459	1	74	74	NUM
dpc-5333	459	2	.	.	PUNCT
dpc-5333	460	1	kishimoto	kishimoto	PROPN
dpc-5333	460	2	y	y	PROPN
dpc-5333	460	3	,	,	PUNCT
dpc-5333	460	4	yamamoto	yamamoto	PROPN
dpc-5333	460	5	y	y	PROPN
dpc-5333	460	6	,	,	PUNCT
dpc-5333	460	7	ito	ito	PROPN
dpc-5333	460	8	t	t	PROPN
dpc-5333	460	9	,	,	PUNCT
dpc-5333	460	10	et	et	PROPN
dpc-5333	460	11	al	al	PROPN
dpc-5333	460	12	.	.	PUNCT
dpc-5333	460	13	transfer	transfer	NOUN
dpc-5333	460	14	of	of	ADP
dpc-5333	460	15	autoimmune	autoimmune	ADJ
dpc-5333	460	16	thyroiditis	thyroiditis	NOUN
dpc-5333	460	17	and	and	CCONJ
dpc-5333	460	18	resolution	resolution	NOUN
dpc-5333	460	19	of	of	ADP
dpc-5333	460	20	palmoplantar	palmoplantar	NOUN
dpc-5333	460	21	pustular	pustular	ADJ
dpc-5333	460	22	psoriasis	psoriasis	NOUN
dpc-5333	460	23	following	follow	VERB
dpc-5333	460	24	allogeneic	allogeneic	ADJ
dpc-5333	460	25	bone	bone	NOUN
dpc-5333	460	26	marrow	marrow	NOUN
dpc-5333	460	27	transplantation	transplantation	NOUN
dpc-5333	460	28	.	.	PUNCT
dpc-5333	461	1	bone	bone	NOUN
dpc-5333	461	2	marrow	marrow	NOUN
dpc-5333	461	3	transplantation	transplantation	NOUN
dpc-5333	461	4	.	.	PUNCT
dpc-5333	462	1	1997;19(10):1041–1043	1997;19(10):1041–1043	NUM
dpc-5333	462	2	.	.	PUNCT
dpc-5333	462	3	doi:10.1038	doi:10.1038	NOUN
dpc-5333	462	4	/	/	SYM
dpc-5333	462	5	sj.bmt	sj.bmt	NOUN
dpc-5333	462	6	.1700789	.1700789	NOUN
dpc-5333	462	7	75	75	NUM
dpc-5333	462	8	.	.	PUNCT
dpc-5333	463	1	snowden	snowden	PROPN
dpc-5333	463	2	ja	ja	PROPN
dpc-5333	463	3	,	,	PUNCT
dpc-5333	463	4	kearney	kearney	PROPN
dpc-5333	463	5	p	p	PROPN
dpc-5333	463	6	,	,	PUNCT
dpc-5333	463	7	kearney	kearney	PROPN
dpc-5333	463	8	a	a	PROPN
dpc-5333	463	9	,	,	PUNCT
dpc-5333	463	10	et	et	PROPN
dpc-5333	463	11	al	al	PROPN
dpc-5333	463	12	.	.	PUNCT
dpc-5333	464	1	long	long	ADJ
dpc-5333	464	2	-	-	PUNCT
dpc-5333	464	3	term	term	NOUN
dpc-5333	464	4	outcome	outcome	NOUN
dpc-5333	464	5	of	of	ADP
dpc-5333	464	6	autoimmune	autoimmune	ADJ
dpc-5333	464	7	disease	disease	NOUN
dpc-5333	464	8	following	follow	VERB
dpc-5333	464	9	allogeneic	allogeneic	ADJ
dpc-5333	464	10	bone	bone	NOUN
dpc-5333	464	11	marrow	marrow	NOUN
dpc-5333	464	12	transplantation	transplantation	NOUN
dpc-5333	464	13	.	.	PUNCT
dpc-5333	465	1	arthritis	arthritis	NOUN
dpc-5333	465	2	&	&	CCONJ
dpc-5333	465	3	rheumatism	rheumatism	NOUN
dpc-5333	465	4	:	:	PUNCT
dpc-5333	465	5	official	official	ADJ
dpc-5333	465	6	journal	journal	NOUN
dpc-5333	465	7	of	of	ADP
dpc-5333	465	8	the	the	DET
dpc-5333	465	9	american	american	PROPN
dpc-5333	465	10	college	college	PROPN
dpc-5333	465	11	of	of	ADP
dpc-5333	465	12	rheumatology	rheumatology	NOUN
dpc-5333	465	13	.	.	PUNCT
dpc-5333	466	1	1998;41(3):453–459	1998;41(3):453–459	X
dpc-5333	466	2	.	.	PUNCT
dpc-5333	466	3	doi:10.1002/1529	doi:10.1002/1529	NOUN
dpc-5333	466	4	-	-	PUNCT
dpc-5333	466	5	0131(199803)41	0131(199803)41	NUM
dpc-5333	466	6	76	76	NUM
dpc-5333	466	7	.	.	PUNCT
dpc-5333	467	1	slavin	slavin	PROPN
dpc-5333	467	2	s	s	PROPN
dpc-5333	467	3	,	,	PUNCT
dpc-5333	467	4	nagler	nagler	X
dpc-5333	467	5	a	a	NOUN
dpc-5333	467	6	,	,	PUNCT
dpc-5333	467	7	varadi	varadi	NOUN
dpc-5333	467	8	g	g	NOUN
dpc-5333	467	9	,	,	PUNCT
dpc-5333	467	10	or	or	CCONJ
dpc-5333	467	11	r.	r.	PROPN
dpc-5333	467	12	graft	graft	NOUN
dpc-5333	467	13	vs	vs	ADP
dpc-5333	467	14	autoimmunity	autoimmunity	NOUN
dpc-5333	467	15	following	follow	VERB
dpc-5333	467	16	allogeneic	allogeneic	ADJ
dpc-5333	467	17	non	non	ADJ
dpc-5333	467	18	-	-	ADJ
dpc-5333	467	19	myeloablative	myeloablative	ADJ
dpc-5333	467	20	blood	blood	NOUN
dpc-5333	467	21	stem	stem	NOUN
dpc-5333	467	22	cell	cell	NOUN
dpc-5333	467	23	transplantation	transplantation	NOUN
dpc-5333	467	24	in	in	ADP
dpc-5333	467	25	a	a	DET
dpc-5333	467	26	patient	patient	NOUN
dpc-5333	467	27	with	with	ADP
dpc-5333	467	28	chronic	chronic	ADJ
dpc-5333	467	29	myelogenous	myelogenous	ADJ
dpc-5333	467	30	leukemia	leukemia	NOUN
dpc-5333	467	31	and	and	CCONJ
dpc-5333	467	32	severe	severe	ADJ
dpc-5333	467	33	systemic	systemic	ADJ
dpc-5333	467	34	psoriasis	psoriasis	NOUN
dpc-5333	467	35	and	and	CCONJ
dpc-5333	467	36	psoriatic	psoriatic	ADJ
dpc-5333	467	37	polyarthritis	polyarthritis	NOUN
dpc-5333	467	38	.	.	PUNCT
dpc-5333	468	1	experimental	experimental	ADJ
dpc-5333	468	2	hematology	hematology	NOUN
dpc-5333	468	3	.	.	PUNCT
dpc-5333	469	1	2000;28(7):853–857	2000;28(7):853–857	X
dpc-5333	469	2	.	.	PUNCT
dpc-5333	469	3	doi:10.1016	doi:10.1016	PROPN
dpc-5333	469	4	/s0301	/s0301	PROPN
dpc-5333	470	1	-	-	PUNCT
dpc-5333	470	2	472x(00)00172	472x(00)00172	NUM
dpc-5333	470	3	-	-	PUNCT
dpc-5333	470	4	7	7	NUM
dpc-5333	470	5	77	77	NUM
dpc-5333	470	6	.	.	PUNCT
dpc-5333	471	1	chakrabarti	chakrabarti	PROPN
dpc-5333	471	2	s	s	PART
dpc-5333	471	3	,	,	PUNCT
dpc-5333	471	4	handa	handa	PROPN
dpc-5333	471	5	sk	sk	PROPN
dpc-5333	471	6	,	,	PUNCT
dpc-5333	471	7	bryon	bryon	PROPN
dpc-5333	471	8	rj	rj	PROPN
dpc-5333	471	9	,	,	PUNCT
dpc-5333	471	10	griffiths	griffiths	PROPN
dpc-5333	471	11	mj	mj	PROPN
dpc-5333	471	12	,	,	PUNCT
dpc-5333	471	13	milligan	milligan	PROPN
dpc-5333	471	14	dw	dw	PROPN
dpc-5333	471	15	.	.	PROPN
dpc-5333	471	16	will	will	AUX
dpc-5333	471	17	mixed	mixed	VERB
dpc-5333	471	18	chimerism	chimerism	NOUN
dpc-5333	471	19	cure	cure	NOUN
dpc-5333	471	20	autoimmune	autoimmune	ADJ
dpc-5333	471	21	diseases	disease	NOUN
dpc-5333	471	22	after	after	ADP
dpc-5333	471	23	a	a	DET
dpc-5333	471	24	nonmyeloablative	nonmyeloablative	ADJ
dpc-5333	471	25	stem	stem	NOUN
dpc-5333	471	26	cell	cell	NOUN
dpc-5333	471	27	transplant	transplant	NOUN
dpc-5333	471	28	?	?	PUNCT
dpc-5333	472	1	transplantation	transplantation	NOUN
dpc-5333	472	2	.	.	PUNCT
dpc-5333	473	1	2001;72(2	2001;72(2	NUM
dpc-5333	473	2	):	):	PUNCT
dpc-5333	473	3	340–342	340–342	NUM
dpc-5333	473	4	.	.	PUNCT
dpc-5333	474	1	doi:10.1097/00007890	doi:10.1097/00007890	VERB
dpc-5333	474	2	-	-	PUNCT
dpc-5333	474	3	200107270	200107270	NUM
dpc-5333	474	4	-	-	SYM
dpc-5333	474	5	00032	00032	NUM
dpc-5333	474	6	78	78	NUM
dpc-5333	474	7	.	.	PUNCT
dpc-5333	475	1	kanamori	kanamori	PROPN
dpc-5333	475	2	h	h	PROPN
dpc-5333	475	3	,	,	PUNCT
dpc-5333	475	4	tanaka	tanaka	PROPN
dpc-5333	475	5	m	m	PROPN
dpc-5333	475	6	,	,	PUNCT
dpc-5333	475	7	kawaguchi	kawaguchi	PROPN
dpc-5333	475	8	h	h	PROPN
dpc-5333	475	9	,	,	PUNCT
dpc-5333	475	10	et	et	PROPN
dpc-5333	475	11	al	al	PROPN
dpc-5333	475	12	.	.	PUNCT
dpc-5333	476	1	resolution	resolution	NOUN
dpc-5333	476	2	of	of	ADP
dpc-5333	476	3	psoriasis	psoriasis	NOUN
dpc-5333	476	4	following	follow	VERB
dpc-5333	476	5	allogeneic	allogeneic	ADJ
dpc-5333	476	6	bone	bone	NOUN
dpc-5333	476	7	marrow	marrow	NOUN
dpc-5333	476	8	transplantation	transplantation	NOUN
dpc-5333	476	9	for	for	ADP
dpc-5333	476	10	chronic	chronic	ADJ
dpc-5333	476	11	myelogenous	myelogenous	ADJ
dpc-5333	476	12	leukemia	leukemia	NOUN
dpc-5333	476	13	:	:	PUNCT
dpc-5333	476	14	case	case	NOUN
dpc-5333	476	15	report	report	NOUN
dpc-5333	476	16	and	and	CCONJ
dpc-5333	476	17	review	review	NOUN
dpc-5333	476	18	of	of	ADP
dpc-5333	476	19	the	the	DET
dpc-5333	476	20	literature	literature	NOUN
dpc-5333	476	21	.	.	PUNCT
dpc-5333	477	1	american	american	PROPN
dpc-5333	477	2	journal	journal	PROPN
dpc-5333	477	3	of	of	ADP
dpc-5333	477	4	hematology	hematology	NOUN
dpc-5333	477	5	.	.	PUNCT
dpc-5333	478	1	2002;71(1):41–44	2002;71(1):41–44	X
dpc-5333	478	2	.	.	PUNCT
dpc-5333	478	3	doi:10.1002	doi:10.1002	NOUN
dpc-5333	478	4	/	/	SYM
dpc-5333	478	5	ajh.10169	ajh.10169	X
dpc-5333	478	6	79	79	NUM
dpc-5333	478	7	.	.	PUNCT
dpc-5333	479	1	kojima	kojima	PROPN
dpc-5333	479	2	r	r	PROPN
dpc-5333	479	3	,	,	PUNCT
dpc-5333	479	4	kami	kami	PROPN
dpc-5333	479	5	m	m	PROPN
dpc-5333	479	6	,	,	PUNCT
dpc-5333	479	7	kim	kim	PROPN
dpc-5333	479	8	s	s	PROPN
dpc-5333	479	9	,	,	PUNCT
dpc-5333	479	10	et	et	PROPN
dpc-5333	479	11	al	al	PROPN
dpc-5333	479	12	.	.	PROPN
dpc-5333	479	13	induction	induction	NOUN
dpc-5333	479	14	of	of	ADP
dpc-5333	479	15	graft	graft	NOUN
dpc-5333	479	16	-	-	PUNCT
dpc-5333	479	17	versus	versus	ADJ
dpc-5333	479	18	autoimmune	autoimmune	NOUN
dpc-5333	479	19	(	(	PUNCT
dpc-5333	479	20	gva	gva	ADJ
dpc-5333	479	21	)	)	PUNCT
dpc-5333	479	22	disease	disease	NOUN
dpc-5333	479	23	effect	effect	NOUN
dpc-5333	479	24	against	against	ADP
dpc-5333	479	25	refractory	refractory	NOUN
dpc-5333	479	26	psoriasis	psoriasis	NOUN
dpc-5333	479	27	by	by	ADP
dpc-5333	479	28	complete	complete	ADJ
dpc-5333	479	29	donor	donor	NOUN
dpc-5333	479	30	-	-	PUNCT
dpc-5333	479	31	type	type	NOUN
dpc-5333	479	32	chimerism	chimerism	NOUN
dpc-5333	479	33	and	and	CCONJ
dpc-5333	479	34	graft	graft	NOUN
dpc-5333	479	35	-	-	PUNCT
dpc-5333	479	36	versus	versus	ADP
dpc-5333	479	37	-	-	PUNCT
dpc-5333	479	38	host	host	NOUN
dpc-5333	479	39	disease	disease	NOUN
dpc-5333	479	40	after	after	ADP
dpc-5333	479	41	allogeneic	allogeneic	VERB
dpc-5333	479	42	hematopoietic	hematopoietic	ADJ
dpc-5333	479	43	stem	stem	NOUN
dpc-5333	479	44	cell	cell	NOUN
dpc-5333	479	45	transplantation	transplantation	NOUN
dpc-5333	479	46	.	.	PUNCT
dpc-5333	480	1	bone	bone	NOUN
dpc-5333	480	2	marrow	marrow	NOUN
dpc-5333	480	3	transplantation	transplantation	NOUN
dpc-5333	480	4	.	.	PUNCT
dpc-5333	481	1	2003;32(4):439–442	2003;32(4):439–442	NUM
dpc-5333	481	2	.	.	PUNCT
dpc-5333	481	3	doi:10.1038	doi:10.1038	NOUN
dpc-5333	481	4	/	/	SYM
dpc-5333	481	5	sj.bmt	sj.bmt	NOUN
dpc-5333	481	6	.	.	PUNCT
dpc-5333	481	7	1704146	1704146	NUM
dpc-5333	481	8	80	80	NUM
dpc-5333	481	9	.	.	PUNCT
dpc-5333	481	10	ciurea	ciurea	VERB
dpc-5333	481	11	so	so	ADV
dpc-5333	481	12	,	,	PUNCT
dpc-5333	481	13	hansrivijit	hansrivijit	ADJ
dpc-5333	481	14	p	p	X
dpc-5333	481	15	,	,	PUNCT
dpc-5333	481	16	ciurea	ciurea	AUX
dpc-5333	481	17	am	am	VERB
dpc-5333	481	18	,	,	PUNCT
dpc-5333	482	1	et	et	PROPN
dpc-5333	482	2	al	al	PROPN
dpc-5333	482	3	.	.	PROPN
dpc-5333	483	1	curative	curative	ADJ
dpc-5333	483	2	potential	potential	NOUN
dpc-5333	483	3	of	of	ADP
dpc-5333	483	4	hematopoietic	hematopoietic	ADJ
dpc-5333	483	5	stem	stem	NOUN
dpc-5333	483	6	cell	cell	NOUN
dpc-5333	483	7	transplantation	transplantation	NOUN
dpc-5333	483	8	for	for	ADP
dpc-5333	483	9	advanced	advanced	ADJ
dpc-5333	483	10	psoriasis	psoriasis	NOUN
dpc-5333	483	11	.	.	PUNCT
dpc-5333	484	1	american	american	ADJ
dpc-5333	484	2	journal	journal	PROPN
dpc-5333	484	3	of	of	ADP
dpc-5333	484	4	hematology	hematology	PROPN
dpc-5333	484	5	.	.	PUNCT
dpc-5333	485	1	2019;94(6):e176	2019;94(6):e176	NOUN
dpc-5333	485	2	–	–	PUNCT
dpc-5333	485	3	e180	e180	NUM
dpc-5333	485	4	.	.	PUNCT
dpc-5333	486	1	doi:10.1002	doi:10.1002	NOUN
dpc-5333	486	2	/	/	SYM
dpc-5333	486	3	ajh.25470	ajh.25470	NUM
dpc-5333	486	4	81	81	NUM
dpc-5333	486	5	.	.	PUNCT
dpc-5333	487	1	cooley	cooley	PROPN
dpc-5333	487	2	hm	hm	PROPN
dpc-5333	487	3	,	,	PUNCT
dpc-5333	487	4	snowden	snowden	PROPN
dpc-5333	487	5	ja	ja	PROPN
dpc-5333	487	6	,	,	PUNCT
dpc-5333	487	7	grigg	grigg	PROPN
dpc-5333	487	8	ap	ap	PROPN
dpc-5333	487	9	,	,	PUNCT
dpc-5333	487	10	wicks	wick	NOUN
dpc-5333	487	11	ip	ip	ADJ
dpc-5333	487	12	.	.	PUNCT
dpc-5333	487	13	outcome	outcome	NOUN
dpc-5333	487	14	of	of	ADP
dpc-5333	487	15	rheumatoid	rheumatoid	VERB
dpc-5333	487	16	arthritis	arthritis	NOUN
dpc-5333	487	17	and	and	CCONJ
dpc-5333	487	18	psoriasis	psoriasis	NOUN
dpc-5333	487	19	following	follow	VERB
dpc-5333	487	20	autologous	autologous	ADJ
dpc-5333	487	21	stem	stem	NOUN
dpc-5333	487	22	cell	cell	NOUN
dpc-5333	487	23	transplantation	transplantation	NOUN
dpc-5333	487	24	for	for	ADP
dpc-5333	487	25	hematologic	hematologic	ADJ
dpc-5333	487	26	malignancy	malignancy	NOUN
dpc-5333	487	27	.	.	PUNCT
dpc-5333	488	1	arthritis	arthritis	NOUN
dpc-5333	488	2	&	&	CCONJ
dpc-5333	488	3	rheumatism	rheumatism	NOUN
dpc-5333	488	4	:	:	PUNCT
dpc-5333	488	5	official	official	ADJ
dpc-5333	488	6	journal	journal	NOUN
dpc-5333	488	7	of	of	ADP
dpc-5333	488	8	the	the	DET
dpc-5333	488	9	american	american	PROPN
dpc-5333	488	10	college	college	PROPN
dpc-5333	488	11	of	of	ADP
dpc-5333	488	12	rheumatology	rheumatology	NOUN
dpc-5333	488	13	.	.	PUNCT
dpc-5333	489	1	1997;40(9):1712–1715	1997;40(9):1712–1715	NOUN
dpc-5333	489	2	.	.	PUNCT
dpc-5333	490	1	doi:10.1002	doi:10.1002	NOUN
dpc-5333	490	2	/	/	SYM
dpc-5333	490	3	art	art	NOUN
dpc-5333	490	4	.	.	PUNCT
dpc-5333	491	1	1780400923	1780400923	NUM
dpc-5333	491	2	82	82	NUM
dpc-5333	491	3	.	.	PUNCT
dpc-5333	492	1	mohren	mohren	PROPN
dpc-5333	492	2	m	m	PROPN
dpc-5333	492	3	,	,	PUNCT
dpc-5333	492	4	daikeler	daikeler	PROPN
dpc-5333	492	5	t	t	PROPN
dpc-5333	492	6	,	,	PUNCT
dpc-5333	492	7	benz	benz	PROPN
dpc-5333	492	8	d	d	PROPN
dpc-5333	492	9	,	,	PUNCT
dpc-5333	492	10	günaydin	günaydin	VERB
dpc-5333	492	11	i	i	PRON
dpc-5333	492	12	,	,	PUNCT
dpc-5333	492	13	kanz	kanz	PROPN
dpc-5333	492	14	l	l	PROPN
dpc-5333	492	15	,	,	PUNCT
dpc-5333	492	16	kötter	kötter	PRON
dpc-5333	492	17	i.	i.	PROPN
dpc-5333	492	18	myeloablative	myeloablative	PROPN
dpc-5333	492	19	immunosuppressive	immunosuppressive	ADJ
dpc-5333	492	20	treatment	treatment	NOUN
dpc-5333	492	21	with	with	ADP
dpc-5333	492	22	autologous	autologous	ADJ
dpc-5333	492	23	haematopoietic	haematopoietic	ADJ
dpc-5333	492	24	stem	stem	NOUN
dpc-5333	492	25	cell	cell	NOUN
dpc-5333	492	26	transplantation	transplantation	NOUN
dpc-5333	492	27	in	in	ADP
dpc-5333	492	28	a	a	DET
dpc-5333	492	29	patient	patient	NOUN
dpc-5333	492	30	with	with	ADP
dpc-5333	492	31	psoriatic	psoriatic	ADJ
dpc-5333	492	32	arthropathy	arthropathy	ADJ
dpc-5333	492	33	and	and	CCONJ
dpc-5333	492	34	monoclonal	monoclonal	NOUN
dpc-5333	492	35	gammopathy	gammopathy	ADJ
dpc-5333	492	36	of	of	ADP
dpc-5333	492	37	undetermined	undetermined	ADJ
dpc-5333	492	38	significance	significance	NOUN
dpc-5333	492	39	.	.	PUNCT
dpc-5333	493	1	annals	annal	NOUN
dpc-5333	493	2	of	of	ADP
dpc-5333	493	3	the	the	DET
dpc-5333	493	4	rheumatic	rheumatic	ADJ
dpc-5333	493	5	diseases	disease	NOUN
dpc-5333	493	6	.	.	PUNCT
dpc-5333	494	1	2004;63(4	2004;63(4	NUM
dpc-5333	494	2	):	):	PUNCT
dpc-5333	494	3	466–467	466–467	NUM
dpc-5333	494	4	.	.	PUNCT
dpc-5333	494	5	doi:10.1136	doi:10.1136	PROPN
dpc-5333	494	6	/	/	SYM
dpc-5333	494	7	ard.2003.010702	ard.2003.010702	PROPN
dpc-5333	494	8	83	83	NUM
dpc-5333	494	9	.	.	PUNCT
dpc-5333	495	1	braiteh	braiteh	PROPN
dpc-5333	495	2	f	f	PROPN
dpc-5333	495	3	,	,	PUNCT
dpc-5333	495	4	hymes	hymes	PROPN
dpc-5333	495	5	sr	sr	PROPN
dpc-5333	495	6	,	,	PUNCT
dpc-5333	495	7	giralt	giralt	PROPN
dpc-5333	495	8	sa	sa	PROPN
dpc-5333	495	9	,	,	PUNCT
dpc-5333	495	10	jones	jones	PROPN
dpc-5333	495	11	r.	r.	PROPN
dpc-5333	495	12	complete	complete	PROPN
dpc-5333	495	13	remission	remission	NOUN
dpc-5333	495	14	of	of	ADP
dpc-5333	495	15	psoriasis	psoriasis	NOUN
dpc-5333	495	16	after	after	ADP
dpc-5333	495	17	autologous	autologous	ADJ
dpc-5333	495	18	hematopoietic	hematopoietic	ADJ
dpc-5333	495	19	stem	stem	NOUN
dpc-5333	495	20	-	-	PUNCT
dpc-5333	495	21	cell	cell	NOUN
dpc-5333	495	22	transplantation	transplantation	NOUN
dpc-5333	495	23	for	for	ADP
dpc-5333	495	24	multiple	multiple	ADJ
dpc-5333	495	25	myeloma	myeloma	NOUN
dpc-5333	495	26	.	.	PUNCT
dpc-5333	496	1	journal	journal	PROPN
dpc-5333	496	2	of	of	ADP
dpc-5333	496	3	clinical	clinical	ADJ
dpc-5333	496	4	oncology	oncology	NOUN
dpc-5333	496	5	.	.	PUNCT
dpc-5333	497	1	2008;26(27):4511–4513	2008;26(27):4511–4513	NUM
dpc-5333	497	2	.	.	PUNCT
dpc-5333	498	1	doi:10.1200	doi:10.1200	PROPN
dpc-5333	498	2	/	/	SYM
dpc-5333	498	3	jco.2008.17.6560	jco.2008.17.6560	PROPN
dpc-5333	498	4	84	84	NUM
dpc-5333	498	5	.	.	PUNCT
dpc-5333	499	1	held	hold	VERB
dpc-5333	499	2	k	k	NOUN
dpc-5333	499	3	,	,	PUNCT
dpc-5333	499	4	rahmetulla	rahmetulla	PROPN
dpc-5333	499	5	r	r	PROPN
dpc-5333	499	6	,	,	PUNCT
dpc-5333	499	7	loew	loew	PROPN
dpc-5333	499	8	t	t	PROPN
dpc-5333	499	9	,	,	PUNCT
dpc-5333	499	10	radhi	radhi	PROPN
dpc-5333	499	11	m.	m.	NOUN
dpc-5333	499	12	complete	complete	ADJ
dpc-5333	499	13	resolution	resolution	NOUN
dpc-5333	499	14	of	of	ADP
dpc-5333	499	15	guttate	guttate	ADJ
dpc-5333	499	16	psoriasis	psoriasis	NOUN
dpc-5333	499	17	following	follow	VERB
dpc-5333	499	18	autologous	autologous	ADJ
dpc-5333	499	19	sct	sct	PROPN
dpc-5333	499	20	for	for	ADP
dpc-5333	499	21	ewing	ewing	PROPN
dpc-5333	499	22	’s	’s	PART
dpc-5333	499	23	sarcoma	sarcoma	NOUN
dpc-5333	499	24	in	in	ADP
dpc-5333	499	25	a	a	DET
dpc-5333	499	26	pediatric	pediatric	ADJ
dpc-5333	499	27	patient	patient	NOUN
dpc-5333	499	28	.	.	PUNCT
dpc-5333	500	1	bone	bone	NOUN
dpc-5333	500	2	marrow	marrow	NOUN
dpc-5333	500	3	transplantation	transplantation	NOUN
dpc-5333	500	4	.	.	PUNCT
dpc-5333	501	1	2012;47(12):1585–1586	2012;47(12):1585–1586	NUM
dpc-5333	501	2	.	.	PUNCT
dpc-5333	501	3	doi:10.1038	doi:10.1038	NOUN
dpc-5333	501	4	/	/	SYM
dpc-5333	501	5	bmt.2012.68	bmt.2012.68	PROPN
dpc-5333	501	6	85	85	NUM
dpc-5333	501	7	.	.	PUNCT
dpc-5333	502	1	sung	sung	PROPN
dpc-5333	502	2	sm	sm	PROPN
dpc-5333	502	3	,	,	PUNCT
dpc-5333	502	4	kimball	kimball	PROPN
dpc-5333	502	5	ab	ab	PROPN
dpc-5333	502	6	.	.	PROPN
dpc-5333	502	7	remission	remission	NOUN
dpc-5333	502	8	of	of	ADP
dpc-5333	502	9	psoriasis	psoriasis	NOUN
dpc-5333	502	10	13	13	NUM
dpc-5333	502	11	years	year	NOUN
dpc-5333	502	12	after	after	ADP
dpc-5333	502	13	autologous	autologous	ADJ
dpc-5333	502	14	stem	stem	NOUN
dpc-5333	502	15	cell	cell	NOUN
dpc-5333	502	16	transplant	transplant	NOUN
dpc-5333	502	17	.	.	PUNCT
dpc-5333	503	1	cutis	cutis	NOUN
dpc-5333	503	2	.	.	PUNCT
dpc-5333	504	1	2015;95(6):e7	2015;95(6):e7	NUM
dpc-5333	504	2	–	–	PUNCT
dpc-5333	504	3	e8	e8	PROPN
dpc-5333	504	4	.	.	PROPN
dpc-5333	504	5	86	86	NUM
dpc-5333	504	6	.	.	PUNCT
dpc-5333	505	1	azevedo	azevedo	PROPN
dpc-5333	505	2	a	a	PROPN
dpc-5333	505	3	,	,	PUNCT
dpc-5333	505	4	gonçalves	gonçalves	PROPN
dpc-5333	505	5	c	c	PROPN
dpc-5333	505	6	,	,	PUNCT
dpc-5333	505	7	selores	selores	PROPN
dpc-5333	505	8	m	m	PROPN
dpc-5333	505	9	,	,	PUNCT
dpc-5333	505	10	torres	torre	VERB
dpc-5333	505	11	t.	t.	NOUN
dpc-5333	505	12	remission	remission	NOUN
dpc-5333	505	13	of	of	ADP
dpc-5333	505	14	psoriasis	psoriasis	NOUN
dpc-5333	505	15	after	after	ADP
dpc-5333	505	16	autologous	autologous	ADJ
dpc-5333	505	17	stem	stem	NOUN
dpc-5333	505	18	cell	cell	NOUN
dpc-5333	505	19	transplantation	transplantation	NOUN
dpc-5333	505	20	-	-	PUNCT
dpc-5333	505	21	until	until	ADP
dpc-5333	505	22	when	when	SCONJ
dpc-5333	505	23	?	?	PUNCT
dpc-5333	506	1	european	european	ADJ
dpc-5333	506	2	journal	journal	PROPN
dpc-5333	506	3	of	of	ADP
dpc-5333	506	4	dermatology	dermatology	NOUN
dpc-5333	506	5	.	.	PUNCT
dpc-5333	507	1	2017;27(1):74–75	2017;27(1):74–75	X
dpc-5333	507	2	.	.	PUNCT
dpc-5333	507	3	doi:10.1684	doi:10.1684	PROPN
dpc-5333	507	4	/	/	SYM
dpc-5333	507	5	ejd	ejd	PROPN
dpc-5333	507	6	.2016.2893	.2016.2893	PROPN
dpc-5333	507	7	87	87	NUM
dpc-5333	507	8	.	.	PUNCT
dpc-5333	508	1	chen	chen	PROPN
dpc-5333	508	2	w	w	PROPN
dpc-5333	508	3	,	,	PUNCT
dpc-5333	508	4	ren	ren	PROPN
dpc-5333	508	5	g	g	NOUN
dpc-5333	508	6	,	,	PUNCT
dpc-5333	508	7	zuo	zuo	PROPN
dpc-5333	508	8	k	k	PROPN
dpc-5333	508	9	,	,	PUNCT
dpc-5333	508	10	huang	huang	PROPN
dpc-5333	508	11	x.	x.	PROPN
dpc-5333	508	12	complete	complete	PROPN
dpc-5333	508	13	remission	remission	NOUN
dpc-5333	508	14	of	of	ADP
dpc-5333	508	15	both	both	DET
dpc-5333	508	16	immunoglobulin	immunoglobulin	NOUN
dpc-5333	508	17	light	light	NOUN
dpc-5333	508	18	chain	chain	NOUN
dpc-5333	508	19	amyloidosis	amyloidosis	NOUN
dpc-5333	508	20	and	and	CCONJ
dpc-5333	508	21	psoriasis	psoriasis	NOUN
dpc-5333	508	22	after	after	ADP
dpc-5333	508	23	autologous	autologous	ADJ
dpc-5333	508	24	hematopoietic	hematopoietic	ADJ
dpc-5333	508	25	stem	stem	NOUN
dpc-5333	508	26	cell	cell	NOUN
dpc-5333	508	27	transplantation	transplantation	NOUN
dpc-5333	508	28	:	:	PUNCT
dpc-5333	508	29	a	a	DET
dpc-5333	508	30	case	case	NOUN
dpc-5333	508	31	report	report	NOUN
dpc-5333	508	32	.	.	PUNCT
dpc-5333	509	1	medicine	medicine	NOUN
dpc-5333	509	2	.	.	PUNCT
dpc-5333	510	1	2018;97(50):e13589	2018;97(50):e13589	NOUN
dpc-5333	510	2	.	.	PUNCT
dpc-5333	511	1	doi:10.1097	doi:10.1097	NOUN
dpc-5333	511	2	/	/	SYM
dpc-5333	512	1	md.0000000	md.0000000	PROPN
dpc-5333	512	2	000013589	000013589	NUM
dpc-5333	512	3	88	88	NUM
dpc-5333	512	4	.	.	PUNCT
dpc-5333	513	1	chen	chen	PROPN
dpc-5333	513	2	h	h	PROPN
dpc-5333	513	3	,	,	PUNCT
dpc-5333	513	4	niu	niu	PROPN
dpc-5333	513	5	j	j	PROPN
dpc-5333	513	6	-	-	PUNCT
dpc-5333	513	7	w	w	PROPN
dpc-5333	513	8	,	,	PUNCT
dpc-5333	513	9	ning	ning	ADJ
dpc-5333	513	10	h	h	PROPN
dpc-5333	513	11	-	-	PUNCT
dpc-5333	513	12	m	m	PROPN
dpc-5333	513	13	,	,	PUNCT
dpc-5333	513	14	et	et	PROPN
dpc-5333	513	15	al	al	PROPN
dpc-5333	513	16	.	.	PUNCT
dpc-5333	513	17	treatment	treatment	NOUN
dpc-5333	513	18	of	of	ADP
dpc-5333	513	19	psoriasis	psoriasis	NOUN
dpc-5333	513	20	with	with	ADP
dpc-5333	513	21	mesenchymal	mesenchymal	ADJ
dpc-5333	513	22	stem	stem	NOUN
dpc-5333	513	23	cells	cell	NOUN
dpc-5333	513	24	.	.	PUNCT
dpc-5333	514	1	the	the	DET
dpc-5333	514	2	american	american	PROPN
dpc-5333	514	3	journal	journal	PROPN
dpc-5333	514	4	of	of	ADP
dpc-5333	514	5	medicine	medicine	NOUN
dpc-5333	514	6	.	.	PUNCT
dpc-5333	515	1	2016;129(3):e13	2016;129(3):e13	PROPN
dpc-5333	515	2	–	–	PUNCT
dpc-5333	515	3	e14	e14	X
dpc-5333	515	4	.	.	PUNCT
dpc-5333	515	5	doi:10.1016	doi:10.1016	PROPN
dpc-5333	515	6	/	/	SYM
dpc-5333	515	7	j.amjmed.2015.11.001	j.amjmed.2015.11.001	PROPN
dpc-5333	515	8	89	89	NUM
dpc-5333	515	9	.	.	PUNCT
dpc-5333	516	1	de	de	PROPN
dpc-5333	516	2	jesus	jesus	PROPN
dpc-5333	516	3	mm	mm	PROPN
dpc-5333	516	4	,	,	PUNCT
dpc-5333	516	5	santiago	santiago	PROPN
dpc-5333	516	6	js	js	PROPN
dpc-5333	516	7	,	,	PUNCT
dpc-5333	516	8	trinidad	trinidad	PROPN
dpc-5333	516	9	cv	cv	PROPN
dpc-5333	516	10	,	,	PUNCT
dpc-5333	516	11	et	et	PROPN
dpc-5333	516	12	al	al	PROPN
dpc-5333	516	13	.	.	PUNCT
dpc-5333	517	1	autologous	autologous	ADJ
dpc-5333	517	2	adipose	adipose	NOUN
dpc-5333	517	3	-	-	PUNCT
dpc-5333	517	4	derived	derive	VERB
dpc-5333	517	5	mesenchymal	mesenchymal	ADJ
dpc-5333	517	6	stromal	stromal	ADJ
dpc-5333	517	7	cells	cell	NOUN
dpc-5333	517	8	for	for	ADP
dpc-5333	517	9	the	the	DET
dpc-5333	517	10	treatment	treatment	NOUN
dpc-5333	517	11	of	of	ADP
dpc-5333	517	12	psoriasis	psoriasis	NOUN
dpc-5333	517	13	vulgaris	vulgaris	NOUN
dpc-5333	517	14	and	and	CCONJ
dpc-5333	517	15	psoriatic	psoriatic	ADJ
dpc-5333	517	16	arthritis	arthritis	NOUN
dpc-5333	517	17	:	:	PUNCT
dpc-5333	517	18	a	a	DET
dpc-5333	517	19	case	case	NOUN
dpc-5333	517	20	report	report	NOUN
dpc-5333	517	21	.	.	PUNCT
dpc-5333	518	1	cell	cell	NOUN
dpc-5333	518	2	transplantation	transplantation	NOUN
dpc-5333	518	3	.	.	PUNCT
dpc-5333	519	1	2016;25(11):2063–2069	2016;25(11):2063–2069	X
dpc-5333	519	2	.	.	PUNCT
dpc-5333	519	3	doi:10.3727/096368916	doi:10.3727/096368916	X
dpc-5333	520	1	x691998	x691998	PROPN
dpc-5333	520	2	90	90	NUM
dpc-5333	520	3	.	.	PUNCT
dpc-5333	521	1	wang	wang	PROPN
dpc-5333	521	2	sg	sg	PROPN
dpc-5333	521	3	,	,	PUNCT
dpc-5333	521	4	hsu	hsu	PROPN
dpc-5333	521	5	nc	nc	PROPN
dpc-5333	521	6	,	,	PUNCT
dpc-5333	521	7	wang	wang	PROPN
dpc-5333	521	8	sm	sm	PROPN
dpc-5333	521	9	,	,	PUNCT
dpc-5333	521	10	wang	wang	PROPN
dpc-5333	521	11	fn	fn	PROPN
dpc-5333	521	12	.	.	PUNCT
dpc-5333	522	1	successful	successful	ADJ
dpc-5333	522	2	treatment	treatment	NOUN
dpc-5333	522	3	of	of	ADP
dpc-5333	522	4	plaque	plaque	NOUN
dpc-5333	522	5	psoriasis	psoriasis	NOUN
dpc-5333	522	6	with	with	ADP
dpc-5333	522	7	allogeneic	allogeneic	ADJ
dpc-5333	522	8	gingival	gingival	NOUN
dpc-5333	522	9	mesenchymal	mesenchymal	NOUN
dpc-5333	522	10	stem	stem	NOUN
dpc-5333	522	11	cells	cell	NOUN
dpc-5333	522	12	:	:	PUNCT
dpc-5333	522	13	a	a	DET
dpc-5333	522	14	case	case	NOUN
dpc-5333	522	15	study	study	NOUN
dpc-5333	522	16	.	.	PUNCT
dpc-5333	523	1	case	case	NOUN
dpc-5333	523	2	reports	report	VERB
dpc-5333	523	3	in	in	ADP
dpc-5333	523	4	dermatological	dermatological	ADJ
dpc-5333	523	5	medicine	medicine	NOUN
dpc-5333	523	6	.	.	PUNCT
dpc-5333	524	1	2020;202	2020;202	PROPN
dpc-5333	524	2	0doi:10.1155/2020/4617520	0doi:10.1155/2020/4617520	PROPN
dpc-5333	525	1	91	91	NUM
dpc-5333	525	2	.	.	PUNCT
dpc-5333	526	1	chen	chen	PROPN
dpc-5333	526	2	m	m	PROPN
dpc-5333	526	3	,	,	PUNCT
dpc-5333	526	4	peng	peng	PROPN
dpc-5333	526	5	j	j	PROPN
dpc-5333	526	6	,	,	PUNCT
dpc-5333	526	7	xie	xie	PROPN
dpc-5333	526	8	q	q	AUX
dpc-5333	526	9	,	,	PUNCT
dpc-5333	526	10	et	et	PROPN
dpc-5333	526	11	al	al	PROPN
dpc-5333	526	12	.	.	PUNCT
dpc-5333	526	13	mesenchymal	mesenchymal	ADJ
dpc-5333	526	14	stem	stem	NOUN
dpc-5333	526	15	cells	cell	NOUN
dpc-5333	526	16	alleviate	alleviate	VERB
dpc-5333	526	17	moderate	moderate	ADJ
dpc-5333	526	18	-	-	PUNCT
dpc-5333	526	19	to	to	ADP
dpc-5333	526	20	-	-	PUNCT
dpc-5333	526	21	severe	severe	ADJ
dpc-5333	526	22	psoriasis	psoriasis	NOUN
dpc-5333	526	23	by	by	ADP
dpc-5333	526	24	reducing	reduce	VERB
dpc-5333	526	25	the	the	DET
dpc-5333	526	26	production	production	NOUN
dpc-5333	526	27	of	of	ADP
dpc-5333	526	28	type	type	NOUN
dpc-5333	526	29	i	i	PRON
dpc-5333	526	30	interferon	interferon	ADJ
dpc-5333	526	31	(	(	PUNCT
dpc-5333	526	32	ifn	ifn	PROPN
dpc-5333	526	33	-	-	PUNCT
dpc-5333	526	34	i	i	NOUN
dpc-5333	526	35	)	)	PUNCT
dpc-5333	526	36	by	by	ADP
dpc-5333	526	37	plasmacytoid	plasmacytoid	NOUN
dpc-5333	526	38	dendritic	dendritic	ADJ
dpc-5333	526	39	cells	cell	NOUN
dpc-5333	526	40	(	(	PUNCT
dpc-5333	526	41	pdcs	pdcs	PROPN
dpc-5333	526	42	)	)	PUNCT
dpc-5333	526	43	.	.	PUNCT
dpc-5333	527	1	stem	stem	NOUN
dpc-5333	527	2	cells	cell	NOUN
dpc-5333	527	3	international	international	ADJ
dpc-5333	527	4	.	.	PUNCT
dpc-5333	528	1	2019;2019doi:10.1155/2019/6961052	2019;2019doi:10.1155/2019/6961052	NUM